Einstellungen in der Druckvorschau Ihres Browsers an.
| Für einen individuellen Ausdruck passen Sie bitte die Einstellungen in der Druckvorschau Ihres Browsers an. | |
VO (EG) 1272/2008, Anhang VI, Teil 3
Tabelle 3 Die Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe ist in einem eigenen Band IIIa enthalten. 17 Tabelle 3.1 Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe 12 17
gültig bis zum 30.11.2019
=> zur ab dem 01.12.2019 gültigen Fassung
| Index-Nr. | Internationale chemische Bezeichnung | EG-Nr. | CAS-Nr. | Einstufung | Kennzeichnung | Spez. Konzentra-tionsgrenzen, M-Fakt. | Anm. | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Kodierung der Gefahrenklassen und -kategorien | Kodierung der Gef.- hinweise |
Piktogr., Kodierung der Signalw. | Kodierung der Gef.- hinweise |
Kodierung der erg. Gef.- merkm. | ||||||
| 001-001-00-9 | hydrogen | 215-605-7 | 1333-74-0 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 001-002-00-4 | aluminium lithium hydride | 240-877-9 | 16853-85-3 | Water-react. 1 Skin Corr. 1A | H260 H314 | GHS02 GHS05 Gef. | H260 H314 | |||
| 001-003-00-X | sodium hydride | 231-587-3 | 7646-69-7 | Water-react. 1 | H260 | GHS02 Gef. | H260 | |||
| 001-004-00-5 | calcium hydride | 232-189-2 | 7789-78-8 | Water-react. 1 | H260 | GHS02 Gef. | H260 | |||
| 003-001-00-4 | lithium | 231-102-5 | 7439-93-2 | Water-react. 1 Skin Corr. 1B | H260 H314 | GHS02 GHS05 Gef. | H260 H314 | EUH014 | ||
| 003-002-00-X | n-hexyllithium | 404-950-0 | 21369-64-2 | Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A | H260 H250 H314 | GHS02 GHS05 Gef. | H260 H250 H314 | EUH014 | ||
| 003-003-00-5 | (2-methylpropyl)lithium; isobutyllithium | 440-620-2 | 920-36-5 | Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H260 H250 H314 H336 H400 H410 | GHS02 GHS05 GHS07 GHS09 Gef. | H260 H250 H314 H336 H410 | EUH014 | ||
| 004-001-00-7 | beryllium | 231-150-7 | 7440-41-7 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H350i H330 H301 H372 ** H319 H335 H315 H317 | GHS06 GHS08 Gef. | H350i H330 H301 H372 ** H319 H335 H315 H317 | |||
| 004-002-00-2 | beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex | - | - | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H350i H330 H301 H372 ** H319 H335 H315 H317 H411 | GHS06 GHS08 GHS09 Gef. | H350i H330 H301 H372 ** H319 H335 H315 H317 H411 | A | ||
| 004-003-00-8 | beryllium oxide | 215-133-1 | 1304-56-9 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H350i H330 H301 H372 ** H319 H335 H315 H317 | GHS06 GHS08 Gef. | H350i H330 H301 H372 ** H319 H335 H315 H317 | |||
| 005-001-00-X | boron trifluoride | 231-569-5 | 7637-07-2 | Press.
Gas Acute Tox. 2 * Skin Corr. 1A | H330 H314 | GHS04 GHS06 GHS05 Gef. | H330 H314 | EUH014 | U | |
| 005-002-00-5 | boron trichloride | 233-658-4 | 10294-34-5 | Press.
Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B | H330 H300 H314 | GHS04 GHS06 GHS05 Gef. | H330 H300 H314 | EUH014 | U | |
| 005-003-00-0 | boron tribromide | 233-657-9 | 10294-33-4 | Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A | H330 H300 H314 | GHS06 GHS05 Gef. | H330 H300 H314 | EUH014 | ||
| 005-004-00-6 | trialkylboranes, solid | - | - | Pyr. Sol. 1 Skin Corr. 1B | H250 H314 | GHS02 GHS05 Gef. | H250 H314 | A | ||
| 005-004-01-3 | trialkylboranes, liquid | - | - | Pyr. Liq. 1 Skin Corr. 1B | H250 H314 | GHS02 GHS05 Gef. | H250 H314 | A | ||
| 005-005-00-1 | trimethyl borate | 204-468-9 | 121-43-7 | Flam. Liq. 3 Acute Tox. 4 * | H226 H312 | GHS02 GHS07 Gef. | H226 H312 | |||
| 005-006-00-7 | dibutyltin hydrogen borate | 401-040-5 | 75113-37-0 | Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H360FD H341 H372** H312 H302 H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H360FD H341 H372** H312 H302 H318 H317 H410 | |||
| 005-007-00-2 | boric acid; [1] boric acid; [2] | 233-139-2 [1] 234-343-4 [2] | 10043-35-3 [1] 11113-50-1 [2] | Repr. 1B | H360FD | GHS08 Gef. | H360FD | Repr. 1B; H360FD: C ≥ 5,5 % | ||
| 005-008-00-8 | diboron trioxide; boric oxide | 215-125-8 | 1303-86-2 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | Repr. 1B; H360FD: C ≥ 3,1 % | ||
| 005-009-00-3 | tetrabutylammonium butyltriphenylborate | 418-080-4 | 120307-06-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 005-010-00-9 | N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate | 422-050-6 | 118612-00-3 | Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 | H351 H302 H315 H318 | GHS08 GHS05 GHS07 Gef. | H351 H302 H315 H318 | |||
| 005-011-00-4 | disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3] | 215-540-4 [1] 235-541-3 [2] 237-560-2 [3] | 1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] | Repr. 1B | H360FD | GHS08 Gef. | H360FD | Repr. 1B; H360FD: C ≥ 4,5 % | ||
| 005-011-01-1 | disodium tetraborate decahydrate; borax decahydrate | 215-540-4 | 1303-96-4 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | Repr. 1B; H360FD: C ≥ 8,5 % | ||
| 005-011-02-9 | disodium tetraborate pentahydrate; borax pentahydrate | 215-540-4 | 12179-04-3 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | Repr. 1B; H360FD: C ≥ 6,5 % | ||
| 005-012-00-X | diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate | 418-070-1 | 141714-54-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 005-013-00-5 | diethylmethoxyborane | 425-380-9 | 7397-46-8 | Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 | H250 H332 H312 H302 H373** H314 H317 H413 | GHS02 GHS05 GHS08 GHS07 Gef. | H250 H332 H312 H302 H373** H314 H317 H413 | |||
| 005-014-00-0 | 4-formylphenylboronic acid | 438-670-5 | 87199-17-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 005-015-00-6 | 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 414-380-4 | 140681-55-6 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H318 H317 H412 | |||
| 005-016-00-1 | tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate | 431-370-5 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 005-017-00-7 | sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] 231-556-4 [2] | 15120-21-5 [1] 7632-04-4 [2] | Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H272 H360Df H302 H335 H318 | GHS03 GHS05 GHS08 GHS07 Gef. | H272 H360Df H302 H335 H318 | Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | ||
| 005-017-01-4 | sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] 231-556-4 [2] | 15120-21-5 [1] 7632-04-4 [2] | Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H272 H360Df H331 H302 H335 H318 | GHS03 GHS06 GHS05 GHS08 Gef. | H272 H360Df H331 H302 H335 H318 | Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | ||
| 005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] | 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] | Repr. 1B STOT SE 3 Eye Dam. 1 | H360Df H335 H318 | GHS05 GHS08 GHS07 Gef. | H360Df H335 H318 | Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % | ||
| 005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] | 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] | Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H360Df H332 H335 H318 | GHS05 GHS08 GHS07 Gef. | H360Df H332 H335 H318 | Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % | ||
| 005-019-00-8 | perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] | 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] | Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H272 H360Df H302 H335 H318 | GHS03 GHS05 GHS08 GHS07 Gef. | H272 H360Df H302 H335 H318 | Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | ||
| 005-019-01-5 | perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate [3] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] | 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] | Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H272 H360Df H331 H302 H335 H318 | GHS03 GHS06 GHS05 GHS08 Gef. | H272 H360Df H331 H302 H335 H318 | Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | ||
| 005-020-00-3 | Dinatriumoctaborat wasserfrei; [1] Dinatriumoctaborat Tetrahydrat [2] | 234-541-0 [1] 234-541-0 [2] | 12008-41-2 [1] 12280-03-4 [2] | Repr. 1B | H360FD | GHS08 Gef. | H360FD | |||
| 006-001-00-2 | carbon monoxide | 211-128-3 | 630-08-0 | Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 * STOT RE 1 | H220 H360D *** H331 H372 ** | GHS02 GHS04 GHS06 GHS08 Gef. | H220 H360D *** H331 H372 ** | U | ||
| 006-002-00-8 | phosgene; carbonyl chloride | 200-870-3 | 75-44-5 | Press.
Gas Acute Tox. 2 * Skin Corr. 1B | H330 H314 | GHS04 GHS06 GHS05 Gef. | H330 H314 | U | ||
| 006-003-00-3 | carbon disulphide | 200-843-6 | 75-15-0 | Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 | H225 H361fd H372 ** H319 H315 | GHS02 GHS08 GHS07 Gef. | H225 H361fd H372 ** H319 H315 | Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0.2 % ≤C < 1 % | ||
| 006-004-00-9 | calcium carbide | 200-848-3 | 75-20-7 | Water-react. 1 | H260 | GHS02 Gef. | H260 | T | ||
| 006-005-00-4 | thiram (ISO); tetramethylthiuram disulphide | 205-286-2 | 137-26-8 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H373 ** H319 H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H332 H302 H373 ** H319 H315 H317 H410 | M=10 | ||
| 006-006-00-X | hydrogen cyanide; hydrocyanic acid | 200-821-6 | 74-90-8 | Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H224 H330 H400 H410 | GHS02 GHS06 GHS09 Gef. | H224 H330 H410 | |||
| 006-006-01-7 | hydrogen cyanide
%; hydrocyanic acid % | 200-821-6 | 74-90-8 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | B | ||
| 006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | EUH032 | A | |
| 006-008-00-0 | antu (ISO); 1-(1-naphthyl)-2-thiourea | 201-706-3 | 86-88-4 | Acute Tox. 2 * Carc. 2 | H300 H351 | GHS06 GHS08 Gef. | H300 H351 | |||
| 006-009-00-6 | 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; isolan | 204-318-2 | 119-38-0 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 006-010-00-1 | 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan | 204-525-8 | 122-15-6 | Acute Tox. 3 * | H301 | GHS06 Gef. | H301 | |||
| 006-011-00-7 | carbaryl (ISO); 1-naphthyl methylcarbamate | 200-555-0 | 63-25-2 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H351 H332 H302 H400 | GHS08 GHS07 GHS09 Achtg. | H351 H332 H302 H400 | M=100 | ||
| 006-012-00-2 | ziram (ISO); zinc bis dimethyldithiocarbamate | 205-288-3 | 137-30-4 | Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H302 H373 ** H335 H318 H317 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H330 H302 H373 ** H335 H318 H317 H410 | M=100 | ||
| 006-013-00-8 | metam-sodium (ISO); sodium methyldithiocarbamate | 205-293-0 | 137-42-8 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H317 H410 | EUH031 | ||
| 006-014-00-3 | nabam (ISO); disodium ethylenebis(N, N'-dithiocarbamate) | 205-547-0 | 142-59-6 | Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H335 H317 H410 | GHS07 GHS09 Gef. | H302 H335 H317 H410 | |||
| 006-015-00-9 | diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea | 206-354-4 | 330-54-1 | Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H373** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H373** H410 | M = 10 | ||
| 006-016-00-4 | propoxur (ISO); 2-isopropyloxyphenyl N-methylcarbamate; 2-isopropoxyphenyl methylcarbamate | 204-043-8 | 114-26-1 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 006-017-00-X | aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime | 204-123-2 | 116-06-3 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H311 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H311 H410 | |||
| 006-018-00-5 | aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate | 217-990-7 | 2032-59-9 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | |||
| 006-019-00-0 | di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate | 218-961-1 | 2303-16-4 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H410 | |||
| 006-020-00-6 | barban (ISO); 4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate | 202-930-4 | 101-27-9 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 006-021-00-1 | linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea | 206-356-5 | 330-55-2 | Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H351 H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Gef. | H360Df H351 H302 H373 ** H410 | |||
| 006-022-00-7 | decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate | - | 1563-67-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 006-023-00-2 | mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate | 217-991-2 | 2032-65-7 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 006-024-00-8 | proxan-sodium (ISO); sodium O-isopropyldithiocarbonate | 205-443-5 | 140-93-2 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 | H302 H315 H411 | GHS07 GHS09 Achtg. | H302 H315 H411 | |||
| 006-025-00-3 | allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1] S-bioallethrin; (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] | 209-542-4 [1] 249-013-5 [2] - [3] | 584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H410 | C | ||
| 006-026-00-9 | carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate | 216-353-0 | 1563-66-2 | Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H410 | |||
| 006-028-00-X | dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate | 213-546-1 | 973-21-7 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 006-029-00-5 | dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate | 230-253-4 | 6988-21-2 | Acute Tox. 3 * Aquatic Chronic 2 | H301 H411 | GHS06 GHS09 Gef. | H301 H411 | |||
| 006-030-00-0 | EPTC (ISO); S-ethyl dipropylthiocarbamate | 212-073-8 | 759-94-4 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-031-00-6 | formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate | 244-879-0 | 22259-30-9 | Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H317 H410 | |||
| 006-032-00-1 | monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea | 217-129-5 | 1746-81-2 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H410 | |||
| 006-033-00-7 | metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea | 243-433-2 | 19937-59-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 006-034-00-2 | pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate | 214-215-4 | 1114-71-2 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 006-035-00-8 | Pirimicarb (ISO); 2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat | 245-430-1 | 23103-98-2 | Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H331 H301 H317 H400 H410 | GHS08 GHS06 GHS09 Gef. | H351 H331 H301 H317 H410 | M = 10 M = 100 | ||
| 006-036-00-3 | benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea | 217-685-9 | 1929-88-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-037-00-9 | promecarb (ISO); 3-isopropyl-5-methylphenyl N-methylcarbamate | 220-113-0 | 2631-37-0 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 006-038-00-4 | sulfallate (ISO); 2-chloroallyl N,N-dimethyldithiocarbamate | 202-388-9 | 95-06-7 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | |||
| 006-039-00-X | tri-allate (ISO); S - 2,3,3-trichloroallyl diisopropylthiocarbamate | 218-962-7 | 2303-17-5 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H317 H410 | |||
| 006-040-00-5 | 3-methylpyrazol-5-yl-dimethylcarbamate; monometilan | - | 2532-43-6 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 006-041-00-0 | dimethylcarbamoyl chloride | 201-208-6 | 79-44-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H350 H331 H302 H319 H335 H315 | GHS06 GHS08 Gef. | H350 H331 H302 H319 H335 H315 | Carc. 1B; H350: C ≥ 0,001 % | ||
| 006-042-00-6 | monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea | 205-766-1 | 150-68-5 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H410 | |||
| 006-043-00-1 | 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA | - | 140-41-0 | Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H319 H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H319 H315 H410 | |||
| 006-044-00-7 | isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea | 251-835-4 | 34123-59-6 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | M=10 | ||
| 006-045-00-2 | methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate | 240-815-0 | 16752-77-5 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H400 H410 | GHS06 GHS09 Gef. | H300 H410 | M=100 | ||
| 006-046-00-8 | Bendiocarb (ISO); 2,2-Dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamat; 2,2-Dimethyl-1,3-benzodioxol-4-yl-methylcarbamat | 245-216-8 | 22781-23-3 | Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H300 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H300 H410 | M = 10 M = 100 | ||
| 006-047-00-3 | bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate | - | 8065-36-9 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | |||
| 006-048-00-9 | ethiofencarb (ISO); 2-(ethylthiomethyl)phenyl N-methylcarbamate | 249-981-9 | 29973-13-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 006-049-00-4 | dixanthogen; O,O-diethyl dithiobis(thioformate) | 207-944-4 | 502-55-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-050-00-X | 1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA | - | 4482-55-7 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 006-051-00-5 | ferbam (ISO); iron tris(dimethyldithiocarbamate) | 238-484-2 | 14484-64-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H410 | |||
| 006-052-00-0 | formetanate hydrochloride; 3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate | 245-656-0 | 23422-53-9 | Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H317 H410 | |||
| 006-053-00-6 | isoprocarb (ISO); 2-isopropylphenyl N-methylcarbamate | 220-114-6 | 2631-40-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 006-054-00-1 | mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate | 206-249-3 | 315-18-4 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H312 H400 H410 | GHS06 GHS09 Gef. | H300 H312 H410 | |||
| 006-055-00-7 | xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC | 219-364-9 | 2425-10-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 006-056-00-2 | metolcarb (ISO); m-tolyl methylcarbamate; MTMC | 214-446-0 | 1129-41-5 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 006-057-00-8 | nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine | 217-682-2 | 1929-82-4 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 006-058-00-3 | noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea | - | 2163-79-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-059-00-9 | oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; | 245-445-3 | 23135-22-0 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2 | H330 H300 H312 H411 | GHS06 GHS09 Gef. | H330 H300 H312 H411 | |||
| 006-060-00-4 | oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide | 226-066-2 | 5259-88-1 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 006-061-00-X | S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride | 243-193-9 | 19622-19-6 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 006-062-00-5 | methyl 3,4-dichlorophenylcarbanilate; SWEP. | - | 1918-18-9 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-063-00-0 | thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate | 248-924-5 | 28249-77-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 006-064-00-6 | thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime | 254-346-4 | 39196-18-4 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 006-065-00-1 | 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid | - | 15271-41-7 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2 | H300 H311 H411 | GHS06 GHS09 Gef. | H300 H311 H411 | |||
| 006-066-00-7 | vernolate (ISO); S-propyl dipropylthiocarbamate | 217-681-7 | 1929-77-7 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 006-067-00-2 | XMC; 3,5-xylyl methylcarbamate | - | 2655-14-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 006-068-00-8 | diazomethane | 206-382-7 | 334-88-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 006-069-00-3 | thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene | 245-740-7 | 23564-05-8 | Muta. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H332 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H341 H332 H317 H410 | |||
| 006-070-00-9 | furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide | 262-302-0 | 60568-05-0 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 006-071-00-4 | cyclooct-4-en-1-yl methyl carbonate | 401-620-8 | 87731-18-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 006-072-00-X | prosulfocarb (ISO); S-benzyl N,N-dipropylthiocarbamate | 401-730-6 | 52888-80-9 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 006-073-00-5 | 3-(dimethylamino)propylurea | 401-950-2 | 31506-43-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 006-074-00-0 | 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate | 402-440-2 | 2094-99-7 | Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H314 H373 ** H334 H317 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H330 H314 H373 ** H334 H317 H410 | |||
| 006-076-00-1 | mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt | - | 8018-01-7 | Repr. 2 Skin Sens. 1 Aquatic Acute 1 | H361d*** H317 H400 | GHS08 GHS07 GHS09 Achtg. | H361d*** H317 H400 | M=10 | ||
| 006-077-00-7 | maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) | 235-654-8 | 12427-38-2 | Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d*** H332 H319 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d*** H332 H319 H317 H410 | M=10 | ||
| 006-078-00-2 | zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric) | 235-180-1 | 12122-67-7 | STOT SE 3 Skin Sens. 1 | H335 H317 | GHS07 Achtg. | H335 H317 | |||
| 006-079-00-8 | disulfiram; tetraethylthiuramdisulfide | 202-607-8 | 97-77-8 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H317 H410 | |||
| 006-080-00-3 | tetramethylthiuram monosulphide | 202-605-7 | 97-74-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 006-081-00-9 | zinc bis(dibutyldithiocarbamate) | 205-232-8 | 136-23-2 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H317 H410 | |||
| 006-082-00-4 | zinc bis(diethyldithiocarbamate) | 238-270-9 | 14324-55-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H315 H317 H410 | |||
| 006-083-00-X | butocarboxim (ISO); 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime | 252-139-3 | 34681-10-2 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H226 H331 H311 H301 H319 H400 H410 | GHS02 GHS06 GHS09 Gef. | H226 H331 H311 H301 H319 H410 | |||
| 006-084-00-5 | carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate | 259-565-9 | 55285-14-8 | Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H301 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H301 H317 H410 | |||
| 006-085-00-0 | fenobucarb (ISO); 2-butylphenyl methylcarbamate | 223-188-8 | 3766-81-2 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 006-086-00-6 | fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate | 276-696-7 | 72490-01-8 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | M = 1 M = 10 000 | ||
| 006-087-00-1 | furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate | 265-974-3 | 65907-30-4 | Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H301 H373** H319 H315 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H301 H373** H319 H315 H317 H410 | M = 100 | ||
| 006-088-00-7 | benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate | - | 82560-54-1 | Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H361f*** H331 H302 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361f*** H331 H302 H410 | |||
| 006-090-00-8 | 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate | 408-010-0 | 88558-41-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H332 H318 H412 | GHS05 GHS07 Gef. | H332 H318 H412 | |||
| 006-091-00-3 | propineb (ISO); polymeric zinc propylenebis(dithiocarbamate) | - | 9016-72-2 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 | H332 H373** H317 H400 | GHS08 GHS07 GHS09 Achtg. | H332 H373** H317 H400 | |||
| 006-092-00-9 | tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate | 425-420-5 | 98737-29-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 006-093-00-4 | 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) | 427-180-7 | - | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 006-094-00-X | O-isobutyl-N-ethoxy carbonylthiocarbamate | 434-350-4 | 103122-66-3 | Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 | H226 H350 H340 H302 H373** H317 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H226 H350 H340 H302 H373** H317 H411 | |||
| 006-095-00-5 | fosetyl-aluminium (ISO); aluminium triethyl triphosphonate | 254-320-2 | 39148-24-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 006-096-00-0 | chlorpropham (ISO); isopropyl 3-chlorocarbanilate | 202-925-7 | 101-21-3 | Carc. 2 STOT RE 2 * Aquatic Chronic 2 | H351 H373** H411 | GHS08 GHS09 Achtg. | H351 H373** H411 | |||
| 006-097-00-6 | 1-phenyl-3-(p-toluenesulfonyl)urea | 424-620-1 | 13909-63-2 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 | H302 H373** H412 | GHS08 GHS07 Achtg. | H302 H373** H412 | |||
| 006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | 429-170-8 | 134575-17-0 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 | H302 H373** H318 H317 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 H317 | |||
| 006-099-00-7 | N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate | 432-520-2 | 232938-43-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 006-101-00-6 | reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] | 423-070-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamate | 432-750-3 | - | Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 | H350 H340 H302 H373** H317 H411 | GHS08 GHS07 GHS09 Gef. | H350 H340 H302 H373** H317 H411 | |||
| 006-103-00-7 | N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea | 445-760-8 | - | Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H334 H400 H410 | GHS05 GHS08 GHS09 Gef. | H318 H334 H410 | M=100 | ||
| 007-001-00-5 | ammonia, anhydrous | 231-635-3 | 7664-41-7 | Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 | H221 H331 H314 H400 | GHS04 GHS06 GHS05 GHS09 Gef. | H221 H331 H314 H400 | U | ||
| 007-001-01-2 | ammonia .% | 215-647-6 | 1336-21-6 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | STOT SE 3; H335: C ≥ 5 % | B | |
| 007-002-00-0 | nitrogen dioxide; [1] dinitrogen tetraoxide [2] | 233-272-6 [1] 234-126-4 [2] | 10102-44-0 [1] 10544-72-6 [2] | Press.
Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B | H270 H330 H314 | GHS04 GHS03 GHS06 GHS05 Gef. | H270 H330 H314 | * STOT SE 3; H335: C ≥ 0,5 % | 5 | |
| 007-003-00-6 | chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride | 213-666-4 | 999-81-5 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 007-004-00-1 | Salpetersäure % | 231-714-2 | 7697-37-2 | Ox. Liq. 2 Skin Corr. 1A | H272 H314 | GHS03 GHS05 Gef. | H272 H314 | EUH071 | Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 99 % > C ≥ 65 % | B |
| 007-006-00-2 | ethyl nitrite | 203-722-6 | 109-95-5 | Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H220 H332 H312 H302 | GHS02 GHS04 GHS07 Gef. | H220 H332 H312 H302 | U | ||
| 007-007-00-8 | ethyl nitrate | 210-903-3 | 625-58-1 | Unst. Expl. | H200 | GHS01 Gef. | H200 | |||
| 007-008-00-3 | hydrazine | 206-114-9 | 302-01-2 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H350 H331 H311 H301 H314 H317 H400 H410 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H226 H350 H331 H311 H301 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % | ||
| 007-009-00-9 | dicyclohexylammonium nitrite | 221-515-9 | 3129-91-7 | Acute Tox. 4 * Acute Tox. 4 * | H332 H302 | GHS07 Achtg. | H332 H302 | * | ||
| 007-010-00-4 | sodium nitrite | 231-555-9 | 7632-00-0 | Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1 | H272 H301 H400 | GHS03 GHS06 GHS09 Gef. | H272 H301 H400 | * | ||
| 007-011-00-X | potassium nitrite | 231-832-4 | 7758-09-0 | Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1 | H272 H301 H400 | GHS03 GHS06 GHS09 Gef. | H272 H301 H400 | * | ||
| 007-012-00-5 | N,N-dimethylhydrazine | 200-316-0 | 57-14-7 | Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 | H225 H350 H331 H301 H314 H411 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H225 H350 H331 H301 H314 H411 | |||
| 007-013-00-0 | 1,2-dimethylhydrazine | - | 540-73-8 | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 | H350 H331 H311 H301 H411 | GHS06 GHS08 GHS09 Gef. | H350 H331 H311 H301 H411 | Carc. 1B; H350: C ≥ 0.01 % | ||
| 007-014-00-6 | salts of hydrazine | - | - | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H331 H311 H301 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H331 H311 H301 H317 H410 | A | ||
| 007-015-00-1 | O-ethylhydroxylamine | 402-030-3 | 624-86-2 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H225 H331 H311 H301 H372 ** H319 H317 H400 | GHS02 GHS06 GHS08 GHS09 Gef. | H225 H331 H311 H301 H372 ** H319 H317 H400 | |||
| 007-016-00-7 | butyl nitrite | 208-862-1 | 544-16-1 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * | H225 H331 H301 | GHS02 GHS06 Gef. | H225 H331 H301 | |||
| 007-017-00-2 | isobutyl nitrite | 208-819-7 | 542-56-3 | Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * | H225 H350 H341 H332 H302 | GHS02 GHS08 GHS07 Gef. | H225 H350 H341 H332 H302 | |||
| 007-018-00-8 | sec-butyl nitrite | 213-104-8 | 924-43-6 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H302 | GHS02 GHS07 Gef. | H225 H332 H302 | |||
| 007-019-00-3 | tert-butyl nitrite | 208-757-0 | 540-80-7 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H302 | GHS02 GHS07 Gef. | H225 H332 H302 | |||
| 007-020-00-9 | pentyl nitrite; [1] amyl nitrite, mixed isomers [2] | 207-332-7 [1] 203-770-8 [2] | 463-04-7 [1] 110-46-3 [2] | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H302 | GHS02 GHS07 Gef. | H225 H332 H302 | |||
| 007-021-00-4 | hydrazobenzene; 1,2-diphenylhydrazine | 204-563-5 | 122-66-7 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | |||
| 007-022-00-X | hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) | 405-030-1 | - | Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H350 H302 H314 H317 H412 | GHS08 GHS05 GHS07 Gef. | H350 H302 H314 H317 H412 | |||
| 007-023-00-5 | sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate | 405-510-0 | - | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 007-024-00-0 | 2-(decylthio)ethylammonium chloride | 405-640-8 | 36362-09-1 | STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 ** H315 H318 H400 H410 | GHS08 GHS05 GHS09 Gef. | H373 ** H315 H318 H410 | |||
| 007-025-00-6 | (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride | 406-090-1 | 81880-96-8 | Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H301 H372 ** H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H301 H372 ** H317 H410 | |||
| 007-026-00-1 | oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide | 413-230-5 | 122035-71-6 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 007-027-00-7 | 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane | 420-190-2 | 771478-66-1 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373 ** H314 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H312 H302 H373 ** H314 H317 H410 | |||
| 007-028-00-2 | hydroxylammonium nitrate | 236-691-2 | 13465-08-2 | Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H201 H351 H311 H302 H373** H319 H315 H317 H400 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H351 H311 H302 H373** H319 H315 H317 H400 | |||
| 007-029-00-8 | diethyldimethylammonium hydroxide | 419-400-5 | 95500-19-9 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 008-001-00-8 | oxygen | 231-956-9 | 7782-44-7 | Ox. Gas 1 Press. Gas | H270 | GHS03 GHS04 Gef. | H270 | U | ||
| 008-003-00-9 | hydrogen peroxide solution ... % | 231-765-0 | 7722-84-1 | Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A | H271 H332 H302 H314 | GHS03 GHS05 GHS07 Gef. | H271 H332 H302 H314 | Ox. Liq. 1; H271: C ≥ 70 %**** Ox. Liq. 2; H272: 50 % ≤ C < 70 %**** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 8 % STOT SE 3; H335; C ≥ 35 % | B | |
| 009-001-00-0 | fluorine | 231-954-8 | 7782-41-4 | Press.
Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A | H270 H330 H314 | GHS04 GHS03 GHS06 GHS05 Gef. | H270 H330 H314 | |||
| 009-002-00-6 | hydrogen fluoride | 231-634-8 | 7664-39-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A | H330 H310 H300 H314 | GHS06 GHS05 Gef. | H330 H310 H300 H314 | |||
| 009-003-00-1 | hydrofluoric acid ... % | 231-634-8 | 7664-39-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A | H330 H310 H300 H314 | GHS06 GHS05 Gef. | H330 H310 H300 H314 | Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C < 7 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % | B | |
| 009-004-00-7 | sodium fluoride | 231-667-8 | 7681-49-4 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 | H301 H319 H315 | GHS06 Gef. | H301 H319 H315 | EUH032 | ||
| 009-005-00-2 | potassium fluoride | 232-151-5 | 7789-23-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 009-006-00-8 | ammonium fluoride | 235-185-9 | 12125-01-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 009-007-00-3 | sodium bifluoride; sodium hydrogen difluoride | 215-608-3 | 1333-83-1 | Acute Tox. 3 * Skin Corr. 1B | H301 H314 | GHS06 GHS05 Gef. | H301 H314 | * Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % | ||
| 009-008-00-9 | potassium bifluoride; potassium hydrogen difluoride | 232-156-2 | 7789-29-9 | Acute Tox. 3 * Skin Corr. 1B | H301 H314 | GHS06 GHS05 Gef. | H301 H314 | * Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % | ||
| 009-009-00-4 | ammonium bifluoride; ammonium hydrogen difluoride | 215-676-4 | 1341-49-7 | Acute Tox. 3 * Skin Corr. 1B | H301 H314 | GHS06 GHS05 Gef. | H301 H314 | * Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % | ||
| 009-010-00-X | fluoroboric acid ... % | 240-898-3 | 16872-11-0 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B | |
| 009-011-00-5 | fluorosilicic acid ... % | 241-034-8 | 16961-83-4 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | B | ||
| 009-012-00-0 | alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3] | 240-934-8 [1] 240-896-2 [2] 240-968-3 [3] | 16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | * | A | |
| 009-013-00-6 | fluorosilicates, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | * | A | |
| 009-014-00-1 | lead hexafluorosilicate | 247-278-1 | 25808-74-6 | Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H332 H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Gef. | H360Df H332 H302 H373 ** H410 | 1 | ||
| 009-015-00-7 | sulphuryl difluoride | 220-281-5 | 2699-79-8 | Press.
Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 | H331 H373 ** H400 | GHS04 GHS06 GHS08 GHS09 Gef. | H331 H373 ** H400 | U | ||
| 009-016-00-2 | trisodium hexafluoroaluminate [1] | 237-410-6 [1] | 13775-53-6 [1] | STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 | H372 H332 H411 | GHS07 GHS08 GHS09 Gef. | H372 H332 H411 | | | |
| trisodium hexafluoroaluminate (cryolite) [2] | 239-148-8 [2] | 15096-52-3 [2] | ||||||||
| 009-017-00-8 | potassium mu-fluoro-bis(triethylaluminium) | 400-040-2 | 12091-08-6 | Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4 * | H228 H270 H314 H332 | GHS02 GHS05 GHS07 Gef. | H228 H270 H314 H332 | EUH014 | T | |
| 009-018-00-3 | magnesium hexafluorosilicate | 241-022-2 | 16949-65-8 | Acute Tox. 3 * | H301 | GHS06 Gef. | H301 | * | ||
| 011-001-00-0 | sodium | 231-132-9 | 7440-23-5 | Water-react. 1 Skin Corr. 1B | H260 H314 | GHS02 GHS05 Gef. | H260 H314 | EUH014 | ||
| 011-002-00-6 | sodium hydroxide; caustic soda | 215-185-5 | 1310-73-2 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % | ||
| 011-003-00-1 | sodium peroxide | 215-209-4 | 1313-60-6 | Ox. Sol. 1 Skin Corr. 1A | H271 H314 | GHS03 GHS05 Gef. | H271 H314 | |||
| 011-004-00-7 | sodium azide | 247-852-1 | 26628-22-8 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H400 H410 | GHS06 GHS09 Gef. | H300 H400 H410 | EUH032 | ||
| 011-005-00-2 | sodium carbonate | 207-838-8 | 497-19-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 011-006-00-8 | sodium cyanate | 213-030-6 | 917-61-3 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 011-007-00-3 | propoxycarbazone-sodium | - | 181274-15-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=10 | ||
| 012-001-00-3 | magnesium powder (pyrophoric) | 231-104-6 | 7439-95-4 | Water-react. 1 Pyr. Sol. 1 | H260 H250 | GHS02 Gef. | H260 H250 | T | ||
| 012-002-00-9 | magnesium, powder or turnings | 231-104-6 | - | Flam. Sol. 1 Water-react. 2 Self-heat. 1 | H228 H261 H252 | GHS02 Gef. | H228 H261 H252 | T | ||
| 012-003-00-4 | magnesium alkyls | - | - | Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B | H250 H260 H314 | GHS02 GHS05 Gef. | H250 H260 H314 | EUH014 | A | |
| 012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | 422-150-1 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 013-001-00-6 | aluminium powder (pyrophoric) | 231-072-3 | 7429-90-5 | Water-react. 2 Pyr. Sol. 1 | H261 H250 | GHS02 Gef. | H261 H250 | T | ||
| 013-002-00-1 | aluminium powder (stabilised) | 231-072-3 | 7429-90-5 | Water-react. 2 Flam. Sol. 1 | H261 H228 | GHS02 Gef. | H261 H228 | T | ||
| 013-003-00-7 | aluminium chloride, anhydrous | 231-208-1 | 7446-70-0 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 013-004-00-2 | aluminium alkyls | - | - | Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B | H250 H260 H314 | GHS02 GHS05 Gef. | H250 H260 H314 | EUH014 | A | |
| 013-005-00-8 | diethyl(ethyldimethylsilanolato)aluminium | 401-160-8 | 55426-95-4 | Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A | H260 H250 H314 | GHS02 GHS05 Gef. | H260 H250 H314 | EUH014 | ||
| 013-006-00-3 | (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised | 402-370-2 | - | Flam. Liq. 3 Eye Dam. 1 | H226 H318 | GHS02 GHS05 Gef. | H226 H318 | |||
| 013-007-00-9 | poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) | 403-430-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 013-008-00-4 | di-n-octylaluminium iodide | 408-190-0 | 7585-14-0 | Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H250 H314 H400 H410 | GHS02 GHS05 GHS09 Gef. | H250 H314 H410 | EUH014 | ||
| 013-009-00-X | sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0.5 y = 1.5 | 418-720-2 | - | Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A | H228 H260 H250 H332 H314 | GHS02 GHS05 GHS07 Gef. | H228 H260 H250 H332 H314 | EUH014 | T | |
| 013-010-00-5 | hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide) | 430-650-4 | 151841-65-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-001-00-9 | trichlorosilane | 233-042-5 | 10025-78-2 | Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A | H224 H250 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H224 H250 H332 H302 H314 | EUH014 EUH029 | * STOT SE 3; H335: C ≥ 1 % | T |
| 014-002-00-4 | silicon tetrachloride | 233-054-0 | 10026-04-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | EUH014 | ||
| 014-003-00-X | dimethyldichlorosilane | 200-901-0 | 75-78-5 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H225 H319 H335 H315 | GHS02 GHS07 Gef. | H225 H319 H335 H315 | |||
| 014-004-00-5 | trichloro(methyl)silane; methyltrichlorosilane | 200-902-6 | 75-79-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H225 H319 H335 H315 | GHS02 GHS07 Gef. | H225 H319 H335 H315 | EUH014 | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 014-005-00-0 | tetraethyl silicate; ethyl silicate | 201-083-8 | 78-10-4 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 | H226 H332 H319 H335 | GHS02 GHS07 Achtg. | H226 H332 H319 H335 | |||
| 014-006-00-6 | bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride | 401-380-4 | - | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 014-007-00-1 | triethoxyisobutylsilane | 402-810-3 | 17980-47-1 | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 014-008-00-7 | (chloromethyl)bis(4-fluorophenyl)methylsilane | 401-200-4 | 85491-26-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-009-00-2 | isobutylisopropyldimethoxysilane | 402-580-4 | 111439-76-0 | Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 | H226 H332 H315 | GHS02 GHS07 Achtg. | H226 H332 H315 | |||
| 014-010-00-8 | disodium metasilicate | 229-912-9 | 6834-92-0 | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | |||
| 014-011-00-3 | cyclohexyldimethoxymethylsilane | 402-140-1 | 17865-32-6 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 014-012-00-9 | bis(3-(trimethoxysilyl)propyl)amine | 403-480-3 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 014-013-00-4 | α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) | 404-920-7 | - | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H312 H302 H314 H411 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H411 | |||
| 014-014-00-X | etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane | 253-704-7 | 37894-46-5 | Repr. 1B Acute Tox. 4 * STOT RE 2 * | H360D *** H302 H373 ** | GHS08 GHS07 Gef. | H360D *** H302 H373 ** | |||
| 014-015-00-5 | α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane)) | 406-420-4 | 69430-40-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 014-016-00-0 | reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane | 406-490-6 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-017-00-6 | flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H - 1,2,4-triazol-1-ylmethyl)silane | - | 85509-19-9 | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 | H351 H360D *** H302 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360D *** H302 H411 | |||
| 014-018-00-1 | octamethylcyclotetrasiloxane | 209-136-7 | 556-67-2 | Repr. 2 Aquatic Chronic 4 | H361f *** H413 | GHS08 Achtg. | H361f *** H413 | |||
| 014-019-00-7 | reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H - 1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H - 1,2,4-triazole | 403-250-2 | - | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 | H351 H360D *** H302 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360D *** H302 H411 | |||
| 014-020-00-2 | bis(1,1-dimethyl-2-propynyloxy)dimethylsilane | 414-960-7 | 53863-99-3 | Acute Tox. 4 * | H332 | GHS07 Achtg. | H332 | |||
| 014-021-00-8 | tris(isopropenyloxy)phenyl silane | 411-340-8 | 52301-18-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H400 H410 | |||
| 014-022-00-3 | reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) | 401-530-9 | - | Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H228 H370 ** H332 H312 H302 | GHS02 GHS08 GHS07 Gef. | H228 H370 ** H332 H312 H302 | T | ||
| 014-023-00-9 | α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole | 408-160-7 | 125613-45-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-024-00-4 | 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene | 412-620-2 | 121626-74-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-025-00-X | 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine | 411-400-3 | 102089-33-8 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H302 H373 ** H315 H318 H412 | GHS08 GHS05 GHS07 Gef. | H302 H373 ** H315 H318 H412 | |||
| 014-026-00-5 | dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane | 407-180-3 | 770722-36-6 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | |||
| 014-027-00-0 | chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane | 410-270-5 | 770722-46-8 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | |||
| 014-028-00-6 | α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) | 415-290-8 | 193159-06-7 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 014-029-00-1 | O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] | 421-870-1 | 156145-66-3 | Repr. 2 Acute Tox. 4 * STOT RE 2 * | H361f *** H302 H373 ** | GHS08 GHS07 Achtg. | H361f *** H302 H373 ** | |||
| 014-030-00-7 | [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium | 422-060-0 | 137390-08-0 | Acute Tox. 2 * | H300 | GHS06 Gef. | H300 | |||
| 014-031-00-2 | bis(1-methylethyl)-dimethoxysilane | 421-540-7 | 18230-61-0 | Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H226 H315 H317 H412 | GHS02 GHS07 Achtg. | H226 H315 H317 H412 | |||
| 014-032-00-8 | dicyclopentyldimethoxysilane | 404-370-8 | 126990-35-0 | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 014-033-00-3 | 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica | 419-030-4 | 125804-20-8 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | |||
| 014-034-00-9 | 3-hexylheptamethyltrisiloxane | 428-700-5 | 1873-90-1 | Acute Tox. 4 * Aquatic Chronic 4 | H332 H413 | GHS07 Achtg. | H332 H413 | |||
| 014-035-00-4 | 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane | 425-050-4 | 10217-34-2 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | 405-020-7 | 105024-66-6 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360F*** H400 H410 | GHS08 GHS09 Gef. | H360F*** H410 | M=1000 | ||
| 014-037-00-5 | 2-butanone-O,O',O''-(phenylsilylidyne)trioxime | 433-360-6 | 34036-80-1 | STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 | H373** H317 H412 | GHS08 GHS07 Achtg. | H373** H317 H412 | |||
| 014-038-00-0 | S-(3-(triethoxysilyl)propyl) octanethioate | 436-690-9 | 220727-26-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | 439-360-2 | 142877-45-0 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H315 H318 H412 | GHS05 Gef. | H315 H318 H412 | |||
| 014-041-00-7 | N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane | 445-890-5 | 201290-01-9 | Acute Tox. 4 * Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 014-042-00-2 | reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-010-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | 432-200-2 | - | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H335 H315 H318 H412 | GHS05 GHS07 Gef. | H335 H315 H318 H412 | |||
| 014-044-00-3 | 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane | 433-050-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-045-00-9 | magnesium sodium fluoride silicate | 442-650-1 | - | STOT RE 2 * | H373** | GHS08 Achtg. | H373** | |||
| 014-046-00-4 | E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] | - | - | Carc. 1B | H350i | GHS08 Gef. | H350i | A | ||
| 014-047-00-X | Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] | - | - | Carc. 2 | H351 (Einatmen) | GHS08 Achtg. | H351 (Einatmen) | A | ||
| 015-001-00-1 | white phosphorus | 231-768-7 | 12185-10-3 | Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 | H250 H330 H300 H314 H400 | GHS02 GHS06 GHS05 GHS09 Gef. | H250 H330 H300 H314 H400 | |||
| 015-002-00-7 | red phosphorus | 231-768-7 | 7723-14-0 | Flam. Sol. 1 Aquatic Chronic 3 | H228 H412 | GHS02 Gef. | H228 H412 | |||
| 015-003-00-2 | Calciumphosphid; Tricalciumdiphosphid | 215-142-0 | 1305-99-3 | Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Eye Dam. 1 Aquatic Acute 1 | H260 H300 H311 H330 H318 H400 | GHS02 GHS06 GHS05 GHS09 Gef. | H260 H300 H311 H330 H318 H400 | EUH029 EUH032 | M = 100 | |
| 015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | | |||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Acute Tox. 1 | H330 | Gef. | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
| 015-005-00-3 | magnesium phosphide; trimagnesium diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | | |||||
| Acute Tox. 3 | H311 | GHS09 | H311 | | ||||||
| Acute Tox. 1 | H330 | Gef. | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
| 015-006-00-9 | trizinc diphosphide; zinc phosphide | 215-244-5 | 1314-84-7 | Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H260 H300 H400 H410 | GHS02 GHS06 GHS09 Gef. | H260 H300 H410 | EUH029 EUH032 | M=100 | T |
| 015-007-00-4 | phosphorus trichloride | 231-749-3 | 7719-12-2 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A | H330 H300 H373 ** H314 | GHS06 GHS08 GHS05 Gef. | H330 H300 H373 ** H314 | EUH014 EUH029 | ||
| 015-008-00-X | phosphorus pentachloride | 233-060-3 | 10026-13-8 | Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B | H330 H302 H373 ** H314 | GHS06 GHS08 GHS05 Gef. | H330 H302 H373 ** H314 | EUH014 EUH029 | ||
| 015-009-00-5 | phosphoryl trichloride | 233-046-7 | 10025-87-3 | Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A | H330 H372 ** H302 H314 | GHS06 GHS08 GHS05 Gef. | H330 H372 ** H302 H314 | EUH014 EUH029 | ||
| 015-010-00-0 | phosphorus pentoxide | 215-236-1 | 1314-56-3 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | |||
| 015-011-00-6 | phosphoric acid ... %, orthophosphoric acid ... % | 231-633-2 | 7664-38-2 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B | |
| 015-012-00-1 | tetraphosphorus trisulphide; phosphorus sesquisulphid | 215-245-0 | 1314-85-8 | Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1 | H228 H260 H302 H400 | GHS02 GHS07 GHS09 Gef. | H228 H260 H302 H400 | T | ||
| 015-013-00-7 | triethyl phosphate | 201-114-5 | 78-40-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 015-014-00-2 | tributyl phosphate | 204-800-2 | 126-73-8 | Carc. 2 Acute Tox. 4 * Skin Irrit. 2 | H351 H302 H315 | GHS08 GHS07 Achtg. | H351 H302 H315 | |||
| 015-015-00-8 | tricresyl phosphate (o - o - o-, o - o - m-, o - o - p-, o - m - m-, o - m - p-, o - p - p-); tritolyl phosphate (o - o - o-, o - o - m-, o - o - p-, o - m - m-, o - m - p-, o - p - p-); | 201-103-5 | 78-30-8 | STOT SE 1 Aquatic Chronic 2 | H370 ** H411 | GHS08 GHS09 Gef. | H370 ** H411 | STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 % | C | |
| 015-016-00-3 | tricresyl phosphate (m - m - m-, m - m - p-, m - p - p-,p - p - p-); tritolyl phosphate (m - m - m-, m - m - p-, m - p - p-, p - p - p-); | 201-105-6 | 78-32-0 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H312 H302 H411 | GHS07 GHS09 Achtg. | H312 H302 H411 | * | C | |
| 015-019-00-X | dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate | 200-547-7 | 62-73-7 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 | H330 H311 H301 H317 H400 | GHS06 GHS09 Gef. | H330 H311 H301 H317 H400 | M=1000 | ||
| 015-020-00-5 | mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate | 232-095-1 | 7786-34-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | M=10000 | ||
| 015-021-00-0 | trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate | 200-149-3 | 52-68-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H400 H410 | M=1000 | ||
| 015-022-00-6 | phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate | 236-116-5 | 13171-21-6 | Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H341 H300 H311 H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H300 H311 H410 | |||
| 015-023-00-1 | pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate | - | 108-34-9 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * | H330 H310 H300 | GHS06 Gef. | H330 H310 H300 | |||
| 015-024-00-7 | triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide | - | 1031-47-6 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-025-00-2 | TEPP (ISO); tetraethyl pyrophosphate | 203-495-3 | 107-49-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 | H310 H300 H400 | GHS06 GHS09 Gef. | H310 H300 H400 | |||
| 015-026-00-8 | schradan (ISO); octamethylpyrophosphoramide | 205-801-0 | 152-16-9 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-027-00-3 | sulfotep (ISO); O,O,O,O-tetraethyl dithiopyrophosphate | 222-995-2 | 3689-24-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | M=1000 | ||
| 015-028-00-9 | demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate | 206-053-8 | 298-03-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 | H310 H300 H400 | GHS06 GHS09 Gef. | H310 H300 H400 | |||
| 015-029-00-4 | demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate | 204-801-8 | 126-75-0 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-030-00-X | demeton-O-methyl (ISO); O-2-ethylthioethyl O,O-dimethyl phosphorothioate | 212-758-1 | 867-27-6 | Acute Tox. 3 * | H301 | GHS06 Gef. | H301 | |||
| 015-031-00-5 | demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate | 213-052-6 | 919-86-8 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 | H311 H301 H411 | GHS06 GHS09 Gef. | H311 H301 H411 | |||
| 015-032-00-0 | prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate | 218-893-2 | 2275-18-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3 | H310 H300 H412 | GHS06 Gef. | H310 H300 H412 | |||
| 015-033-00-6 | phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate | 206-052-2 | 298-02-2 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | M=1000 | ||
| 015-034-00-1 | parathion (ISO); O,O-diethyl O-4-nitrophenyl phosphorothioate | 200-271-7 | 56-38-2 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H311 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H300 H311 H372 ** H410 | M=100 | ||
| 015-035-00-7 | parathion - methyl (ISO); O,O-dimethyl O-4-nitrophenyl phosphorothioate | 206-050-1 | 298-00-0 | Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H226 H330 H300 H311 H373 ** H400 H410 | GHS02 GHS06 GHS08 GHS09 Gef. | H226 H330 H300 H311 H373 ** H410 | M=100 | ||
| 015-036-00-2 | O-ethyl O-4-nitrophenyl phenylphosphonothioate; EPN | 218-276-8 | 2104-64-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 015-037-00-8 | phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate | 218-892-7 | 2275-14-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | |||
| 015-038-00-3 | coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate | 200-285-3 | 56-72-4 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H312 H400 H410 | GHS06 GHS09 Gef. | H300 H312 H410 | |||
| 015-039-00-9 | azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate | 201-676-1 | 86-50-0 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H311 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H311 H317 H410 | |||
| 015-040-00-4 | diazinon (ISO); O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate | 206-373-8 | 333-41-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H400 H410 | |||
| 015-041-00-X | malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] | 204-497-7 | 121-75-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | M=1000 | ||
| 015-042-00-5 | chlorthion O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate | 207-902-5 | 500-28-7 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | M=100 | ||
| 015-043-00-0 | phosnichlor (ISO); O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate | - | 5826-76-6 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | |||
| 015-044-00-6 | carbophenothion (ISO); 4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate | 212-324-1 | 786-19-6 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | |||
| 015-045-00-1 | mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate | 219-993-9 | 2595-54-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H400 H410 | |||
| 015-046-00-7 | oxydemeton-methyl; S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate | 206-110-7 | 301-12-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 | H311 H301 H400 | GHS06 GHS09 Gef. | H311 H301 H400 | |||
| 015-047-00-2 | ethion (ISO); O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate); diethion | 209-242-3 | 563-12-2 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | M=10000 | ||
| 015-048-00-8 | fenthion (ISO); O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate | 200-231-9 | 55-38-9 | Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H331 H312 H302 H372** H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H331 H312 H302 H372** H410 | M=100 | ||
| 015-049-00-3 | endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate | 220-472-3 | 2778-04-3 | Acute Tox. 3 * Acute Tox. 3 * | H311 H301 | GHS06 Gef. | H311 H301 | |||
| 015-050-00-9 | thiometon (ISO); S-2-ethylthioethyl O,O-dimethyl phosphorodithioate | 211-362-6 | 640-15-3 | Acute Tox. 3 * Acute Tox. 4 * | H301 H312 | GHS06 Gef. | H301 H312 | |||
| 015-051-00-4 | dimethoate (ISO); O,O-dimethyl methylcarbamoylmethyl phosphorodithioate | 200-480-3 | 60-51-5 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 015-052-00-X | fenchlorphos (ISO); O,O-dimethyl O - 2,4,5-trichlorophenyl phosphorothioate | 206-082-6 | 299-84-3 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 015-053-00-5 | menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate | 201-123-4 | 78-57-9 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 015-054-00-0 | fenitrothion (ISO); O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate | 204-524-2 | 122-14-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 015-055-00-6 | naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate | 206-098-3 | 300-76-5 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 | H312 H302 H319 H315 H400 | GHS07 GHS09 Achtg. | H312 H302 H319 H315 H400 | M=1000 | ||
| 015-056-00-1 | azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate | 220-147-6 | 2642-71-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | M=100 | ||
| 015-057-00-7 | formothion (ISO); N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate | 219-818-6 | 2540-82-1 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 015-058-00-2 | morphothion (ISO); O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate | 205-628-0 | 144-41-2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | |||
| 015-059-00-8 | vamidothion (ISO); O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate | 218-894-8 | 2275-23-2 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 | H301 H312 H400 | GHS06 GHS09 Gef. | H301 H312 H400 | |||
| 015-060-00-3 | disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate | 206-054-3 | 298-04-4 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 015-061-00-9 | dimefox (ISO); tetramethylphosphorodiamidic fluoride | 204-076-8 | 115-26-4 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-062-00-4 | mipafox (ISO); N,N'- di-isopropylphosphorodiamidic fluoride | 206-742-3 | 371-86-8 | STOT SE 1 | H370 ** | GHS08 Gef. | H370 ** | |||
| 015-063-00-X | dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) | 201-107-7 | 78-34-2 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H311 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H311 H410 | M=1000 | ||
| 015-064-00-5 | bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate | 225-399-0 | 4824-78-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | |||
| 015-065-00-0 | S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate | - | 2703-37-9 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 | H330 H310 H300 H411 | GHS06 GHS09 Gef. | H330 H310 H300 H411 | |||
| 015-066-00-6 | omethoate (ISO); O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate | 214-197-8 | 1113-02-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 | H301 H312 H400 | GHS06 GHS09 Gef. | H301 H312 H400 | |||
| 015-067-00-1 | phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate | 218-996-2 | 2310-17-0 | Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H332 H312 H317 H400 H410 | GHS06 GHS09 Gef. | H301 H332 H312 H317 H410 | M=1000 | ||
| 015-068-00-7 | dichlofenthion (ISO); O - 2,4-dichlorophenyl O,O-diethyl phosphorothioate | 202-564-5 | 97-17-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H400 H410 | |||
| 015-069-00-2 | methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate | 213-449-4 | 950-37-8 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H312 H400 H410 | GHS06 GHS09 Gef. | H300 H312 H410 | |||
| 015-070-00-8 | cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate | 223-099-4 | 3734-95-0 | Acute Tox. 2 * Acute Tox. 3 * | H300 H311 | GHS06 Gef. | H300 H311 | |||
| 015-071-00-3 | chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate | 207-432-0 | 470-90-6 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | |||
| 015-072-00-9 | monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate | 230-042-7 | 6923-22-4 | Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H341 H330 H300 H311 H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H330 H300 H311 H410 | |||
| 015-073-00-4 | dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate | 205-494-3 | 141-66-2 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | |||
| 015-074-00-X | crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate | 206-083-1 | 299-86-5 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 015-075-00-5 | S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate | - | 2635-50-9 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 015-076-00-0 | potasan; O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate | - | 299-45-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | M=1000 | ||
| 015-077-00-6 | 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate | - | 7076-53-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 015-078-00-1 | demeton-S-methylsulphon (ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate | 241-109-5 | 17040-19-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 | H301 H312 H411 | GHS06 GHS09 Gef. | H301 H312 H411 | |||
| 015-079-00-7 | acephate (ISO); O,S-dimethyl acetylphosphoramidothioate | 250-241-2 | 30560-19-1 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 015-080-00-2 | amidithion (ISO); 2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate | - | 919-76-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 015-081-00-8 | O,O,O',O'-tetrapropyl dithiopyrophosphate | 221-817-0 | 3244-90-4 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 015-082-00-3 | azothoate (ISO); O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate | 227-419-3 | 5834-96-8 | Acute Tox. 4 * Acute Tox. 4 * | H332 H302 | GHS07 Achtg. | H332 H302 | |||
| 015-083-00-9 | bensulide (ISO); O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate | 212-010-4 | 741-58-2 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 015-084-00-4 | chlorpyrifos (ISO); O,O-diethyl O - 3,5,6-trichloro-2-pyridyl phosphorothioate | 220-864-4 | 2921-88-2 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H400 H410 | M=10000 | ||
| 015-085-00-X | chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride | 204-105-4 | 115-78-6 | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H301 H312 H319 H315 | GHS06 Gef. | H301 H312 H319 H315 | |||
| 015-086-00-5 | coumithoate (ISO); O,O-diethyl O - 7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate | - | 572-48-5 | Acute Tox. 3 * | H301 | GHS06 Gef. | H301 | |||
| 015-087-00-0 | cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate | 220-130-3 | 2636-26-2 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 015-088-00-6 | dialifos (ISO); 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate | 233-689-3 | 10311-84-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H400 H410 | |||
| 015-089-00-1 | ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate | 204-121-1 | 116-01-8 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 015-090-00-7 | fensulfothion (ISO); O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate | 204-114-3 | 115-90-2 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 015-091-00-2 | fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate | 213-408-0 | 944-22-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 015-092-00-8 | phosacetim (ISO); O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate | 223-874-7 | 4104-14-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 015-093-00-3 | leptophos (ISO); O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate | 244-472-8 | 21609-90-5 | Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H370 ** H312 H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H370 ** H312 H410 | |||
| 015-094-00-9 | mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate | 213-447-3 | 950-10-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 | H310 H300 H411 | GHS06 GHS09 Gef. | H310 H300 H411 | |||
| 015-095-00-4 | methamidophos (ISO); O,S-dimethyl phosphoramidothioate | 233-606-0 | 10265-92-6 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 | H330 H300 H311 H400 | GHS06 GHS09 Gef. | H330 H300 H311 H400 | |||
| 015-096-00-X | oxydisulfoton (ISO); O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate | 219-679-1 | 2497-07-6 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | M=10 | ||
| 015-097-00-5 | phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate | 219-997-0 | 2597-03-7 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | M=100 | ||
| 015-098-00-0 | trichloronate (ISO); O-ethyl O - 2,4,5-trichlorophenyl ethylphosphonothioate | 206-326-1 | 327-98-0 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | |||
| 015-099-00-6 | pirimiphos-ethyl (ISO); O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate | 245-704-0 | 23505-41-1 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | |||
| 015-100-00-X | phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile | 238-887-3 | 14816-18-3 | Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f*** H302 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361f*** H302 H317 H410 | M=1000 | ||
| 015-101-00-5 | phosmet (ISO); O,O-dimethyl phthalimidomethyl S-phosphorodithioate | 211-987-4 | 732-11-6 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | M=100 | ||
| 015-102-00-0 | tris(2-chloroethyl)phosphate | 204-118-5 | 115-96-8 | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 | H351 H360F*** H302 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360F*** H302 H411 | |||
| 015-103-00-6 | phosphorus tribromide | 232-178-2 | 7789-60-8 | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | EUH014 | ||
| 015-104-00-1 | diphosphorus pentasulphide; phosphorus pentasulphide | 215-242-4 | 1314-80-3 | Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H228 H260 H332 H302 H400 | GHS02 GHS07 GHS09 Gef. | H228 H260 H332 H302 H400 | EUH029 | T | |
| 015-105-00-7 | triphenyl phosphite | 202-908-4 | 101-02-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % | ||
| 015-106-00-2 | hexamethylphosphoric triamide; hexamethylphosphoramide | 211-653-8 | 680-31-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | Carc. 1B; H350: C ≥ 0.01 % | ||
| 015-107-00-8 | ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate | 236-152-1 | 13194-48-4 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H301 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H301 H317 H410 | |||
| 015-108-00-3 | bromophos (ISO); O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate | 218-277-3 | 2104-96-3 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=100 | ||
| 015-109-00-9 | crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate | 231-720-5 | 7700-17-6 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | M=10 | ||
| 015-110-00-4 | cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate | - | 13067-93-1 | Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 | H301 H370 ** H312 H319 H411 | GHS06 GHS08 GHS09 Gef. | H301 H370 ** H312 H319 H411 | |||
| 015-111-00-X | phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate | 213-423-2 | 947-02-4 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-112-00-5 | thionazin (ISO); O,O-diethyl O-pyrazin-2-yl phosphorothioate; | 206-049-6 | 297-97-2 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-113-00-0 | tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate | 260-515-3 | 57018-04-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 015-114-00-6 | chlormephos (ISO); S-chloromethyl O,O-diethyl phosphorodithioate | 246-538-1 | 24934-91-6 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | M = 10 | ||
| 015-115-00-1 | chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates] | 244-663-6 | 21923-23-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | M = 1000 | ||
| 015-116-00-7 | demephion-O (ISO); O,O-dimethyl O-2-methylthioethyl phosphorothioate | 211-666-9 | 682-80-4 | Acute Tox. 2 * Acute Tox. 3 * | H300 H311 | GHS06 Gef. | H300 H311 | |||
| 015-117-00-2 | demephion-S (ISO); O,O-dimethyl S-2-methylthioethyl phosphorothioate | 219-971-9 | 2587-90-8 | Acute Tox. 2 * Acute Tox. 3 * | H300 H311 | GHS06 Gef. | H300 H311 | |||
| 015-118-00-8 | demeton | - | 8065-48-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 | H310 H300 H400 | GHS06 GHS09 Gef. | H310 H300 H400 | |||
| 015-119-00-3 | dimethyl 4-(methylthio)phenyl phosphate | - | 3254-63-5 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-120-00-9 | ditalimfos (ISO); O,O-diethyl phthalimidophosphonothioate | 225-875-8 | 5131-24-8 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 015-121-00-4 | edifenphos (ISO); O-ethyl S,S-diphenyl phosphorodithioate | 241-178-1 | 17109-49-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H312 H317 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H312 H317 H410 | |||
| 015-122-00-X | etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate | 253-855-9 | 38260-54-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=10 | ||
| 015-123-00-5 | fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | H300 | GHS06 | H300 | | M = 100 | |
| Acute Tox. 2 | H310 | GHS09 | H310 | M = 100 | ||||||
| Acute Tox. 2 | H330 | Gef. | H330 | | ||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 015-124-00-0 | fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate | 244-437-7 | 21548-32-3 | Acute Tox. 1 Acute Tox. 2 * | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 015-125-00-6 | glyphosine (ISO); N,N-bis(phosphonomethyl)glycine | 219-468-4 | 2439-99-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 015-126-00-1 | heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate | 245-737-0 | 23560-59-0 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | M=100 | ||
| 015-127-00-7 | iprobenfos(ISO); S-benzyl diisopropyl phosphorothioate | 247-449-0 | 26087-47-8 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 015-128-00-2 | IPSP; S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate | - | 5827-05-4 | Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H301 H400 H410 | GHS06 GHS09 Gef. | H310 H301 H410 | M=100 | ||
| 015-129-00-8 | isofenphos (ISO); O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate | 246-814-1 | 25311-71-1 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | M=100 | ||
| 015-130-00-3 | isothioate (ISO); S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; | - | 36614-38-7 | Acute Tox. 3 * Acute Tox. 3 * | H311 H301 | GHS06 Gef. | H311 H301 | |||
| 015-131-00-9 | isoxathion (ISO); O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate | 242-624-8 | 18854-01-8 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | |||
| 015-132-00-4 | S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione | - | 953-17-3 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | M=1000 | ||
| 015-133-00-X | piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate | - | 24151-93-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=10 | ||
| 015-134-00-5 | pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate | 249-528-5 | 29232-93-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 015-135-00-0 | profenofos (ISO) O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; | 255-255-2 | 41198-08-7 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | M=1000 | ||
| 015-136-00-6 | trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO) | 250-517-2 | 31218-83-4 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | M=100 | ||
| 015-137-00-1 | pyrazophos (ISO); O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate | 236-656-1 | 13457-18-6 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H410 | |||
| 015-138-00-7 | quinalphos (ISO); O,O-diethyl-O-quinoxalin-2-yl phosphorothioate | 237-031-6 | 13593-03-8 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | M=1000 | ||
| 015-139-00-2 | terbufos (ISO); S - tert-butylthiomethyl O, O-diethylphosphorodithioate; | 235-963-8 | 13071-79-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | M=1000 | ||
| 015-140-00-8 | triazophos (ISO); O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate | 245-986-5 | 24017-47-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H312 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H312 H410 | M=100 | ||
| 015-141-00-3 | ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers | 400-520-1 | - | Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H314 H302 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H302 H410 | |||
| 015-142-00-9 | butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate | 401-100-0 | - | Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 | H225 H319 H411 | GHS02 GHS07 GHS09 Gef. | H225 H319 H411 | T | ||
| 015-143-00-4 | reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers | 401-740-0 | - | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 015-144-00-X | reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate | 402-090-0 | 87025-52-3 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 015-145-00-5 | reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate | 401-520-4 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 015-146-00-0 | S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate | 401-850-9 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 015-147-00-6 | reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) | 400-930-0 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H315 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H411 | |||
| 015-148-00-1 | 2-(diphosphonomethyl)succinic acid | 403-070-4 | 51395-42-7 | Skin Corr. 1B Skin Sens. 1 | H314 H317 | GHS05 GHS07 Gef. | H314 H317 | |||
| 015-149-00-7 | reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide | 403-470-9 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 015-150-00-2 | (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide | 404-940-6 | 86608-70-0 | Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3 | H302 H318 H373 ** H412 | GHS08 GHS05 GHS07 Gef. | H302 H318 H373 ** H412 | |||
| 015-151-00-8 | tris(isopropyl/tert-butylphenyl) phosphate | 405-010-2 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 015-152-00-3 | dioxabenzofos (ISO); 2-methoxy-4H - 1,3,2-benzodioxaphosphorin 2-sulphide | 223-292-3 | 3811-49-2 | Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2 | H311 H301 H370 ** H411 | GHS06 GHS08 GHS09 Gef. | H311 H301 H370 ** H411 | |||
| 015-153-00-9 | isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate | 255-863-8 | 42509-80-8 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H311 H301 H373 ** H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H311 H301 H373 ** H317 H410 | |||
| 015-154-00-4 | ethephon; 2-chloroethylphosphonic acid | 240-718-3 | 16672-87-0 | Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 | H311 H332 H302 H314 H411 | GHS06 GHS05 GHS09 Gef. | H311 H332 H302 H314 H411 | EUH071 | ||
| 015-155-00-X | glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate | 278-636-5 | 77182-82-2 | Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | H360Fd H332 H312 H302 H373** | GHS08 GHS07 Gef. | H360Fd H332 H312 H302 H373** | |||
| 015-156-00-5 | methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] | 250-366-9 [1] - [2] | 30864-28-9 [1] 62610-77-9 [2] | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 015-157-00-0 | phosphonic acid; [1] phosphorous acid [2] | 237-066-7 [1] 233-663-1 [2] | 13598-36-2 [1] 10294-56-1 [2] | Acute Tox. 4 * Skin Corr. 1A | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | |||
| 015-158-00-6 | (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) | 402-340-9 | 32760-80-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 015-159-00-1 | hydroxyphosphonoacetic acid | 405-710-8 | 23783-26-8 | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 | H302 H373 ** H314 H317 | GHS08 GHS05 GHS07 Gef. | H302 H373 ** H314 H317 | |||
| 015-160-00-7 | vanadyl pyrophosphate | 406-260-5 | 58834-75-6 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H317 H412 | GHS07 Achtg. | H319 H317 H412 | |||
| 015-161-00-2 | divanadyl pyrophosphate | 407-130-0 | 65232-89-5 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 015-162-00-8 | vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped | 407-350-7 | - | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 | H332 H373 ** H318 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H332 H373 ** H318 H411 | |||
| 015-163-00-3 | bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide | 412-010-6 | 145052-34-2 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 015-164-00-9 | calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate | 400-480-5 | 36669-85-9 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 015-165-00-4 | reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate | 404-986-7 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 015-166-00-X | 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | 410-290-4 | 80693-00-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 015-167-00-5 | 3-(hydroxyphenylphosphinyl)propanoic acid | 411-200-6 | 14657-64-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 015-168-00-0 | fosthiazate (ISO); (RS)-S - sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate | - | 98886-44-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H312 H317 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H312 H317 H410 | EUH070 | ||
| 015-169-00-6 | tributyltetradecylphosphonium tetrafluoroborate | 413-520-1 | - | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H314 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H302 H373 ** H314 H317 H410 | |||
| 015-170-00-1 | reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate; 1-octane-N,N,N-trimethylammonium di-octylphosphate; 1-octane-N,N,N-trimethylammonium octylphosphate | 407-490-9 | - | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 015-171-00-7 | O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate | 406-940-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 015-172-00-2 | reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate | 406-240-6 | - | Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 | H226 H314 H411 | GHS02 GHS05 GHS09 Gef. | H226 H314 H411 | |||
| 015-173-00-8 | methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate | 414-080-3 | 117291-73-3 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 015-174-00-3 | 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine | 411-370-1 | 82857-68-9 | Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2 | H301 H318 H411 | GHS06 GHS05 GHS09 Gef. | H301 H318 H411 | |||
| 015-175-00-9 | tert-butyl (triphenylphosphoranylidene) acetate | 412-880-7 | 35000-38-5 | Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H301 H373 ** H319 H317 H411 | GHS06 GHS08 GHS09 Gef. | H301 H373 ** H319 H317 H411 | |||
| 015-176-00-4 | P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine | 413-430-2 | 116163-96-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 015-177-00-X | ((4-phenylbutyl)hydroxyphosphoryl)acetic acid | 412-170-7 | 83623-61-4 | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 | H373 ** H318 H317 | GHS08 GHS05 Gef. | H373 ** H318 H317 | |||
| 015-178-00-5 | (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate | 418-570-8 | 25383-07-7 | Repr. 2 Aquatic Chronic 2 | H361f *** H411 | GHS08 GHS09 Achtg. | H361f *** H411 | |||
| 015-179-00-0 | UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine | 422-720-8 | 166242-53-1 | Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H373 ** H314 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H351 H302 H373 ** H314 H317 H410 | |||
| 015-180-00-6 | [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt | 415-820-8 | 137590-32-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 015-181-00-1 | phosphine | 232-260-8 | 7803-51-2 | Flam. Gas 1 Press. Gas Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 | H220 H330 H314 H400 | GHS02 GHS04 GHS06 GHS05 GHS09 Gef. | H220 H330 H314 H400 | U | ||
| 015-182-00-7 | tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate) | 430-630-5 | 10596-22-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 | H302 H319 H317 | GHS07 Achtg. | H302 H319 H317 | |||
| 015-183-00-2 | (1-hydroxydodecylidene)diphosphonic acid | 425-230-2 | 16610-63-2 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 015-184-00-8 | Salts of glyphosate, with the exception of those specified elsewhere in this Annex | - | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | A | ||
| 015-186-00-9 | chlorpyrifos-methyl (ISO) O, O-dimethyl O - 3,5,6-trichloro-2-pyridyl phosphorothioate | 227-011-5 | 5598-13-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M=10000 | ||
| 015-187-00-4 | reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; trisodium ((tetrahydro-2-hydroxy-4H - 1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide | 417-540-1 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 015-189-00-5 | phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide | 423-340-5 | 162881-26-7 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 015-190-00-0 | bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | 421-920-2 | 154862-43-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 015-191-00-6 | dodecyldiphenyl phosphate | 431-760-5 | 27460-02-2 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) | 442-960-7 | 332350-93-3 | Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H318 H400 H410 | GHS05 GHS06 GHS09 Gef. | H301 H318 H410 | |||
| 015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | 444-440-5 | 220689-12-3 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 015-195-00-8 | reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate | 433-860-4 | - | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H317 H412 | GHS07 Achtg. | H319 H317 H412 | |||
| 015-196-00-3 | reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate | 435-960-3 | - | Carc. 1B Muta. 1B Skin Sens. 1 | H350 H340 H317 | GHS08 GHS07 Gef. | H350 H340 H317 | |||
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | 420-160-9 | 107667-02-7 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H226 H331 H302 H314 H411 | GHS02 GHS06 GHS05 GHS09 Gef. | H226 H331 H302 H314 H411 | |||
| 015-198-00-4 | (4-phenylbutyl)phosphinic acid | 420-450-5 | 86552-32-1 | Carc. 2 Eye Dam. 1 | H351 H318 | GHS05 GHS08 Gef. | H351 H318 | |||
| 015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08 Achtg. | H351 | |||
| 015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 | Carc. 1B Repr. 2 STOT RE 1 | H350 H361f H372 (Lunge) | GHS08 Gef. | H350 H361f H372 (Lunge) | STOT RE 1; H372: C ≥ 0,1 % Carc 1B; H350: C ≥ 0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % | ||
| 015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08 Gef. | H360F | |||
| 015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (verursacht Hodenatrophie) | GHS08 Achtg. | H361f (verursacht Hodenatrophie) | |||
| 016-001-00-4 | hydrogen sulphide | 231-977-3 | 7783-06-4 | Flam. Gas 1 Press. Gas Acute Tox. 2 * Aquatic Acute 1 | H220 H330 H400 | GHS02 GHS04 GHS06 GHS09 Gef. | H220 H330 H400 | U | ||
| 016-002-00-X | barium sulphide | 244-214-4 | 21109-95-5 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H332 H302 H400 | GHS07 GHS09 Achtg. | H332 H302 H400 | EUH031 | ||
| 016-003-00-5 | barium polysulphides | 256-814-3 | 50864-67-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H319 H335 H315 H400 | GHS07 GHS09 Achtg. | H319 H335 H315 H400 | EUH031 | ||
| 016-004-00-0 | calcium sulphide | 243-873-5 | 20548-54-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H319 H335 H315 H400 | GHS07 GHS09 Achtg. | H319 H335 H315 H400 | EUH031 | ||
| 016-005-00-6 | calcium polysulphides | 215-709-2 | 1344-81-6 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H319 H335 H315 H400 | GHS07 GHS09 Achtg. | H319 H335 H315 H400 | EUH031 | ||
| 016-006-00-1 | dipotassium sulphide; potassium sulphide | 215-197-0 | 1312-73-8 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | EUH031 | ||
| 016-007-00-7 | potassium polysulphides | 253-390-1 | 37199-66-9 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | EUH031 | ||
| 016-008-00-2 | ammonium polysulphides | 232-989-1 | 9080-17-5 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | EUH031 | EUH031: C ≥ 1 % | |
| 016-009-00-8 | disodium sulfide; sodium sulfide | 215-211-5 | 1313-82-2 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 | H311 H302 H314 H400 | GHS06 GHS05 GHS09 Gef. | H311 H302 H314 H400 | |||
| 016-010-00-3 | sodium polysulphides | 215-686-9 | 1344-08-7 | Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 | H301 H314 H400 | GHS06 GHS05 GHS09 Gef. | H301 H314 H400 | EUH031 | ||
| 016-011-00-9 | sulphur dioxide | 231-195-2 | 7446-09-5 | Press.
Gas Acute Tox. 3 * Skin Corr. 1B | H331 H314 | GHS04 GHS06 GHS05 Gef. | H331 H314 | * | U5 | |
| 016-012-00-4 | disulphur dichloride; sulfur monochloride | 233-036-2 | 10025-67-9 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 | H301 H332 H314 H400 | GHS06 GHS05 GHS09 Gef. | H301 H332 H314 H400 | EUH014 EUH029 | STOT SE 3; H335: C ≥ 1 % | |
| 016-013-00-X | sulphur dichloride | 234-129-0 | 10545-99-0 | Skin Corr. 1B STOT SE 3 Aquatic Acute 1 | H314 H335 H400 | GHS05 GHS07 GHS09 Gef. | H314 H335 H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-014-00-5 | sulphur tetrachloride | - | 13451-08-6 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-015-00-0 | thionyl dichloride; thionyl chloride | 231-748-8 | 7719-09-7 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A | H332 H302 H314 | GHS05 GHS07 Gef. | H332 H302 H314 | EUH014 EUH029 | STOT SE 3; H335: C ≥ 1 % | |
| 016-016-00-6 | sulphuryl chloride | 232-245-6 | 7791-25-5 | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | EUH014 | ||
| 016-017-00-1 | chlorosulphonic acid | 232-234-6 | 7790-94-5 | Skin Corr. 1A STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | EUH014 | ||
| 016-018-00-7 | fluorosulphonic acid | 232-149-4 | 7789-21-1 | Acute Tox. 4 * Skin Corr. 1A | H332 H314 | GHS05 GHS07 Gef. | H332 H314 | |||
| 016-019-00-2 | oleum ... % SO3 | - | - | Skin Corr. 1A STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | EUH014 | B | |
| 016-020-00-8 | sulphuric acid ... % | 231-639-5 | 7664-93-9 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % | B | |
| 016-021-00-3 | methanethiol; methyl mercaptan | 200-822-1 | 74-93-1 | Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H220 H331 H400 H410 | GHS02 GHS04 GHS06 GHS09 Gef. | H220 H331 H410 | U | ||
| 016-022-00-9 | ethanethiol; ethyl mercaptan | 200-837-3 | 75-08-1 | Flam. Liq. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H225 H332 H400 H410 | GHS02 GHS07 GHS09 Gef. | H225 H332 H410 | |||
| 016-023-00-4 | dimethyl sulphate | 201-058-1 | 77-78-1 | Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 | H350 H341 H330 H301 H314 H317 | GHS06 GHS08 GHS05 Gef. | H350 H341 H330 H301 H314 H317 | Carc. 1B; H350: C ≥ 0.01 % Muta. 2; H341: C ≥ 0.01 % STOT SE 3; H335: C ≥ 5 % | ||
| 016-024-00-X | dimexano(ISO); bis(methoxythiocarbonyl) disulphide | 215-993-8 | 1468-37-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 016-025-00-5 | disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES | 205-259-5 | 149-26-8 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 | H302 H315 H318 | GHS05 GHS07 Gef. | H302 H315 H318 | |||
| 016-026-00-0 | sulphamidic acid; sulphamic acid; sulfamic acid | 226-218-8 | 5329-14-6 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H319 H315 H412 | GHS07 Achtg. | H319 H315 H412 | |||
| 016-027-00-6 | diethyl sulphate | 200-589-6 | 64-67-5 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H350 H340 H332 H312 H302 H314 | GHS05 GHS08 GHS07 Gef. | H350 H340 H332 H312 H302 H314 | |||
| 016-028-00-1 | sodium dithionite; sodium hydrosulphite | 231-890-0 | 7775-14-6 | Self-heat. 1 Acute Tox. 4 * | H251 H302 | GHS02 GHS07 Gef. | H251 H302 | EUH031 | ||
| 016-029-00-7 | p-toluenesulphonic acid, containing more than 5 % H2SO4 | - | - | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | ||
| 016-030-00-2 | p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) | 203-180-0 | 104-15-4 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | STOT SE 3; H335: C ≥ 20 % | ||
| 016-031-00-8 | tetrahydrothiophene-1,1-dioxide; sulpholane | 204-783-1 | 126-33-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 016-032-00-3 | 1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide | 214-317-9 | 1120-71-4 | Carc. 1B Acute Tox. 4 * Acute Tox. 4 * | H350 H312 H302 | GHS08 GHS07 Gef. | H350 H312 H302 | Carc. 1B; H350: C ≥ 0,01 % | ||
| 016-033-00-9 | dimethylsulfamoylchloride | 236-412-4 | 13360-57-1 | Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H350 H330 H312 H302 H314 | GHS06 GHS05 GHS08 Gef. | H350 H330 H312 H302 H314 | |||
| 016-034-00-4 | tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) | 400-010-9 | 81898-60-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-035-00-X | pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate | 400-120-7 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 016-036-00-5 | tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate | 400-130-1 | - | Resp. Sens. 1 Aquatic Chronic 2 | H334 H411 | GHS08 GHS09 Gef. | H334 H411 | |||
| 016-037-00-0 | disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate | 400-350-8 | 85153-93-1 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 016-038-00-6 | disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate | 400-380-1 | 86393-35-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-039-00-1 | tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate | 400-430-2 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-040-00-7 | reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate | 400-570-4 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 016-041-00-2 | calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate | 400-710-4 | - | Acute Tox. 4 * | H332 | GHS07 Achtg. | H332 | |||
| 016-042-00-8 | tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate | 400-790-0 | 85665-97-0 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | |||
| 016-043-00-3 | dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate | 401-010-1 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-044-00-9 | disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate | 401-320-7 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 016-045-00-4 | lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate | 401-560-2 | 108624-00-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-046-00-X | sodium hydrogensulphate | 231-665-7 | 7681-38-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 016-047-00-5 | hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate | 401-650-1 | 85665-96-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-048-00-0 | sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate | 401-870-8 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 016-049-00-6 | calcium octadecylxylenesulphonate | 402-040-8 | - | Skin Corr. 1B Aquatic Chronic 2 | H314 H411 | GHS05 GHS09 Gef. | H314 H411 | |||
| 016-050-00-1 | potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat | 402-150-6 | - | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 016-051-00-7 | trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate | 402-170-5 | 106359-91-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-052-00-2 | benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate | 402-240-5 | 102561-46-6 | Acute Tox. 4 * Aquatic Chronic 2 | H332 H411 | GHS07 GHS09 Achtg. | H332 H411 | |||
| 016-053-00-8 | (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate | 402-460-1 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H315 H317 H413 | GHS07 Achtg. | H315 H317 H413 | |||
| 016-054-00-3 | sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate | 400-030-8 | - | Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Sens. 1 | H331 H372 ** H302 H319 H335 H317 | GHS06 GHS08 Gef. | H331 H372 ** H302 H319 H335 H317 | |||
| 016-055-00-9 | tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) | 400-510-7 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 016-056-00-4 | potassium hydrogensulphate | 231-594-1 | 7646-93-7 | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | |||
| 016-057-00-X | styrene-4-sulfonyl chloride | 404-770-2 | 2633-67-2 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H315 H318 H317 | GHS05 GHS07 Gef. | H315 H318 H317 | |||
| 016-058-00-5 | thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14 - tert-alkylamine | 404-820-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H315 H317 H412 | GHS07 Achtg. | H315 H317 H412 | |||
| 016-059-00-0 | N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride | 405-300-9 | 17339-60-5 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H317 H410 | |||
| 016-060-00-6 | diammonium peroxodisulphate; ammonium persulphate | 231-786-5 | 7727-54-0 | Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 | H272 H302 H319 H335 H315 H334 H317 | GHS03 GHS08 GHS07 Gef. | H272 H302 H319 H335 H315 H334 H317 | |||
| 016-061-00-1 | dipotassium peroxodisulphate; potassium persulphate | 231-781-8 | 7727-21-1 | Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 | H272 H302 H319 H335 H315 H334 H317 | GHS03 GHS08 GHS07 Gef. | H272 H302 H319 H335 H315 H334 H317 | |||
| 016-062-00-7 | bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane | - | 17606-31-4 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 016-063-00-2 | sodium metabisulphite | 231-673-0 | 7681-57-4 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | EUH031 | ||
| 016-064-00-8 | sodium hydrogensulphite . . . %; sodium bisulphite . . . % | 231-548-0 | 7631-90-5 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | EUH031 | B | |
| 016-065-00-3 | sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate | 400-100-8 | 84057-97-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 016-066-00-9 | tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) | 404-070-7 | 116912-62-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 016-067-00-4 | (4-methylphenyl)mesitylene sulfonate | 407-530-5 | 67811-06-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-068-00-X | sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate | 407-720-8 | 155160-86-4 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 016-069-00-5 | 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid | 407-990-7 | 141915-64-2 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 016-070-00-0 | 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone | 408-220-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-071-00-6 | trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate | 410-130-3 | 136248-03-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 016-072-00-1 | 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide | 411-520-6 | 112195-27-4 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 016-073-00-7 | tetrakis(phenylmethyl)thioperoxydi(carbothioamide) | 404-310-0 | 10591-85-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-074-00-2 | 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene | 405-410-7 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H315 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H411 | |||
| 016-075-00-8 | 2,2'-diallyl-4,4'-sulfonyldiphenol | 411-570-9 | 41481-66-7 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 016-076-00-3 | 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol | 411-290-7 | 131538-00-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H410 | |||
| 016-077-00-9 | 2-chloro-p-toluenesulfochloride | 412-890-1 | 42413-03-6 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H314 H317 H412 | GHS05 GHS07 Gef. | H314 H317 H412 | |||
| 016-078-00-4 | 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide | 413-300-5 | 56187-04-3 | Aquatic Chronic 4 | H413 | - | ||||
| 016-079-00-X | N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide | 412-920-3 | 16695-22-0 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 016-080-00-5 | sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate | 412-320-1 | 31361-99-6 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 016-081-00-0 | hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide | 418-350-1 | - | Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H341 H302 H319 H317 H411 | GHS08 GHS07 GHS09 Achtg. | H341 H302 H319 H317 H411 | |||
| 016-082-00-6 | ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea | - | 126801-58-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 016-083-00-1 | acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester | 420-050-0 | 135158-54-2 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H317 H410 | |||
| 016-084-00-7 | prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea | - | 94125-34-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=100 | ||
| 016-085-00-2 | flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea | - | 104040-78-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 016-086-00-8 | tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | 402-590-9 | 109125-56-6 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 016-087-00-3 | reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate | 403-490-8 | 104558-95-4 | Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H319 H317 H400 H410 | GHS07 GHS09 Achtg. | H319 H317 H410 | |||
| 016-088-00-9 | 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid | 407-280-7 | 71297-11-5 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 016-089-00-4 | reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene | 413-840-1 | - | Self-react.
C **** Aquatic Chronic 4 | H242 H413 | GHS02 Gef. | H242 H413 | |||
| 016-090-00-X | 4-methyl-N-(methylsulfonyl)benzenesulfonamide | 415-040-8 | 14653-91-9 | Acute Tox. 4 * STOT SE 3 Eye Dam. 1 | H302 H335 H318 | GHS05 GHS07 Gef. | H302 H335 H318 | |||
| 016-091-00-5 | C12-14 - tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate | 414-110-5 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 016-092-00-0 | reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol | 427-050-1 | - | Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361f H315 H317 H410 | |||
| 016-093-00-6 | reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) | 414-770-4 | 140698-96-0 | Self-react.
C**** Carc. 2 | H242 H351 | GHS02 GHS08 Gef. | H242 H351 | |||
| 016-094-00-1 | sulfur | 231-722-6 | 7704-34-9 | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 016-095-00-7 | reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) | 417-980-4 | - | Self-react.
C**** Carc. 2 | H242 H351 | GHS02 GHS08 Gef. | H242 H351 | |||
| 016-096-00-2 | thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate | - | 79277-27-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | 434-480-1 | 32047-53-3 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H302 H314 H317 H412 | GHS05 GHS07 Gef. | H302 H314 H317 H412 | |||
| 017-001-00-7 | chlorine | 231-959-5 | 7782-50-5 | Ox. Gas 1 Press. Gas Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H270 H331 H319 H335 H315 H400 | GHS03 GHS04 GHS06 GHS09 Gef. | H270 H331 H319 H335 H315 H400 | M = 100 | U | |
| 017-002-00-2 | hydrogen chloride | 231-595-7 | 7647-01-0 | Press.
Gas Acute Tox. 3 * Skin Corr. 1A | H331 H314 | GHS04 GHS06 GHS05 Gef. | H331 H314 | U5 | ||
| 017-002-01-X | hydrochloric acid ... % | 231-595-7 | - | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % | B | |
| 017-003-00-8 | barium chlorate | 236-760-7 | 13477-00-4 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H271 H332 H302 H411 | GHS03 GHS07 GHS09 Gef. | H271 H332 H302 H411 | |||
| 017-004-00-3 | potassium chlorate | 223-289-7 | 3811-04-9 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H271 H332 H302 H411 | GHS03 GHS07 GHS09 Gef. | H271 H332 H302 H411 | |||
| 017-005-00-9 | sodium chlorate | 231-887-4 | 7775-09-9 | Ox. Sol. 1 Acute Tox. 4 * Aquatic Chronic 2 | H271 H302 H411 | GHS03 GHS07 GHS09 Gef. | H271 H302 H411 | |||
| 017-006-00-4 | perchloric acid ... % | 231-512-4 | 7601-90-3 | Ox. Liq. 1 Skin Corr. 1A | H271 H314 | GHS03 GHS05 Gef. | H271 H314 | Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: | B | |
| 017-007-00-X | barium perchlorate | 236-710-4 | 13465-95-7 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * | H271 H332 H302 | GHS03 GHS07 Gef. | H271 H332 H302 | |||
| 017-008-00-5 | potassium perchlorate | 231-912-9 | 7778-74-7 | Ox. Sol. 1 Acute Tox. 4 * | H271 H302 | GHS03 GHS07 Gef. | H271 H302 | |||
| 017-009-00-0 | ammonium perchlorate | 232-235-1 | 7790-98-9 | Expl. 1,1 Ox. Sol. 1 | H201 H271 | GHS01 Gef. | H201 H271 | T | ||
| 017-010-00-6 | sodium perchlorate | 231-511-9 | 7601-89-0 | Ox. Sol. 1 Acute Tox. 4 * | H271 H302 | GHS03 GHS07 Gef. | H271 H302 | |||
| 017-011-00-1 | sodium hypochlorite, solution ... % Cl active | 231-668-3 | 7681-52-9 | Skin Corr. 1B Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | EUH031 | EUH031: C ≥ 5 % | B |
| 017-012-00-7 | calcium hypochlorite | 231-908-7 | 7778-54-3 | Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 | H272 H302 H314 H400 | GHS03 GHS05 GHS07 GHS09 Gef. | H272 H302 H314 H400 | EUH031 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 | T |
| 017-013-00-2 | calcium chloride | 233-140-8 | 10043-52-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 017-014-00-8 | ammonium chloride | 235-186-4 | 12125-02-9 | Acute Tox. 4 * Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 017-015-00-3 | (2-(aminomethyl)phenyl)acetylchloride hydrochloride | 417-410-4 | 61807-67-8 | Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 | H302 H314 H317 | GHS05 GHS07 Gef. | H302 H314 H317 | |||
| 017-016-00-9 | methyltriphenylphosphonium chloride | 418-400-2 | 1031-15-8 | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H312 H302 H315 H318 H411 | GHS05 GHS07 GHS09 Gef. | H312 H302 H315 H318 H411 | |||
| 017-017-00-4 | (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride | 426-210-6 | 120086-58-0 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 017-018-00-X | N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride | 405-660-7 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 017-019-00-5 | (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride | 415-110-8 | 54417-53-7 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 017-020-00-0 | ethyl propoxy aluminium chloride | 421-790-7 | 13014-29-4 | Water-react. 1 Skin Corr. 1A | H260 H314 | GHS02 GHS05 Gef. | H260 H314 | EUH014 | ||
| 017-021-00-6 | behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride | 423-420-1 | 136920-10-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H318 H317 H410 | |||
| 017-023-00-7 | [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides | 425-520-9 | 197179-61-6 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 017-026-00-3 | chlorine dioxide | 233-162-8 | 10049-04-4 | Press.
Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 | H270 H330 H314 H400 | GHS04 GHS03 GHS06 GHS05 GHS09 Gef. | H270 H330 H314 H400 | M = 10 | 5 | |
| 017-026-01-0 | chlorine dioxide % | 233-162-8 | 10049-04-4 | Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 | H301 H314 H400 | GHS06 GHS05 GHS09 Gef. | H301 H314 H400 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 | B | |
| 019-001-00-2 | potassium | 231-119-8 | 7440-09-7 | Water-react. 1 Skin Corr. 1B | H260 H314 | GHS02 GHS05 Gef. | H260 H314 | EUH014 | ||
| 019-002-00-8 | potassium hydroxide; caustic potash | 215-181-3 | 1310-58-3 | Acute Tox. 4 * Skin Corr. 1A | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % | ||
| 019-003-00-3 | Kalium-(E,E)-hexa-2,4-dienoat | 246-376-1 | 24634-61-5 | Eye Irrit. 2 | H319 | GSH07 Achtg. | H319 | |||
| 020-001-00-X | calcium | 231-179-5 | 7440-70-2 | Water-react. 2 | H261 | GHS02 Gef. | H261 | |||
| 020-002-00-5 | calcium cyanide | 209-740-0 | 592-01-8 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H400 H410 | GHS06 GHS09 Gef. | H300 H410 | EUH032 | ||
| 020-003-00-0 | reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] | 420-470-4 | - | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | |||
| 022-001-00-5 | titanium tetrachloride | 231-441-9 | 7550-45-0 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | EUH014 | ||
| 022-002-00-0 | titanium(4+) oxalate | 403-260-7 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 022-003-00-6 | bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium | 412-000-1 | 125051-32-3 | Flam. Sol. 1 Repr. 2 STOT RE 2 * Aquatic Chronic 2 | H228 H361f *** H373 ** H411 | GHS02 GHS08 GHS09 Gef. | H228 H361f *** H373 ** H411 | T | ||
| 022-004-00-1 | potassium titanium oxide (K2Ti6O13) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium | 419-840-8 | 169104-71-6 | Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 | H228 H314 H317 H413 | GHS02 GHS05 GHS07 Gef. | H228 H314 H317 H413 | |||
| 023-001-00-8 | divanadium pentaoxide; vanadium pentoxide | 215-239-8 | 1314-62-1 | Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Chronic 2 | H341 H361d *** H372 ** H332 H302 H335 H411 | GHS08 GHS07 GHS09 Gef. | H341 H361d *** H372 ** H332 H302 H335 H411 | |||
| 024-001-00-0 | chromium (VI) trioxide | 215-607-8 | 1333-82-0 | Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H400 H410 | GHS03 GHS06 GHS08 GHS05 GHS09 Gef. | H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H410 | STOT SE 3; H335: C ≥ 1 % | ||
| 024-002-00-6 | potassium dichromate | 231-906-6 | 7778-50-9 | Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 | GHS03 GHS06 GHS08 GHS05 GHS09 Gef. | H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 | STOT SE 3; H335: C ≥ 5 % | 3 | |
| 024-003-00-1 | ammonium dichromate | 232-143-1 | 7789-09-5 | Ox. Sol. 2 **** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 | GHS03 GHS06 GHS08 GHS05 GHS09 Gef. | H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 | STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317: C ≥ 0,2 % | G3 | |
| 024-004-00-7 | sodium dichromate | 234-190-3 | 10588-01-9 | Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 | GHS03 GHS06 GHS05 GHS08 GHS09 Gef. | H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 | Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317: C ≥ 0,2 % STOT SE 3; H335: C ≥ 5 % | 3 | |
| 024-005-00-2 | chromyl dichloride; chromic oxychloride | 239-056-8 | 14977-61-8 | Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H271 H350i H340 H314 H317 H400 H410 | GHS03 GHS08 GHS05 GHS07 GHS09 Gef. | H271 H350i H340 H314 H317 H410 | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % | T3 | |
| 024-006-00-8 | potassium chromate | 232-140-5 | 7789-00-6 | Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H340 H319 H335 H315 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H340 H319 H335 H315 H317 H410 | Skin Sens. 1; H317: C ≥ 0.5 % | 3 | |
| 024-007-00-3 | zinc chromates including zinc potassium chromate | - | - | Carc. 1A Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H317 H410 | A | ||
| 024-008-00-9 | calcium chromate | 237-366-8 | 13765-19-0 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | |||
| 024-009-00-4 | strontium chromate | 232-142-6 | 7789-06-2 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H400 H410 | |||
| 024-010-00-X | dichromium tris(chromate); chromium III chromate; chromic chromate | 246-356-2 | 24613-89-6 | Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H271 H350 H314 H317 H400 H410 | GHS03 GHS08 GHS05 GHS07 GHS09 Gef. | H271 H350 H314 H317 H410 | T | ||
| 024-011-00-5 | ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) | 400-110-2 | 109125-51-1 | Self-react.
C **** Aquatic Acute 1 Aquatic Chronic 1 | H242 H400 H410 | GHS02 GHS09 Gef. | H242 H410 | |||
| 024-012-00-0 | trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) | 400-810-8 | - | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 024-013-00-6 | trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) | 402-500-8 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 024-014-00-1 | trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) | 402-870-0 | 93952-24-0 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 024-015-00-7 | disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) | 404-930-1 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H332 H318 H411 | GHS05 GHS07 GHS09 Gef. | H332 H318 H411 | |||
| 024-016-00-2 | tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) | 405-110-6 | 88377-66-6 | STOT RE 2 * Aquatic Chronic 4 | H373 ** H413 | GHS08 Achtg. | H373 ** H413 | |||
| 024-017-00-8 | Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex | - | - | Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H317 H410 | A | ||
| 024-018-00-3 | sodium chromate | 231-889-5 | 7775-11-3 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 | Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317: C ≥ 0,2 % | 3 | |
| 024-019-00-9 | Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) | 419-230-1 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 024-020-00-4 | trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) | 418-220-4 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 024-021-00-X | potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) | 425-830-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 025-001-00-3 | manganese dioxide | 215-202-6 | 1313-13-9 | Acute Tox. 4 * Acute Tox. 4 * | H332 H302 | GHS07 Achtg. | H332 H302 | |||
| 025-002-00-9 | potassium permanganate | 231-760-3 | 7722-64-7 | Ox. Sol. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H272 H302 H400 H410 | GHS03 GHS07 GHS09 Gef. | H272 H302 H410 | |||
| 025-003-00-4 | manganese sulphate | 232-089-9 | 7785-87-7 | STOT RE 2 * Aquatic Chronic 2 | H373 ** H411 | GHS08 GHS09 Achtg. | H373 ** H411 | |||
| 025-004-00-X | bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate | 411-760-1 | 116633-53-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 025-005-00-5 | reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-); tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-); pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) | 417-660-4 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 026-001-00-6 | (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate | 407-840-0 | 100011-37-8 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 026-002-00-1 | (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate | 407-880-9 | 117549-13-0 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 026-003-00-7 | iron(II) sulfate | 231-753-5 | 7720-78-7 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H302 H319 H315 | GHS07 Achtg. | H302 H319 H315 | |||
| 026-003-01-4 | iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate | 231-753-5 | 7782-63-0 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H302 H319 H315 | GHS07 Achtg. | H302 H319 H315 | Skin Irrit. 2; H315: C ≥ 25 % | ||
| 026-004-00-2 | potassium ferrite | 430-010-4 | 12160-44-0 | Skin Corr. 1B Skin Sens. 1 | H314 H317 | GHS05 GHS07 Gef. | H314 H317 | |||
| 027-001-00-9 | cobalt | 231-158-0 | 7440-48-4 | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 | H334 H317 H413 | GHS08 Gef. | H334 H317 H413 | |||
| 027-002-00-4 | cobalt oxide | 215-154-6 | 1307-96-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | M=10 | ||
| 027-003-00-X | cobalt sulfide | 215-273-3 | 1317-42-6 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M=10 | ||
| 027-004-00-5 | cobalt dichloride | 231-589-4 | 7646-79-9 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360F*** H302 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360F*** H302 H334 H317 H410 | Carc. 1B; H350i: C ≥ 0,01 % M=10 | 1 | |
| 027-005-00-0 | cobalt sulfate | 233-334-2 | 10124-43-3 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360F*** H302 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360F*** H302 H334 H317 H410 | Carc. 1B; H350i: C ≥ 0,01 % M=10 | 1 | |
| 027-006-00-6 | cobalt di(acetate) | 200-755-8 | 71-48-7 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360F*** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360F*** H334 H317 H410 | Carc. 1B; H350i: C ≥ 0,01 % M = 10 | 1 | |
| 027-007-00-1 | zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex | 425-240-7 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 027-008-00-7 | complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3) | 427-390-9 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 027-009-00-2 | cobalt dinitrate | 233-402-1 | 10141-05-6 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360F*** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360F*** H334 H317 H410 | Carc. 1B; H350i: C ≥ 0,01 % M = 10 | 1 | |
| 027-010-00-8 | cobalt carbonate | 208-169-4 | 513-79-1 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360F*** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360F*** H334 H317 H410 | Carc. 1B; H350i: C ≥ 0,01 % M=10 | 1 | |
| 028-001-00-1 | tetracarbonylnickel; nickel tetracarbonyl | 236-669-2 | 13463-39-3 | Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H225 H351 H360D *** H330 H400 H410 | GHS02 GHS06 GHS08 GHS09 Gef. | H225 H351 H360D *** H330 H410 | |||
| 028-002-00-7 | nickel | 231-111-4 | 7440-02-0 | Carc. 2 STOT RE 1 Skin Sens. 1 | H351 H372** H317 | GHS08 GHS07 Gef. | H351 H372** H317 | S7 | ||
| 028-002-01-4 | nickel powder; [particle diameter < 1 mm] | 231-111-4 | 7440-02-0 | Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 | H351 H372** H317 H412 | GHS08 GHS07 Gef. | H351 H372** H317 H412 | |||
| 028-003-00-2 | nickel monoxide; [1] nickel oxide; [2] bunsenite [3] | 215-215-7 [1] 234-323-5 [2] - [3] | 1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 | H350i H372** H317 H413 | GHS08 GHS07 Gef. | H350i H372** H317 H413 | |||
| 028-004-00-8 | nickel dioxide | 234-823-3 | 12035-36-8 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 | H350i H372** H317 H413 | GHS08 GHS07 Gef. | H350i H372** H317 H413 | |||
| 028-005-00-3 | dinickel trioxide | 215-217-8 | 1314-06-3 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 | H350i H372** H317 H413 | GHS08 GHS07 Gef. | H350i H372** H317 H413 | |||
| 028-006-00-9 | nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] | 240-841-2 [1] 234-349-7 [2] - [3] | 16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] | Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H372** H317 H410 | |||
| 028-007-00-4 | trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] | 234-829-6 [1] - [2] | 12035-72-2 [1] 12035-71-1 [2] | Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H372** H317 H410 | |||
| 028-008-00-X | nickel dihydroxide; [1] nickel hydroxide [2] | 235-008-5 [1] 234-348-1 [2] | 12054-48-7 [1] 11113-74-9 [2] | Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 | |||
| 028-009-00-5 | nickel sulfate | 232-104-9 | 7786-81-4 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 | ||
| 028-010-00-0 | nickel carbonate; basic nickel carbonate; carbonic acid, nickel (2+) salt; [1] carbonic acid, nickel salt; [2] [μ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3] [carbonato(2-)] tetrahydroxytrinickel [4] | 222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] | 3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 | |||
| 028-011-00-6 | nickel dichloride | 231-743-0 | 7718-54-9 | Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 | ||
| 028-012-00-1 | nickel dinitrate; [1] nitric acid, nickel salt [2] | 236-068-5 [1] 238-076-4 [2] | 13138-45-9 [1] 14216-75-2 [2] | Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 | GHS03 GHS05 GHS08 GHS07 GHS09 Gef. | H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 | ||
| 028-013-00-7 | nickel matte | 273-749-6 | 69012-50-6 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | 295-859-3 | 92129-57-2 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | 305-433-1 | 94551-87-8 | Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | |||
| 028-016-00-3 | nickel diperchlorate; perchloric acid, nickel(II) salt | 237-124-1 | 13637-71-3 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H314 H334 H317 H400 H410 | GHS05 GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H314 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-017-00-9 | nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] | 237-563-9 [1] 239-793-2 [2] | 13842-46-1 [1] 15699-18-0 [2] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360D*** H372** H332 H302 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-018-00-4 | nickel bis(sulfamidate); nickel sulfamate | 237-396-1 | 13770-89-3 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-019-00-X | nickel bis(tetrafluoroborate) | 238-753-4 | 14708-14-6 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-021-00-0 | nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] | 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] | 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-022-00-6 | nickel di(acetate); [1] nickel acetate [2] | 206-761-7 [1] 239-086-1 [2] | 373-02-4 [1] 14998-37-9 [2] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H341 H360D*** H372** H332 H302 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 | ||
| 028-024-00-7 | nickel dibenzoate | 209-046-8 | 553-71-9 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | 223-463-2 | 3906-55-6 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-026-00-8 | nickel(II) stearate; nickel(II) octadecanoate | 218-744-1 | 2223-95-2 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-027-00-3 | nickel dilactate | - | 16039-61-5 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-028-00-9 | nickel(II) octanoate | 225-656-7 | 4995-91-9 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H314 H334 H317 H400 H410 | GHS05 GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H314 H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-029-00-4 | nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] | 233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] | 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-030-00-X | nickel hexafluorosilicate | 247-430-7 | 26043-11-8 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-031-00-5 | nickel selenate | 239-125-2 | 15060-62-5 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-032-00-0 | nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] | 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] | 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | |||
| 028-033-00-6 | diammonium nickel hexacyanoferrate | - | 74195-78-1 | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | |||
| 028-034-00-1 | nickel dicyanide | 209-160-8 | 557-19-7 | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | EUH032 | ||
| 028-035-00-7 | nickel chromate | 238-766-5 | 14721-18-7 | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | |||
| 028-036-00-2 | nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] | 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] | 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-037-00-8 | dinickel hexacyanoferrate | 238-946-3 | 14874-78-3 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-038-00-3 | trinickel bis(arsenate); nickel(II) arsenate | 236-771-7 | 13477-70-8 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H372** H317 H410 | |||
| 028-039-00-9 | nickel oxalate; [1] oxalic acid, nickel salt [2] | 208-933-7 [1] 243-867-2 [2] | 547-67-1 [1] 20543-06-0 [2] | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-040-00-4 | nickel telluride | 235-260-6 | 12142-88-0 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-041-00-X | trinickel tetrasulfide | - | 12137-12-1 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-042-00-5 | trinickel bis(arsenite) | - | 74646-29-0 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-043-00-0 | cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] | 269-051-6 [1] 261-346-8 [2] - [3] | 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] | Carc. 1A STOT RE 1 Skin Sens. 1 | H350i H372** H317 | GHS08 GHS07 Gef. | H350i H372** H317 | |||
| 028-044-00-6 | nickel tin trioxide; nickel stannate | 234-824-9 | 12035-38-0 | Carc. 1A STOT RE 1 Skin Sens. 1 | H350i H372** H317 | GHS08 GHS07 Gef. | H350i H372** H317 | |||
| 028-045-00-1 | nickel triuranium decaoxide | 239-876-6 | 15780-33-3 | Carc. 1A STOT RE 1 Skin Sens. 1 | H350i H372** H317 | GHS08 GHS07 Gef. | H350i H372** H317 | |||
| 028-046-00-7 | nickel dithiocyanate | 237-205-1 | 13689-92-4 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | EUH032 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | |
| 028-047-00-2 | nickel dichromate | 239-646-5 | 15586-38-6 | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-048-00-8 | nickel(II) selenite | 233-263-7 | 10101-96-9 | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | |||
| 028-049-00-3 | nickel selenide | 215-216-2 | 1314-05-2 | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-050-00-9 | silicic acid, lead nickel salt | - | 68130-19-8 | Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H360Df H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H360Df H372** H317 H410 | |||
| 028-051-00-4 | nickel diarsenide; [1] nickel arsenide [2] | 235-103-1 [1] 248-169-1 [2] | 12068-61-0 [1] 27016-75-7 [2] | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-052-00-X | nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 | 271-853-6 | 68610-24-2 | Carc. 1A STOT RE 1 Skin Sens. 1 | H350i H372** H317 | GHS08 GHS07 Gef. | H350i H372** H317 | |||
| 028-053-00-5 | nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] | 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] | 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-054-00-0 | nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(d-gluconato-O 1,O 2)nickel; [18] nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] | 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] | 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] | Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H341 H360D*** H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H341 H360D*** H372** H334 H317 H410 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 | ||
| 028-055-00-6 | nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] | 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] | 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] | Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H334 H317 H400 H410 | GHS08 GHS09 Gef. | H350i H372** H334 H317 H410 | |||
| 028-056-00-1 | nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] | 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] | 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] | Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H372** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350i H372** H317 H410 | |||
| 028-057-00-7 | dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] | 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] | 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] | Carc. 1A STOT RE 1 Skin Sens. 1 | H350i H372** H317 | GHS08 GHS07 Gef. | H350i H372** H317 | |||
| 028-058-00-2 | cobalt lithium nickel oxide | 442-750-5 | - | Carc. 1A Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350i H330 H372** H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350i H330 H372** H317 H410 | |||
| 029-001-00-4 | copper chloride; copper (I) chloride; cuprous chloride | 231-842-9 | 7758-89-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H400 H410 | |||
| 029-002-00-X | Dikupferoxid; Kupfer(I)-oxid | 215-270-7 | 1317-39-1 | Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H318 H400 H410 | GHS07 GHS05 GHS09 Gef. | H332 H302 H318 H410 | M = 100 | ||
| 029-003-00-5 | Naphthenic acids, copper salts; copper naphthenate | 215-657-0 | 1338-02-9 | Flam. Liq. 3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H226 H302 H400 H410 | GHS02 GHS07 GHS09 Achtg. | H226 H302 H410 | |||
| 029-004-00-0 | copper sulphate | 231-847-6 | 7758-98-7 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H315 H410 | |||
| 029-005-00-6 | (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid | 401-260-1 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 029-006-00-1 | tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) | 403-210-4 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 029-007-00-7 | (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide | 404-670-9 | 89797-01-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | G | ||
| 029-008-00-2 | copper(II) methanesulfonate | 405-400-2 | 54253-62-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 029-009-00-8 | phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex | 413-650-9 | 93971-95-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 029-010-00-3 | reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) | 407-700-9 | 101408-30-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 029-011-00-9 | sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex | 412-730-0 | 150522-10-4 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 029-012-00-4 | sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) | 407-340-2 | 124719-24-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | 407-580-8 | 130201-51-3 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 029-014-00-5 | reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex; 2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex | 419-610-7 | 171866-24-3 | STOT RE 2 * Aquatic Chronic 2 | H373** H411 | GHS08 GHS09 Achtg. | H373** H411 | |||
| 029-015-00-0 | Kupferthiocyanat | 214-183-1 | 1111-67-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | EUH032 | M = 10 | |
| 029-016-00-6 | Kupfer(II)-oxid | 215-269-1 | 1317-38-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 100 | ||
| 029-017-00-1 | Dikupferchloridtrihydroxid | 215-572-9 | 1332-65-6 | Acute Tox. 4 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 | H332 H301 H400 H410 | GHS06 GHS09 Gef. | H332 H301 H410 | M = 10 | ||
| 029-018-00-7 | Tetrakupferhexahydroxidsulfat; [1] Tetrakupferhexahydroxidsulfathydrat; [2] | 215-582-3 [1] 215-582-3 [2] | 1333-22-8 [1] 12527-76-3 [2] | Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M = 10 | ||
| 029-019-01-X | Kupferflocken (mit einem Überzug aus aliphatischer Säure) | - | - | Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H319 H400 H410 | GHS06 GHS09 Gef. | H331 H302 H319 H410 | M = 10 | ||
| 029-020-00-8 | Kupfer(II)-carbonat - Kupfer(II)-hydroxid (1:1) | 235-113-6 | 12069-69-1 | Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H319 H410 | M = 10 | ||
| 029-021-00-3 | Kupferdihydroxid; Kupfer(II)-hydroxid | 243-815-9 | 20427-59-2 | Acute Tox. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H302 H318 H400 H410 | GHS06 GHS05 GHS09 Gef. | H330 H302 H318 H410 | M = 10 | ||
| 029-022-00-9 | Kupferkalkbrühe (Bordeauxbrühe); Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid | - | 8011-63-0 | Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H318 H400 H410 | GHS07 GHS05 GHS09 Gef. | H332 H318 H410 | M = 10 | ||
| 029-023-00-4 | Kupfersulfat-Pentahydrat | 231-847-6 | 7758-99-8 | Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS07 GHS05 GHS09 Gef. | H302 H318 H410 | M = 10 | ||
| 030-001-00-1 | zinc powder - zinc dust (pyrophoric) | 231-175-3 | 7440-66-6 | Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 | H260 H250 H400 H410 | GHS02 GHS09 Gef. | H260 H250 H410 | T | ||
| 030-001-01-9 | zinc powder - zinc dust (stabilised) | 231-175-3 | 7440-66-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 030-003-00-2 | zinc chloride | 231-592-0 | 7646-85-7 | Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H410 | STOT SE 3; H335: C ≥ 5 % | ||
| 030-004-00-8 | dimethylzinc; [1] diethylzinc [2] | 208-884-1 [1] 209-161-3 [2] | 544-97-8 [1] 557-20-0 [2] | Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H250 H260 H314 H400 H410 | GHS02 GHS05 GHS09 Gef. | H250 H260 H314 H410 | EUH014 | ||
| 030-005-00-3 | diamminediisocyanatozinc | 401-610-3 | - | Acute Tox. 4 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 | H302 H318 H334 H317 H400 | GHS05 GHS08 GHS07 GHS09 Gef. | H302 H318 H334 H317 H400 | |||
| 030-006-00-9 | zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1] zinc sulphate (anhydrous) [2] | 231-793-3 [1] 231-793-3 [2] | 7446-19-7 [1] 7733-02-0 [2] | Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 030-007-00-4 | bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc | 403-360-0 | 42405-40-3 | Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H228 H302 H400 H410 | GHS02 GHS07 GHS09 Gef. | H228 H302 H410 | T | ||
| 030-008-00-X | hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) | 403-750-0 | 113036-91-2 | Acute Tox. 4 * Aquatic Chronic 2 | H332 H411 | GHS07 GHS09 Achtg. | H332 H411 | |||
| 030-009-00-5 | zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate | 417-130-2 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 030-010-00-0 | 2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt | 430-740-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 030-011-00-6 | trizinc bis(orthophosphate) | 231-944-3 | 7779-90-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | H413 | ||||
| 030-013-00-7 | zinc oxide | 215-222-5 | 1314-13-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | 440-060-9 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 031-001-00-4 | Galliumarsenid | 215-114-8 | 1303-00-0 | Repr. 1B Carc. 1B STOT RE 1 | H360F H350 H372 (Atmungssystem und hämatopoetisches System) | GHS08 Gef. | H360F H350 H372 (Atmungssystem und hämatopoetisches System) | |||
| 033-001-00-X | arsenic | 231-148-6 | 7440-38-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | |||
| 033-002-00-5 | arsenic compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | * | A1 | |
| 033-003-00-0 | diarsenic trioxide; arsenic trioxide | 215-481-4 | 1327-53-3 | Carc. 1A Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H300 H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H350 H300 H314 H410 | |||
| 033-004-00-6 | diarsenic pentaoxide; arsenic pentoxide; arsenic oxide | 215-116-9 | 1303-28-2 | Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H331 H301 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H331 H301 H410 | |||
| 033-005-00-1 | arsenic acid and its salts with the exception of those specified elsewhere in this Annex | - | - | Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H331 H301 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H331 H301 H410 | A | ||
| 033-006-00-7 | arsine | 232-066-3 | 7784-42-1 | Flam. Gas 1 Press. Gas Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H220 H330 H373 ** H400 H410 | GHS02 GHS04 GHS06 GHS08 GHS09 Gef. | H220 H330 H373 ** H410 | U | ||
| 033-007-00-2 | tert-butylarsine | 423-320-6 | 4262-43-5 | Pyr. Liq. 1 Acute Tox. 2 * | H250 H330 | GHS02 GHS06 Gef. | H250 H330 | |||
| 034-001-00-2 | selenium | 231-957-4 | 7782-49-2 | Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 4 | H331 H301 H373 ** H413 | GHS06 GHS08 Gef. | H331 H301 H373 ** H413 | |||
| 034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H373** H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H301 H373** H410 | A | ||
| 034-003-00-3 | sodium selenite | 233-267-9 | 10102-18-8 | Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 2 | H300 H331 H317 H411 | GHS06 GHS09 Gef. | H300 H331 H317 H411 | EUH031 | ||
| 035-001-00-5 | bromine | 231-778-1 | 7726-95-6 | Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 | H330 H314 H400 | GHS06 GHS05 GHS09 Gef. | H330 H314 H400 | |||
| 035-002-00-0 | hydrogen bromide | 233-113-0 | 10035-10-6 | Press.
Gas Skin Corr. 1A STOT SE 3 | H314 H335 | GHS04 GHS05 GHS07 Gef. | H314 H335 | U | ||
| 035-002-01-8 | hydrobromic acid ... % | - | - | Skin Corr. 1B STOT SE 3 | H314 H335 | GHS05 GHS07 Gef. | H314 H335 | Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % | B | |
| 035-003-00-6 | potassium bromate | 231-829-8 | 7758-01-2 | Ox. Sol. 1 Carc. 1B Acute Tox. 3 * | H271 H350 H301 | GHS03 GHS06 GHS08 Gef. | H271 H350 H301 | |||
| 035-004-00-1 | 2-hydroxyethylammonium perbromide | 407-440-6 | - | Ox. Sol. 2 **** Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 | H272 H302 H314 H317 H400 | GHS03 GHS05 GHS07 GHS09 Gef. | H272 H302 H314 H317 H400 | |||
| 040-001-00-3 | zirconium powder (pyrophoric) | 231-176-9 | 7440-67-7 | Water-react. 1 Pyr. Sol. 1 | H260 H250 | GHS02 Gef. | H260 H250 | T | ||
| 040-002-00-9 | zirconium powder, dry (non pyrophoric) | - | - | Self-heat. 1 | H251 | GHS02 Gef. | H251 | T | ||
| 040-003-00-4 | reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5 | 430-610-6 | 226996-19-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 042-001-00-9 | molybdenum trioxide | 215-204-7 | 1313-27-5 | Carc. 2 Eye Irrit. 2 STOT SE 3 | H351 H319 H335 | GHS08 GHS07 Achtg. | H351 H319 H335 | |||
| 042-002-00-4 | tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) | 404-760-8 | 117342-25-3 | Acute Tox. 3 * Eye Dam. 1 | H331 H318 | GHS06 GHS05 Gef. | H331 H318 | |||
| 042-003-00-X | tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) | 404-860-1 | 116810-46-9 | Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H228 H318 H400 H410 | GHS02 GHS05 GHS09 Gef. | H228 H318 H410 | T | ||
| 042-004-00-5 | Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) | 412-780-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H315 H317 H411 | GHS07 GHS09 Achtg. | H315 H317 H411 | |||
| 042-005-00-0 | reaction mass of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex | 434-240-6 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 046-001-00-X | tetraammine palladium(II) hydrogen carbonate | 425-270-0 | 134620-00-1 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H302 H373** H318 H317 H410 | |||
| 047-001-00-2 | silver nitrate | 231-853-9 | 7761-88-8 | Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H272 H314 H400 H410 | GHS03 GHS05 GHS09 Gef. | H272 H314 H410 | |||
| 047-002-00-8 | polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt | 416-850-4 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 047-003-00-3 | Silber-Zink-Zeolith (Zeolith, Linde Typ A, Oberfläche mit Silber- und Zinkionen modifiziert) [Dieser Eintrag betrifft Zeolith vom Typ LTA (Linde Typ A), dessen Oberfläche mit Silber- und Zinkionen mit einem Gehalt von Ag+ 0,5 %-6 %, Zn2 + 5 %-16 % und möglicherweise Phospor, NH4+, Mg2+ und/oder Ca2+ jeweils < 3 % modifiziert wurde.] | - | 130328-20-0 | Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H315 H318 H400 H410 | GHS08 GHS05 GHS09 Gef. | H361d H315 H318 H410 | M = 100 M = 100 | ||
| 048-001-00-5 | cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | * | A1 | |
| 048-002-00-0 | cadmium (non-pyrophoric); [1] cadmium oxide (non-pyrophoric) [2] | 231-152-8 [1] 215-146-2 [2] | 7440-43-9 [1] 1306-19-0 [2] | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H361fd H330 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361fd H330 H372 ** H410 | |||
| 048-003-00-6 | cadmium diformate; cadmiumformate | 224-729-0 | 4464-23-7 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H351 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H301 H351 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,25 % | ||
| 048-004-00-1 | cadmium cyanide | 208-829-1 | 542-83-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H351 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H351 H373 ** H410 | EUH032 | STOT RE 2; H373: C ≥ 0,1 % EUH032: C ≥ 1 % | |
| 048-005-00-7 | cadmiumhexafluorosilicate(2-); cadmium fluorosilica | 241-084-0 | 17010-21-8 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H351 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H301 H351 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,1 % | ||
| 048-006-00-2 | cadmium fluoride | 232-222-0 | 7790-79-6 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H360FD H330 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H340 H360FD H330 H301 H372 ** H410 | Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C < 7 % | ||
| 048-007-00-8 | cadmium iodide | 232-223-6 | 7790-80-9 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H351 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H301 H351 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,1 % | ||
| 048-008-00-3 | cadmium chloride | 233-296-7 | 10108-64-2 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H360FD H330 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H340 H360FD H330 H301 H372 ** H410 | Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % | ||
| 048-009-00-9 | cadmium sulphate | 233-331-6 | 10124-36-4 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H360FD H330 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H340 H360FD H330 H301 H372 ** H410 | Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % | ||
| 048-010-00-4 | cadmium sulphide | 215-147-8 | 1306-23-6 | Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 4 | H350 H341 H361fd H372 ** H302 H413 | GHS08 GHS07 Gef. | H350 H341 H361fd H372 ** H302 H413 | * STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % | 1 | |
| 048-011-00-X | cadmium (pyrophoric) | 231-152-8 | 7440-43-9 | Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H250 H350 H341 H361fd H330 H372 ** H400 H410 | GHS02 GHS06 GHS08 GHS09 Gef. | H250 H350 H341 H361fd H330 H372 ** H410 | |||
| 048-012-00-5 | Cadmiumcarbonat | 208-168-9 | 513-78-0 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 | A1 | ||
| 048-013-00-0 | Cadmiumhydroxid; Cadmiumdihydroxid | 244-168-5 | 21041-95-2 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 | A1 | ||
| 048-014-00-6 | Cadmiumnitrat; Cadmiumdinitrat | 233-710-6 | 10325-94-7 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 | Carc. 1B; H350: C ≥ 0,01 % | A1 | |
| 050-001-00-5 | tin tetrachloride; stannic chloride | 231-588-9 | 7646-78-8 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | STOT SE 3; H335: C ≥ 5 % | ||
| 050-002-00-0 | cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide | 236-049-1 | 13121-70-5 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | M=1000 | ||
| 050-003-00-6 | fentin acetate (ISO); triphenyltin acetate | 212-984-0 | 900-95-8 | Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 | M=10 | ||
| 050-004-00-1 | fentin hydroxide (ISO); triphenyltin hydroxide | 200-990-6 | 76-87-9 | Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 | M=10 | ||
| 050-005-00-7 | trimethyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | * | A1 | |
| 050-006-00-2 | triethyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | * | A1 | |
| 050-007-00-8 | tripropyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | * | A1 | |
| 050-008-00-3 | Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführt | - | - | Repr. 1B Acute Tox. 3 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H360FD H301 H312 H372** H315 H319 H400 H410 | GHS08 GHS06 GHS09 Gef. | H360FD H301 H312 H372** H315 H319 H410 | * STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; H315:C ≥ 1 % Eye Irrit. 2; H319:C ≥ 1 % M = 10 | A 1 | |
| 050-009-00-9 | fluorotripentylstannane; [1] hexapentyldistannoxane [2] | 243-546-7 [1] 247-143-7 [2] | 20153-49-5 [1] 25637-27-8 [2] | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | * | 1 | |
| 050-010-00-4 | fluorotrihexylstannane | 243-547-2 | 20153-50-8 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | * | 1 | |
| 050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | * M=100 | A1 | |
| 050-012-00-5 | tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3] | 215-910-5 [1] 221-437-5 [2] 230-358-5 [3] | 1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | * | A1 | |
| 050-013-00-0 | trioctyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 | H319 H335 H315 H413 | GHS07 Achtg. | H319 H335 H315 H413 | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | A1 | |
| 050-017-00-2 | fenbutatin oxide (ISO); bis(tris(2-methyl-2-phenylpropyl)tin)oxide | 236-407-7 | 13356-08-6 | Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H330 H319 H315 H400 H410 | GHS06 GHS09 Gef. | H330 H319 H315 H410 | |||
| 050-018-00-8 | tin(II) methanesulphonate | 401-640-7 | 53408-94-9 | Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H314 H302 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H302 H317 H411 | |||
| 050-019-00-3 | azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H - 1,2,4-triazole | 255-209-1 | 41083-11-8 | Acute Tox. 2 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H301 H335 H315 H318 H400 H410 | GHS06 GHS05 GHS09 Gef. | H330 H301 H335 H315 H318 H410 | |||
| 050-020-00-9 | trioctylstannane | 413-320-4 | 869-59-0 | STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 | H372 ** H315 H413 | GHS08 GHS07 Gef. | H372 ** H315 H413 | |||
| 050-021-00-4 | dichlorodioctyl stannane | 222-583-2 | 3542-36-7 | Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 | H331 H372** H412 | GHS06 GHS08 Gef. | H331 H372** H412 | |||
| 050-022-00-X | dibutyltin dichloride; (DBTC) | 211-670-0 | 683-18-1 | Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H341 H360FD H330 H301 H312 H372** H314 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H341 H360FD H330 H301 H312 H372** H314 H410 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 | ||
| 050-023-00-5 | reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane | 422-920-5 | - | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373** H400 H410 | GHS08 GHS09 Achtg. | H373** H410 | M=10 | ||
| 050-024-00-0 | reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane | 432-230-6 | - | STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H372** H302 H315 H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H372** H302 H315 H318 H317 H410 | |||
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08 Achtg. | H361d | |||
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08 Achtg. | H361d | |||
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08 Gef. | H360D | |||
| 050-028-00-2 | 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-829-0 | 57583-35-4 | Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A | H361d H302 H372 (Nervensystem, Immunsystem) H317 | GHS08 GHS07 Gef. | H361d H302 H372 (Nervensystem, Immunsystem) H317 | |||
| 050-029-00-8 | dimethyltin dichloride | 212-039-2 | 753-73-1 | Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B | H361d H330 H301 H311 H372 (Nervensystem, Immunsystem) H314 | GHS08 GHS06 GHS05 Gef. | H361d H330 H301 H311 H372 (Nervensystem, Immunsystem) H314 | EUH071 | ||
| 050-030-00-3 | Dibutylzinndilaurat; Dibutyl[bis(dodecanoyloxy)]-stannan | 201-039-8 | 77-58-7 | Muta. 2 Repr. 1B STOT RE 1 | H341 H360FD H372 (Immunsystem) | GHS08 Gef. | H341 H360FD H372 (Immunsystem) | |||
| 051-001-00-8 | antimony trichloride | 233-047-2 | 10025-91-9 | Skin Corr. 1B Aquatic Chronic 2 | H314 H411 | GHS05 GHS09 Gef. | H314 H411 | STOT SE 3; H335: C ≥ 5 % | ||
| 051-002-00-3 | antimony pentachloride | 231-601-8 | 7647-18-9 | Skin Corr. 1B Aquatic Chronic 2 | H314 H411 | GHS05 GHS09 Gef. | H314 H411 | STOT SE 3; H335: C ≥ 5 % | ||
| 051-003-00-9 | antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H332 H302 H411 | GHS07 GHS09 Achtg. | H332 H302 H411 | * | A1 | |
| 051-004-00-4 | antimony trifluoride | 232-009-2 | 7783-56-4 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 | H331 H311 H301 H411 | GHS06 GHS09 Gef. | H331 H311 H301 H411 | |||
| 051-005-00-X | antimony trioxide | 215-175-0 | 1309-64-4 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 051-006-00-5 | diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate | 403-500-0 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 051-007-00-0 | bis(4-dodecylphenyl)iodonium hexafluoroantimonate | 404-420-9 | 71786-70-4 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 053-001-00-3 | iodine | 231-442-4 | 7553-56-2 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H332 H312 H400 | GHS07 GHS09 Achtg. | H332 H312 H400 | |||
| 053-002-00-9 | hydrogen iodide | 233-109-9 | 10034-85-2 | Press.
Gas Skin Corr. 1A | H314 | GHS04 GHS05 Gef. | H314 | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥ 0,02 % | U5 | |
| 053-002-01-6 | hydriodic acid ... % | - | - | Skin Corr. 1B | H314 | GHS05 Gef. | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B | ||
| 053-003-00-4 | iodoxybenzene | - | 696-33-3 | Expl. **** | **** | **** | **** | |||
| 053-004-00-X | calcium iodoxybenzoate | - | - | Expl. **** | **** | **** | **** | C | ||
| 053-005-00-5 | (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) | 422-960-3 | 178233-72-2 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H312 H302 H373 ** H410 | |||
| 056-001-00-1 | barium peroxide | 215-128-4 | 1304-29-6 | Ox. Sol. 2 Acute Tox. 4 * Acute Tox. 4 * | H272 H332 H302 | GHS03 GHS07 Gef. | H272 H332 H302 | |||
| 056-002-00-7 | barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * | H332 H302 | GHS07 Achtg. | H332 H302 | * | A1 | |
| 056-003-00-2 | barium carbonate | 208-167-3 | 513-77-9 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 056-004-00-8 | barium chloride | 233-788-1 | 10361-37-2 | Acute Tox. 3 * Acute Tox. 4 * | H301 H332 | GHS06 Gef. | H301 H332 | |||
| 064-001-00-8 | gadolinium(III)sulfite trihydrate | 456-900-2 | 51285-81-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 072-001-00-4 | hafnium tetra-n-butoxide | 411-740-2 | 22411-22-9 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 074-001-00-X | hexasodium tungstate hydrate | 412-770-9 | 12141-67-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 074-002-00-5 | Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione | 408-250-6 | - | Flam. Liq. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H225 H332 H314 H317 H400 H410 | GHS02 GHS05 GHS07 GHS09 Gef. | H225 H332 H314 H317 H410 | |||
| 076-001-00-5 | osmium tetraoxide; osmic acid | 244-058-7 | 20816-12-0 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B | H330 H310 H300 H314 | GHS06 GHS05 Gef. | H330 H310 H300 H314 | |||
| 078-001-00-0 | tetrachloroplatinates with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H318 H334 H317 | A | ||
| 078-002-00-6 | diammonium tetrachloroplatinate | 237-499-1 | 13820-41-2 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H315 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H315 H318 H334 H317 | |||
| 078-003-00-1 | disodium tetrachloroplatinate | 233-051-4 | 10026-00-3 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H315 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H315 H318 H334 H317 | |||
| 078-004-00-7 | dipotassium tetrachloroplatinate | 233-050-9 | 10025-99-7 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H315 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H315 H318 H334 H317 | |||
| 078-005-00-2 | hexachloroplatinates with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H318 H334 H317 | A | ||
| 078-006-00-8 | disodium hexachloroplatinate | 240-983-5 | 16923-58-3 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H318 H334 H317 | |||
| 078-007-00-3 | dipotassium hexachloroplatinate | 240-979-3 | 16921-30-5 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H318 H334 H317 | |||
| 078-008-00-9 | diammonium hexachloroplatinate | 240-973-0 | 16919-58-7 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H301 H318 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H318 H334 H317 | |||
| 078-009-00-4 | hexachloroplatinic acid | 241-010-7 | 16941-12-1 | Acute Tox. 3 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 | H301 H314 H334 H317 | GHS06 GHS05 GHS08 Gef. | H301 H314 H334 H317 | |||
| 078-010-00-X | tetraammine platinum(II) hydrogen carbonate | 426-730-3 | 123439-82-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 078-011-00-5 | hydroxydisulfito platinum(II) acid | 423-310-1 | 61420-92-6 | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H373 H314 H334 H317 H412 | GHS05 GHS08 GHS07 Gef. | H302 H373 H314 H334 H317 H412 | |||
| 078-012-00-0 | platinum(IV) nitrate/nitric acid solution | 432-400-1 | - | Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 080-001-00-0 | mercury | 231-106-7 | 7439-97-6 | Repr. 1B Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D*** H330 H372** H400 H410 | GHS06 GHS08 GHS09 Gef. | H360D*** H330 H372** H410 | |||
| 080-002-00-6 | inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,1 % | A1 | |
| 080-003-00-1 | dimercury dichloride; mercurous chloride; calomel | 233-307-5 | 10112-91-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H315 H410 | |||
| 080-004-00-7 | organic compounds of mercury with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,1 % | A1 | |
| 080-005-00-2 | mercury difulminate; mercuric fulminate; fulminate of mercury | 211-057-8 | 628-86-4 | Unst. Expl. Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H200 H331 H311 H301 H373 ** H400 H410 | GHS01 GHS06 GHS08 GHS09 Gef. | H200 H331 H311 H301 H373 ** H400 H410 | |||
| 080-005-01-X | mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser] | 211-057-8 | 628-86-4 | Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H201 H331 H311 H301 H373 ** H400 H410 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H331 H311 H301 H373 ** H400 H410 | |||
| 080-006-00-8 | dimercury dicyanide oxide; mercuric oxycyanide | 215-629-8 | 1335-31-5 | Expl. 1,1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H201 H331 H311 H301 H373** H400 H410 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H331 H311 H301 H373** H410 | |||
| 080-007-00-3 | dimethylmercury; [1] diethylmercury [2] | 209-805-3 [1] 211-000-7 [2] | 593-74-8 [1] 627-44-1 [2] | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 ** H410 | * STOT RE 2; H373: C ≥ 0,05 % | 1 | |
| 080-008-00-9 | phenylmercury nitrate; [1] phenylmercury hydroxide; [2] basic phenylmercury nitrate [3] | 200-242-9 [1] 202-866-7 [2] - [3] | 55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] | Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H301 H372 ** H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H301 H372 ** H314 H410 | |||
| 080-009-00-4 | 2-methoxyethylmercury chloride | 204-659-7 | 123-88-6 | Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H301 H372 ** H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H301 H372 ** H314 H410 | |||
| 080-010-00-X | mercury dichloride; mercuric chloride | 231-299-8 | 7487-94-7 | Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H341 H361f*** H300 H372** H314 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H341 H361f*** H300 H372** H314 H410 | |||
| 080-011-00-5 | phenylmercury acetate | 200-532-5 | 62-38-4 | Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H301 H372 ** H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H301 H372 ** H314 H410 | |||
| 081-001-00-3 | thallium | 231-138-1 | 7440-28-0 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 | H330 H300 H373 ** H413 | GHS06 GHS08 Gef. | H330 H300 H373 ** H413 | |||
| 081-002-00-9 | thallium compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 | H330 H300 H373 ** H411 | GHS06 GHS08 GHS09 Gef. | H330 H300 H373 ** H411 | A | ||
| 081-003-00-4 | dithallium sulphate; thallic sulphate | 231-201-3 | 7446-18-6 | Acute Tox. 2 * STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 | H300 H372 ** H315 H411 | GHS06 GHS08 GHS09 Gef. | H300 H372 ** H315 H411 | |||
| 082-001-00-6 | lead compounds with the exception of those specified elsewhere in this Annex | - | - | Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H332 H302 H373 ** H400 H410 | GHS08 GHS07 GHS09 Gef. | H360Df H332 H302 H373 ** H410 | Repr. 2; H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥ 0,5 % | A1 | |
| 082-002-00-1 | lead alkyls | - | - | Repr. 1A Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H330 H310 H300 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H360Df H330 H310 H300 H373 ** H410 | Repr. 1A; H360D: C ≥ 0,1 % * STOT RE 2; H373: C ≥ 0,05 % | A1 | |
| 082-003-00-7 | lead diazide; lead azide | 236-542-1 | 13424-46-9 | Unst. Expl. Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H200 H360Df H332 H302 H373 ** H400 H410 | GHS01 GHS08 GHS07 GHS09 Gef. | H200 H360Df H332 H302 H373 ** H410 | 1 | ||
| 082-003-01-4 | lead diazide; lead azide [≥ 20 % phlegmatiser] | 236-542-1 | 13424-46-9 | Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H201 H360Df H332 H302 H373 ** H400 H410 | GHS01 GHS08 GHS07 GHS09 Gef. | H201 H360Df H332 H302 H373 ** H410 | 1 | ||
| 082-004-00-2 | lead chromate | 231-846-0 | 7758-97-6 | Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H350 H360Df H373** H400 H410 | GHS08 GHS09 Gef. | H350 H360Df H373** H410 | 1 | ||
| 082-005-00-8 | lead di(acetate) | 206-104-4 | 301-04-2 | Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H373 ** H400 H410 | GHS08 GHS09 Gef. | H360Df H373 ** H410 | 1 | ||
| 082-006-00-3 | trilead bis(orthophosphate) | 231-205-5 | 7446-27-7 | Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360Df H373 ** H400 H410 | GHS08 GHS09 Gef. | H360Df H373 ** H410 | 1 | ||
| 082-007-00-9 | lead acetate, basic | 215-630-3 | 1335-32-6 | Carc. 2 Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H360Df H373 ** H400 H410 | GHS08 GHS09 Gef. | H351 H360Df H373 ** H410 | 1 | ||
| 082-008-00-4 | lead(II) methanesulphonate | 401-750-5 | 17570-76-2 | Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 | H360Df H332 H302 H373 ** H315 H318 | GHS08 GHS05 GHS07 Gef. | H360Df H332 H302 H373 ** H315 H318 | 1 | ||
| 082-009-00-X | lead sulfochromate yellow; C.I. Pigment Yellow 34; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] | 215-693-7 | 1344-37-2 | Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H350 H360Df H373** H400 H410 | GHS08 GHS09 Gef. | H350 H360Df H373** H410 | 1 | ||
| 082-010-00-5 | lead chromate molybdate sulfate red; C.I. Pigment Red 104; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] | 235-759-9 | 12656-85-8 | Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H350 H360Df H373** H400 H410 | GHS08 GHS09 Gef. | H350 H360Df H373** H410 | 1 | ||
| 082-011-00-0 | lead hydrogen arsenate | 232-064-2 | 7784-40-9 | Carc. 1A Repr. 1A Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H360Df H331 H301 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H360Df H331 H301 H373 ** H410 | 1 | ||
| 082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | 431-780-4 | 199876-46-5 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 | H302 H373** H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H411 | |||
| 082-013-00-1 | Bleipulver; [Partikeldurchmesser < 1 mm] | 231-100-4 | 7439-92-1 | Repr. 1 A Lakt. | H360FD H362 | GHS08 Gef. | H360FD H362 | Repr. 1 A; H360D: C ≥ 0,03 % | ||
| 082-014-00-7 | Blei, massiv: [Partikeldurchmesser ≥ 1 mm] | 231-100-4 | 7439-92-1 | Repr. 1 A Lakt. | H360FD H362 | GHS08 Gef. | H360FD H362 | |||
| 092-001-00-8 | uranium | 231-170-6 | 7440-61-1 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 | H330 H300 H373 ** H413 | GHS06 GHS08 Gef. | H330 H300 H373 ** H413 | |||
| 092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 | H330 H300 H373** H411 | GHS06 GHS08 GHS09 Gef. | H330 H300 H373** H411 | A | ||
| 601-001-00-4 | methane | 200-812-7 | 74-82-8 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 601-002-00-X | ethane | 200-814-8 | 74-84-0 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 601-003-00-5 | propane | 200-827-9 | 74-98-6 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 601-004-00-0 | butane; [1] and isobutane [2] | 203-448-7 [1] 200-857-2 [2] | 106-97-8 [1] 75-28-5 [2] | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | C U | ||
| 601-004-01-8 | butane (containing ≥ 0.1 % butadiene (203-450-8)); [1] isobutane (containing ≥ 0.1 % butadiene (203-450-8)) [2] | 203-448-7 [1] 200-857-2 [2] | 106-97-8 [1] 75-28-5 [2] | Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B | H220 H350 H340 | GHS02 GHS04 GHS08 Gef. | H220 H350 H340 | C S U | ||
| 601-005-00-6 | 2,2-dimethylpropane; neopentane | 207-343-7 | 463-82-1 | Flam. Gas 1 Press. Gas Aquatic Chronic 2 | H220 H411 | GHS02 GHS04 GHS09 Gef. | H220 H411 | U | ||
| 601-006-00-1 | pentane | 203-692-4 | 109-66-0 | Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 | H225 H304 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H336 H411 | EUH066 | C | |
| 601-007-00-7 | hexane (containing < 5 % n-hexane (203-777-6)); 2-methylpentane; [1] 3-methylpentane; [2] 2,2-dimethylbutane; [3] 2,3-dimethylbutane [4] | 203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] | 107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 | H225 H304 H315 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H411 | C | ||
| 601-008-00-2 | heptane; n-heptane; [1] 2,4-dimethylpentane; [2] 2,2,3-trimethylbutane; [3] 3,3-dimethylpentane; [4] 2,3-dimethylpentane; [5] 3-methylhexane; [6] 2,2-dimethylpentane; [7] 2-methylhexane; [8] 3-ethylpentane; [9] isoheptane; [10] | 205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] | 142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H225 H304 H315 H336 H400 H410 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H410 | C | ||
| 601-009-00-8 | octane; n-octane; [1] 2,2,4-trimethylpentane; [2] 2,3,3-trimethylpentane; [3] 3,3-dimethylhexane; [4] 2,2,3-trimethylpentane; [5] 2,3,4-trimethylpentane; [6] 3,4-dimethylhexane; [7] 2,3-dimethylhexane; [8] 2,4-dimethylhexane; [9] 4-methylheptane; [10] 3-methylheptane; [11] 2,2-dimethylhexane; [12] 2,5-dimethylhexane; [13] 2-methylheptane; [14] 2,2,3,3-tetramethylbutane; [15] 3-ethyl-2-methylpentane; [16] 3-ethylhexane; [17] 3-ethyl-3-methylpentane; [18] isooctane; [19] | 203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] | 111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H225 H304 H315 H336 H400 H410 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H410 | C | ||
| 601-010-00-3 | ethylene | 200-815-3 | 74-85-1 | Flam. Gas 1 Press. Gas STOT SE 3 | H220 H336 | GHS02 GHS04 GHS07 Gef. | H220 H336 | U | ||
| 601-011-00-9 | propene; propylene | 204-062-1 | 115-07-1 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 601-012-00-4 | but-1-ene; [1] butene, mixed-1-and-2-isomers; [2] 2-methylpropene; [3] (Z)-but-2-ene; [4] (E)-but-2-ene [5] | 203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] | 106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | C U | ||
| 601-013-00-X | 1,3-butadiene; buta-1,3-diene | 203-450-8 | 106-99-0 | Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B | H220 H350 H340 | GHS02 GHS04 GHS08 Gef. | H220 H350 H340 | D U | ||
| 601-014-00-5 | isoprene (stabilised) 2-methyl-1,3-butadiene | 201-143-3 | 78-79-5 | Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 | H224 H350 H341 H412 | GHS02 GHS08 Gef. | H224 H350 H341 H412 | D | ||
| 601-015-00-0 | acetylene; ethyne | 200-816-9 | 74-86-2 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | EUH006 | U | |
| 601-016-00-6 | cyclopropane | 200-847-8 | 75-19-4 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 601-017-00-1 | cyclohexane | 203-806-2 | 110-82-7 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H225 H304 H315 H336 H400 H410 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H410 | |||
| 601-018-00-7 | methylcyclohexane | 203-624-3 | 108-87-2 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 | H225 H304 H315 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H411 | |||
| 601-019-00-2 | 1,4-dimethylcyclohexane | 209-663-2 | 589-90-2 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 | H225 H304 H315 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H304 H315 H336 H411 | |||
| 601-020-00-8 | benzene | 200-753-7 | 71-43-2 | Flam. Liq. 2 Carc. 1A Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 | H225 H350 H340 H372 ** H304 H319 H315 | GHS02 GHS08 GHS07 Gef. | H225 H350 H340 H372 ** H304 H319 H315 | E | ||
| 601-021-00-3 | toluene | 203-625-9 | 108-88-3 | Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 | H225 H361d *** H304 H373 ** H315 H336 | GHS02 GHS08 GHS07 Gef. | H225 H361d *** H304 H373 ** H315 H336 | |||
| 601-022-00-9 | o-xylene; [1] p-xylene; [2] m-xylene; [3] xylene [4] | 202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] | 95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 | H226 H332 H312 H315 | GHS02 GHS07 Achtg. | H226 H332 H312 H315 | * | C | |
| 601-023-00-4 | ethylbenzene | 202-849-4 | 100-41-4 | Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 | H225 H332 H373 (Hörorgane) H304 | GHS02 GHS07 GHS08 Gef. | H225 H332 H373 (Hörorgane) H304 | |||
| 601-024-00-X | cumene; [1] propylbenzene [2] | 202-704-5 [1] 203-132-9 [2] | 98-82-8 [1] 103-65-1 [2] | Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 | H226 H304 H335 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H226 H304 H335 H411 | C | ||
| 601-025-00-5 | mesitylene; 1,3,5-trimethylbenzene | 203-604-4 | 108-67-8 | Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 | H226 H335 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H335 H411 | STOT SE 3; H335: C ≥ 25 % | ||
| 601-026-00-0 | styrene | 202-851-5 | 100-42-5 | Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 | H226 H361d H332 H372 (Hörorgane) H315 H319 | GHS02 GHS08 GHS07 Gef. | H226 H361d H332 H372 (Hörorgane) H315 H319 | * | D | |
| 601-027-00-6 | 2-phenylpropene; α-methylstyrene | 202-705-0 | 98-83-9 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 | H226 H319 H335 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H319 H335 H411 | STOT SE 3; H335: C ≥ 25 % | ||
| 601-028-00-1 | 2-methylstyrene; 2-vinyltoluene | 210-256-7 | 611-15-4 | Acute Tox. 4 * Aquatic Chronic 2 | H332 H411 | GHS07 GHS09 Achtg. | H332 H411 | |||
| 601-029-00-7 | dipentene; limonene; [1] (R)-p-mentha-1,8-diene; d-limonene; [2] (S)-p-mentha-1,8-diene; l-limonene; [3] trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4] (±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] | 205-341-0 [1] 227-813-5 [2] 227-815-6 [3] 229-977-3 [4] 231-732-0 [5] | 138-86-3 [1] 5989-27-5 [2] 5989-54-8 [3] 6876-12-6 [4] 7705-14-8 [5] | Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H315 H317 H400 H410 | GHS02 GHS07 GHS09 Achtg. | H226 H315 H317 H410 | C | ||
| 601-030-00-2 | cyclopentane | 206-016-6 | 287-92-3 | Flam. Liq. 2 Aquatic Chronic 3 | H225 H412 | GHS02 Gef. | H225 H412 | |||
| 601-031-00-8 | 2,4,4-trimethylpent-1-ene | 203-486-4 | 107-39-1 | Flam. Liq. 2 Aquatic Chronic 2 | H225 H411 | GHS02 GHS09 Gef. | H225 H411 | |||
| 601-032-00-3 | benzo[a]pyrene; benzo[def]chrysene | 200-028-5 | 50-32-8 | Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H340 H360FD H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H340 H360FD H317 H410 | Carc. 1B; H350: C ≥ 0,01 % | ||
| 601-033-00-9 | benz[a]anthracene | 200-280-6 | 56-55-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | M=100 | ||
| 601-034-00-4 | benz[e]acephenanthrylene | 205-911-9 | 205-99-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 601-035-00-X | benzo[j]fluoranthene | 205-910-3 | 205-82-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 601-036-00-5 | benzo[k]fluoranthene | 205-916-6 | 207-08-9 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 601-037-00-0 | n-hexane | 203-777-6 | 110-54-3 | Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 | H225 H361f *** H304 H373 ** H315 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H361f *** H304 H373 ** H315 H336 H411 | STOT RE 2; H373: C ≥ 5 % | ||
| 601-041-00-2 | dibenz[a,h]anthracene | 200-181-8 | 53-70-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | Carc. 1B; H350: C ≥ 0,01 % M=100 | ||
| 601-042-00-8 | biphenyl; diphenyl | 202-163-5 | 92-52-4 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H410 | |||
| 601-043-00-3 | 1,2,4-trimethylbenzene | 202-436-9 | 95-63-6 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H226 H332 H319 H335 H315 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H332 H319 H335 H315 H411 | |||
| 601-044-00-9 | 3a,4,7,7a-tetrahydro-4,7-methanoindene | 201-052-9 | 77-73-6 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H225 H332 H302 H319 H335 H315 H411 | GHS02 GHS07 GHS09 Gef. | H225 H332 H302 H319 H335 H315 H411 | |||
| 601-045-00-4 | 1,2,3,4-tetrahydronaphthalene | 204-340-2 | 119-64-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H319 H315 H411 | GHS07 GHS09 Achtg. | H319 H315 H411 | EUH019 | ||
| 601-046-00-X | 7-methylocta-1,6-diene | 404-210-7 | 42152-47-6 | Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 | H226 H400 H410 | GHS02 GHS09 Achtg. | H226 H410 | |||
| 601-047-00-5 | m-mentha-1,3(8)-diene | 404-150-1 | 17092-80-7 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 601-048-00-0 | chrysene | 205-923-4 | 218-01-9 | Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H400 H410 | GHS08 GHS09 Gef. | H350 H341 H410 | |||
| 601-049-00-6 | benzo[e]pyrene | 205-892-7 | 192-97-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 601-051-00-7 | 4-phenylbut-1-ene | 405-980-7 | 768-56-9 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 601-052-00-2 | naphthalene | 202-049-5 | 91-20-3 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H400 H410 | GHS07 GHS08 GHS09 Achtg. | H351 H302 H410 | |||
| 601-053-00-8 | nonylphenol; [1] 4-nonylphenol, branched [2] | 246-672-0 [1] 284-325-5 [2] | 25154-52-3 [1] 84852-15-3 [2] | Repr. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H314 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H361fd H302 H314 H410 | |||
| 601-054-00-3 | reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene | 405-570-8 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 601-055-00-9 | reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes | 410-190-0 | 132983-41-6 | Eye Irrit. 2 Aquatic Chronic 4 | H319 H413 | GHS07 Achtg. | H319 H413 | |||
| 601-056-00-4 | reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane | 405-470-4 | 73807-39-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 601-057-00-X | N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate | 421-130-8 | 156679-41-3 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H318 H317 H410 | |||
| 601-058-00-5 | di-L-para-menthene | 417-870-6 | 83648-84-4 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 601-059-00-0 | methyl 2-benzylidene-3-oxobutyrate | 420-940-9 | 15768-07-7 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H319 H315 H411 | GHS07 GHS09 Achtg. | H319 H315 H411 | |||
| 601-060-00-6 | 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 | 417-610-1 | 155522-09-1 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 601-061-00-1 | (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) | 418-960-8 | - | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H317 H411 | |||
| 601-062-00-7 | reaction mass of: branched triacontane; branched dotriacontane; branched tetratriacontane; branched hexatriacontane | 417-030-9 | 151006-59-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 601-063-00-2 | reaction mass of isomers of branched tetracosane | 417-060-2 | 151006-61-0 | Acute Tox. 4 * Aquatic Chronic 4 | H332 H413 | GHS07 Achtg. | H332 H413 | |||
| 601-064-00-8 | branched hexatriacontane | 417-070-7 | 151006-62-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 601-065-00-3 | reaction mass of: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) | 416-930-9 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 601-066-00-9 | 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone | 426-820-2 | 78531-60-9 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 601-067-00-4 | triethyl arsenate | 427-700-2 | 15606-95-8 | Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H331 H301 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H331 H301 H410 | |||
| 601-068-00-X | 1,2-diacetoxybut-3-ene | 421-720-5 | 18085-02-4 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 601-069-00-5 | 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide | 422-680-1 | 287933-44-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 601-070-00-0 | reaction mass of: branched icosane; branched docosane; branched tetracosane | 417-050-8 | 151006-58-5 | Acute Tox. 4 * Aquatic Chronic 4 | H332 H413 | GHS07 Achtg. | H332 H413 | |||
| 601-071-00-6 | 1-dimethoxymethyl-2-nitro-benzene | 423-830-9 | 20627-73-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 601-072-00-1 | reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane | 430-690-2 | 52783-21-8 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 601-073-00-7 | 1-bromo-3,5-difluorobenzene | 416-710-2 | 461-96-1 | Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H302 H373 ** H315 H317 H400 H410 | GHS02 GHS08 GHS07 GHS09 Achtg. | H226 H302 H373 ** H315 H317 H410 | |||
| 601-074-00-2 | reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] | 422-040-1 | - | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H319 H315 H411 | GHS07 GHS09 Achtg. | H319 H315 H411 | |||
| 601-075-00-8 | 4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane | 418-770-5 | 151882-81-4 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 601-076-00-3 | ethynyl cyclopropane | 425-430-1 | 6746-94-7 | Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H225 H315 H318 H412 | GHS02 GHS05 Gef. | H225 H315 H318 H412 | |||
| 601-077-00-9 | reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane | 426-510-7 | 196965-91-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 601-078-00-4 | reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane | 427-040-5 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 601-079-00-X | reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene | 429-620-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H315 H317 H413 | GHS07 Achtg. | H315 H317 H413 | |||
| 601-080-00-5 | reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers | 431-100-6 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 601-081-00-0 | cyclohexadeca-1,9-diene | 431-730-1 | 4277-06-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H315 H317 H413 | GHS07 Achtg. | H315 H317 H413 | |||
| 601-082-00-6 | reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane | 434-420-4 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | 435-000-3 | 22094-83-3 | Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 | H304 H315 H413 | GHS08 GHS07 Gef. | H304 H315 H413 | |||
| 601-084-00-7 | reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) | 435-180-3 | - | Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H304 H315 H400 H410 | GHS08 GHS07 GHS09 Gef. | H304 H315 H410 | |||
| 601-085-00-2 | isopentane; 2-methylbutane | 201-142-8 | 78-78-4 | Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 | H224 H304 H336 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H224 H304 H336 H411 | EUH066 | ||
| 601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Asp. Tox. 1 | H304 | GHS07 | H304 | |||||||
| STOT SE 3 | H336 | GHS08 Gef. | H336 | |||||||
| 601-088-00-9 | 4-vinylcyclohexene | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 601-089-00-4 | muscalure; cis-tricos-9-ene | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07 Achtg. | H317 | |||
| 602-001-00-7 | chloromethane; methyl chloride | 200-817-4 | 74-87-3 | Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 * | H220 H351 H373 ** | GHS02 GHS04 GHS08 Gef. | H220 H351 H373 ** | U | ||
| 602-002-00-2 | bromomethane; methylbromide | 200-813-2 | 74-83-9 | Press.
Gas Muta. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 | H341 H331 H301 H373 ** H319 H335 H315 H400 H420 | GHS04 GHS06 GHS08 GHS09 Gef. | H341 H331 H301 H373 ** H319 H335 H315 H400 H420 | U | ||
| 602-003-00-8 | dibromomethane | 200-824-2 | 74-95-3 | Acute Tox. 4 * Aquatic Chronic 3 | H332 H412 | GHS07 Achtg. | H332 H412 | * | ||
| 602-004-00-3 | dichloromethane; methylene chloride | 200-838-9 | 75-09-2 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 602-005-00-9 | methyl iodide; iodomethane | 200-819-5 | 74-88-4 | Carc. 2 Acute Tox. 4 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 | H351 H312 H331 H301 H335 H315 | GHS06 GHS08 Gef. | H351 H312 H331 H301 H335 H315 | |||
| 602-006-00-4 | chloroform; trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | H351 | GHS06 | H351 | | | |
| Repr. 2 | H361d | GHS08 | H361d | |||||||
| Acute Tox. 3 | H331 | Gef. | H331 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 | H372 | ||||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Skin Irrit. 2 | H315 | H315 | ||||||||
| 602-007-00-X | bromoform; tribromomethane | 200-854-6 | 75-25-2 | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H331 H302 H319 H315 H411 | GHS06 GHS09 Gef. | H331 H302 H319 H315 H411 | |||
| 602-008-00-5 | carbon tetrachloride; tetrachloromethane | 200-262-8 | 56-23-5 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 Ozone 1 | H351 H331 H311 H301 H372 ** H412 H420 | GHS06 GHS08 Gef. | H351 H331 H311 H301 H372 ** H412 H420 | * STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % | ||
| 602-009-00-0 | chloroethane | 200-830-5 | 75-00-3 | Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 | H220 H351 H412 | GHS02 GHS04 GHS08 Gef. | H220 H351 H412 | U | ||
| 602-010-00-6 | 1,2-dibromoethane | 203-444-5 | 106-93-4 | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H350 H331 H311 H301 H319 H335 H315 H411 | GHS06 GHS08 GHS09 Gef. | H350 H331 H311 H301 H319 H335 H315 H411 | * | ||
| 602-011-00-1 | 1,1-dichloroethane | 200-863-5 | 75-34-3 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 | H225 H302 H319 H335 H412 | GHS02 GHS07 Gef. | H225 H302 H319 H335 H412 | * | ||
| 602-012-00-7 | 1,2-dichloroethane; ethylene dichloride | 203-458-1 | 107-06-2 | Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H225 H350 H302 H319 H335 H315 | GHS02 GHS08 GHS07 Gef. | H225 H350 H302 H319 H335 H315 | |||
| 602-013-00-2 | 1,1,1-trichloroethane; methyl chloroform | 200-756-3 | 71-55-6 | Acute Tox. 4 * Ozone 1 | H332 H420 | GHS07 Achtg. | H332 H420 | F | ||
| 602-014-00-8 | 1,1,2-trichloroethane | 201-166-9 | 79-00-5 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H351 H332 H312 H302 | GHS08 GHS07 Achtg. | H351 H332 H312 H302 | EUH066 | * | |
| 602-015-00-3 | 1,1,2,2-tetrachloroethane | 201-197-8 | 79-34-5 | Acute Tox. 2 * Acute Tox. 1 Aquatic Chronic 2 | H330 H310 H411 | GHS06 GHS09 Gef. | H330 H310 H411 | |||
| 602-016-00-9 | 1,1,2,2-tetrabromoethane | 201-191-5 | 79-27-6 | Acute Tox. 2 * Eye Irrit. 2 Aquatic Chronic 3 | H330 H319 H412 | GHS06 Gef. | H330 H319 H412 | |||
| 602-017-00-4 | pentachloroethane | 200-925-1 | 76-01-7 | Carc. 2 STOT RE 1 Aquatic Chronic 2 | H351 H372 ** H411 | GHS08 GHS09 Gef. | H351 H372 ** H411 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % | ||
| 602-018-00-X | 1-chloropropane; [1] 2-chloropropane [2] | 208-749-7 [1] 200-858-8 [2] | 540-54-5 [1] 75-29-6 [2] | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H312 H302 | GHS02 GHS07 Gef. | H225 H332 H312 H302 | C | ||
| 602-019-00-5 | 1-bromopropane; n-propyl bromide | 203-445-0 | 106-94-5 | Flam. Liq. 2 Repr. 1B STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 | H225 H360FD H373 ** H319 H335 H315 H336 | GHS02 GHS08 GHS07 Gef. | H225 H360FD H373 ** H319 H335 H315 H336 | |||
| 602-020-00-0 | 1,2-Dichlorpropan; Propylendichlorid | 201-152-2 | 78-87-5 | Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* | H225 H350 H332 H302 | GHS02 GHS08 GHS07 Gef. | H225 H350 H332 H302 | |||
| 602-021-00-6 | 1,2-dibromo-3-chloropropane | 202-479-3 | 96-12-8 | Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 | H350 H340 H360F *** H301 H373 ** H412 | GHS06 GHS08 Gef. | H350 H340 H360F *** H301 H373 ** H412 | |||
| 602-022-00-1 | 1-chloropentane; [1] 2-chloropentane; [2] 3-chloropentane [3] | 208-846-4 [1] 210-885-7 [2] 210-467-4 [3] | 543-59-9 [1] 625-29-6 [2] 616-20-6 [3] | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H312 H302 | GHS02 GHS07 Gef. | H225 H332 H312 H302 | C | ||
| 602-023-00-7 | vinyl chloride; chloroethylene | 200-831-0 | 75-01-4 | Press.
Gas Flam. Gas 1 Carc. 1A | H220 H350 | GHS02 GHS08 Gef. | H220 H350 | D U | ||
| 602-024-00-2 | bromoethylene | 209-800-6 | 593-60-2 | Press.
Gas Flam. Gas 1 Carc. 1B | H220 H350 | GHS02 GHS08 Gef. | H220 H350 | U | ||
| 602-025-00-8 | 1,1-dichloroethylene; vinylidene chloride | 200-864-0 | 75-35-4 | Flam. Liq. 1 Carc. 2 Acute Tox. 4 * | H224 H351 H332 | GHS02 GHS08 GHS07 Gef. | H224 H351 H332 | * | D | |
| 602-026-00-3 | 1,2-dichloroethylene; [1] cis-dichloroethylene; [2] trans-dichloroethylene [3] | 208-750-2 [1] 205-859-7 [2] 205-860-2 [3] | 540-59-0 [1] 156-59-2 [2] 156-60-5 [3] | Flam. Liq. 2 Acute Tox. 4 * Aquatic Chronic 3 | H225 H332 H412 | GHS02 GHS07 Gef. | H225 H332 H412 | * | C | |
| 602-027-00-9 | trichloroethylene; trichloroethene | 201-167-4 | 79-01-6 | Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 | H350 H341 H319 H315 H336 H412 | GHS08 GHS07 Gef. | H350 H341 H319 H315 H336 H412 | |||
| 602-028-00-4 | tetrachloroethylene | 204-825-9 | 127-18-4 | Carc. 2 Aquatic Chronic 2 | H351 H411 | GHS08 GHS09 Achtg. | H351 H411 | |||
| 602-029-00-X | 3-chloropropene; allyl chloride | 203-457-6 | 107-05-1 | Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 | GHS02 GHS08 GHS07 GHS09 Gef. | H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 | D | ||
| 602-030-00-5 | 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] | 208-826-5 [1] 233-195-8 [2] | 542-75-6 [1] 10061-01-5 [2] | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 | GHS02 GHS06 GHS08 GHS09 Gef. | H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 | C D | ||
| 602-031-00-0 | 1,1-dichloropropene | 209-253-3 | 563-58-6 | Flam. Liq. 2 Acute Tox. 3 * Aquatic Chronic 3 | H225 H301 H412 | GHS02 GHS06 Gef. | H225 H301 H412 | |||
| 602-032-00-6 | 3-chloro-2-methylpropene | 209-251-2 | 563-47-3 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H225 H332 H302 H314 H317 H411 | GHS02 GHS05 GHS07 GHS09 Gef. | H225 H332 H302 H314 H317 H411 | |||
| 602-033-00-1 | Chlorbenzol | 203-628-5 | 108-90-7 | Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 | H226 H332 H315 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H332 H315 H411 | |||
| 602-034-00-7 | 1,2-dichlorobenzene; o-dichlorobenzene | 202-425-9 | 95-50-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H315 H410 | * | ||
| 602-035-00-2 | 1,4-dichlorobenzene; p-dichlorobenzene | 203-400-5 | 106-46-7 | Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H319 H400 H410 | GHS08 GHS09 Achtg. | H351 H319 H410 | |||
| 602-036-00-8 | chloroprene (stabilised); 2-chlorobuta-1,3-diene (stabilised) | 204-818-0 | 126-99-8 | Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H225 H350 H332 H302 H373 ** H319 H335 H315 | GHS02 GHS08 GHS07 Gef. | H225 H350 H332 H302 H373 ** H319 H335 H315 | D | ||
| 602-037-00-3 | α-chlorotoluene; benzyl chloride | 202-853-6 | 100-44-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H350 H331 H302 H373 ** H335 H315 H318 | GHS06 GHS08 GHS05 Gef. | H350 H331 H302 H373 ** H335 H315 H318 | |||
| 602-038-00-9 | α, α,α-trichlorotoluene; benzotrichloride | 202-634-5 | 98-07-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H350 H331 H302 H335 H315 H318 | GHS06 GHS08 GHS05 Gef. | H350 H331 H302 H335 H315 H318 | |||
| 602-039-00-4 | polychlorobiphenyls; PCB | 215-648-1 | 1336-36-3 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373 ** H400 H410 | GHS08 GHS09 Achtg. | H373 ** H410 | STOT RE 2; H373: C ≥ 0,005 % | C | |
| 602-040-00-X | 2-chlorotoluene; [1] 3-chlorotoluene; [2] 4-chlorotoluene; [3] chlorotoluene [4] | 202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] | 95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] | Acute Tox. 4 * Aquatic Chronic 2 | H332 H411 | GHS07 GHS09 Achtg. | H332 H411 | C | ||
| 602-041-00-5 | penthachloronaphthalene | 215-320-8 | 1321-64-8 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H319 H315 H410 | C | ||
| 602-042-00-0 | 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex | - | - | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H301 H312 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H301 H312 H410 | A C | ||
| 602-043-00-6 | lindane (ISO); γ-HCH or γ-BHC; γ-1,2,3,4,5,6-hexachlorocyclohexane | 200-401-2 | 58-89-9 | Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 | H301 H332 H312 H373 ** H362 H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H332 H312 H373 ** H362 H410 | M=10 | ||
| 602-044-00-1 | camphechlor (ISO); toxaphene; | 232-283-3 | 8001-35-2 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H301 H312 H335 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H301 H312 H335 H315 H410 | |||
| 602-045-00-7 | DDT (ISO); clofenotane (INN); dicophane; 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane | 200-024-3 | 50-29-3 | Carc. 2 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H301 H372 ** H410 | |||
| 602-046-00-2 | heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene | 200-962-3 | 76-44-8 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H311 H301 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H311 H301 H373 ** H410 | |||
| 602-047-00-8 | chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan | 200-349-0 | 57-74-9 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H312 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H312 H302 H410 | |||
| 602-048-00-3 | aldrin (ISO) | 206-215-8 | 309-00-2 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H311 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H311 H301 H372 ** H410 | |||
| 602-049-00-9 | dieldrin (ISO) | 200-484-5 | 60-57-1 | Carc. 2 Acute Tox. 1 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H310 H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H310 H301 H372 ** H410 | |||
| 602-050-00-4 | isodrin; (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 207-366-2 | 465-73-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | M=100 | ||
| 602-051-00-X | endrin (ISO); 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 200-775-7 | 72-20-8 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H311 H400 H410 | GHS06 GHS09 Gef. | H300 H311 H410 | |||
| 602-052-00-5 | endosulfan (ISO); 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite | 204-079-4 | 115-29-7 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H312 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H312 H410 | |||
| 602-053-00-0 | isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran | 206-045-4 | 297-78-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 | H310 H300 H400 | GHS06 GHS09 Gef. | H310 H300 H400 | |||
| 602-054-00-6 | 3-iodpropene; allyl iodide | 209-130-4 | 556-56-9 | Flam. Liq. 2 Skin Corr. 1B | H225 H314 | GHS02 GHS05 Gef. | H225 H314 | |||
| 602-055-00-1 | bromoethane; ethyl bromide | 200-825-8 | 74-96-4 | Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * | H225 H351 H332 H302 | GHS02 GHS08 GHS07 Gef. | H225 H351 H332 H302 | |||
| 602-056-00-7 | α, α,α-trifluorotoluene; benzotrifluoride | 202-635-0 | 98-08-8 | Flam. Liq. 2 Aquatic Chronic 2 | H225 H411 | GHS02 GHS09 Gef. | H225 H411 | |||
| 602-057-00-2 | α-bromotoluene; benzyl bromide | 202-847-3 | 100-39-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | |||
| 602-058-00-8 | α, α-dichlorotoluene; benzylidene chloride; benzal chloride | 202-709-2 | 98-87-3 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H351 H331 H302 H335 H315 H318 | GHS06 GHS08 GHS05 Gef. | H351 H331 H302 H335 H315 H318 | |||
| 602-059-00-3 | 1-chlorobutane; butyl chloride | 203-696-6 | 109-69-3 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 602-060-00-9 | bromobenzene | 203-623-8 | 108-86-1 | Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 | H226 H315 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H315 H411 | |||
| 602-061-00-4 | hexafluoropropene; hexafluoropropylene | 204-127-4 | 116-15-4 | Press.
Gas Acute Tox. 4 * STOT SE 3 | H332 H335 | GHS07 Achtg. | H332 H335 | U | ||
| 602-062-00-X | 1,2,3-trichloropropane | 202-486-1 | 96-18-4 | Carc. 1B Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H350 H360F *** H332 H312 H302 | GHS08 GHS07 Gef. | H350 H360F *** H332 H312 H302 | D | ||
| 602-063-00-5 | heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane | 213-831-0 | 1024-57-3 | Carc. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H301 H373 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H301 H373 ** H410 | |||
| 602-064-00-0 | 1,3-dichloro-2-propanol | 202-491-9 | 96-23-1 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * | H350 H301 H312 | GHS06 GHS08 Gef. | H350 H301 H312 | |||
| 602-065-00-6 | hexachlorobenzene | 204-273-9 | 118-74-1 | Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H372 ** H400 H410 | GHS08 GHS09 Gef. | H350 H372 ** H410 | |||
| 602-066-00-1 | tetrachloro-p-benzoquinone | 204-274-4 | 118-75-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | |||
| 602-067-00-7 | 1,3-dichlorbenzene | 208-792-1 | 541-73-1 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 602-068-00-2 | ethylene bis(trichloroacetate) | 219-732-9 | 2514-53-6 | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 602-069-00-8 | dichloroacetylene | - | 7572-29-4 | Unst. Expl. Carc. 2 STOT RE 2 * | H200 H351 H373 ** | GHS01 GHS08 Achtg. | H200 H351 H373 ** | |||
| 602-070-00-3 | 3-chloro-4,5,α, α,α-pentafluorotoluene | 401-930-3 | 77227-99-7 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H226 H332 H302 H400 | GHS02 GHS07 GHS09 Achtg. | H226 H332 H302 H400 | |||
| 602-071-00-9 | bromobenzylbromotoluene, reaction mass of isomers | 402-210-1 | 99688-47-8 | STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 ** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 ** H317 H410 | |||
| 602-072-00-4 | dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) | 278-404-3 | 76253-60-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 602-073-00-X | 1,4-dichlorobut-2-ene | 212-121-8 | 764-41-0 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H330 H311 H301 H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H350 H330 H311 H301 H314 H410 | Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 % | ||
| 602-074-00-5 | pentachlorobenzene | 210-172-0 | 608-93-5 | Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H228 H302 H400 H410 | GHS02 GHS07 GHS09 Gef. | H228 H302 H410 | T | ||
| 602-075-00-0 | 4,4,5,5-tetrachloro-1,3-dioxolan-2-one | 404-060-2 | 22432-68-4 | Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B | H330 H302 H314 | GHS06 GHS05 Gef. | H330 H302 H314 | |||
| 602-076-00-6 | 2,3,4-trichlorobut-1-ene | 219-397-9 | 2431-50-7 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H331 H302 H319 H335 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H331 H302 H319 H335 H315 H410 | Carc. 2; H351: C ≥ 0,1 % | ||
| 602-077-00-1 | dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex | 219-196-6 | 2385-85-5 | Carc. 2 Repr. 2 Lact. Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H361fd H362 H312 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H361fd H362 H312 H302 H410 | |||
| 602-078-00-7 | hexachlorocyclopentadiene | 201-029-3 | 77-47-4 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H330 H311 H302 H314 H400 H410 | GHS06 GHS05 GHS09 Gef. | H330 H311 H302 H314 H410 | |||
| 602-079-00-2 | 2,3-dichloropropene; 2,3-dichloropropylene | 201-153-8 | 78-88-6 | Flam. Liq. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H225 H341 H332 H312 H302 H335 H315 H318 H412 | GHS02 GHS08 GHS05 GHS07 Gef. | H225 H341 H332 H312 H302 H335 H315 H318 H412 | |||
| 602-080-00-8 | alkanes, C10-13, chloro; chlorinated paraffins, C10-13 | 287-476-5 | 85535-84-8 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | EUH066 | ||
| 602-081-00-3 | 2-chloro-4,5-difluorobenzoic acid | 405-380-5 | - | Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 | H312 H302 H318 H317 | GHS05 GHS07 Gef. | H312 H302 H318 H317 | |||
| 602-082-00-9 | 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol | 408-020-5 | 109678-33-3 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 602-083-00-4 | diphenyl ether, pentabromo derivative pentabromodiphenyl ether | 251-084-2 | 32534-81-9 | STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 | H373 ** H362 H400 H410 | GHS08 GHS09 Achtg. | H373 ** H362 H410 | |||
| 602-084-00-X | 1,1-dichloro-1-fluoroethane | 404-080-1 | 1717-00-6 | Aquatic Chronic 3 Ozone 1 | H412 H420 | GHS07 Achtg. | H412 H420 | |||
| 602-085-00-5 | 2-bromopropane | 200-855-1 | 75-26-3 | Flam. Liq. 2 Repr. 1A STOT RE 2 * | H225 H360F *** H373 ** | GHS02 GHS08 Gef. | H225 H360F *** H373 ** | EUH066 | ||
| 602-086-00-0 | trifluoroiodomethane; trifluoromethyl iodide | 219-014-5 | 2314-97-8 | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 602-087-00-6 | 1,2,4-trichlorobenzene | 204-428-0 | 120-82-1 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H315 H410 | |||
| 602-088-00-1 | 2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol | 202-480-9 | 96-13-9 | Carc. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H350 H361f *** H311 H332 H302 H412 | GHS08 GHS07 Gef. | H350 H361f *** H311 H332 H302 H412 | |||
| 602-089-00-7 | 4-bromo-2-chlorofluorobenzene | 405-580-2 | 60811-21-4 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H315 H410 | |||
| 602-090-00-2 | 1-allyl-3-chloro-4-fluorobenzene | 406-630-6 | 121626-73-1 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 602-091-00-8 | 1,3-dichloro-4-fluorobenzene | 406-160-1 | 1435-48-9 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 | H302 H373 ** H315 H411 | GHS08 GHS07 Achtg. | H302 H373 ** H315 H411 | |||
| 602-092-00-3 | 1-bromo-3,4,5-trifluorobenzene | 418-480-9 | 138526-69-9 | Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H226 H351 H315 H318 H411 | GHS02 GHS08 GHS05 GHS09 Gef. | H226 H351 H315 H318 H411 | |||
| 602-093-00-9 | α, α,α,4-tetrachlorotoluene; p-chlorobenzotrichloride | 226-009-1 | 5216-25-1 | Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 | H350 H361f *** H372 ** H312 H302 H335 H315 | GHS08 GHS07 Gef. | H350 H361f *** H372 ** H312 H302 H335 H315 | |||
| 602-094-00-4 | diphenylether; octabromo derivate | 251-087-9 | 32536-52-0 | Repr. 1B | H360Df | GHS08 Gef. | H360Df | |||
| 602-095-00-X | alkanes, C14-17, chloro; chlorinated paraffins, C14-17 | 287-477-0 | 85535-85-9 | Lact. Aquatic Acute 1 Aquatic Chronic 1 | H362 H400 H410 | GHS09 Achtg. | H362 H410 | EUH066 | ||
| 602-096-00-5 | malachite green hydrochloride; [1] malachite green oxalate [2] | 209-322-8 [1] 219-441-7 [2] | 569-64-2 [1] 2437-29-8 [2] | Repr. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d *** H302 H318 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H361d *** H302 H318 H410 | |||
| 602-097-00-0 | 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane | 422-850-5 | 148757-89-5 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 602-098-00-6 | 2-(3-bromophenoxy)tetrahydro-2H-pyran | 429-030-6 | 57999-49-2 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 602-099-00-1 | 3-(4-fluorophenyl)-2-methylpropionylchloride | 426-370-7 | - | Skin Corr. 1A Acute Tox. 4 * Aquatic Chronic 3 | H314 H302 H412 | GHS05 GHS07 Gef. | H314 H302 H412 | EUH014 EUH029 | ||
| 602-100-00-5 | reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane | 420-640-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 602-101-00-0 | 2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate | 427-020-6 | 141772-37-4 | STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373** H317 H410 | |||
| 602-102-00-6 | 1,1,1,3,3-pentafluorobutane | 430-250-1 | 406-58-6 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 602-103-00-1 | 1-(chlorophenylmethyl)-2-methylbenzene | 431-450-1 | 41870-52-4 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 602-104-00-7 | 1,1,2,2,3,3,4-heptafluorocyclopentane | 430-710-1 | 15290-77-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | 422-100-7 | 102061-82-5 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 602-106-00-8 | 2-bromo-4,6-difluoroaniline | 429-430-0 | 444-14-4 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | 439-500-2 | 33831-83-3 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 | H302 H315 H411 | GHS07 GHS09 Achtg. | H302 H315 H411 | |||
| 602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | 443-840-7 | 4084-38-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 | H302 H319 H317 | GHS07 Achtg. | H302 H319 H317 | |||
| 602-109-00-4 | Hexabromocyclododecane [1] | 247-148-4 [1] | 25637-99-4[1] | Repr. 2 Lact. | H361 H362 | GHS08 Achtg. | H361 H362 | | | |
| 1,2,5,6,9,10-hexabromocyclododecane [2] | 221-695-9[2] | 3194-55-6[2] | ||||||||
| 603-001-00-X | methanol | 200-659-6 | 67-56-1 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 | H225 H331 H311 H301 H370 ** | GHS02 GHS06 GHS08 Gef. | H225 H331 H311 H301 H370 ** | * STOT SE 1; H370: C ≥ 10 % STOT SE 2; H371: 3 % ≤ C < 10 % | ||
| 603-002-00-5 | ethanol; ethyl alcohol | 200-578-6 | 64-17-5 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 603-003-00-0 | propan-1-ol; n-propanol | 200-746-9 | 71-23-8 | Flam. Liq. 2 Eye Dam. 1 STOT SE 3 | H225 H318 H336 | GHS02 GHS05 GHS07 Gef. | H225 H318 H336 | |||
| 603-004-00-6 | butan-1-ol; n-butanol | 200-751-6 | 71-36-3 | Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 | H226 H302 H335 H315 H318 H336 | GHS02 GHS05 GHS07 Gef. | H226 H302 H335 H315 H318 H336 | |||
| 603-005-00-1 | 2-methylpropan-2-ol; tert-butyl alcohol | 200-889-7 | 75-65-0 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 | H225 H332 H319 H335 | GHS02 GHS07 Gef. | H225 H332 H319 H335 | |||
| 603-006-00-7 | pentanol isomers, with the exception fo those specified elsewhere in this Annex | 250-378-8 | Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 | H226 H332 H335 | GHS02 GHS07 Achtg. | H226 H332 H335 | EUH066 | C | ||
| 603-007-00-2 | 2-methylbutan-2-ol; tert-pentanol | 200-908-9 | 75-85-4 | Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 | H225 H332 H335 H315 | GHS02 GHS07 Gef. | H225 H332 H335 H315 | |||
| 603-008-00-8 | 4-methylpentan-2-ol; methyl isobutyl carbinol | 203-551-7 | 108-11-2 | Flam. Liq. 3 STOT SE 3 | H226 H335 | GHS02 GHS07 Achtg. | H226 H335 | STOT SE 3; H335: C ≥ 25 % | ||
| 603-009-00-3 | cyclohexanol | 203-630-6 | 108-93-0 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 | H332 H302 H335 H315 | GHS07 Achtg. | H332 H302 H335 H315 | |||
| 603-010-00-9 | 2-methylcyclohexanol, mixed isomers; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] | 209-512-0 [1] 231-187-9 [2] 231-186-3 [3] | 583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] | Acute Tox. 4 * | H332 | GHS07 Achtg. | H332 | C | ||
| 603-011-00-4 | 2-methoxyethanol; ethylene glycol monomethyl ether | 203-713-7 | 109-86-4 | Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H226 H360FD H332 H312 H302 | GHS02 GHS08 GHS07 Gef. | H226 H360FD H332 H312 H302 | |||
| 603-012-00-X | 2-ethoxyethanol; ethylene glycol monoethyl ether | 203-804-1 | 110-80-5 | Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 | H226 H360FD H331 H302 | GHS02 GHS08 GHS06 Gef. | H226 H360FD H331 H302 | |||
| 603-013-00-5 | 2-isopropoxyethanol; ethylene glycol monoisopropyl ether | 203-685-6 | 109-59-1 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 | H332 H312 H319 | GHS07 Achtg. | H332 H312 H319 | |||
| 603-014-00-0 | 2-butoxyethanol; ethylene glycol monobutyl ether; butyl cellosolve | 203-905-0 | 111-76-2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H332 H312 H302 H319 H315 | GHS07 Achtg. | H332 H312 H302 H319 H315 | |||
| 603-015-00-6 | allyl alcohol | 203-470-7 | 107-18-6 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H225 H331 H311 H301 H319 H335 H315 H400 | GHS02 GHS06 GHS09 Gef. | H225 H331 H311 H301 H319 H335 H315 H400 | |||
| 603-016-00-1 | 4-hydroxy-4-methylpentan-2-one; diacetone alcohol | 204-626-7 | 123-42-2 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | Eye Irrit. 2; H319: C ≥ 10 % | ||
| 603-018-00-2 | furfuryl alcohol | 202-626-1 | 98-00-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 | H351 H331 H312 H302 H373** H319 H335 | GHS06 GHS08 Gef. | H351 H331 H312 H302 H373** H319 H335 | |||
| 603-019-00-8 | dimethyl ether | 204-065-8 | 115-10-6 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 603-020-00-3 | ethyl methyl ether | - | 540-67-0 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | U | ||
| 603-021-00-9 | methyl vinyl ether | 203-475-4 | 107-25-5 | Flam. Gas 1 Press. Gas | H220 | GHS02 GHS04 Gef. | H220 | D U | ||
| 603-022-00-4 | diethyl ether; ether | 200-467-2 | 60-29-7 | Flam. Liq. 1 Acute Tox. 4 * STOT SE 3 | H224 H302 H336 | GHS02 GHS07 Gef. | H224 H302 H336 | EUH019 EUH066 | ||
| 603-023-00-X | ethylene oxide; oxirane | 200-849-9 | 75-21-8 | Press.
Gas Flam. Gas 1 Carc. 1B Muta. 1B Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H220 H350 H340 H331 H319 H335 H315 | GHS02 GHS04 GHS06 GHS08 Gef. | H220 H350 H340 H331 H319 H335 H315 | U | ||
| 603-024-00-5 | 1,4-dioxane | 204-661-8 | 123-91-1 | Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 | H225 H351 H319 H335 | GHS02 GHS08 GHS07 Gef. | H225 H351 H319 H335 | EUH019 EUH066 | D | |
| 603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 | H225 H351 H319 H335 | GHS02 GHS07 GHS08 Gef. | H225 H351 H319 H335 | EUH019 | STOT SE 3; H335: C ≥ 25 % Eye Irrit.2; H319: C ≥ 25 % | |
| 603-026-00-6 | 1-chloro-2,3-epoxypropane; epichlorhydrin | 203-439-8 | 106-89-8 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 | H226 H350 H331 H311 H301 H314 H317 | GHS02 GHS06 GHS08 GHS05 Gef. | H226 H350 H331 H311 H301 H314 H317 | * | ||
| 603-027-00-1 | ethanediol; ethylene glycol | 203-473-3 | 107-21-1 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 603-028-00-7 | 2-chloroethanol; ethylene chlorohydrin | 203-459-7 | 107-07-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * | H330 H310 H300 | GHS06 Gef. | H330 H310 H300 | |||
| 603-029-00-2 | bis(2-chloroethyl) ether | 203-870-1 | 111-44-4 | Carc. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * | H351 H330 H310 H300 | GHS06 GHS08 Gef. | H351 H330 H310 H300 | |||
| 603-030-00-8 | 2-aminoethanol; ethanolamine | 205-483-3 | 141-43-5 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H332 H312 H302 H314 | GHS05 GHS07 Gef. | H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 603-031-00-3 | 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME | 203-794-9 | 110-71-4 | Flam. Liq. 2 Repr. 1B Acute Tox. 4 * | H225 H360FD H332 | GHS02 GHS08 GHS07 Gef. | H225 H360FD H332 | EUH019 | ||
| 603-032-00-9 | ethylene dinitrate; ethylene glycol dinitrate | 211-063-0 | 628-96-6 | Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 | H200 H330 H310 H300 H373** | GHS01 GHS06 GHS08 Gef. | H200 H330 H310 H300 H373** | |||
| 603-033-00-4 | oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate | 211-745-8 | 693-21-0 | Unst. Expl Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 | H200 H330 H310 H300 H373 ** H412 | GHS01 GHS06 GHS08 Gef. | H200 H330 H310 H300 H373 ** H412 | |||
| 603-033-01-1 | oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate; [>25 % phlegmatiser] | 211-745-8 | 693-21-0 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 | H201 H330 H310 H300 H373 ** H412 | GHS01 GHS06 GHS08 Gef. | H201 H330 H310 H300 H373 ** H412 | |||
| 603-034-00-X | glycerol trinitrate; nitroglycerine | 200-240-8 | 55-63-0 | Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 | H200 H330 H310 H300 H373 ** H411 | GHS01 GHS06 GHS08 GHS09 Gef. | H200 H330 H310 H300 H373 ** H411 | |||
| 603-034-01-7 | glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser] | 200-240-8 | 55-63-0 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 | H201 H330 H310 H300 H373 ** H411 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H330 H310 H300 H373 ** H411 | |||
| 603-035-00-5 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N. | 201-084-3 | 78-11-5 | Unst. Expl. | H200 | GHS01 Gef. | H200 | |||
| 603-035-01-2 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.; [>20 % phlegmatiser] | 201-084-3 | 78-11-5 | Expl. 1.1 | H201 | GHS01 Gef. | H201 | T | ||
| 603-036-00-0 | mannitol hexanitrate; nitromannite | 239-924-6 | 15825-70-4 | Unst. Expl. | H200 | GHS01 Gef. | H200 | |||
| 603-036-01-8 | mannitol hexanitrate; nitromannite; [≥40 % phlegmatiser] | 239-924-6 | 15825-70-4 | Expl. 1.1 | H201 | GHS01 Gef. | H201 | |||
| 603-037-00-6 | cellulose nitrate; nitrocellulose | - | - | Expl. 1.1 | H201 | GHS01 Gef. | H201 | T | ||
| 603-038-00-1 | allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether | 203-442-4 | 106-92-3 | Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 | |||
| 603-039-00-7 | butyl glycidyl ether; butyl 2,3-epoxypropyl ether | 219-376-4 | 2426-08-6 | Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 | H226 H351 H341 H332 H302 H335 H317 H412 | GHS02 GHS08 GHS07 Achtg. | H226 H351 H341 H332 H302 H335 H317 H412 | |||
| 603-040-00-2 | sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3] | 204-699-5 [1] 212-736-1 [2] 212-737-7 [3] | 124-41-4 [1] 865-33-8 [2] 865-34-9 [3] | Self-heat 1 Skin Corr. 1B | H251 H314 | GHS02 GHS05 Gef. | H251 H314 | EUH014 | T | |
| 603-041-00-8 | potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2] | 213-029-0 [1] 205-487-5 [2] | 917-58-8 [1] 141-52-6 [2] | Self-heat 1 Skin Corr. 1B | H251 H314 | GHS02 GHS05 Gef. | H251 H314 | EUH014 | T | |
| 603-042-00-3 | aluminium-tri-isopropoxide | 209-090-8 | 555-31-7 | Flam. Sol. 1 | H228 | GHS02 Gef. | H228 | T | ||
| 603-043-00-9 | triarimol (ISO); 2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol | - | 26766-27-8 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 603-044-00-4 | dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol | 204-082-0 | 115-32-2 | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H315 H317 H410 | |||
| 603-045-00-X | diisopropyl ether; [1] dipropyl ether [2] | 203-560-6 [1] 203-869-6 [2] | 108-20-3 [1] 111-43-3 [2] | Flam. Liq. 2 STOT SE 3 | H225 H336 | GHS02 GHS07 Gef. | H225 H336 | EUH019 EUH066 | C | |
| 603-046-00-5 | bis(chloromethyl) ether; oxybis(chloromethane) | 208-832-8 | 542-88-1 | Flam. Liq. 2 Carc. 1A Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * | H225 H350 H330 H311 H302 | GHS02 GHS06 GHS08 Gef. | H225 H350 H330 H311 H302 | Carc. 1A; H350: C ≥ 0,001 % | ||
| 603-047-00-0 | 2-dimethylaminoethanol; N,N-dimethylethanolamine | 203-542-8 | 108-01-0 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H226 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H226 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 603-048-00-6 | 2-diethylaminoethanol; N,N-diethylethanolamine | 202-845-2 | 100-37-8 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H226 H332 H312 H302 H314 | GHS02 GHS05 GHS07 GHS09 Gef. | H226 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 603-049-00-1 | chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol | 201-246-3 | 80-06-8 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 603-050-00-7 | 1-(2-butoxypropoxy)propan-2-ol | 246-011-6 | 24083-03-2 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 603-051-00-2 | 2-ethylbutan-1-ol | 202-621-4 | 97-95-0 | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 603-052-00-8 | 3-butoxypropan-2-ol; propylene glycol monobutyl ether | 225-878-4 | 5131-66-8 | Eye Irrit. 2 Skin Irrit. 2 | H319 H315 | GHS07 Achtg. | H319 H315 | |||
| 603-053-00-3 | 2-methylpentane-2,4-diol | 203-489-0 | 107-41-5 | Eye Irrit. 2 Skin Irrit. 2 | H319 H315 | GHS07 Achtg. | H319 H315 | |||
| 603-054-00-9 | di-n-butyl ether; dibutyl ether | 205-575-3 | 142-96-1 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 | H226 H319 H335 H315 H412 | GHS02 GHS07 Achtg. | H226 H319 H335 H315 H412 | STOT SE 3; H335: C ≥ 10 % | ||
| 603-055-00-4 | Propylenoxid; 1,2-Epoxypropan; Methyloxiran | 200-879-2 | 75-56-9 | Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 | H224 H350 H340 H331 H311 H302 H335 H319 | GHS02 GHS08 GHS06 Gef. | H224 H350 H340 H331 H311 H302 H335 H319 | |||
| 603-056-00-X | [(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2] 2,3-epoxypropyl o-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4] | 218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] | 2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] | Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H341 H315 H317 H411 | GHS08 GHS07 GHS09 Achtg. | H341 H315 H317 H411 | C | ||
| 603-057-00-5 | benzyl alcohol | 202-859-9 | 100-51-6 | Acute Tox. 4 * Acute Tox. 4 * | H332 H302 | GHS07 Achtg. | H332 H302 | |||
| 603-058-00-0 | 1,3-propylene oxide | 207-964-3 | 503-30-0 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 H332 H312 H302 | GHS02 GHS07 Gef. | H225 H332 H312 H302 | |||
| 603-059-00-6 | hexan-1-ol | 203-852-3 | 111-27-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 603-060-00-1 | 2,2'-bioxirane; 1,2:3,4-diepoxybutane | 215-979-1 | 1464-53-5 | Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B | H350 H340 H330 H311 H301 H314 | GHS06 GHS08 GHS05 Gef. | H350 H340 H330 H311 H301 H314 | |||
| 603-061-00-7 | tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol | 202-625-6 | 97-99-4 | Repr. 1B Eye Irrit. 2 | H360Df H319 | GHS08 GHS07 Gef. | H360Df H319 | |||
| 603-062-00-2 | tetrahydrofuran-2,5-diyldimethanol | 203-239-0 | 104-80-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | STOT SE 3; H335: C ≥ 10 % | ||
| 603-063-00-8 | 2,3-epoxypropan-1-ol; glycidol; oxiranemethanol | 209-128-3 | 556-52-5 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H350 H341 H360F *** H331 H312 H302 H319 H335 H315 | GHS06 GHS08 Gef. | H350 H341 H360F *** H331 H312 H302 H319 H335 H315 | |||
| 603-064-00-3 | 1-methoxy-2-propanol; monopropylene glycol methyl ether | 203-539-1 | 107-98-2 | Flam. Liq. 3 STOT SE 3 | H226 H336 | GHS02 GHS07 Achtg. | H226 H336 | |||
| 603-065-00-9 | resorcinol diglycidyl ether; 1,3-bis(2,3-epoxypropoxy)benzene | 202-987-5 | 101-90-6 | Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H351 H341 H312 H302 H319 H315 H317 H412 | GHS08 GHS07 Achtg. | H351 H341 H312 H302 H319 H315 H317 H412 | |||
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide | 203-437-7 | 106-87-6 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H351 H331 H311 H301 | GHS06 GHS08 Gef. | H351 H331 H311 H301 | * | ||
| 603-067-00-X | phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropane | 204-557-2 | 122-60-1 | Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H350 H341 H332 H335 H315 H317 H412 | GHS08 GHS07 Gef. | H350 H341 H332 H335 H315 H317 H412 | |||
| 603-068-00-5 | 2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether | - | 130014-35-6 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | |||
| 603-069-00-0 | 2,4,6-tris(dimethylaminomethyl)phenol | 202-013-9 | 90-72-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H302 H319 H315 | GHS07 Achtg. | H302 H319 H315 | |||
| 603-070-00-6 | 2-amino-2-methylpropanol | 204-709-8 | 124-68-5 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H319 H315 H412 | GHS07 Achtg. | H319 H315 H412 | |||
| 603-071-00-1 | 2,2'-iminodiethanol; diethanolamine | 203-868-0 | 111-42-2 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 | H302 H373 ** H315 H318 | GHS08 GHS05 GHS07 Gef. | H302 H373 ** H315 H318 | |||
| 603-072-00-7 | 1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether | 219-371-7 | 2425-79-8 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H332 H312 H319 H315 H317 | GHS07 Achtg. | H332 H312 H319 H315 H317 | |||
| 603-073-00-2 | bis-[4-(2,3-epoxipropoxi)phenyl]propane | 216-823-5 | 1675-54-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | ||
| 603-074-00-8 | reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700) | 500-033-5 | 25068-38-6 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H315 H317 H411 | GHS07 GHS09 Achtg. | H319 H315 H317 H411 | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | ||
| 603-075-00-3 | chlormethyl methyl ether; chlorodimethyl ether | 203-480-1 | 107-30-2 | Flam. Liq. 2 Carc. 1A Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 H350 H332 H312 H302 | GHS02 GHS08 GHS07 Gef. | H225 H350 H332 H312 H302 | |||
| 603-076-00-9 | but-2-yne-1,4-diol; 2-butyne-1,4-diol | 203-788-6 | 110-65-6 | Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 | H314 H331 H301 H312 H373 ** H317 | GHS06 GHS05 GHS08 Gef. | H314 H331 H301 H312 H373 ** H317 | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 25 % ≤ C < 50 % Eye Irrit. 2; H319: 25 % ≤ C < 50 % | D | |
| 603-077-00-4 | 1-dimethylaminopropan-2-ol; dimepranol (INN) | 203-556-4 | 108-16-7 | Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B | H226 H302 H314 | GHS02 GHS05 GHS07 Gef. | H226 H302 H314 | |||
| 603-078-00-X | prop-2-yn-1-ol; propargyl alcohol | 203-471-2 | 107-19-7 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 | H226 H331 H311 H301 H314 H411 | GHS02 GHS06 GHS05 GHS09 Gef. | H226 H331 H311 H301 H314 H411 | |||
| 603-079-00-5 | 2,2'-(methylimino)diethanol; N-methyldiethanolamine | 203-312-7 | 105-59-9 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-080-00-0 | 2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol | 203-710-0 | 109-83-1 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 603-081-00-6 | 2,2'-thiodiethanol; thiodiglycol | 203-874-3 | 111-48-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-082-00-1 | 1-aminopropan-2-ol; isopropanolamine | 201-162-7 | 78-96-6 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 603-083-00-7 | 1,1'-iminodipropan-2-ol; di-isopropanolamine | 203-820-9 | 110-97-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-084-00-2 | styrene oxide; (epoxyethyl)benzene; phenyloxirane | 202-476-7 | 96-09-3 | Carc. 1B Acute Tox. 4 * Eye Irrit. 2 | H350 H312 H319 | GHS08 GHS07 Gef. | H350 H312 H319 | |||
| 603-085-00-8 | bronopol (INN); 2-bromo-2-nitropropane-1,3-diol | 200-143-0 | 52-51-7 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 | H312 H302 H335 H315 H318 H400 | GHS05 GHS07 GHS09 Gef. | H312 H302 H335 H315 H318 H400 | M=10 | ||
| 603-086-00-3 | ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol | 245-949-3 | 23947-60-6 | Acute Tox. 4 * | H312 | GHS07 Achtg. | H312 | |||
| 603-087-00-9 | 2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol | 202-377-9 | 94-96-2 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-088-00-4 | 2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide | 222-598-4 | 3547-33-9 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-089-00-X | 7,7-dimethyl-3-oxa-6-azaoctan-1-ol | 400-390-6 | - | Skin Corr. 1A Acute Tox. 4 * | H314 H302 | GHS05 GHS07 Gef. | H314 H302 | |||
| 603-090-00-5 | 2-(2-bromoethoxy)anisole | 402-010-4 | 4463-59-6 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-091-00-0 | exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol | 402-470-6 | 87172-89-2 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 603-092-00-6 | 2-methyl-4-phenylpentanol | 402-770-7 | 92585-24-5 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 603-093-00-1 | cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane | 402-410-9 | 87818-31-3 | Acute Tox. 4 * Aquatic Chronic 2 | H332 H411 | GHS07 GHS09 Gef. | H332 H411 | |||
| 603-094-00-7 | 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane | 241-536-7 | 17557-23-2 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 603-095-00-2 | 2-(propyloxy)ethanol; EGPE | 220-548-6 | 2807-30-9 | Acute Tox. 4 * Eye Irrit. 2 | H312 H319 | GHS07 Achtg. | H312 H319 | |||
| 603-096-00-8 | 2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether | 203-961-6 | 112-34-5 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-097-00-3 | 1,1′,1″-nitrilotripropan-2-ol; triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-098-00-9 | 2-phenoxyethanol | 204-589-7 | 122-99-6 | Acute Tox. 4 * Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 603-099-00-4 | 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride | 403-440-5 | 93633-79-5 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-100-00-8 | 1,2-dimethoxypropane | 404-630-0 | 7778-85-0 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | EUH019 | ||
| 603-101-00-3 | tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) | 405-040-6 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-102-00-9 | 1,2-Epoxybutan | 203-438-2 | 106-88-7 | Flam. Liq. 2 Carc. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 | H225 H351 H302 H312 H332 H335 H315 H319 | GHS02 GHS08 GHS07 Gef. | H225 H351 H302 H312 H332 H335 H315 H319 | |||
| 603-103-00-4 | oxirane, mono[(C12-14-alkyloxy)methyl] derivs. | 271-846-8 | 68609-97-2 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 603-104-00-X | fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol | 262-095-7 | 60168-88-9 | Repr. 2 Lact. Aquatic Chronic 2 | H361fd H362 H411 | GHS08 GHS09 Achtg. | H361fd H362 H411 | |||
| 603-105-00-5 | furan | 203-727-3 | 110-00-9 | Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 | H224 H350 H341 H332 H302 H373 ** H315 H412 | GHS02 GHS08 GHS07 Gef. | H224 H350 H341 H332 H302 H373 ** H315 H412 | EUH019 | ||
| 603-106-00-0 | 2-methoxypropanol | 216-455-5 | 1589-47-5 | Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H226 H360D *** H335 H315 H318 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H360D *** H335 H315 H318 | |||
| 603-107-00-6 | 2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether | 203-906-6 | 111-77-3 | Repr. 2 | H361d *** | GHS08 Achtg. | H361d *** | |||
| 603-108-00-1 | 2-methylpropan-1-ol; iso-butanol | 201-148-0 | 78-83-1 | Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 | H226 H335 H315 H318 H336 | GHS02 GHS05 GHS07 Gef. | H226 H335 H315 H318 H336 | |||
| 603-109-00-7 | reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane | 425-340-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-110-00-2 | reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane | 426-130-1 | 166301-21-9 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 603-111-00-8 | reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane | 426-530-6 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 603-112-00-3 | cyclopentyl 2-phenylethyl ether | 428-340-9 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 603-113-00-9 | 6-glycidyloxynapht-1-yl oxymethyloxirane | 429-960-2 | 27610-48-6 | Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H341 H312 H315 H317 H412 | GHS08 GHS07 Achtg. | H341 H312 H315 H317 H412 | |||
| 603-114-00-4 | 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene | 430-830-2 | 26912-64-1 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 603-115-00-X | reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-580-0 | - | STOT RE 2 * Aquatic Chronic 4 | H373** H413 | GHS08 Achtg. | H373** H413 | |||
| 603-116-00-5 | (Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride | 424-740-2 | 138271-16-6 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 603-117-00-0 | propan-2-ol; isopropyl alcohol; isopropanol | 200-661-7 | 67-63-0 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | |||
| 603-118-00-6 | 6-dimethylaminohexan-1-ol | 404-680-3 | 1862-07-3 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 | H302 H314 H412 | GHS05 GHS07 Gef. | H302 H314 H412 | |||
| 603-119-00-1 | 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) | 405-840-5 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 603-120-00-7 | 2-methyl-5-phenylpentanol | 405-890-8 | 25634-93-9 | Eye Irrit. 2 Skin Irrit. 2 | H319 H315 | GHS07 Achtg. | H319 H315 | |||
| 603-121-00-2 | 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone | 406-057-1 | 114565-66-1 | Carc. 2 Skin Sens. 1 Aquatic Chronic 4 | H351 H317 H413 | GHS08 GHS07 Achtg. | H351 H317 H413 | |||
| 603-122-00-8 | sodium 2-ethylhexanolate | 406-150-7 | 38411-13-1 | Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 | H228 H314 H412 | GHS02 GHS05 Gef. | H228 H314 H412 | T | ||
| 603-123-00-3 | 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol | 406-330-5 | 122760-84-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H315 H317 H411 | GHS07 GHS09 Achtg. | H315 H317 H411 | |||
| 603-124-00-9 | 1,4-bis[2-(vinyloxy)ethoxy]benzene | 406-900-3 | 84563-49-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-125-00-4 | 2-(2,4-dichlorophenyl)-1-(1H - 1,2,4-triazol-1-yl)pent-4-en-2-ol | 407-850-5 | 89544-40-1 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 603-126-00-X | 2-((4-methyl-2-nitrophenyl)amino)ethanol | 408-090-7 | 100418-33-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 603-127-00-5 | butan-2-ol; [1] (S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4] | 201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] | 78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 | H226 H319 H335 H336 | GHS02 GHS07 Achtg. | H226 H319 H335 H336 | C | ||
| 603-128-00-0 | 2-(phenylmethoxy)naphthalene | 405-490-3 | 613-62-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-129-00-6 | 1-tert-butoxypropan-2-ol | 406-180-0 | 57018-52-7 | Flam. Liq. 3 Eye Dam. 1 | H226 H318 | GHS02 GHS05 Gef. | H226 H318 | |||
| 603-130-00-1 | reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) | 406-325-8 | - | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-131-00-7 | reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) | 407-290-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-132-00-2 | 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane | 408-200-3 | 63187-91-7 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H315 H318 H412 | GHS05 Gef. | H315 H318 H412 | |||
| 603-133-00-8 | reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) | 408-240-1 | - | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-134-00-3 | reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. | 410-450-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-135-00-9 | bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium | 410-500-4 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 603-136-00-4 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | 410-910-3 | 104226-19-9 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 603-137-00-X | reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol | 411-130-6 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-138-00-5 | 3-(2,2-dimethyl-3-hydroxypropyl)toluene; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol | 403-140-4 | 103694-68-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-139-00-0 | bis(2-methoxyethyl) ether | 203-924-4 | 111-96-6 | Flam. Liq. 3 Repr. 1B | H226 H360FD | GHS02 GHS08 Gef. | H226 H360FD | EUH019 | ||
| 603-140-00-6 | 2,2' -oxybisethanol; diethylene glycol | 203-872-2 | 111-46-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 603-141-00-1 | reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane | 413-780-6 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-142-00-7 | 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane | 407-360-1 | 116230-20-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 | H312 H302 H373 ** H315 H318 | GHS06 GHS08 GHS05 Gef. | H312 H302 H373 ** H315 H318 | |||
| 603-143-00-2 | R - 2,3-epoxy-1-propanol | 404-660-4 | 57044-25-4 | Self-react.
C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H242 H350 H341 H360F *** H331 H312 H302 H314 | GHS02 GHS06 GHS08 GHS05 Gef. | H242 H350 H341 H360F *** H331 H312 H302 H314 | |||
| 603-144-00-8 | reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol | 413-530-6 | 111850-00-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-145-00-3 | 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane | 406-970-5 | 129228-11-1 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 603-146-00-9 | 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol | 406-080-7 | 83016-70-0 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 | H302 H314 H412 | GHS05 GHS07 Gef. | H302 H314 H412 | |||
| 603-147-00-4 | (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 406-030-4 | 105812-81-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 603-148-00-X | 1,4-bis[(vinyloxy)methyl]cyclohexane | 413-370-7 | 17351-75-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 603-149-00-5 | reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane | 407-640-3 | 63767-86-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H319 H315 H411 | GHS07 GHS09 Achtg. | H319 H315 H411 | |||
| 603-150-00-0 | (±) trans - 3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol | 411-580-3 | 107898-54-4 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 603-151-00-6 | (±)-2-(2,4-dichlorophenyl)-3-(1H - 1,2,4-triazol-1-yl)propan-1-ol | 413-570-4 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-152-00-1 | 2-(4-tert-butylphenyl)ethanol | 410-020-5 | 5406-86-0 | Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 | H361f *** H373 ** H318 H411 | GHS08 GHS05 GHS09 Gef. | H361f *** H373 ** H318 H411 | |||
| 603-153-00-7 | 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol | 410-010-0 | 104333-00-8 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-154-00-2 | 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol | 412-300-2 | 139504-68-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-156-00-3 | 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane | 411-210-0 | 89544-48-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 603-157-00-9 | 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol | 411-450-6 | 143747-72-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-158-00-4 | reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene | 412-460-3 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 603-159-00-X | 2-cyclododecylpropan-1-ol | 411-410-8 | 118562-73-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-160-00-5 | 1,2-diethoxypropane | 412-180-1 | 10221-57-5 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | EUH019 | ||
| 603-161-00-0 | 1,3-diethoxypropane | 413-140-6 | 3459-83-4 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | |||
| 603-162-00-6 | α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] | 413-420-8 | 144736-29-8 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H317 H411 | |||
| 603-163-00-1 | 2-phenyl-1,3-propanediol | 411-810-2 | 1570-95-2 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-164-00-7 | 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole | 412-420-5 | 133909-99-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-165-00-2 | reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol | 417-470-1 | - | Muta. 2 Skin Sens. 1 | H341 H317 | GHS08 GHS07 Achtg. | H341 H317 | |||
| 603-166-00-8 | R-1-chloro-2,3-epoxypropane | 424-280-2 | 51594-55-9 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 | H226 H350 H331 H311 H301 H314 H317 | GHS02 GHS06 GHS08 GHS05 Gef. | H226 H350 H331 H311 H301 H314 H317 | |||
| 603-167-00-3 | 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol | 407-920-5 | 6390-69-8 | Aquatic Chronic 4 | H413 | GHS05 Gef. | H413 | |||
| 603-168-00-9 | 3-(2-ethylhexyloxy)propane-1,2-diol | 408-080-2 | 70445-33-9 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 603-169-00-4 | (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 415-550-0 | 109887-53-8 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 603-170-00-X | reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol | 415-990-3 | 67739-11-1 | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 603-171-00-5 | 5-thiazolylmethanol | 414-780-9 | 38585-74-9 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 603-172-00-0 | mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate | 415-180-1 | 773058-82-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 603-173-00-6 | 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane | 421-750-9 | 57280-22-5 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 603-174-00-1 | 4-cyclohexyl-2-methyl-2-butanol | 420-630-3 | 83926-73-2 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 603-175-00-7 | 2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol | 203-988-3 | 112-59-4 | Acute Tox. 4 * Eye Dam. 1 | H312 H318 | GHS05 GHS07 Gef. | H312 H318 | |||
| 603-176-00-2 | 1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme | 203-977-3 | 112-49-2 | Repr. 1B | H360Df | GHS08 Gef. | H360Df | EUH019 | ||
| 603-177-00-8 | 1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEA [2] | 216-374-5 [1] 259-370-9 [2] | 1569-02-4 [1] 54839-24-6 [2] | Flam. Liq. 3 STOT SE 3 | H226 H336 | GHS02 GHS07 Achtg. | H226 H336 | |||
| 603-178-00-3 | 2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol | 203-951-1 | 112-25-4 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 603-179-00-9 | ergocalciferol (ISO); Vitamin D2 | 200-014-9 | 50-14-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330 H311 H301 H372 ** | GHS06 GHS08 Gef. | H330 H311 H301 H372 ** | |||
| 603-180-00-4 | colecalciferol; Vitamin D3 | 200-673-2 | 67-97-0 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330 H311 H301 H372 ** | GHS06 GHS08 Gef. | H330 H311 H301 H372 ** | |||
| 603-181-00-X | tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane | 216-653-1 | 1634-04-4 | Flam. Liq. 2 Skin Irrit. 2 | H225 H315 | GHS02 GHS07 Gef. | H225 H315 | |||
| 603-182-00-5 | reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutumL., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide | 428-630-5 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 603-183-00-0 | 2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutyl ether; butoxytriethylene glycol | 205-592-6 | 143-22-6 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | Eye Dam. 1; H318: C ≥ 30 % Eye Irrit. 2; H319: 20 % ≤ C < 30 % | ||
| 603-184-00-6 | 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol | 416-380-1 | 146925-83-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-185-00-1 | 2,4-dichloro-3-ethyl-6-nitrophenol | 420-740-1 | 99817-36-4 | Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H318 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H301 H318 H317 H410 | |||
| 603-186-00-7 | trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | 419-050-3 | 79944-37-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 603-187-00-2 | 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride | 419-360-9 | 163661-77-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-188-00-8 | reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene | 426-970-9 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-189-00-3 | reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol | 405-250-8 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-190-00-9 | 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane | 424-030-2 | 62406-73-9 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 603-191-00-4 | 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol | 419-740-4 | 137658-79-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-192-00-X | (E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol | 423-240-1 | 125474-34-2 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 603-193-00-5 | disodium 9,10-anthracenedioxide | 426-030-8 | 46492-07-3 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | |||
| 603-194-00-0 | 2-(2-aminoethylamino)ethanol; (AEEA) | 203-867-5 | 111-41-1 | Repr. 1B Skin Corr. 1B Skin Sens. 1 | H360Df H314 H317 | GHS05 GHS08 GHS07 Gef. | H360Df H314 H317 | STOT SE 3; H335: C ≥ 5 % | ||
| 603-195-00-6 | 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol | 430-810-3 | 154825-62-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-196-00-1 | 2-(7-ethyl-1H-indol-3-yl)ethanol | 431-020-1 | 41340-36-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 | H302 H373 ** H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H411 | |||
| 603-197-00-7 | Tebuconazol (ISO); 1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol | 403-640-2 | 107534-96-3 | Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 | H361d*** H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d*** H302 H410 | M = 1 M = 10 | ||
| 603-199-00-8 | etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole | - | 153233-91-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=100 | ||
| 603-200-00-1 | 1-pentanol; [1] 3-pentanol [2] | 200-752-1 [1] 209-526-7 [2] | 71-41-0 [1] 584-02-1 [2] | Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 | H226 H332 H335 H315 | GHS02 GHS07 Achtg. | H226 H332 H335 H315 | |||
| 603-201-00-7 | (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol | 416-120-5 | - | Skin Irrit. 2 Aquatic Chronic 4 | H315 H413 | GHS07 Achtg. | H315 H413 | |||
| 603-202-00-2 | 4,4,5,5,5-pentafluoropentan-1-ol | 421-360-9 | 148043-73-6 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 603-203-00-8 | (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane | 427-580-1 | - | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 603-204-00-3 | reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane | 428-110-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-205-00-9 | (1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride | 426-200-1 | 172015-79-1 | STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H372** H302 H318 H317 H412 | GHS05 GHS08 GHS07 Gef. | H372** H302 H318 H317 H412 | |||
| 603-206-00-4 | 2,2-dichloro-1,3-benzodioxol | 426-850-6 | 2032-75-9 | Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 | H226 H314 H302 H317 | GHS02 GHS05 GHS07 Gef. | H226 H314 H302 H317 | EUH014 | ||
| 603-207-00-X | 2-isobutyl-2-isopropyl-1,3-dimethoxypropane | 430-800-9 | 129228-21-3 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 603-208-00-5 | 1,2-diethoxyethane | 211-076-1 | 629-14-1 | Flam. Liq. 2 Repr. 1A Eye Irrit. 2 | H225 H360Df H319 | GHS02 GHS08 GHS07 Gef. | H225 H360Df H319 | EUH019 | ||
| 603-209-00-0 | spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3] | - [1] - [2] - [3] | - [1] 131929-60-7 [2] 131929-63-0 [3] | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=10 | ||
| 603-210-00-6 | 2,4-diethyl-1,5-pentanediol | 429-310-8 | 57987-55-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride
%; glycidyl trimethylammonium chloride % | 221-221-0 | 3033-77-0 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H350 H341 H361f*** H312 H302 H373** H318 H317 H412 | GHS05 GHS08 GHS07 Gef. | H350 H341 H361f*** H312 H302 H373** H318 H317 H412 | B | ||
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) | 214-946-9 | 1222-05-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 603-213-00-2 | 2-methoxy-2-methylbutane; tert-amyl methyl ether | 213-611-4 | 994-05-8 | Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 | H225 H302 H336 | GHS02 GHS07 Gef. | H225 H302 H336 | |||
| 603-214-00-8 | 1,1-diisopropoxycyclohexane | 413-740-8 | 1132-95-2 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 418-330-2 | 162241-33-0 | Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H201 H302 H373** H318 H317 H400 H410 | GHS01 GHS05 GHS08 GHS07 GHS09 Gef. | H201 H302 H373** H318 H317 H410 | |||
| 603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | 422-660-2 | 7480-35-5 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 603-217-00-4 | 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | 423-560-1 | 161717-32-4 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | 432-890-5 | 72955-94-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] | 433-580-2 | 214353-17-0 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H302 H314 H411 | GHS05 GHS07 GHS09 Gef. | H302 H314 H411 | |||
| 603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] | 433-580-2 | 214353-17-0 | Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H350 H302 H314 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H350 H302 H314 H411 | |||
| 603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | 433-820-6 | 118058-74-5 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 603-223-00-7 | 2-cyclopentylidene cyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol | 434-270-1 | 6261-30-9 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H315 H318 H412 | GHS05 Gef. | H315 H318 H412 | |||
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | 435-790-1 | 297730-93-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-225-00-8 | erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) | 437-070-0 | 13127-18-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-226-00-3 | 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | 444-500-0 | 1440-00-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate | 445-060-2 | 203574-04-3 | **** Aquatic Acute 1 Aquatic Chronic 1 | **** H400 H410 | **** GHS09 Achtg. | **** H410 | |||
| 603-228-00-4 | (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane | 419-620-1 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 603-229-00-X | sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | 420-800-7 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | 440-030-5 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 | H315 H318 H413 | GHS05 Gef. | H315 H318 H413 | |||
| 603-231-00-0 | (S)-1,1-diphenyl-1,2-propanediol | 443-220-6 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | 444-420-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-233-00-1 | reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | 444-430-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | 444-480-3 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 603-235-00-2 | Linalool: 3,7-Dimethyl-1,6-octadien-3-ol; DL-Linalool; [1] Coriandrol; (S)-3,7-Dimethyl-1,6-octadien-3-ol; D- Linalool; [2] Licareol; (R)-3,7-Dimethyl-1,6-octadien-3-ol; L- Linalool [3] | 201-134-4 [1] 204-810-7 [2] 204-811-2 [3] | 78-70-6 [1] 126-90-9 [2] 126-91-0 [3] | Skin Sens. 1B | H317 | GHS07 Achtg. | H317 | |||
| 604-001-00-2 | phenol; carbolic acid; monohydroxybenzene; phenylalcohol | 203-632-7 | 108-95-2 | Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B | H341 H331 H311 H301 H373 ** H314 | GHS06 GHS08 GHS05 Gef. | H341 H331 H311 H301 H373 ** H314 | * Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315: 1 % ≤ C < 3 % Eye Irrit. 2; H319: 1 % ≤ C < 3 % | ||
| 604-002-00-8 | pentachlorophenol | 201-778-6 | 87-86-5 | Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H330 H311 H301 H319 H335 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H330 H311 H301 H319 H335 H315 H410 | |||
| 604-003-00-3 | sodium pentachlorophenolate; [1] potassium pentachlorophenolate [2] | 205-025-2 [1] 231-911-3 [2] | 131-52-2 [1] 7778-73-6 [2] | Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H330 H311 H301 H319 H335 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H330 H311 H301 H319 H335 H315 H410 | |||
| 604-004-00-9 | m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] | 203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] | 108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] | Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B | H311 H301 H314 | GHS06 GHS05 Gef. | H311 H301 H314 | * | C | |
| 604-005-00-4 | 1,4-dihydroxybenzene; hydroquinone; quinol | 204-617-8 | 123-31-9 | Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H351 H341 H302 H318 H317 H400 | GHS05 GHS08 GHS07 GHS09 Gef. | H351 H341 H302 H318 H317 H400 | M=10 | ||
| 604-006-00-X | 3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7] | 202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] | 95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] | Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 | H311 H301 H314 H411 | GHS06 GHS05 GHS09 Gef. | H311 H301 H314 H411 | C | ||
| 604-007-00-5 | 2-naphthol | 205-182-7 | 135-19-3 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 | H332 H302 H400 | GHS07 GHS09 Achtg. | H332 H302 H400 | |||
| 604-008-00-0 | 2-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4] | 202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] | 95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H332 H312 H302 H411 | GHS07 GHS09 Achtg. | H332 H312 H302 H411 | C | ||
| 604-009-00-6 | pyrogallol; 1,2,3-trihydroxybenzene | 201-762-9 | 87-66-1 | Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H341 H332 H312 H302 H412 | GHS08 GHS07 Achtg. | H341 H332 H312 H302 H412 | * | ||
| 604-010-00-1 | resorcinol; 1,3-benzenediol | 203-585-2 | 108-46-3 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 | H302 H319 H315 H400 | GHS07 GHS09 Achtg. | H302 H319 H315 H400 | * | ||
| 604-011-00-7 | 2,4-dichlorophenol | 204-429-6 | 120-83-2 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H311 H302 H314 H411 | GHS06 GHS05 GHS09 Gef. | H311 H302 H314 H411 | |||
| 604-012-00-2 | 4-chloro-o-cresol; 4-chloro-2-methyl phenol | 216-381-3 | 1570-64-5 | Acute Tox. 3 * Skin Corr. 1A Aquatic Acute 1 | H331 H314 H400 | GHS06 GHS05 GHS09 Gef. | H331 H314 H400 | STOT SE 3; H335: C ≥ 1 % | ||
| 604-013-00-8 | 2,3,4,6-tetrachlorophenol | 200-402-8 | 58-90-2 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H301 H319 H315 H400 H410 | GHS06 GHS09 Gef. | H301 H319 H315 H410 | * Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | ||
| 604-014-00-3 | chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol | 200-431-6 | 59-50-7 | Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H312 H302 H318 H317 H400 | GHS05 GHS07 GHS09 Gef. | H312 H302 H318 H317 H400 | * | ||
| 604-015-00-9 | 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene | 200-733-8 | 70-30-4 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H311 H301 H400 H410 | GHS06 GHS09 Gef. | H311 H301 H410 | * | ||
| 604-016-00-4 | 1,2-dihydroxybenzene; pyrocatechol | 204-427-5 | 120-80-9 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H312 H302 H319 H315 | GHS07 Achtg. | H312 H302 H319 H315 | |||
| 604-017-00-X | 2,4,5-trichlorophenol | 202-467-8 | 95-95-4 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H315 H410 | * Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | ||
| 604-018-00-5 | 2,4,6-trichlorophenol | 201-795-9 | 88-06-2 | Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H319 H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H319 H315 H410 | |||
| 604-019-00-0 | dichlorophen (ISO) | 202-567-1 | 97-23-4 | Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H410 | |||
| 604-020-00-6 | 2-phenylphenol (ISO) biphenyl-2-ol; 2-hydroxybiphenyl; | 201-993-5 | 90-43-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H319 H335 H315 H400 | GHS07 GHS09 Achtg. | H319 H335 H315 H400 | |||
| 604-021-00-1 | sodium 2-biphenylate; 2-phenylphenol, sodium salt | 205-055-6 | 132-27-4 | Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 | H302 H335 H315 H318 H400 | GHS05 GHS07 GHS09 Achtg. | H302 H335 H315 H318 H400 | |||
| 604-022-00-7 | 2,2-dimethyl-1,3-benzodioxol-4-ol | 400-900-7 | 22961-82-6 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 604-023-00-2 | 2,4-dichloro-3-ethylphenol | 401-060-4 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | |||
| 604-024-00-8 | 4,4-isobutylethylidenediphenol | 401-720-1 | 6807-17-6 | Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H360F *** H319 H400 H410 | GHS08 GHS09 Gef. | H360F *** H319 H410 | |||
| 604-025-00-3 | 2,5-bis(1,1-dimethylbutyl)hydroquinone | 400-220-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-026-00-9 | 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) | 400-270-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-027-00-4 | 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone | 400-530-6 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 604-028-00-X | 4-amino-3-fluorophenol | 402-230-0 | 399-95-1 | Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H350 H302 H317 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H317 H411 | |||
| 604-029-00-5 | 1-naphtol | 201-969-4 | 90-15-3 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H312 H302 H335 H315 H318 | GHS05 GHS07 Gef. | H312 H302 H335 H315 H318 | |||
| 604-030-00-0 | Bisphenol A; 4,4′-Isopropylidendiphenol | 201-245-8 | 80-05-7 | Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 | H360F H335 H318 H317 | GHS08 GHS05 GHS07 Gef. | H360F H335 H318 H317 | |||
| 604-031-00-6 | guaiacol | 201-964-7 | 90-05-1 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 | H302 H319 H315 | GHS07 Achtg. | H302 H319 H315 | |||
| 604-032-00-1 | thymol | 201-944-8 | 89-83-8 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 | H302 H314 H411 | GHS05 GHS07 GHS09 Gef. | H302 H314 H411 | |||
| 604-033-00-7 | isobutyl but-3-enoate | 401-170-2 | 24342-03-8 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | |||
| 604-034-00-2 | 4,4'-thiodi-o-cresol | 403-330-7 | 24197-34-0 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 604-035-00-8 | 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol | 404-160-6 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 604-036-00-3 | 4,4'-oxybis(ethylenethio)diphenol | 404-590-4 | 90884-29-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 604-037-00-9 | 3,5-xylenol; 3,5-dimethylphenol | 203-606-5 | 108-68-9 | Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B | H311 H301 H314 | GHS06 GHS05 Gef. | H311 H301 H314 | |||
| 604-038-00-4 | 4-chloro-3,5-dimethylphenol; [1] chloroxylenol [2] | 201-793-8 [1] 215-316-6 [2] | 88-04-0 [1] 1321-23-9 [2] | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H302 H319 H315 H317 | GHS07 Achtg. | H302 H319 H315 H317 | |||
| 604-039-00-X | ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl | 266-362-9 | 66441-23-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 604-040-00-5 | fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide | 276-439-9 | 72178-02-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 604-041-00-0 | acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2] | 256-634-5 [1] 263-560-7 [2] | 50594-66-6 [1] 62476-59-9 [2] | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H410 | |||
| 604-042-00-6 | 4-nitrosophenol | 203-251-6 | 104-91-6 | Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H341 H302 H318 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H341 H302 H318 H411 | |||
| 604-043-00-1 | monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether | 203-083-3 | 103-16-2 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 604-044-00-7 | mequinol; 4-methoxyphenol; hydroquinone monomethyl ether | 205-769-8 | 150-76-5 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 | H302 H319 H317 | GHS07 Achtg. | H302 H319 H317 | |||
| 604-045-00-2 | 2,3,5-trimethylhydroquinone | 211-838-3 | 700-13-0 | Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H335 H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H332 H335 H315 H318 H317 H410 | |||
| 604-046-00-8 | 4-(4-isopropoxyphenylsulfonyl)phenol | 405-520-5 | 95235-30-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-047-00-3 | 4-(4-tolyloxy)biphenyl | 405-730-7 | 51601-57-1 | STOT RE 2 * Aquatic Chronic 4 | H373 ** H413 | GHS08 Achtg. | H373 ** H413 | |||
| 604-048-00-9 | 4,4',4''-(ethan-1,1,1-triyl)triphenol | 405-800-7 | 27955-94-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-049-00-4 | 4-4'-methylenebis(oxyethylenethio)diphenol | 407-480-4 | 93589-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-051-00-5 | 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol | 401-110-5 | 87113-78-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 604-052-00-0 | 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) | 403-800-1 | 103597-45-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-053-00-6 | 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol | 410-760-9 | 157661-93-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 604-054-00-1 | reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol | 412-020-0 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 604-055-00-7 | 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane | 413-900-7 | 85954-11-6 | Carc. 2 Skin Sens. 1 | H351 H317 | GHS08 GHS07 Achtg. | H351 H317 | |||
| 604-056-00-2 | 2-(2-hydroxy-3,5-dinitroanilino)ethanol | 412-520-9 | 99610-72-7 | Flam. Sol. 2 Repr. 2 Acute Tox. 4 * | H228 H361f *** H302 | GHS02 GHS07 GHS08 Gef. | H228 H361f *** H302 | |||
| 604-057-00-8 | Reaktionsmasse aus Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-5,6-didodecylphenol; n = 5 oder 6 | 401-680-5 | - | Aquatic Chronic 4 | H413 | H413 | ||||
| 604-058-00-3 | 1,2-bis(3-methylphenoxy)ethane | 402-730-9 | 54914-85-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 604-059-00-9 | 2-n-hexadecylhydroquinone | 406-400-5 | - | STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H373 ** H315 H317 H413 | GHS08 GHS07 Achtg. | H373 ** H315 H317 H413 | |||
| 604-060-00-4 | 9,9-bis(4-hydroxyphenyl)fluorene | 406-950-6 | 3236-71-3 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | |||
| 604-061-00-X | reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl= 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl | 407-740-7 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H315 H317 H412 | GHS07 Achtg. | H315 H317 H412 | |||
| 604-062-00-5 | 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol | 411-220-5 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 604-063-00-0 | 5,6-dihydroxyindole | 412-130-9 | 3131-52-0 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 604-064-00-6 | 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol | 411-380-6 | 147315-50-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-065-00-1 | 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) | 407-460-5 | 111850-25-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-066-00-7 | reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol | 414-550-8 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 604-067-00-2 | reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) | 414-520-4 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 604-068-00-8 | (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride | 415-170-5 | 90274-24-1 | Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 | H332 H302 H317 | GHS07 Achtg. | H332 H302 H317 | |||
| 604-069-00-3 | 2-(1-methylpropyl)-4-tert-butylphenol | 421-740-4 | 51390-14-8 | Skin Corr. 1B Aquatic Chronic 2 | H314 H411 | GHS05 GHS09 Gef. | H314 H411 | |||
| 604-070-00-9 | triclosan; 2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol | 222-182-2 | 3380-34-5 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | M=100 | ||
| 604-071-00-4 | 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol | 425-600-3 | 110726-28-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-072-00-X | 1,2-bis(phenoxymethyl)benzene | 428-620-0 | 10403-74-4 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 604-073-00-5 | (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | 428-010-4 | 82413-20-5 | Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H360F*** H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H351 H360F*** H317 H410 | |||
| 604-074-00-0 | tetrabromobisphenol-A; 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol | 201-236-9 | 79-94-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol | 205-426-2 | 140-66-9 | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | M=10 | ||
| 604-076-00-1 | phenolphthalein | 201-004-7 | 77-09-8 | Carc. 1B Muta. 2 Repr. 2 | H350 H341 H361f*** | GHS08 Gef. | H350 H341 H361f*** | Carc. 1B; H350: C ≥ 1 % | ||
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | 419-750-9 | 98809-58-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-079-00-8 | 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | 428-970-4 | 13595-25-0 | Repr. 2 Skin Sens. 1 Aquatic Chronic 2 | H361f*** H317 H411 | GHS08 GHS07 GHS09 Achtg. | H361f*** H317 H411 | |||
| 604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | 432-560-0 | 61721-07-1 | Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 | H332 H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H332 H314 H317 H411 | |||
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | 433-130-5 | 1571-75-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 604-082-00-4 | 2-chloro-6-fluoro-phenol | 433-890-8 | 2040-90-6 | Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H340 H361f*** H302 H314 H317 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H340 H361f*** H302 H314 H317 H411 | |||
| 604-083-00-X | 4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH4Cl), pentachlorophosphorane and phenol | 439-270-3 | 260408-02-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | 441-000-4 | 121219-07-6 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 604-087-00-1 | reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol | 433-640-8 | - | Pyr. Sol. 1 Aquatic Chronic 4 | H250 H413 | GHS02 Gef. | H250 H413 | EUH044 | ||
| 604-089-00-2 | 2-methyl-5-tert-butylthiophenol | 444-970-7 | - | Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 | GHS02 GHS08 GHS07 GHS09 Gef. | H226 H361d*** H373** H304 H319 H315 H317 H336 H410 | |||
| 604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. 2 Skin Irrit. 2 Eye Dam. 1 | H361f H315 H318 | GHS08 GHS05 Gef. | H361f H315 H318 | |||
| 604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether | 407-980-2 | 80844-07-1 | Lact. Aquatic Acute 1 Aquatic Chronic 1 | H362 H400 H410 | GHS09 Achtg. | H362 H410 | M = 100 M = 1 000 | ||
| 604-092-00-9 | Phenol, dodecyl-, verzweigt; [1] Phenol, 2-dodecyl-, verzweigt; [2] Phenol, 3-dodecyl-, verzweigt; [3] Phenol, 4-dodecyl-, verzweigt; [4] Phenol, (tetrapropenyl) Derivate [5] | 310-154-3 [1] [2] [3] [4] [5] | 121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] | Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H360F H314 H318 H400 H410 | GHS08 GHS05 GHS09 Gef. | H360F H314 H410 | M = 10 M = 10 | ||
| 604-093-00-4 | Clorofen; Chlorophen; 2-Benzyl-4-chlorphenol | 204-385-8 | 120-32-1 | Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361f H332 H315 H317 H318 H373 (Nieren) H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H351 H361f H332 H315 H317 H318 H373 (Nieren) H410 | M = 1 M = 100 | ||
| 605-001-00-5 | formaldehyde ...% | 200-001-8 | 50-00-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 | H351 H331 H311 H301 H314 H317 | GHS06 GHS08 GHS05 Gef. | H351 H331 H311 H301 H314 H317 | * Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % STOT SE 3; H335: C ≥ 5 % Skin Sens. 1; H317: C ≥ 0,2 % | B D | |
| 605-002-00-0 | 1,3,5-trioxan; trioxymethylene | 203-812-5 | 110-88-3 | Flam. Sol. 1 Repr. 2 STOT SE 3 | H228 H361d *** H335 | GHS02 GHS08 GHS07 Gef. | H228 H361d *** H335 | T | ||
| 605-003-00-6 | acetaldehyde; ethanal | 200-836-8 | 75-07-0 | Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 | H224 H351 H319 H335 | GHS02 GHS08 GHS07 Gef. | H224 H351 H319 H335 | |||
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde | 204-639-8 | 123-63-7 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | |||
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde | 203-600-2 | 108-62-3 | Flam. Sol. 2 Acute Tox. 4 * | H228 H302 | GHS02 GHS07 Achtg. | H228 H302 | |||
| 605-006-00-2 | butyraldehyde | 204-646-6 | 123-72-8 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 605-007-00-8 | 1,1-dimethoxyethane; dimethyl acetal | 208-589-8 | 534-15-6 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 605-008-00-3 | acrolein; prop-2-enal; acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H225 H330 H300 H311 H314 H400 H410 | GHS02 GHS06 GHS05 GHS09 Gef. | H225 H330 H300 H311 H314 H410 | EUH071 | Skin Corr. 1B; H314: C ≥ 0,1 % M = 100 M = 1 | D |
| 605-009-00-9 | crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] | 224-030-0 [1] 204-647-1 [2] | 4170-30-3 [1] 123-73-9 [2] | Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 | H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 | |||
| 605-010-00-4 | 2-furaldehyde | 202-627-7 | 98-01-1 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H351 H331 H301 H312 H319 H335 H315 | GHS06 GHS08 Gef. | H351 H331 H301 H312 H319 H335 H315 | |||
| 605-011-00-X | 2-chlorobenzaldehyde; o-chlorobenzaldehyde | 201-956-3 | 89-98-5 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 605-012-00-5 | benzaldehyde | 202-860-4 | 100-52-7 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 605-013-00-0 | Chloralose (INN); (R)-1,2-O-(2,2,2-Trichlorethyliden)-α-D-glucofuranose; Glucochloralose; Anhydroglucochloral | 240-016-7 | 15879-93-3 | Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H332 H301 H336 H400 H410 | GHS06 GHS09 Gef. | H332 H301 H336 H410 | M = 10 M = 10 | C | |
| 605-014-00-6 | chloral hydrate; 2,2,2-trichloroethane-1,1-diol | 206-117-5 | 302-17-0 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 | H301 H319 H315 | GHS06 Gef. | H301 H319 H315 | |||
| 605-015-00-1 | 1,1-diethoxyethane; acetal | 203-310-6 | 105-57-7 | Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 | H225 H319 H315 | GHS02 GHS07 Gef. | H225 H319 H315 | |||
| 605-016-00-7 | glyoxal...%; ethandial...% | 203-474-9 | 107-22-2 | Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H341 H332 H319 H315 H317 | GHS07 GHS08 Achtg. | H341 H332 H319 H315 H317 | * | B | |
| 605-017-00-2 | 1,3-dioxolane | 211-463-5 | 646-06-0 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 605-018-00-8 | propanal; propionaldehyde | 204-623-0 | 123-38-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H225 H319 H335 H315 | GHS02 GHS07 Gef. | H225 H319 H335 H315 | |||
| 605-019-00-3 | citral | 226-394-6 | 5392-40-5 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 605-020-00-9 | safrole; 5-allyl-1,3-benzodioxole | 202-345-4 | 94-59-7 | Carc. 1B Muta. 2 Acute Tox. 4 * | H350 H341 H302 | GHS08 GHS07 Gef. | H350 H341 H302 | |||
| 605-021-00-4 | formaldehyde, reaction products with butylphenol | 294-145-9 | 91673-30-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 605-022-00-X | Glutaral; Glutaraldehyd; 1,5-Pentandial | 203-856-5 | 111-30-8 | Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 A Aquatic Acute 1 Aquatic Chronic 2 | H330 H301 H335 H314 H334 H317 H400 H411 | GHS06 GHS05 GHS08 GHS09 Gef. | H330 H301 H335 H314 H334 H317 H410 | EUH071 | STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1 | |
| 605-023-00-5 | 5-Chlor-2-(4-chlorphenoxy)phenol; [DCPP] | 429-290-0 | 3380-30-1 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | M = 10 M = 10 | ||
| 605-024-00-0 | 2-bromo-5-hydroxy-4-methoxybenzaldehyde | 426-540-0 | 2973-59-3 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 605-025-00-6 | chloroacetaldehyde | 203-472-8 | 107-20-0 | Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 | H351 H330 H311 H301 H314 H400 | GHS06 GHS08 GHS05 GHS09 Gef. | H351 H330 H311 H301 H314 H400 | STOT SE 3; H335: C ≥ 5 % | ||
| 605-026-00-1 | 2,5,7,7-tetramethyloctanal | 405-690-0 | 114119-97-0 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H315 H317 H411 | GHS07 GHS09 Achtg. | H315 H317 H411 | |||
| 605-027-00-7 | reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde | 410-480-7 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 605-028-00-2 | β-methyl-3-(1-methylethyl)-benzenepropanal | 412-050-4 | 125109-85-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 605-029-00-8 | 2-cyclohexylpropanal | 412-270-0 | 2109-22-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 605-030-00-3 | 1-(p-methoxyphenyl)acetaldehyde oxime | 411-510-1 | 3353-51-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 605-031-00-9 | reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition.
However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate; water(Including free water and water in hydrated 2,2-dimethoxyethanal)] | 421-890-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 605-032-00-4 | 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal | 425-370-4 | 93957-50-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 605-033-00-X | reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal | 425-910-9 | 32480-08-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 605-034-00-5 | reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde | 429-860-9 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 605-035-00-0 | (E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal | 426-330-9 | 177964-68-0 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H319 H317 H413 | GHS07 Achtg. | H319 H317 H413 | |||
| 605-036-00-6 | 2-bromomalonaldehyde | 430-470-6 | 2065-75-0 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 605-037-00-1 | trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde | 421-800-1 | 120578-03-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | 433-900-0 | 55066-49-4 | Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H302 H315 H317 H411 | GHS07 GHS09 Achtg. | H302 H315 H317 H411 | |||
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | 441-810-8 | 116313-85-0 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 | H302 H318 H317 | GHS05 GHS07 Gef. | H302 H318 H317 | |||
| 605-040-00-8 | Hydroxyisohexyl-3-cyclohexencarboxaldehyd (INCI); Reaktionsmasse von 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd und 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [1] 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [2] 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [3] | - [1] 250-863-4 [2] 257-187-9 [3] | 130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3] | Skin Sens. 1 A | H317 | GHS07 Achtg. | H317 | |||
| 606-001-00-8 | acetone; propan-2-one; propanone | 200-662-2 | 67-64-1 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | EUH066 | ||
| 606-002-00-3 | butanone; ethyl methyl ketone | 201-159-0 | 78-93-3 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | EUH066 | ||
| 606-003-00-9 | heptan-3-one; butyl ethyl ketone | 203-388-1 | 106-35-4 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 | H226 H332 H319 | GHS02 GHS07 Achtg. | H226 H332 H319 | |||
| 606-004-00-4 | 4-methylpentan-2-one; isobutyl methyl ketone | 203-550-1 | 108-10-1 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 | H225 H332 H319 H335 | GHS02 GHS07 Gef. | H225 H332 H319 H335 | EUH066 | ||
| 606-005-00-X | 2,6-dimethylheptan-4-one; di-isobutyl ketone | 203-620-1 | 108-83-8 | Flam. Liq. 3 STOT SE 3 | H226 H335 | GHS02 GHS07 Achtg. | H226 H335 | STOT SE 3; H335: C ≥ 10 % | ||
| 606-006-00-5 | pentan-3-one; diethyl ketone | 202-490-3 | 96-22-0 | Flam. Liq. 2 STOT SE 3 STOT SE 3 | H225 H335 H336 | GHS02 GHS07 Gef. | H225 H335 H336 | EUH066 | ||
| 606-007-00-0 | 3-methylbutan-2-one; methyl isopropyl ketone | 209-264-3 | 563-80-4 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 606-009-00-1 | 4-methylpent-3-en-2-one; mesityl oxide | 205-502-5 | 141-79-7 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H226 H332 H312 H302 | GHS02 GHS07 Achtg. | H226 H332 H312 H302 | * | ||
| 606-010-00-7 | cyclohexanone | 203-631-1 | 108-94-1 | Flam. Liq. 3 Acute Tox. 4 * | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 606-011-00-2 | 2-methylcyclohexanone | 209-513-6 | 583-60-8 | Flam. Liq. 3 Acute Tox. 4 * | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 606-012-00-8 | 3,5,5-trimethylcyclohex-2-enone; isophorone | 201-126-0 | 78-59-1 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 | H351 H312 H302 H319 H335 | GHS08 GHS07 Achtg. | H351 H312 H302 H319 H335 | STOT SE 3; H335: C ≥ 10 % | ||
| 606-013-00-3 | p-benzoquinone; quinone | 203-405-2 | 106-51-4 | Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 | H331 H301 H319 H335 H315 H400 | GHS06 GHS09 Gef. | H331 H301 H319 H335 H315 H400 | M=10 | ||
| 606-014-00-9 | Chlorphacinon (ISO); 2-[(4-Chlorphenyl)(phenyl)acetyl]-1H-inden-1,3(2H)-dion | 223-003-0 | 3691-35-8 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,1 % STOT RE 2; H373 (Blut): 0,01 % ≤ C < 0,1 % M = 1 M = 1 | ||
| 606-016-00-X | pindone (ISO); 2-pivaloylindan-1,3-dione | 201-462-8 | 83-26-1 | Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H372 ** H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H372 ** H410 | |||
| 606-017-00-5 | diketene; diketen | 211-617-1 | 674-82-8 | Flam. Liq. 3 Acute Tox. 4 * | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | D | ||
| 606-018-00-0 | dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone | 204-210-5 | 117-80-6 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H315 H410 | |||
| 606-019-00-6 | chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one | 205-601-3 | 143-50-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H311 H301 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H311 H301 H410 | |||
| 606-020-00-1 | 5-methylheptan-3-one | 208-793-7 | 541-85-5 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 | H226 H319 H335 | GHS02 GHS07 Achtg. | H226 H319 H335 | STOT SE 3; H335: C ≥ 10 % | ||
| 606-021-00-7 | N-Methyl-2-pyrrolidon; 1-Methyl-2-pyrrolidon | 212-828-1 | 872-50-4 | Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 | H360D*** H335 H315 H319 | GHS08 GHS07 Gef. | H360D*** H335 H315 H319 | STOT SE 3; H335: C ≥ 10 % | ||
| 606-022-00-2 | 1-phenyl-3-pyrazolidone | 202-155-1 | 92-43-3 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 606-023-00-8 | 4-methoxy-4-methylpentan-2-one | 203-512-4 | 107-70-0 | Flam. Liq. 3 Acute Tox. 4 ((*)) | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 606-024-00-3 | heptan-2-one; methyl amyl ketone | 203-767-1 | 110-43-0 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) | H226 H332 H302 | GHS02 GHS07 Achtg. | H226 H332 H302 | |||
| 606-025-00-9 | cyclopentanone | 204-435-9 | 120-92-3 | Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 | H226 H319 H315 | GHS02 GHS07 Achtg. | H226 H319 H315 | |||
| 606-026-00-4 | 5-methylhexan-2-one; isoamyl methyl ketone | 203-737-8 | 110-12-3 | Flam. Liq. 3 Acute Tox. 4 (*) | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 606-027-00-X | heptan-4-one; di-n-propyl ketone | 204-608-9 | 123-19-3 | Flam. Liq. 3 Acute Tox. 4 (*) | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 606-028-00-5 | 2,4-dimethylpentan-3-one; di-isopropyl ketone | 209-294-7 | 565-80-0 | Flam. Liq. 2 Acute Tox. 4 (*) | H225 H332 | GHS02 GHS07 Gef. | H225 H332 | |||
| 606-029-00-0 | pentane-2,4-dione; acetylacetone | 204-634-0 | 123-54-6 | Flam. Liq. 3 Acute Tox. 4 (*) | H226 H302 | GHS02 GHS07 Achtg. | H226 H302 | |||
| 606-030-00-6 | hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone | 209-731-1 | 591-78-6 | Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 | H226 H361f (*)(*)(*) H372 (*)(*) H336 | GHS02 GHS08 GHS07 Gef. | H226 H361f (*)(*)(*) H372 (*)(*) H336 | |||
| 606-031-00-1 | 3-propanolide; 1,3-propiolactone | 200-340-1 | 57-57-8 | Carc. 1B Acute Tox. 2 (*) Eye Irrit. 2 Skin Irrit. 2 | H350 H330 H319 H315 | GHS06 GHS08 Gef. | H350 H330 H319 H315 | |||
| 606-032-00-7 | hexachloroacetone | 204-129-5 | 116-16-5 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 606-033-00-2 | 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole | 243-761-6 | 20354-26-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H312 H302 H319 H315 H411 | GHS07 GHS09 Achtg. | H312 H302 H319 H315 H411 | |||
| 606-034-00-8 | metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one | 244-209-7 | 21087-64-9 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=10 | ||
| 606-035-00-3 | chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon | 216-920-2 | 1698-60-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 606-036-00-9 | quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one | 219-455-3 | 2439-01-2 | Repr. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f (*)(*)(*) H332 H312 H302 H373 (*)(*) H319 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361f (*)(*)(*) H332 H312 H302 H373 (*)(*) H319 H317 H410 | |||
| 606-037-00-4 | triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone | 256-103-8 | 43121-43-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 606-038-00-X | diphacinone (ISO); 2-diphenylacetylindan-1,3-dione | 201-434-5 | 82-66-6 | Acute Tox. 2 (*) STOT RE 1 | H300 H372 (*)(*) | GHS06 GHS08 Gef. | H300 H372 (*)(*) | |||
| 606-039-00-5 | 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one | 400-680-2 | - | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H332 H400 H410 | GHS07 GHS09 Achtg. | H332 H410 | |||
| 606-040-00-0 | (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride | 401-840-4 | 55845-90-4 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 606-041-00-6 | 2-Methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-on | 400-600-6 | 71868-10-5 | Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 | H360FD H302 H411 | GHS08 GHS07 GHS09 Gef. | H360FD H302 H411" | |||
| 606-042-00-1 | acetophenone | 202-708-7 | 98-86-2 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 606-043-00-7 | 2,4-di-tert-butylcyclohexanone | 405-340-7 | 13019-04-0 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 606-044-00-2 | 2,4,6-trimethylbenzophenone | 403-150-9 | 954-16-5 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H410 | |||
| 606-045-00-8 | oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | 243-215-7 | 19666-30-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-046-00-3 | reaction mass of cis- and trans-cyclohexadec-8-en-1-one | 401-700-2 | 3100-36-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-047-00-9 | 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone | 404-360-3 | 119313-12-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-048-00-4 | 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one | 406-480-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-049-00-X | 4-(trans-4-propylcyclohexyl)acetophenone | 406-700-6 | 78531-61-0 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-050-00-5 | 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione | 412-480-2 | 72453-58-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-051-00-0 | 4-pentylcyclohexanone | 406-670-4 | 61203-83-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-052-00-6 | 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone | 410-410-5 | 54574-82-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 606-053-00-1 | flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one | - | 96525-23-4 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-054-00-7 | Isoxaflutol (ISO); 5-Cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluor-2-mesyl-p-tolyl keton | - | 141112-29-0 | Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 | H361d*** H400 H410 | GHS08 GHS09 Achtg. | H361d*** H410 | M = 10 M = 100 | ||
| 606-055-00-2 | 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone | 411-180-9 | 92836-10-7 | Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Chronic 2 | H302 H373 (*)(*) H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373 (*)(*) H411 | |||
| 606-056-00-8 | 4-chloro-3',4'-dimethoxybenzophenone | 404-610-1 | 116412-83-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-057-00-3 | 4-propylcyclohexanone | 406-810-4 | 40649-36-3 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 606-058-00-9 | 4'-fluoro-2,2-dimethoxyacetophenone | 407-500-1 | 21983-80-2 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 606-059-00-4 | 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride | 412-390-3 | 86386-75-6 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 | H302 H318 H317 | GHS05 GHS07 Gef. | H302 H318 H317 | |||
| 606-060-00-X | reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane | 412-950-7 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-061-00-5 | (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone | 423-290-4 | 66938-41-8 | Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 | H341 H400 H410 | GHS08 GHS09 Achtg. | H341 H410 | |||
| 606-062-00-0 | tetrahydrothiopyran-3-carboxaldehyde | 407-330-8 | 61571-06-0 | Repr. 1B Eye Dam. 1 Aquatic Chronic 3 | H360D (*)(*)(*) H318 H412 | GHS08 GHS05 Gef. | H360D (*)(*)(*) H318 H412 | |||
| 606-063-00-6 | (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal | 410-980-5 | 112704-51-5 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 606-064-00-1 | pregn-5-ene-3,20-dione bis(ethylene ketal) | 407-450-0 | 7093-55-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-065-00-7 | 1-(4-morpholinophenyl)butan-1-one | 413-790-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-066-00-2 | (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone | 410-440-9 | 164058-20-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-067-00-8 | reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone | 414-870-8 | 96792-67-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-068-00-3 | 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 415-770-7 | 1638-05-7 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 | H373 (*)(*) H317 H412 | GHS08 GHS07 Achtg. | H373 (*)(*) H317 H412 | |||
| 606-069-00-9 | spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] | 415-460-1 | 154171-76-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-070-00-4 | butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one | 414-790-3 | 138164-12-2 | Repr. 2 Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361fd H302 H315 H410 | |||
| 606-071-00-X | 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one | 421-050-3 | 13258-43-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-072-00-5 | 3-acetyl-1-phenyl-pyrrolidine-2,4-dione | 421-600-2 | 719-86-8 | STOT RE 2 (*) Aquatic Chronic 2 | H373 (*)(*) H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H411 | |||
| 606-073-00-0 | 4,4'-bis(dimethylamino)benzophenone; Michler's ketone | 202-027-5 | 90-94-8 | Carc. 1B Muta. 2 Eye Dam. 1 | H350 H341 H318 | GHS08 GHS05 Gef. | H350 H341 H318 | |||
| 606-074-00-6 | reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene | 425-570-1 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-075-00-1 | 1-benzyl-5-ethoxyimidazolidine-2,4-dione | 417-340-4 | 65855-02-9 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 606-076-00-7 | 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione | 418-630-3 | 136465-99-1 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 606-077-00-2 | (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | 418-650-2 | 104872-06-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-078-00-8 | 1-octylazepin-2-one | 420-040-6 | 59227-88-2 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H317 H411 | |||
| 606-079-00-3 | 2-n-butyl-benzo[d]isothiazol-3-one | 420-590-7 | 4299-07-4 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 606-081-00-4 | (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one | 419-790-7 | 4229-69-0 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 606-082-00-X | reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane | 406-930-7 | STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 | H372 (*)(*) H317 H412 | GHS08 GHS07 Gef. | H372 (*)(*) H317 H412 | ||||
| 606-083-00-5 | 2-chloro-5-sec-hexadecylhydroquinone | 407-750-1 | 137193-60-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H315 H317 H412 | GHS07 Achtg. | H319 H315 H317 H412 | |||
| 606-084-00-0 | 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione | 414-540-3 | 484-33-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-085-00-6 | (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 418-530-1 | 79200-56-9 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 | H302 H318 H317 | GHS05 GHS07 Gef. | H302 H318 H317 | |||
| 606-086-00-1 | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 422-330-8 | 56973-87-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-087-00-7 | 6-ethyl-5-fluoro-4(3H)-pyrimidone | 422-460-5 | 137234-87-8 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 606-088-00-2 | 2,4,4,7-tetramethyl-6-octen-3-one | 422-520-0 | 74338-72-0 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 606-089-00-8 | reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone | 423-220-2 | 12223-77-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-090-00-3 | 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone | 430-920-1 | 73096-98-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 606-091-00-9 | 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one | 421-320-0 | 118289-55-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-092-00-4 | reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a)(Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one | 422-320-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | ||||
| 606-093-00-X | 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one | 414-470-3 | 95885-13-5 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 606-094-00-5 | N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one | 417-460-7 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-095-00-0 | (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 421-830-3 | 49805-30-3 | Acute Tox. 4 * Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 606-096-00-6 | 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one | 424-170-4 | 130603-71-3 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 606-097-00-1 | 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone | 424-210-0 | 23911-85-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-098-00-7 | 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione | 431-220-9 | 158574-65-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-099-00-2 | 5-methoxy-4'-(trifluoromethyl)valerophenone | 425-000-1 | 61718-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-100-00-6 | 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one | 425-150-8 | 94723-86-1 | Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 | H360F*** H302 H317 H412 | GHS08 GHS07 Gef. | H360F*** H302 H317 H412 | |||
| 606-101-00-1 | reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione | 426-050-7 | 165038-51-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 606-102-00-7 | 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone | 431-490-8 | 79876-59-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-103-00-2 | 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone | 426-460-6 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 606-104-00-8 | 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone | 426-830-7 | 78531-59-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-105-00-3 | 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione | 431-500-0 | 226065-73-2 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-106-00-9 | 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone | 427-320-7 | 83626-30-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-107-00-4 | 8-azaspiro[4.5]decane-7,9-dione | 427-770-4 | 1075-89-4 | Acute Tox. 3 * Aquatic Chronic 2 | H301 H411 | GHS06 GHS09 Gef. | H301 H411 | |||
| 606-108-00-X | 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone | 436-710-6 | 756-13-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 606-109-00-5 | 2-(4-methyl-3-pentenyl)anthraquinone | 428-320-1 | 71308-16-2 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 | H302 H317 H413 | GHS07 Achtg. | H302 H317 H413 | |||
| 606-110-00-0 | 5-ethoxy-5H-furan-2-one | 428-330-4 | 2833-30-9 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 | H314 H312 H302 H373** H317 | GHS05 GHS08 GHS07 Gef. | H314 H312 H302 H373** H317 | |||
| 606-111-00-6 | 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one | 428-410-9 | 67014-36-2 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 606-112-00-1 | (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one | 428-690-2 | 1668-86-6 | Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 | H302 H319 H412 | GHS07 Achtg. | H302 H319 H412 | |||
| 606-113-00-7 | 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one | 429-040-0 | 272460-97-6 | Eye Dam. 1 Aquatic Chronic 4 | H318 H413 | GHS05 Gef. | H318 H413 | |||
| 606-114-00-2 | 4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone | 429-150-9 | 67887-47-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-115-00-8 | profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one | - | 139001-49-3 | Carc. 2 Repr. 2 Skin Sens. 1 | H351 H361d H317 | GHS08 GHS07 Achtg. | H351 H361d H317 | |||
| 606-116-00-3 | tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one | - | 149979-41-9 | Carc. 2 Repr. 2 | H351 H361fd | GHS08 Achtg. | H351 H361fd | |||
| 606-117-00-9 | 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one | 429-460-4 | 7078-98-0 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-118-00-4 | N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine | 429-640-2 | 52870-46-9 | Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H400 H410 | GHS07 GHS09 Achtg. | H319 H410 | |||
| 606-119-00-X | (E)-3-methyl-5-cyclopentadecen-1-one | 429-900-5 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 606-120-00-5 | 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one | 430-170-5 | 114625-74-0 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 606-121-00-0 | (+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) | 430-460-1 | 133636-82-5 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 606-122-00-6 | 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one | 430-820-8 | 114341-88-7 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H315 H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H302 H373** H315 H318 H317 H410 | |||
| 606-123-00-1 | 4-hexadecyl-1-phenylpyrazolidin-3-one | 430-840-7 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | 421-080-7 | 161462-35-7 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373** H400 H410 | GHS08 GHS09 Achtg. | H373** H410 | |||
| 606-125-00-2 | 1-benzylimidazolidine-2,4-dione | 421-340-1 | 6777-05-5 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | 421-470-7 | 99788-75-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-128-00-9 | 2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | 422-650-8 | 148935-94-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | 423-090-7 | 156732-13-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | 423-860-2 | 56309-94-5 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | 427-230-8 | 5571-36-8 | Repr. 1B STOT RE 2 * Aquatic Chronic 2 | H360F*** H373** H411 | GHS08 GHS09 Gef. | H360F*** H373** H411 | |||
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | 433-490-3 | 6563-83-3 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | 433-560-3 | 15375-21-0 | Repr. 2 | H361f*** | GHS08 Achtg. | H361f*** | |||
| 606-135-00-7 | cyclohexadecanone | 438-930-8 | 2550-52-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | 444-350-6 | 133413-70-4 | Eye Irrit. 2 Aquatic Chronic 4 | H319 H413 | GHS07 Achtg. | H319 H413 | |||
| 606-137-00-8 | trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione | 444-750-0 | 211387-26-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | 444-800-1 | 141645-23-0 | Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H302 H373** H315 H318 H317 H400 H410 | GHS02 GHS05 GHS08 GHS07 GHS09 Gef. | H226 H302 H373** H315 H318 H317 H410 | M=10 | ||
| 606-139-00-9 | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | 444-830-5 | 124379-29-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | 444-860-9 | 474510-57-1 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373** H400 H410 | GHS08 GHS09 Achtg. | H373** H410 | |||
| 606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | 418-410-7 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 606-142-00-5 | reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | 434-290-9 | - | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (Nervensystem) H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d H300 H330 H372 (Nervensystem) H410 | | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤ C < 5 % M = 10 000 | |
| avermectin B1a (purity ≥ 80 %); [2] | 265-610-3 [2] | 65195-55-3 [2] | ||||||||
| 606-144-00-6 | acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate | - | 57960-19-7 | Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H317 H370 (Lunge) (Einatmung) H373 (Blutkreislauf) H400 H410 | GHS07 GHS08 GHS09 Gef. | H317 H370 (Lunge) (Einatmung) H373 (Blutkreislauf) H410 | M = 1 000 | ||
| 606-145-00-1 | sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione | | 99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | | M = 1 M = 10 | |
| STOT RE 2 | H373 (Nieren) | GHS07 | H373 (Nieren) | |||||||
| Skin Sens. 1A | H317 | HS09 | H317 | |||||||
| Aquatic Acute 1 | H400 | Achtg. | ||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one | - | 87820-88-0 | Carc. 2 Acute Tox. 4 Aquatic Chronic 2 | H351 H302 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H411 | |||
| 606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08 Achtg. | H361d | |||
| 606-148-00-8 | Carvon (ISO); 2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1] d-Carvon; (5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2] l-Carvon; (5R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3] | 202-759-5 [1] 218-827-2 [2] 229-352-5 [3] | 99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 606-149-00-3 | Tembotrion (ISO); 2-{2-Chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyclohexan-1,3-dion | - | 335104-84-2 | Repr. 2 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H373 (Augen, Nieren, Leber) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d H373 (Augen, Nieren, Leber) H317 H410 | M = 100 M = 10 | ||
| 606-150-00-9 | Clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-Chlorallyloxyimino]propyl}-5-[(2RS)- 2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on | - | 99129-21-2 | Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | EUH066 | ||
| 606-151-00-4 | Anthrachinon | 201-549-0 | 84-65-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 607-001-00-0 | formic acid ... % | 200-579-1 | 64-18-6 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤ C < 10 % Eye Irrit. 2; H319: 2 % ≤ C < 10 % | B | |
| 607-002-00-6 | acetic acid ... % | 200-580-7 | 64-19-7 | Flam. Liq. 3 Skin Corr. 1A | H226 H314 | GHS02 GHS05 Gef. | H226 H314 | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 25 % ≤ C < 90 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B | |
| 607-003-00-1 | chloroacetic acid | 201-178-4 | 79-11-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 | H331 H311 H301 H314 H400 | GHS06 GHS05 GHS09 Gef. | H331 H311 H301 H314 H400 | STOT SE 3; H335: C ≥ 5 % | ||
| 607-004-00-7 | TCA (ISO); trichloroacetic acid | 200-927-2 | 76-03-9 | Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | STOT SE 3; H335: C ≥ 1 % | ||
| 607-005-00-2 | TCA-sodium (ISO); sodium trichloroacetate | 211-479-2 | 650-51-1 | STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H335 H400 H410 | GHS07 GHS09 Achtg. | H335 H410 | |||
| 607-006-00-8 | oxalic acid | 205-634-3 | 144-62-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H312 H302 | GHS07 Achtg. | H312 H302 | (*) | ||
| 607-007-00-3 | salts of oxalic acid with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * | H312 H302 | GHS07 Achtg. | H312 H302 | * | A | |
| 607-008-00-9 | acetic anhydride | 203-564-8 | 108-24-7 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H226 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H226 H332 H302 H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤ C < 5 % STOT SE 3; H335: C ≥ 5 % | ||
| 607-009-00-4 | phthalic anhydride | 201-607-5 | 85-44-9 | Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H302 H335 H315 H318 H334 H317 | GHS08 GHS05 GHS07 Gef. | H302 H335 H315 H318 H334 H317 | |||
| 607-010-00-X | propionic anhydride | 204-638-2 | 123-62-6 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | ||
| 607-011-00-5 | acetyl chloride | 200-865-6 | 75-36-5 | Flam. Liq. 2 Skin Corr. 1B | H225 H314 | GHS02 GHS05 Gef. | H225 H314 | EUH014 | ||
| 607-012-00-0 | benzoyl chloride | 202-710-8 | 98-88-4 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | H332 H312 H302 H314 H317 | GHS05 GHS07 Gef. | H332 H312 H302 H314 H317 | |||
| 607-013-00-6 | dimethyl carbonate | 210-478-4 | 616-38-6 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 607-014-00-1 | methyl formate | 203-481-7 | 107-31-3 | Flam. Liq. 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 | H224 H332 H302 H319 H335 | GHS02 GHS07 Gef. | H224 H332 H302 H319 H335 | |||
| 607-015-00-7 | ethyl formate | 203-721-0 | 109-94-4 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 | H225 H332 H302 H319 H335 | GHS02 GHS07 Gef. | H225 H332 H302 H319 H335 | |||
| 607-016-00-2 | propyl formate; [1] isopropyl formate [2] | 203-798-0 [1] 210-901-2 [2] | 110-74-7 [1] 625-55-8 [2] | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 | H225 H319 H335 H336 | GHS02 GHS07 Gef. | H225 H319 H335 H336 | C | ||
| 607-017-00-8 | butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] | 209-772-5 [1] 212-105-0 [2] 208-818-1 [3] | 592-84-7 [1] 762-75-4 [2] 542-55-2 [3] | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H335 | GHS02 GHS07 Gef. | H225 H319 H335 | C | ||
| 607-018-00-3 | isopentyl formate; [1] 2-methylbutyl formate [2] | 203-769-2 [1] 252-343-2 [2] | 110-45-2 [1] 35073-27-9 [2] | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H335 | GHS02 GHS07 Gef. | H225 H319 H335 | C | ||
| 607-019-00-9 | methyl chloroformate | 201-187-3 | 79-22-1 | Flam. Liq. 2 Acute Tox. 2 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H225 H330 H312 H302 H314 | GHS02 GHS06 GHS05 Gef. | H225 H330 H312 H302 H314 | |||
| 607-020-00-4 | ethyl chloroformate | 208-778-5 | 541-41-3 | Flam. Liq. 2 Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B | H225 H330 H302 H314 | GHS02 GHS06 GHS05 Gef. | H225 H330 H302 H314 | |||
| 607-021-00-X | methyl acetate | 201-185-2 | 79-20-9 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | EUH066 | ||
| 607-022-00-5 | ethyl acetate | 205-500-4 | 141-78-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | EUH066 | ||
| 607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Carc. 2 | H351 | GHS08 | H351 | |||||||
| Acute Tox. 4 | H332 | GHS07 | H332 | |||||||
| STOT SE 3 | H335 | Gef. | H335 | |||||||
| 607-024-00-6 | propyl acetate; [1] isopropyl acetate [2] | 203-686-1 [1] 203-561-1 [2] | 109-60-4 [1] 108-21-4 [2] | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 | H225 H319 H336 | GHS02 GHS07 Gef. | H225 H319 H336 | EUH066 | C | |
| 607-025-00-1 | n-butyl acetate | 204-658-1 | 123-86-4 | Flam. Liq. 3 STOT SE 3 | H226 H336 | GHS02 GHS07 Achtg. | H226 H336 | EUH066 | ||
| 607-026-00-7 | sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] | 203-300-1 [1] 203-745-1 [2] 208-760-7 [3] | 105-46-4 [1] 110-19-0 [2] 540-88-5 [3] | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | EUH066 | C | |
| 607-027-00-2 | methyl propionate | 209-060-4 | 554-12-1 | Flam. Liq. 2 Acute Tox. 4 (*) | H225 H332 | GHS02 GHS07 Gef. | H225 H332 | |||
| 607-028-00-8 | ethyl propionate | 203-291-4 | 105-37-3 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 607-029-00-3 | n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] | 209-669-5 [1] [2] 208-746-0 [3] | 590-01-2 [1] 591-34-4 [2] 540-42-1 [3] | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | C | ||
| 607-030-00-9 | propyl propionate | 203-389-7 | 106-36-5 | Flam. Liq. 3 Acute Tox. 4 (*) | H226 H332 | GHS02 GHS07 Achtg. | H226 H332 | |||
| 607-031-00-4 | butyl butyrate | 203-656-8 | 109-21-7 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | C | ||
| 607-032-00-X | ethyl acrylate | 205-438-8 | 140-88-5 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H225 H332 H312 H302 H319 H335 H315 H317 | GHS02 GHS07 Gef. | H225 H332 H312 H302 H319 H335 H315 H317 | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % | D | |
| 607-033-00-5 | n-butyl methacrylate | 202-615-1 | 97-88-1 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H226 H319 H335 H315 H317 | GHS02 GHS07 Achtg. | H226 H319 H335 H315 H317 | D | ||
| 607-034-00-0 | methyl acrylate; methyl propenoate | 202-500-6 | 96-33-3 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H225 H332 H312 H302 H319 H335 H315 H317 | GHS02 GHS07 Gef. | H225 H332 H312 H302 H319 H335 H315 H317 | D | ||
| 607-035-00-6 | methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H225 H335 H315 H317 | GHS02 GHS07 Gef. | H225 H335 H315 H317 | D | ||
| 607-036-00-1 | 2-methoxyethyl acetate; methylglycol acetate | 203-772-9 | 110-49-6 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H360FD H332 H312 H302 | GHS08 GHS07 Gef. | H360FD H332 H312 H302 | |||
| 607-037-00-7 | 2-ethoxyethyl acetate; ethylglycol acetate | 203-839-2 | 111-15-9 | Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H226 H360FD H332 H312 H302 | GHS02 GHS08 GHS07 Gef. | H226 H360FD H332 H312 H302 | |||
| 607-038-00-2 | 2-butoxyethyl acetate; butylglycol acetate | 203-933-3 | 112-07-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 | GHS07 Achtg. | H332 H312 | |||
| 607-039-00-8 | 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid | 202-361-1 | 94-75-7 | Acute Tox. 4 (*) STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H335 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H335 H318 H317 H412 | |||
| 607-040-00-3 | salts of 2,4-D | - | - | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | A | ||
| 607-041-00-9 | 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid | 202-273-3 | 93-76-5 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H315 H410 | |||
| 607-042-00-4 | salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid | - | - | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H315 H410 | A | ||
| 607-043-00-X | dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid | 217-635-6 | 1918-00-9 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 607-044-00-5 | 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate [2] | 218-951-7 [1] 233-002-7 [2] | 2300-66-5 [1] 10007-85-9 [2] | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 607-045-00-0 | dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid | 204-390-5 | 120-36-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 | H312 H302 H315 H318 | GHS05 GHS07 Gef. | H312 H302 H315 H318 | |||
| 607-046-00-6 | salts of dichlorprop | - | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | A | ||
| 607-047-00-1 | fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid | 202-271-2 | 93-72-1 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H315 H410 | |||
| 607-048-00-7 | salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid | - | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | A | ||
| 607-049-00-2 | mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] | 230-386-8 [1] 202-264-4 [2] | 7085-19-0 [1] 708519-0 [2] | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H410 | M=100 | ||
| 607-050-00-8 | salts of mecoprop | - | - | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H410 | A | ||
| 607-051-00-3 | MCPA (ISO); 4-chloro-o-tolyloxyacetic acid | 202-360-6 | 94-74-6 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H410 | |||
| 607-052-00-9 | salts and esters of MCPA | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | A | ||
| 607-053-00-4 | MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid | 202-365-3 | 94-81-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-054-00-X | salts and esters of MCPB | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | A | ||
| 607-055-00-5 | endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate | 204-959-8 | 129-67-9 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H301 H312 H319 H335 H315 | GHS06 Gef. | H301 H312 H319 H335 H315 | |||
| 607-056-00-0 | Warfarin (ISO); 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-on; [1] (S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [2] (R)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [3] | 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] | 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] | Repr. 1 A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 | H360D H330 H310 H300 H372 (Blut) H411 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H411 | Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,5 % STOT RE 2; H373 (Blut): 0,05 % ≤ C < 0,5 % | ||
| 607-057-00-6 | coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin | 201-378-1 | 81-82-3 | STOT RE 2 (*) Aquatic Chronic 3 | H373 (*)(*) H412 | GHS08 Achtg. | H373 (*)(*) H412 | |||
| 607-058-00-1 | coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin | 204-195-5 | 117-52-2 | Acute Tox. 3 (*) STOT RE 1 Aquatic Chronic 3 | H301 H372 (*)(*) H412 | GHS06 GHS08 Gef. | H301 H372 (*)(*) H412 | |||
| 607-059-00-7 | Coumatetralyl (ISO); 4-Hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)cumarin | 227-424-0 | 5836-29-3 | Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 | H360D H330 H311 H300 H372 (Blut) H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H311 H300 H372 (Blut) H410 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 1,0 % STOT RE 2; H373 (Blut) 0,1 % ≤ C < 1,0 % M = 10 | ||
| 607-060-00-2 | dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) | 200-632-9 | 66-76-2 | STOT RE 1 Acute Tox. 4 (*) Aquatic Chronic 2 | H372 (*)(*) H302 H411 | GHS08 GHS07 GHS09 Gef. | H372 (*)(*) H302 H411 | |||
| 607-061-00-8 | acrylic acid; prop-2-enoic acid | 201-177-9 | 79-10-7 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A Aquatic Acute 1 | H226 H332 H312 H302 H314 H400 | GHS02 GHS05 GHS07 GHS09 Gef. | H226 H332 H312 H302 H314 H400 | STOT SE 3; H335: C ≥ 1 % | D | |
| 607-062-00-3 | n-butyl acrylate | 205-480-7 | 141-32-2 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H226 H319 H335 H315 H317 | GHS02 GHS07 Achtg. | H226 H319 H335 H315 H317 | D | ||
| 607-063-00-9 | isobutyric acid | 201-195-7 | 79-31-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 607-064-00-4 | benzyl chloroformate | 207-925-0 | 501-53-1 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H314 H400 H410 | GHS05 GHS09 Gef. | H314 H410 | STOT SE 3; H335: C ≥ 5 % | ||
| 607-065-00-X | bromoacetic acid | 201-175-8 | 79-08-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 | H331 H311 H301 H314 H317 H400 | GHS06 GHS05 GHS09 Gef. | H331 H311 H301 H314 H317 H400 | |||
| 607-066-00-5 | dichloroacetic acid | 201-207-0 | 79-43-6 | Skin Corr. 1A Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | |||
| 607-067-00-0 | dichloroacetyl chloride | 201-199-9 | 79-36-7 | Skin Corr. 1A Aquatic Acute 1 | H314 H400 | GHS05 GHS09 Gef. | H314 H400 | |||
| 607-068-00-6 | iodoacetic acid | 200-590-1 | 64-69-7 | Acute Tox. 3 (*) Skin Corr. 1A | H301 H314 | GHS06 GHS05 Gef. | H301 H314 | |||
| 607-069-00-1 | ethyl bromoacetate | 203-290-9 | 105-36-2 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) | H330 H310 H300 | GHS06 Gef. | H330 H310 H300 | |||
| 607-070-00-7 | ethyl chloroacetate | 203-294-0 | 105-39-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 | H331 H311 H301 H400 | GHS06 GHS09 Gef. | H331 H311 H301 H400 | |||
| 607-071-00-2 | ethyl methacrylate | 202-597-5 | 97-63-2 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H225 H319 H335 H315 H317 | GHS02 GHS07 Gef. | H225 H319 H335 H315 H317 | D | ||
| 607-072-00-8 | 2-hydroxyethyl acrylate | 212-454-9 | 818-61-1 | Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 | H311 H314 H317 H400 | GHS06 GHS05 GHS09 Gef. | H311 H314 H317 H400 | (*) Skin Sens. 1; H317: C ≥ 0,2 % | D | |
| 607-073-00-3 | 4-CPA (ISO); 4-chlorophenoxyacetic acid | 204-581-3 | 122-88-3 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-074-00-9 | chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid | 201-599-3 | 85-34-7 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-075-00-4 | chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate | 238-413-5 | 14437-17-3 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 607-076-00-X | dodine(ISO); dodecylguanidinium acetate | 219-459-5 | 2439-10-3 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H315 H410 | |||
| 607-077-00-5 | erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate | - | 136-25-4 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-078-00-0 | fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate | - | 4301-50-2 | Acute Tox. 1 Acute Tox. 2 (*) | H310 H300 | GHS06 Gef. | H310 H300 | |||
| 607-079-00-6 | kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate | - | 4234-79-1 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Chronic 2 | H311 H302 H411 | GHS06 GHS09 Gef. | H311 H302 H411 | |||
| 607-080-00-1 | chloroacetyl chloride | 201-171-6 | 79-04-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Skin Corr. 1A Aquatic Acute 1 | H331 H311 H301 H372 (*)(*) H314 H400 | GHS06 GHS08 GHS05 GHS09 Gef. | H331 H311 H301 H372 (*)(*) H314 H400 | EUH014 EUH029 | ||
| 607-081-00-7 | fluoroacetic acid | 205-631-7 | 144-49-0 | Acute Tox. 2 (*) Aquatic Acute 1 | H300 H400 | GHS06 GHS09 Gef. | H300 H400 | |||
| 607-082-00-2 | fluoroacetates, soluble | - | - | Acute Tox. 2 (*) Aquatic Acute 1 | H300 H400 | GHS06 GHS09 Gef. | H300 H400 | A | ||
| 607-083-00-8 | 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid | 202-366-9 | 94-82-6 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-084-00-3 | salts of 2,4-DB | - | - | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | A | ||
| 607-085-00-9 | benzyl benzoate | 204-402-9 | 120-51-4 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-086-00-4 | diallyl phthalate | 205-016-3 | 131-17-9 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-088-00-5 | methacrylic acid; 2-methylpropenoic acid | 201-204-4 | 79-41-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | STOT SE 3; H335: C ≥ 1 % | D | |
| 607-089-00-0 | propionic acid ... % | 201-176-3 | 79-09-4 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % | B | |
| 607-090-00-6 | thioglycolic acid | 200-677-4 | 68-11-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B | H331 H311 H301 H314 | GHS06 GHS05 Gef. | H331 H311 H301 H314 | (*) | ||
| 607-091-00-1 | trifluoroacetic acid . . . % | 200-929-3 | 76-05-1 | Acute Tox. 4 (*) | H332 | GHS05 | H332 | * | B | |
| Skin Corr. 1A Aquatic Chronic 3 | H314 H412 | GHS07 Gef. | H314 H412 | |||||||
| 607-092-00-7 | methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] | 208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] | 547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 | H226 H319 H335 | GHS02 GHS07 Achtg. | H226 H319 H335 | C | ||
| 607-093-00-2 | propionyl chloride | 201-170-0 | 79-03-8 | Flam. Liq. 2 Skin Corr. 1B | H225 H314 | GHS02 GHS05 Gef. | H225 H314 | EUH014 | B D | |
| 607-094-00-8 | peracetic acid . . . % | 201-186-8 | 79-21-0 | Flam. Liq. 3 Org. Perox. D (*)(*)(*)(*) Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A Aquatic Acute 1 | H226 H242 H332 H312 H302 H314 H400 | GHS02 GHS05 GHS07 GHS09 Gef. | H226 H242 H332 H312 H302 H314 H400 | (*) STOT SE 3; H335: C ≥ 1 % | B D | |
| 607-095-00-3 | maleic acid | 203-742-5 | 110-16-7 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H302 H319 H335 H315 H317 | GHS07 Achtg. | H302 H319 H335 H315 H317 | Skin Sens. 1; H317: C ≥ 0,1 % | ||
| 607-096-00-9 | maleic anhydride | 203-571-6 | 108-31-6 | Acute Tox. 4 (*) Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 | H302 H314 H334 H317 | GHS08 GHS05 GHS07 Gef. | H302 H314 H334 H317 | |||
| 607-097-00-4 | benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride | 209-008-0 | 552-30-7 | STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H335 H318 H334 H317 | GHS08 GHS05 GHS07 Gef. | H335 H318 H334 H317 | |||
| 607-098-00-X | benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride | 201-898-9 | 89-32-7 | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H318 H334 H317 | GHS08 GHS05 Gef. | H318 H334 H317 | |||
| 607-099-00-5 | 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalic anhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] | 201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] | 85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H334 H317 H412 | GHS08 GHS05 Gef. | H318 H334 H317 H412 | C | ||
| 607-100-00-9 | benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) | 219-348-1 | 2421-28-5 | Eye Irrit. 2 STOT SE 3 | H319 H335 | GHS07 Achtg. | H319 H335 | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | ||
| 607-101-00-4 | 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride | 204-077-3 | 115-27-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | ||
| 607-102-00-X | cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylic anhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] | 201-604-9 [1] 236-086-3 [2] 238-009-9 [3] | 85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H318 H334 H317 | GHS08 GHS05 Gef. | H318 H334 H317 | C | ||
| 607-103-00-5 | succinic anhydride | 203-570-0 | 108-30-5 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 | H302 H319 H335 | GHS07 Achtg. | H302 H319 H335 | * Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | ||
| 607-104-00-0 | cyclopentane-1,2,3,4-tetracarboxylic dianhydride | 227-964-7 | 6053-68-5 | Eye Irrit. 2 STOT SE 3 | H319 H335 | GHS07 Achtg. | H319 H335 | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | ||
| 607-105-00-6 | 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] | 204-957-7 [1] 212-557-9 [2] 220-384-5 [3] | 129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H318 H334 H317 | GHS08 GHS05 Gef. | H318 H334 H317 | C | ||
| 607-106-00-1 | 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride | - | 123748-85-6 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H302 H319 H335 H315 H334 | GHS08 GHS07 Gef. | H302 H319 H335 H315 H334 | STOT SE 3; H335: C ≥ 10 % | C | |
| 607-107-00-7 | 2-ethylhexyl acrylate | 203-080-7 | 103-11-7 | STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H335 H315 H317 | GHS07 Achtg. | H335 H315 H317 | D | ||
| 607-108-00-2 | 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3] | 220-852-9 [1] 213-663-8 [2] 247-118-0 [3] | 2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 | H331 H311 H301 H314 H317 | GHS06 GHS05 Gef. | H331 H311 H301 H314 H317 | (*) Skin Sens. 1; H317: C ≥ 0,2 % | C D | |
| 607-109-00-8 | hexamethylene diacrylate; hexane-1,6-diol diacrylate | 235-921-9 | 13048-33-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-110-00-3 | pentaerythritol triacrylate | 222-540-8 | 3524-68-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-111-00-9 | 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate | 239-701-3 | 15625-89-5 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-112-00-4 | 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate | 218-741-5 | 2223-82-7 | Acute Tox. 3 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H311 H319 H315 H317 | GHS06 Gef. | H311 H319 H315 H317 | (*) | D | |
| 607-113-00-X | isobutyl methacrylate | 202-613-0 | 97-86-9 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H226 H319 H335 H315 H317 H400 | GHS02 GHS07 GHS09 Achtg. | H226 H319 H335 H315 H317 H400 | D | ||
| 607-114-00-5 | ethylene dimethacrylate | 202-617-2 | 97-90-5 | STOT SE 3 Skin Sens. 1 | H335 H317 | GHS07 Achtg. | H335 H317 | STOT SE 3; H335: C ≥ 10 % | D | |
| 607-115-00-0 | isobutyl acrylate | 203-417-8 | 106-63-8 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 | H226 H332 H312 H315 H317 | GHS02 GHS07 Achtg. | H226 H332 H312 H315 H317 | D | ||
| 607-116-00-6 | cyclohexyl acrylate | 221-319-3 | 3066-71-5 | STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H335 H315 H411 | GHS07 GHS09 Achtg. | H335 H315 H411 | STOT SE 3; H335: C ≥ 10 % | D | |
| 607-117-00-1 | 2,3-epoxypropyl acrylate; glycidyl acrylate | 203-440-3 | 106-90-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 | H331 H311 H301 H314 H317 | GHS06 GHS05 Gef. | H331 H311 H301 H314 H317 | (*) Skin Sens. 1; H317: C ≥ 0,2 % | D | |
| 607-118-00-7 | 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate | 243-105-9 | 19485-03-1 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H312 H314 H317 | GHS05 GHS07 Gef. | H312 H314 H317 | D | ||
| 607-119-00-2 | tetramethylene diacrylate; 1,4-butyleneglycol diacrylate | 213-979-6 | 1070-70-8 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H312 H314 H317 | GHS05 GHS07 Gef. | H312 H314 H317 | D | ||
| 607-120-00-8 | 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate | 223-791-6 | 4074-88-8 | Acute Tox. 3 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H311 H319 H315 H317 | GHS06 Gef. | H311 H319 H315 H317 | (*) Skin Sens. 1; H317: C ≥ 0,2 % | D | |
| 607-121-00-3 | 8,9,10-trinorborn-2-yl acrylate | - | 10027-06-2 | Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 | H312 H315 H317 | GHS07 Achtg. | H312 H315 H317 | D | ||
| 607-122-00-9 | pentaerythritol tetraacrylate | 225-644-1 | 4986-89-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-123-00-4 | 2,3-Epoxypropylmethacrylat; Glycidylmethacrylat | 203-441-9 | 106-91-2 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 | H350 H341 H360F H311 H302 H335 H372 (Atemwege) (Einatmung) H318 H314 H317 | GHS08 GHS06 GHS05 Gef. | H350 H341 H360F H311 H302 H335 H372 (Atemwege) (Einatmung) H314 H317 | D | ||
| 607-124-00-X | 2-hydroxyethyl methacrylate | 212-782-2 | 868-77-9 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-125-00-5 | 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate [2] | 213-090-3 [1] 220-426-2 [2] | 923-26-2 [1] 2761-09-3 [2] | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | C D | ||
| 607-126-00-0 | 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate | 216-853-9 | 1680-21-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-127-00-6 | 2-diethylaminoethyl methacrylate | 203-275-7 | 105-16-8 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H332 H319 H315 H317 | GHS07 Achtg. | H332 H319 H315 H317 | D | ||
| 607-128-00-1 | 2-tert-butylaminoethyl methacrylate | 223-228-4 | 3775-90-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | D | ||
| 607-129-00-7 | ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] | 202-598-0 [1] 211-694-1 [2] | 97-64-3 [1] 687-47-8 [2] | Flam. Liq. 3 STOT SE 3 Eye Dam. 1 | H226 H335 H318 | GHS02 GHS05 GHS07 Gef. | H226 H335 H318 | C | ||
| 607-130-00-2 | pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] | 211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] | 628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] | Flam. Liq. 3 | H226 | GHS02 | H226 | EUH066 | C | |
| 607-131-00-8 | isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] | 203-322-1 [1] 210-852-7 [2] 219-449-0 [3] | 105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | C | ||
| 607-132-00-3 | 2-dimethylaminoethyl methacrylate | 220-688-8 | 2867-47-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H312 H302 H319 H315 H317 | GHS07 Achtg. | H312 H302 H319 H315 H317 | D | ||
| 607-133-00-9 | monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H319 H335 H315 H411 | GHS07 GHS09 Achtg. | H319 H335 H315 H411 | STOT SE 3; H335: C ≥ 10 % | A | |
| 607-134-00-4 | monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | STOT SE 3; H335: C ≥ 10 % | A | |
| 607-135-00-X | butyric acid | 203-532-3 | 107-92-6 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 607-136-00-5 | butyryl chloride | 205-498-5 | 141-75-3 | Flam. Liq. 2 Skin Corr. 1B | H225 H314 | GHS02 GHS05 Gef. | H225 H314 | |||
| 607-137-00-0 | methyl acetoacetate | 203-299-8 | 105-45-3 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-138-00-6 | butyl chloroformate; chloroformic acid butyl ester | 209-750-5 | 592-34-7 | Flam. Liq. 3 Acute Tox. 3 (*) Skin Corr. 1B | H226 H331 H314 | GHS02 GHS06 GHS05 Gef. | H226 H331 H314 | |||
| 607-139-00-1 | 2-chloropropionic acid | 209-952-3 | 598-78-7 | Acute Tox. 4 (*) Skin Corr. 1A | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | |||
| 607-140-00-7 | isobutyryl chloride | 201-194-1 | 79-30-1 | Flam. Liq. 2 Skin Corr. 1A | H225 H314 | GHS02 GHS05 Gef. | H225 H314 | |||
| 607-141-00-2 | oxydiethylene bis(chloroformate) | 203-430-9 | 106-75-2 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H302 H315 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H411 | |||
| 607-142-00-8 | propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate | 203-687-7 | 109-61-5 | Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B | H225 H331 H314 | GHS02 GHS06 GHS05 Gef. | H225 H331 H314 | |||
| 607-143-00-3 | valeric acid | 203-677-2 | 109-52-4 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 607-144-00-9 | adipic acid | 204-673-3 | 124-04-9 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-145-00-4 | methanesulphonic acid | 200-898-6 | 75-75-2 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 607-146-00-X | fumaric acid | 203-743-0 | 110-17-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-147-00-5 | oxalic acid diethylester; diethyl oxalate | 202-464-1 | 95-92-1 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 607-148-00-0 | guanidinium chloride; guanadine hydrochloride | 200-002-3 | 50-01-1 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 | H302 H319 H315 | GHS07 Achtg. | H302 H319 H315 | |||
| 607-149-00-6 | urethane (INN); ethyl carbamate | 200-123-1 | 51-79-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 607-150-00-1 | endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid | 205-660-5 | 145-73-3 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H301 H312 H319 H335 H315 | GHS06 Gef. | H301 H312 H319 H335 H315 | |||
| 607-151-00-7 | propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite | 219-006-1 | 2312-35-8 | Carc. 2 Acute Tox. 3 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H331 H315 H318 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H351 H331 H315 H318 H410 | M=10 | ||
| 607-152-00-2 | 2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid | 200-026-4 | 50-31-7 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-153-00-8 | benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid | 223-297-0 | 3813-05-6 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H319 H315 H412 | GHS07 Achtg. | H319 H315 H412 | |||
| 607-154-00-3 | ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO) | 244-845-5 | 22212-55-1 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-155-00-9 | 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s | - | 2079-00-7 | Acute Tox. 2 (*) | H300 | GHS06 Gef. | H300 | |||
| 607-156-00-4 | chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate | 201-270-4 | 80-33-1 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H315 H410 | |||
| 607-157-00-X | Difenacoum (ISO); 3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycumarin | 259-978-4 | 56073-07-5 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 10 M = 10 | ||
| 607-158-00-5 | sodium salt of chloroacetic acid; sodium chloroacetate | 223-498-3 | 3926-62-3 | Acute Tox. 3 (*) Skin Irrit. 2 Aquatic Acute 1 | H301 H315 H400 | GHS06 GHS09 Gef. | H301 H315 H400 | |||
| 607-159-00-0 | chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate | 208-110-2 | 510-15-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-160-00-6 | isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) | - | 51337-71-4 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-161-00-1 | diethanolamine salt of 4-CPA | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-162-00-7 | dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate [2] | 200-923-0 [1] 204-828-5 [2] | 75-99-0 [1] 127-20-8 [2] | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H315 H318 H412 | GHS05 Gef. | H315 H318 H412 | |||
| 607-163-00-2 | 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid | 208-293-9 | 520-45-6 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-164-00-8 | sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate | 224-580-1 | 4418-26-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-165-00-3 | diclofop-methyl (ISO) methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; | 257-141-8 | 51338-27-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 607-166-00-9 | medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate | 219-634-6 | 2487-01-6 | Acute Tox. 3 (*) Acute Tox. 4 (*) | H301 H312 | GHS06 Gef. | H301 H312 | |||
| 607-167-00-4 | sodium 3-chloroacrylate | - | 4312-97-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 607-168-00-X | dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome | - | 83-59-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H311 H302 H400 H410 | GHS06 GHS09 Gef. | H311 H302 H410 | |||
| 607-169-00-5 | sodium fluoroacetate | 200-548-2 | 62-74-8 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 | H330 H310 H300 H400 | GHS06 GHS09 Gef. | H330 H310 H300 H400 | |||
| 607-170-00-0 | bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate | 250-859-2 | 31895-22-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 607-172-00-1 | Brodifacoum (ISO); 4-Hydroxy-3-(3-(4′-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)cumarin | 259-980-5 | 56073-10-0 | Repr. 1 A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 10 M = 10 | ||
| 607-173-00-7 | dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate | 400-460-6 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-174-00-2 | reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate | 400-580-9 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-175-00-8 | methyl 2-(2-nitrobenzylidene)acetoacetate | 400-650-9 | 39562-27-1 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-176-00-3 | reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) | 400-830-7 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-177-00-9 | tribenuron-methyl (ISO); methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate | 401-190-1 | 101200-48-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M = 100 | ||
| 607-178-00-4 | methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate | 401-340-6 | 83055-99-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-179-00-X | (benzothiazol-2-ylthio)succinic acid | 401-450-4 | 95154-01-1 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-180-00-5 | potassium 2-hydroxycarbazole-1-carboxylate | 401-630-2 | 96566-70-0 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 | H302 H319 H335 H412 | GHS07 Achtg. | H302 H319 H335 H412 | |||
| 607-181-00-0 | 3,5-dichloro-2,4-difluorobenzoyl fluoride | 401-800-6 | 101513-70-6 | Acute Tox. 3 (*) Skin Corr. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 | H331 H314 H302 H317 H412 | GHS06 GHS05 Gef. | H331 H314 H302 H317 H412 | EUH029 | ||
| 607-182-00-6 | methyl 3-sulphamoyl-2-thenoate | 402-050-2 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-183-00-1 | zinc 2-hydroxy-5-C13-18alkylbenzoate | 402-280-3 | - | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H319 H315 H411 | GHS07 GHS09 Achtg. | H319 H315 H411 | |||
| 607-184-00-7 | S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate | 402-290-8 | 85702-90-5 | Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 | H226 H334 H317 | GHS02 GHS08 Gef. | H226 H334 H317 | |||
| 607-185-00-2 | ethyl trans-3-dimethylaminoacrylate | 402-650-4 | 1117-37-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-186-00-8 | quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid | 402-780-1 | 84087-01-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-187-00-3 | bis(2,2,6,6-tetramethyl-4-piperidyl) succinate | 402-940-0 | 62782-03-0 | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 607-188-00-9 | hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate | 402-970-4 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-189-00-4 | trimethylenediaminetetraacetic acid | 400-400-9 | 1939-36-2 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 607-190-00-X | methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) | 401-890-7 | 77402-03-0 | Carc. 1B Muta. 1B Acute Tox. 4 (*) Eye Irrit. 2 | H350 H340 H302 H319 | GHS08 GHS07 Gef. | H350 H340 H302 H319 | |||
| 607-191-00-5 | isobutyl 3,4-epoxybutyrate | 401-920-9 | 100181-71-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 607-192-00-0 | disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate | 402-360-8 | 92511-22-3 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-194-00-1 | propylene carbonate | 203-572-1 | 108-32-7 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-195-00-7 | 2-methoxy-1-methylethyl acetate | 203-603-9 | 108-65-6 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | |||
| 607-196-00-2 | heptanoic acid | 203-838-7 | 111-14-8 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 607-197-00-8 | Nonansäure | 203-931-2 | 112-05-0 | Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 | H315 H319 H412 | GHS07 Achtg. | H315 H319 H412 | |||
| 607-198-00-3 | propyl 3,4,5-trihydroxybenzoate | 204-498-2 | 121-79-9 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 607-199-00-9 | octyl 3,4,5-trihydroxybenzoate | 213-853-0 | 1034-01-1 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 607-200-00-2 | dodecyl 3,4,5-trihydroxybenzoate | 214-620-6 | 1166-52-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-201-00-8 | thiocarbonyl chloride | 207-341-6 | 463-71-8 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H331 H302 H319 H335 H315 | GHS06 Gef. | H331 H302 H319 H335 H315 | |||
| 607-203-00-9 | 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate | 279-452-8 | 80387-97-9 | Repr. 1B Skin Sens. 1 Aquatic Chronic 3 | H360D (*)(*)(*) H317 H412 | GHS08 GHS07 Gef. | H360D (*)(*)(*) H317 H412 | |||
| 607-204-00-4 | (chlorophenyl)(chlorotolyl)methane, mixed isomers | 400-140-6 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-205-00-X | methyl chloroacetate | 202-501-1 | 96-34-4 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 3 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H226 H331 H301 H335 H315 H318 | GHS02 GHS06 GHS05 Gef. | H226 H331 H301 H335 H315 H318 | |||
| 607-206-00-5 | isopropyl chloroacetate | 203-301-7 | 105-48-6 | Flam. Liq. 3 Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H226 H301 H319 H335 H315 | GHS02 GHS06 Gef. | H226 H301 H319 H335 H315 | |||
| 607-207-00-0 | haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) | 402-560-5 | 87237-48-7 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-208-00-6 | 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers | 403-000-2 | 91853-67-7 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 607-209-00-1 | reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate | 403-030-6 | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 607-210-00-7 | methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) | 403-230-3 | 77402-05-2 | Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 | H350 H340 H314 H317 | GHS08 GHS05 GHS07 Gef. | H350 H340 H314 H317 | |||
| 607-211-00-2 | methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate | 403-270-1 | 6386-39-6 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-212-00-8 | poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate | 403-300-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-213-00-3 | ethyl 3,3-bis(tert-pentylperoxy)butyrate | 403-320-2 | 67567-23-1 | Org. Perox.
D**** Flam. Liq. 3 Aquatic Chronic 2 | H242 H226 H411 | GHS02 GHS09 Gef. | H242 H226 H411 | |||
| 607-214-00-9 | N,N-hydrazinodiacetic acid | 403-510-5 | 19247-05-3 | Acute Tox. 3 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 | H301 H373 (*)(*) H317 H412 | GHS06 GHS08 Gef. | H301 H373 (*)(*) H317 H412 | |||
| 607-215-00-4 | 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid | 403-920-4 | 107551-67-7 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 607-216-00-X | glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine | 403-950-8 | - | Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 | H330 H302 H314 H400 | GHS06 GHS05 GHS09 Gef. | H330 H302 H314 H400 | |||
| 607-217-00-5 | 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate | 403-960-2 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-218-00-0 | dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid | 403-980-1 | 15165-67-0 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-219-00-6 | bis(2-ethylhexyl) dithiodiacetate | 404-510-8 | 62268-47-7 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 607-221-00-7 | 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid | 404-550-6 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-222-00-2 | 6-(2,3-dimethylmaleimido)hexyl methacrylate | 404-870-6 | 63740-41-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-223-00-8 | transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate | 405-060-5 | 118712-89-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 607-224-00-3 | methyl 2-(3-nitrobenzylidene)acetoacetate | 405-270-7 | 39562-17-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-225-00-9 | 3-azidosulfonylbenzoic acid | 405-310-3 | 15980-11-7 | Self-React.
C (*)(*)(*)(*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 | H241 H373 (*)(*) H318 H317 | GHS02 GHS08 GHS05 GHS07 Gef. | H241 H373 (*)(*) H318 H317 | |||
| 607-226-00-4 | reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate | 405-360-6 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H315 H318 H317 H412 | GHS05 GHS07 Gef. | H315 H318 H317 H412 | |||
| 607-227-00-X | potassium 2-amino-2-methylpropionate octahydrate | 405-560-3 | 120447-91-8 | Acute Tox. 4 (*) Skin Corr. 1A | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | |||
| 607-228-00-5 | bis(2-methoxyethyl) phthalate | 204-212-6 | 117-82-8 | Repr. 1B | H360Df | GHS08 Gef. | H360Df | |||
| 607-229-00-0 | diethylcarbamoyl chloride | 201-798-5 | 88-10-8 | Carc. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H351 H332 H302 H319 H335 H315 | GHS08 GHS07 Achtg. | H351 H332 H302 H319 H335 H315 | |||
| 607-230-00-6 | 2-ethylhexanoic acid | 205-743-6 | 149-57-5 | Repr. 2 | H361d (*)(*)(*) | GHS08 Achtg. | H361d (*)(*)(*) | |||
| 607-231-00-1 | clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid | 216-935-4 | 1702-17-6 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-232-00-7 | pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate | 259-686-7 | 55512-33-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 607-233-00-2 | hexyl acrylate | 219-698-5 | 2499-95-8 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H335 H315 H317 H411 | GHS07 GHS09 Achtg. | H319 H335 H315 H317 H411 | |||
| 607-234-00-8 | flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid | 207-397-1 | 467-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-235-00-3 | mecrilate; methyl 2-cyanoacrylate | 205-275-2 | 137-05-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | STOT SE 3; H335: C ≥ 10 % | ||
| 607-236-00-9 | ethyl 2-cyanoacrylate | 230-391-5 | 7085-85-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | STOT SE 3; H335: C ≥ 10 % | ||
| 607-237-00-4 | benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole | 276-942-3 | 72850-64-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-238-00-X | tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate | - | 102851-06-9 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H315 H400 H410 | GHS07 GHS09 Achtg. | H302 H315 H410 | |||
| 607-239-00-5 | fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate | 254-485-0 | 39515-41-8 | Acute Tox. 2 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H301 H312 H400 H410 | GHS06 GHS09 Gef. | H330 H301 H312 H410 | |||
| 607-240-00-0 | cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalic anhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalic anhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] | 216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] | 1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H318 H334 H317 | GHS08 GHS05 Gef. | H318 H334 H317 | C | ||
| 607-241-00-6 | hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalic anhydride [4] | 243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] | 19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H318 H334 H317 | GHS08 GHS05 Gef. | H318 H334 H317 | C | ||
| 607-242-00-1 | tetrachlorophthalic anhydride | 204-171-4 | 117-08-8 | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H334 H317 H400 H410 | GHS08 GHS05 GHS09 Gef. | H318 H334 H317 H410 | |||
| 607-243-00-7 | sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] | 217-846-3 [1] 246-590-5 [2] 258-527-9 [3] | 1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-244-00-2 | isooctyl acrylate | 249-707-8 | 29590-42-9 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H410 | STOT SE 3; H335: C ≥ 10 % | ||
| 607-245-00-8 | tert-butyl acrylate | 216-768-7 | 1663-39-4 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H225 H332 H312 H302 H335 H315 H317 H411 | GHS02 GHS07 GHS09 Gef. | H225 H332 H312 H302 H335 H315 H317 H411 | D | ||
| 607-246-00-3 | allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester | 202-473-0 | 96-05-9 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 | H226 H331 H312 H302 H400 | GHS02 GHS06 GHS09 Gef. | H226 H331 H312 H302 H400 | |||
| 607-247-00-9 | dodecyl methacrylate | 205-570-6 | 142-90-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H335 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H335 H315 H410 | STOT SE 3; H335: C ≥ 10 % | ||
| 607-248-00-4 | naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate | 205-073-4 | 132-67-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-249-00-X | (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate | 256-032-2 | 42978-66-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H335 H315 H317 H411 | GHS07 GHS09 Achtg. | H319 H335 H315 H317 H411 | STOT SE 3; H335: C ≥ 10 % | ||
| 607-250-00-5 | 4H-3,1-benzoxazine-2,4(1H)-dione | 204-255-0 | 118-48-9 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 607-251-00-0 | 2-methoxypropyl acetate | 274-724-2 | 70657-70-4 | Flam. Liq. 3 Repr. 1B STOT SE 3 | H226 H360D (*)(*)(*) H335 | GHS02 GHS08 GHS07 Gef. | H226 H360D (*)(*)(*) H335 | |||
| 607-252-00-6 | lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) | 415-130-7 | 91465-08-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H330 H301 H312 H400 H410 | GHS06 GHS09 Gef. | H330 H301 H312 H410 | M=10000 | ||
| 607-253-00-1 | cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 269-855-7 | 68359-37-5 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H300 H331 H400 H410 | GHS06 GHS09 Gef. | H300 H331 H410 | M=1000 | ||
| 607-254-00-7 | α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin | 269-855-7 | 68359-37-5 | Acute Tox. 2 (*) Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H410 | |||
| 607-255-00-2 | fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid | - | 69377-81-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-256-00-8 | azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate | - | 131860-33-8 | Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H400 H410 | GHS06 GHS09 Gef. | H331 H410 | |||
| 607-257-00-3 | isopropyl propionate | 211-300-8 | 637-78-5 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | |||
| 607-258-00-9 | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate | 403-990-6 | 70950-45-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-259-00-4 | methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate | 404-130-2 | 105560-93-8 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-260-00-X | ethyl 2-(3-nitrobenzylidene)acetoacetate | 404-490-0 | 39562-16-8 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-261-00-5 | iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate | 404-800-4 | 118832-72-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-262-00-0 | 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 405-050-0 | 86393-33-1 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 607-263-00-6 | potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate | 405-680-6 | - | Self-heat. 2 (*)(*)(*)(*) Aquatic Chronic 2 | H252 H411 | GHS02 GHS09 Achtg. | H252 H411 | |||
| 607-264-00-1 | 2-chloro-4-(methylsulfonyl)benzoic acid | 406-520-8 | 53250-83-2 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-265-00-7 | ethyl-2-chloro-2,2-diphenylacetate | 406-580-5 | 52460-86-3 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 607-266-00-2 | reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid | 406-890-0 | 130296-87-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-267-00-8 | tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | 407-620-4 | 33610-13-8 | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H334 H317 H412 | GHS08 Gef. | H334 H317 H412 | |||
| 607-268-00-3 | 2-methylpropyl (R)-2-hydroxypropanoate | 407-770-0 | 61597-96-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-269-00-9 | (R)-2-(4-hydroxyphenoxy)propanoic acid | 407-960-3 | 94050-90-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-270-00-4 | 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane | 410-730-5 | 90498-90-1 | Acute Tox. 4 (*) | H312 | GHS07 Achtg. | H312 | |||
| 607-271-00-X | 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane | 417-420-9 | 156324-82-2 | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 607-272-00-5 | fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] | 279-752-9 [1] [2] | 81406-37-3 [1] 154486-27-8 [2] | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-273-00-0 | ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate | 404-520-2 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-274-00-6 | 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate | 405-350-1 | 54527-73-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-275-00-1 | sodium benzoyloxybenzene-4-sulfonate | 405-450-5 | 66531-87-1 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-276-00-7 | bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex | 405-635-0 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 607-277-00-2 | reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate | 405-720-2 | - | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 607-278-00-8 | reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate | 405-760-0 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-279-00-3 | reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate | 405-960-8 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-280-00-9 | sodium 4-chloro-1-hydroxybutane-1-sulfonate | 406-190-5 | 54322-20-2 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 | H302 H319 H317 | GHS07 Achtg. | H302 H319 H317 | |||
| 607-281-00-4 | reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates | 407-000-3 | 127519-17-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-282-00-X | 2-acetoxymethyl-4-benzyloxybut-1-yl acetate | 407-140-5 | 131266-10-9 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-283-00-5 | E-ethyl-4-oxo-4-phenylcrotonate | 408-040-4 | 15121-89-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H312 H302 H315 H318 H317 H410 | |||
| 607-284-00-0 | reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) | 410-040-4 | 136213-76-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-285-00-6 | reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate | 410-065-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | ||||
| 607-286-00-1 | reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate | 410-070-8 | 141880-36-6 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-287-00-7 | O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate | 410-140-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-288-00-2 | tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively | 410-160-7 | 148732-74-5 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H317 H412 | GHS07 Achtg. | H319 H317 H412 | |||
| 607-289-00-8 | 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid | 410-370-9 | 105488-33-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-290-00-3 | reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate | 410-540-2 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 607-291-00-9 | dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate | 410-630-1 | 104051-92-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-292-00-4 | reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid | 410-640-6 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 607-293-00-X | reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate | 410-650-0 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 607-294-00-5 | sodium 2-benzoyloxy-1-hydroxyethane-sulfonate | 410-680-4 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-295-00-0 | reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate | 410-800-5 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-296-00-6 | reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid | 410-830-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-297-00-1 | (E - E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) | 410-960-6 | 92761-26-7 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-298-00-7 | 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate | 411-010-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-299-00-2 | methyl 3-(acetylthio)-2-methyl-propanoate | 411-040-7 | 97101-46-7 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 607-300-00-6 | trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 | 411-430-7 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-301-00-1 | reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid | 411-860-5 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-302-00-7 | reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid | 411-910-6 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H315 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H411 | |||
| 607-303-00-2 | 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 413-760-7 | 93107-30-3 | Repr. 2 Aquatic Chronic 3 | H361f (*)(*)(*) H412 | GHS08 Achtg. | H361f (*)(*)(*) H412 | |||
| 607-304-00-8 | fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | 274-125-6 | 69806-50-4 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360D (*)(*)(*) H400 H410 | GHS08 GHS09 Gef. | H360D (*)(*)(*) H410 | |||
| 607-305-00-3 | fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | - | 79241-46-6 | Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H400 H410 | GHS08 GHS09 Achtg. | H361d (*)(*)(*) H410 | |||
| 607-306-00-9 | chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate | 282-714-4 | 84332-86-5 | Carc. 2 Aquatic Chronic 2 | H351 H411 | GHS08 GHS09 Achtg. | H351 H411 | |||
| 607-307-00-4 | vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione | 256-599-6 | 50471-44-8 | Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 | H351 H360FD H317 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360FD H317 H411 | |||
| 607-308-00-X | esters of 2,4-D | - | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | A | ||
| 607-309-00-5 | carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate | - | 128639-02-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-310-00-0 | kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate | - | 143390-89-0 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 607-311-00-6 | benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate | 246-591-0 | 25059-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-312-00-1 | methoxyacetic acid | 210-894-6 | 625-45-6 | Repr. 1B Acute Tox. 4 (*) Skin Corr. 1B | H360FD H302 H314 | GHS08 GHS05 GHS07 Gef. | H360FD H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 607-313-00-7 | neodecanoyl chloride | 254-875-0 | 40292-82-8 | Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B | H330 H302 H314 | GHS06 GHS06 Gef. | H330 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 607-314-00-2 | ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate | 247-525-3 | 26225-79-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-315-00-8 | glyphosate (ISO); N-(phosphonomethyl)glycine | 213-997-4 | 1071-83-6 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 607-316-00-3 | glyphosate-trimesium; glyphosate-trimethylsulfonium | - | 81591-81-3 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-317-00-9 | bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP | 204-211-0 | 117-81-7 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | |||
| 607-318-00-4 | dibutyl phthalate; DBP | 201-557-4 | 84-74-2 | Repr. 1B Aquatic Acute 1 | H360Df H400 | GHS08 GHS09 Gef. | H360Df H400 | |||
| 607-319-00-X | deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate | 258-256-6 | 52918-63-5 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | M=1000000 | ||
| 607-320-00-5 | bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate | 413-930-0 | 130066-57-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-321-00-0 | (S)-methyl-2-chloropropionate | 412-470-8 | 73246-45-4 | Flam. Liq. 3 STOT RE 2 (*) Eye Irrit. 2 | H226 H373 (*)(*) H319 | GHS02 GHS08 Achtg. | H226 H373 (*)(*) H319 | |||
| 607-322-00-6 | 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid | 413-120-7 | 107144-30-9 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-323-00-1 | 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate | 413-850-6 | 123968-25-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-324-00-7 | reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine | 413-800-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-325-00-2 | (S)-2-chloropropionic acid | 411-150-5 | 29617-66-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 607-326-00-8 | reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate | 410-720-0 | 141847-13-4 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 607-327-00-3 | 2-(2-iodoethyl)-1,3-propanediol diacetate | 411-780-0 | 127047-77-2 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-328-00-9 | methyl 4-bromomethyl-3-methoxybenzoate | 410-310-1 | 70264-94-7 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 607-329-00-4 | reaction mass of: sodium 2-(C12-18 - n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate | 411-250-9 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-330-00-X | (S)-2,3-dihydro-1H-indole-2-carboxylic acid | 410-860-2 | 79815-20-6 | Repr. 2 STOT RE 2 (*) Skin Sens. 1 | H361f (*)(*)(*) H373 (*)(*) H317 | GHS08 GHS07 Achtg. | H361f (*)(*)(*) H373 (*)(*) H317 | |||
| 607-332-00-0 | cyclopentyl chloroformate | 411-460-0 | 50715-28-1 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 | H226 H331 H302 H373 (*)(*) H318 H317 | GHS02 GHS06 GHS08 GHS05 Gef. | H226 H331 H302 H373 (*)(*) H318 H317 | |||
| 607-333-00-6 | reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate | 405-670-1 | - | Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 (*)(*) H314 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H302 H373 (*)(*) H314 H410 | |||
| 607-334-00-1 | ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate | 405-880-3 | 100501-62-0 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-335-00-7 | methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate | 406-250-0 | 72619-32-0 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 607-336-00-2 | 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate | 406-560-6 | 122760-85-4 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H315 H317 H411 | GHS07 GHS09 Achtg. | H315 H317 H411 | |||
| 607-337-00-8 | di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate | 406-052-4 | 125078-60-6 | Flam. Liq. 3 Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H226 H302 H315 H318 H411 | GHS02 GHS05 GHS07 GHS09 Gef. | H226 H302 H315 H318 H411 | |||
| 607-338-00-3 | 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate | 406-235-9 | 72531-53-4 | Eye Irrit. 2 Skin Irrit. 2 | H319 H315 | GHS07 Achtg. | H319 H315 | |||
| 607-339-00-9 | 2,3,4,5-tetrachlorobenzoylchloride | 406-760-3 | 42221-52-3 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H302 H314 H317 | GHS05 GHS07 Gef. | H302 H314 H317 | |||
| 607-340-00-4 | 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate | 406-990-4 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-341-00-X | (9S)-9-amino-9-deoxyerythromycin | 406-790-7 | 26116-56-3 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 607-342-00-5 | 4-chlorobutyl veratrate | 410-950-1 | 69788-75-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-343-00-0 | 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) | 407-410-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-344-00-6 | reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate | 407-810-7 | - | STOT RE 2 (*) | H373 (*)(*) | GHS08 Achtg. | H373 (*)(*) | |||
| 607-345-00-1 | potassium 2-(2,4-dichlorophenoxy)-(R)-propionate | 413-580-9 | 113963-87-4 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-346-00-7 | 3-icosyl-4-henicosylidene-2-oxetanone | 401-210-9 | 83708-14-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-347-00-2 | sodium (R)-2-(2,4-dichlorophenoxy)propionate | 413-340-3 | 119299-10-4 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-348-00-8 | magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) | 413-360-2 | - | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-349-00-3 | mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate | 411-270-8 | - | Aquatic Chronic 3 | H412 | H412 | ||||
| 607-350-00-9 | bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane | 412-060-9 | 136210-32-7 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-351-00-4 | methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate | 407-550-4 | 69184-17-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-352-00-X | 4,4'-oxydiphthalic anhydride | 412-830-4 | 1823-59-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-353-00-5 | reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate | 407-520-0 | 80657-64-3 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-354-00-0 | ethyl 2-cyclohexylpropionate | 412-280-5 | 2511-00-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-355-00-6 | p-tolyl 4-chlorobenzoate | 411-530-0 | 15024-10-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-356-00-1 | ethyl trans-2,2,6-trimethylcyclohexanecarboxylate | 412-540-8 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-357-00-7 | reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran | 412-450-9 | 131766-73-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-358-00-2 | (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate | 412-670-5 | 54275-93-3 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 607-359-00-8 | (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate | 412-800-0 | 76109-32-5 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 607-360-00-3 | sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate | 411-680-7 | 133167-77-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-361-00-9 | methyl (R)-2-(4-hydroxyphenoxy)propionate | 411-950-4 | 96562-58-2 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-362-00-4 | reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate | 413-500-2 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H315 H318 H411 | GHS05 GHS09 Gef. | H315 H318 H411 | |||
| 607-363-00-X | methyl-3-methoxyacrylate | 412-900-4 | 5788-17-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-364-00-5 | 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione | 413-330-9 | 134724-55-3 | Aquatic Chronic 4 | H413 | H413 | ||||
| 607-365-00-0 | 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride | 410-620-7 | 119154-86-8 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H302 H314 H317 | GHS05 GHS07 Gef. | H302 H314 H317 | |||
| 607-366-00-6 | 3,5-dimethylbenzoyl chloride | 413-010-9 | 6613-44-1 | Skin Corr. 1B Skin Sens. 1 | H314 H317 | GHS05 GHS07 Gef. | H314 H317 | |||
| 607-367-00-1 | potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate | 411-640-9 | 153352-59-1 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-368-00-7 | 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole | 411-650-3 | 110895-43-7 | Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | |||
| 607-369-00-2 | reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid | 411-660-8 | 147027-04-1 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-370-00-8 | 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 412-210-3 | 41620-33-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-371-00-3 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate | 413-410-3 | 88150-62-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-372-00-9 | ethoxylated bis phenol A di-(norbornene carboxylate) | 412-410-0 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-373-00-4 | (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate | 414-200-4 | 119738-06-6 | Muta. 2 Repr. 1B Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H341 H360Df H302 H373 (*)(*) H400 H410 | GHS08 GHS07 GHS09 Gef. | H341 H360Df H302 H373 (*)(*) H410 | |||
| 607-374-00-X | 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride | 417-220-1 | 37441-29-5 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-375-00-5 | Flocoumafen (ISO); Reaktionsmasse aus: cis-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin und trans-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin | 421-960-0 | 90035-08-8 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,05 % STOT RE 2; H373 (Blut): 0,005 % ≤ C < 0,05 % M = 10 M = 10 | ||
| 607-376-00-0 | benzyl 2,4-dibromobutanoate | 420-710-8 | 23085-60-1 | Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f (*)(*)(*) H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361f (*)(*)(*) H315 H317 H410 | |||
| 607-377-00-6 | trans-4-cyclohexyl-L-proline monohydrochloride | 419-160-1 | 90657-55-9 | Repr. 2 Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H361f (*)(*)(*) H302 H315 H318 H317 | GHS08 GHS05 GHS07 Gef. | H361f (*)(*)(*) H302 H315 H318 H317 | |||
| 607-378-00-1 | ammonium (Z)-α-methoxyimino-2-furylacetate | 405-990-1 | 97148-39-5 | Flam. Sol. 2 | H228 | GHS02 Gef. | H228 | T | ||
| 607-379-00-7 | reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide | 401-230-8 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-380-00-2 | reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate | 407-320-3 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H315 H318 H412 | GHS05 Gef. | H315 H318 H412 | |||
| 607-381-00-8 | reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid | 413-710-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-382-00-3 | 2-((4-amino-2-nitrophenyl)amino)benzoic acid | 411-260-3 | 117907-43-4 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-383-00-9 | reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate | 415-430-8 | 86403-32-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H318 H317 H410 | |||
| 607-384-00-4 | reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate | 413-750-2 | 171090-93-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-385-00-X | Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate | 414-590-6 | 125229-74-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-386-00-5 | reaction mass of: tetradecanoic acid (42,5 -47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5 - 57,5 %) | 412-580-6 | 174591-51-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 607-387-00-0 | reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) | 412-590-0 | 58856-63-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 607-388-00-6 | 4-ethylamino-3-nitrobenzoic acid | 412-090-2 | 2788-74-1 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 607-389-00-1 | trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate | 414-130-4 | 119710-96-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 607-390-00-7 | 1,2,3,4-tetrahydro-6-nitro-quinoxaline | 414-270-6 | 41959-35-7 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-391-00-2 | dimethylcyclopropane-1,1-dicarboxylate | 414-240-2 | 6914-71-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-392-00-8 | 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate | 414-260-1 | 88938-37-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-393-00-3 | 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 415-750-8 | 106447-44-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-394-00-9 | 5-methylpyrazine-2-carboxylic acid | 413-260-9 | 5521-55-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-395-00-4 | reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate | 410-230-7 | - | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H317 H411 | |||
| 607-396-00-X | bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate | 414-840-4 | 147783-69-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-397-00-5 | reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) | 415-930-6 | - | Repr. 2 Skin Sens. 1 | H361f*** H317 | GHS08 GHS07 Achtg. | H361f*** H317 | |||
| 607-398-00-0 | ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate | 414-820-5 | 125630-94-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-399-00-6 | 2,2-dimethyl 3-methyl-3-butenyl propanoate | 415-610-6 | 104468-21-5 | Skin Irrit. 2 Aquatic Chronic 3 | H315 H412 | GHS07 Achtg. | H315 H412 | |||
| 607-400-00-X | methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate | 414-400-1 | 32750-89-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-401-00-5 | ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate | 414-450-4 | 88805-65-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H315 H318 H317 | GHS05 GHS07 Gef. | H315 H318 H317 | |||
| 607-402-00-0 | methyl N-(phenoxycarbonyl)-L-valinate | 414-500-5 | 153441-77-1 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-403-00-6 | reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol | 414-810-0 | - | STOT RE 2 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H318 H400 H410 | GHS08 GHS05 GHS09 Gef. | H373 (*)(*) H318 H410 | |||
| 607-404-00-1 | reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid | 415-190-4 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-405-00-7 | 2-hexyldecyl-p-hydroxybenzoate | 415-380-7 | 148348-12-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-406-00-2 | potassium 2,5-dichlorobenzoate | 415-700-5 | 184637-62-5 | Acute Tox. 4 (*) Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 607-407-00-8 | ethyl 2-carboxy-3-(2-thienyl)propionate | 415-680-8 | 143468-96-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H315 H318 H317 | GHS05 GHS07 Gef. | H315 H318 H317 | |||
| 607-408-00-3 | potassium N-(4-fluorophenyl)glycinate | 415-710-1 | 184637-63-6 | STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H373 (*)(*) H318 H317 H412 | GHS08 GHS05 GHS07 Gef. | H373 (*)(*) H318 H317 H412 | |||
| 607-409-00-9 | reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus | 415-840-7 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-410-00-4 | mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate | 415-880-5 | 779343-34-9 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 607-411-00-X | oxiranemethanol, 4-methylbenzene-sulfonate, (S)- | 417-210-7 | 70987-78-9 | Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H350 H341 H318 H317 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H350 H341 H318 H317 H411 | |||
| 607-412-00-5 | ethyl 2-(1-cyanocyclohexyl)acetate | 415-970-4 | 133481-10-4 | Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Chronic 3 | H302 H373 (*)(*) H412 | GHS08 GHS07 Achtg. | H302 H373 (*)(*) H412 | |||
| 607-413-00-0 | trans-4-phenyl-L-proline | 416-020-1 | 96314-26-0 | Repr. 2 Skin Sens. 1 | H361f (*)(*)(*) H317 | GHS08 GHS07 Achtg. | H361f (*)(*)(*) H317 | |||
| 607-414-00-6 | tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate | 402-070-1 | 88122-99-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-415-00-1 | poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) | 419-590-1 | - | Flam. Sol. 1 Skin Sens. 1 | H228 H317 | GHS02 GHS07 Gef. | H228 H317 | T | ||
| 607-416-00-7 | 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide | 420-730-7 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-417-00-2 | 3-chloropropyl chloroformiate | 425-770-9 | 628-11-5 | Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H331 H302 H373** H315 H318 H317 | GHS06 GHS05 GHS08 Gef. | H331 H302 H373** H315 H318 H317 | |||
| 607-418-00-8 | 2-ethylhexyl 4-aminobenzoate | 420-170-3 | 26218-04-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-419-00-3 | (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid | 422-240-9 | 166596-68-5 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-420-00-9 | 2,2-bis(hydroxymethyl)butanoic acid | 424-090-1 | 10097-02-6 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-421-00-4 | cypermethrin cis/trans +/- 40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 52315-07-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H335 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H335 H410 | |||
| 607-422-00-X | α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 67375-30-8 | Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H301 H373** H335 H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H373** H335 H410 | M=1000 | ||
| 607-423-00-5 | esters of mecoprop and of mecoprop-P | - | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | A | ||
| 607-424-00-0 | trifloxystrobin (ISO); (E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester | - | 141517-21-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-425-00-6 | metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate | 260-979-7 | 57837-19-1 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 607-426-00-1 | 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] | 284-032-2 [1] [2] 205-017-9 [3] 210-088-4 [4] | 84777-06-0 [1] [2] 131-18-0 [3] 605-50-5 [4] | Repr. 1B Aquatic Acute 1 | H360FD H400 | GHS08 GHS09 Gef. | H360FD H400 | |||
| 607-427-00-7 | bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate | 260-300-4 | 56634-95-8 | Repr. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H332 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d (*)(*)(*) H332 H302 H317 H410 | |||
| 607-428-00-2 | tetrasodium ethylene diamine tetraacetate | 200-573-9 | 64-02-8 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 607-429-00-8 | edetic acid; (EDTA) | 200-449-4 | 60-00-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-430-00-3 | BBP; benzyl butyl phthalate e | 201-622-7 | 85-68-7 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360Df H400 H410 | GHS08 GHS09 Gef. | H360Df H410 | |||
| 607-431-00-9 | prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 245-387-9 | 23031-36-9 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H400 H410 | GHS06 GHS09 Gef. | H331 H302 H410 | |||
| 607-432-00-4 | S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] | [1] [2] | 87392-12-9 [1] 178961-20-1 [2] | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-433-00-X | cypermethrin cis/trans +/- 80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 52315-07-8 | Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H335 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H335 H315 H317 H410 | |||
| 607-434-00-5 | mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid | 240-539-0 | 16484-77-8 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 607-435-00-0 | 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate | 416-810-6 | 111969-64-3 | STOT RE 2 (*) Eye Dam. 1 Aquatic Chronic 2 | H373 (*)(*) H318 H411 | GHS08 GHS05 GHS09 Gef. | H373 (*)(*) H318 H411 | |||
| 607-436-00-6 | 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate | 417-350-9 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 607-437-00-1 | 3-(4-aminophenyl)-2-cyano-2-propenoic acid | 417-480-6 | 252977-62-1 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-438-00-7 | methyl-2-[(aminosulfonyl)methyl]benzoate | 419-010-5 | 112941-26-1 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 607-439-00-2 | methyl tetrahydro-2-furancarboxylate | 420-670-1 | 37443-42-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-440-00-8 | methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate | 421-220-7 | 144740-59-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-441-00-3 | 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid | 421-490-6 | 167684-63-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-442-00-9 | benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate | 416-050-5 | 87460-09-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-444-00-X | reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate | 416-230-3 | 35541-81-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-445-00-5 | Iron (III) tris(4-methylbenzenesulfonate) | 420-960-8 | 77214-82-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-446-00-0 | methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate | 416-240-8 | 155522-12-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-447-00-6 | sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate | 416-370-5 | 156738-27-1 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-448-00-1 | 2,3,5,6-tetrafluorobenzoic acid | 416-800-1 | 652-18-6 | Skin Irrit. 2 Eye Dam. 1 | H315 H318 | GHS05 Gef. | H315 H318 | |||
| 607-449-00-7 | reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] | 417-080-1 | - | Self-react.
D (*)(*)(*)(*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H242 H317 H400 H410 | GHS02 GHS07 GHS09 Gef. | H242 H317 H410 | |||
| 607-450-00-2 | 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | 419-040-9 | 89604-92-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-451-00-8 | 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt | 417-640-5 | 161935-19-9 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-453-00-9 | 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) | 418-100-1 | 172964-15-7 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-454-00-4 | reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid | 418-170-3 | 116193-72-7 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-455-00-X | 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt | 419-520-8 | 172890-93-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-456-00-5 | 3-amino-4-chlorobenzoic acid, hexadecyl ester | 419-700-6 | 143269-74-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-457-00-0 | tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) | 420-350-1 | 172277-97-3 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 607-458-00-6 | reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] | 420-850-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-459-00-1 | isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate | 418-930-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-460-00-7 | 3-tridecyloxy-propyl-ammonium 9-octadecenoate | 418-990-1 | 778577-53-0 | STOT RE 2 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H319 H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 (*)(*) H319 H315 H410 | |||
| 607-461-00-2 | reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate | 421-160-1 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-462-00-8 | reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates | 421-230-1 | 88230-35-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-463-00-3 | 3-(phenothiazin-10-yl)propionic acid | 421-260-5 | 362-03-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-464-00-9 | reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid | 421-280-4 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-465-00-4 | tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate | 421-440-3 | 778583-04-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-466-00-X | reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate | 421-480-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-467-00-5 | 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 419-430-9 | 56533-00-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373 (*)(*) H314 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H312 H302 H373 (*)(*) H314 H410 | |||
| 607-468-00-0 | reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate | 419-450-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-469-00-6 | disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate | 419-460-2 | 120029-06-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-470-00-1 | potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-100-0 | 154336-20-6 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-471-00-7 | 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane | 429-280-6 | 151900-44-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-473-00-8 | pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid | 426-590-3 | 187412-41-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-474-00-3 | (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | 410-430-4 | 117573-89-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-475-00-9 | reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) | 412-940-2 | 148878-18-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-476-00-4 | trisodium N,N-bis(carboxymethyl)-β-alanine | 414-070-9 | 129050-62-0 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 607-477-00-X | (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt | 426-740-8 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 607-478-00-5 | tetramethylammonium hydrogen phthalate | 416-900-5 | 79723-02-7 | Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 | H301 H373 (*)(*) H400 | GHS06 GHS08 GHS09 Gef. | H301 H373 (*)(*) H400 | |||
| 607-479-00-0 | hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate | 418-550-9 | 168689-49-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-480-00-6 | 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters | 271-084-6 | 68515-42-4 | Repr. 1B | H360Df | GHS08 Gef. | H360Df | |||
| 607-481-00-1 | reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate | 430-290-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-482-00-7 | N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride | 430-360-8 | 84793-24-8 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-483-00-2 | 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich | 276-158-1 | 71888-89-6 | Repr. 1B | H360D*** | GHS08 Gef. | H360D*** | |||
| 607-484-00-8 | ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate | 430-480-0 | 221452-67-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-485-00-3 | (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate | 430-510-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-486-00-9 | potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate | 402-110-8 | 110081-40-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-487-00-4 | reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate | 402-660-9 | - | Repr. 1B Aquatic Chronic 3 | H360D (*)(*)(*) H412 | GHS08 Gef. | H360D (*)(*)(*) H412 | |||
| 607-488-00-X | ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate | 414-210-9 | 147379-38-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-489-00-5 | reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate | 414-890-7 | 71302-79-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-490-00-0 | N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate | 415-060-7 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-491-00-6 | reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) | 427-140-9 | - | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 607-492-00-1 | 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate | 415-490-5 | 141773-73-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-493-00-7 | methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate | 415-670-3 | 78850-37-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-494-00-2 | bis(2-ethylhexyl)octylphosphonate | 417-170-0 | 52894-02-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-495-00-8 | sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate | 417-550-6 | 168151-92-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-496-00-3 | 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite | 418-310-3 | 126050-54-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-497-00-9 | cerium oxide isostearate | 419-760-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-498-00-4 | (E)-3,7-dimethyl-2,6-octadienylhexadecanoate | 421-370-3 | 3681-73-0 | Skin Irrit. 2 Aquatic Chronic 4 | H315 H413 | GHS07 Achtg. | H315 H413 | |||
| 607-499-00-X | bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) | 421-660-1 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 607-500-00-3 | calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate | 421-670-4 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H315 H400 H410 | GHS07 GHS09 Achtg. | H315 H410 | |||
| 607-501-00-9 | reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives | 421-820-9 | 192268-65-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-502-00-4 | (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate | 422-200-0 | 178277-55-9 | Skin Corr. 1B Acute Tox. 4 (*) Aquatic Chronic 2 | H314 H302 H411 | GHS05 GHS07 GHS09 Gef. | H314 H302 H411 | |||
| 607-503-00-X | 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane | 422-210-5 | 68957-94-8 | Skin Corr. 1B | H314 | GHS05 Gef. | H314 | |||
| 607-504-00-5 | diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | 422-670-7 | - | Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H361f H301 H373** H400 H410 | GHS06 GHS08 GHS09 Gef. | H361f H301 H373** H410 | |||
| 607-505-00-0 | pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate | 422-930-1 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-506-00-6 | reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate | 422-970-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | ||||
| 607-507-00-1 | potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate | 422-980-2 | 187026-95-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-508-00-7 | disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] | 423-110-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-509-00-2 | 2-phenoxyethyl 4-aminobenzoate | 430-880-5 | 88938-23-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-510-00-8 | (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | 427-200-4 | 76646-91-8 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H302 H315 H318 H317 | GHS05 GHS07 Gef. | H302 H315 H318 H317 | |||
| 607-511-00-3 | reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid | 423-750-4 | - | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 607-512-00-9 | trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate | 423-970-0 | 182926-43-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-513-00-4 | reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid | 423-200-3 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-514-00-X | potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate | 427-240-2 | 134841-35-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-515-00-5 | reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate | 429-650-7 | 147732-60-3 | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 607-516-00-0 | N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine | 429-670-6 | 105996-54-1 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-517-00-6 | (S)-α-(acetylthio)benzenepropanoic acid | 430-300-0 | 76932-17-7 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 | H302 H318 H317 | GHS05 GHS07 Gef. | H302 H318 H317 | |||
| 607-518-00-1 | 3-oxoandrost-4-ene-17-β-carboxylic acid | 414-990-0 | 302-97-6 | Repr. 2 Aquatic Chronic 4 | H361f H413 | GHS08 Achtg. | H361f H413 | |||
| 607-519-00-7 | poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-280-0 | 176429-27-9 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H335 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H335 H315 H318 H410 | |||
| 607-520-00-2 | reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate | 427-740-0 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-521-00-8 | tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate | 429-270-1 | 136210-30-5 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-522-00-3 | sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate | 429-720-7 | 184246-86-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-523-00-9 | reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10-diamino-6,6',13,13-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate | 430-200-7 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-524-00-4 | tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters | 430-310-5 | - | Aquatic Chronic 4 | H413 | H413 | ||||
| 607-525-00-X | (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | 431-520-1 | 64485-90-1 | Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 | H228 H351 H412 | GHS02 GHS08 Gef. | H228 H351 H412 | |||
| 607-526-00-5 | cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane | - | 15263-53-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-527-00-0 | reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate | 423-180-6 | - | STOT RE 2 (*) | H373 (*)(*) | GHS08 Achtg. | H373 (*)(*) | |||
| 607-528-00-6 | (S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid | 430-900-2 | 192725-50-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-529-00-1 | benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate | 426-070-6 | 67299-45-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-530-00-7 | reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate | 406-040-9 | 125643-61-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-531-00-2 | methyl 3-amino-4,6-dibromo-2-methyl-benzoate | 425-190-6 | 119916-05-1 | STOT RE 2 * Aquatic Chronic 2 | H373** H411 | GHS08 GHS09 Achtg. | H373** H411 | |||
| 607-532-00-8 | (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt | 425-510-4 | 167944-94-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-533-00-3 | pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-910-4 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-534-00-9 | ethyl 2-(3-benzoylphenyl)propanoate | 414-920-9 | 60658-04-0 | Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 | H301 H372** H317 H411 | GHS06 GHS08 GHS09 Gef. | H301 H372** H317 H411 | |||
| 607-535-00-4 | potassium 4-iodo-2-sulfonato-benzoic acid | 426-620-5 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-536-00-X | (2,6-xylyloxy) acetic acid | 430-910-7 | 13335-71-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 607-537-00-5 | isopropylammonium 2-(3-benzoylphenyl)propionate | 417-970-1 | - | Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H372** H318 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H301 H312 H372** H318 H410 | |||
| 607-539-00-6 | propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate | 431-000-2 | 198705-81-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-540-00-1 | 1-(mercaptomethyl)cyclopropylacetic acid | 420-240-3 | 162515-68-6 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H314 H312 H302 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H312 H302 H317 H411 | |||
| 607-541-00-7 | [(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) | 421-940-1 | 28698-31-9 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 607-542-00-2 | methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate | 422-110-1 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-543-00-8 | poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-480-8 | 176429-22-4 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H335 H315 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H335 H315 H318 H410 | |||
| 607-544-00-3 | ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate | 427-490-2 | 158585-86-5 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-545-00-9 | 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate | 424-070-0 | 94346-09-5 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-546-00-4 | reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate | 424-290-7 | 188070-47-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-547-00-X | 18-methylnonadecyl 2,2-dimethylpropanoate | 424-370-1 | 125496-22-2 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H315 H317 H413 | GHS07 Achtg. | H315 H317 H413 | |||
| 607-548-00-5 | 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate | 431-010-7 | 154486-26-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 607-549-00-0 | methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate | 424-430-7 | 125778-19-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-550-00-6 | 2-amino-4-bromo-5-chlorobenzoic acid | 424-700-4 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-551-00-1 | tetrabutylammonium 2-amino-6-iodopurinate | 424-710-9 | 156126-48-6 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H312 H302 H373** H315 H318 H317 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H312 H302 H373** H315 H318 H317 H411 | |||
| 607-552-00-7 | hexadecyl 3-amino-4-isopropoxybenzoate | 424-830-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-553-00-2 | 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt | 424-850-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-554-00-8 | 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid | 424-870-1 | 27624-67-5 | Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 | H201 H318 H412 | GHS01 GHS05 Gef. | H201 H318 H412 | |||
| 607-555-00-3 | 1,1,3,3-tetramethylbutylperoxypivalate | 424-980-8 | 22288-41-1 | Flam. Liq. 2 Org. Perox. D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H225 H242 H315 H317 H411 | GHS02 GHS07 GHS09 Gef. | H225 H242 H315 H317 H411 | |||
| 607-556-00-9 | 2-acetoxymethylene-4-acetylphenylacetate | 425-160-2 | 24085-06-1 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H302 H373** H318 H317 H410 | |||
| 607-557-00-4 | salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid | 425-210-3 | 169939-84-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-558-00-X | 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolane-2-carboxylate | 425-250-1 | 147027-10-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-559-00-5 | coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid | 425-400-6 | 179986-09-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-560-00-0 | (R,S)-2-butyloctanedioic acid | 431-210-4 | 50905-10-7 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-561-00-6 | sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate | 425-460-3 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-562-00-1 | reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate | 425-530-3 | 98769-75-6 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 607-563-00-7 | 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid | 431-250-2 | 171850-30-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-564-00-2 | 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate | 425-730-0 | 51178-75-7 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-565-00-8 | 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate | 425-820-1 | 88150-42-9 | Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H373** H318 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H301 H373** H318 H410 | |||
| 607-566-00-3 | reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate | 426-140-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-567-00-9 | potassium 3-iodo-6-methylbenzenesulfonate | 426-300-5 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-568-00-4 | potassium 2-chloro-3-(benzyloxy)propionate | 426-350-8 | 138666-92-9 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 | H302 H373** H318 H317 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 H317 | |||
| 607-569-00-X | reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate | 426-470-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-570-00-5 | sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate | 426-520-1 | 71420-85-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-571-00-0 | 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate | 431-400-7 | 57374-49-9 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-572-00-6 | diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate | 426-790-0 | 162208-27-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H312 H302 H373** H317 H410 | |||
| 607-573-00-1 | reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate | 426-840-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-574-00-7 | [1R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate | 426-890-4 | 77341-67-4 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-575-00-2 | 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt | 426-900-7 | - | STOT SE 3 Aquatic Chronic 3 | H335 H412 | GHS07 Achtg. | H335 H412 | |||
| 607-576-00-8 | branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate | 427-030-0 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-577-00-3 | (2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate | 427-100-0 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H318 H317 H412 | |||
| 607-578-00-9 | ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate | 427-110-5 | - | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 4 | H302 H373** H413 | GHS08 GHS07 Achtg. | H302 H373** H413 | |||
| 607-579-00-4 | diethyl[(p-ethoxyanilino)methylene]malonate | 431-430-0 | 103976-28-9 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | 422-360-1 | 100491-29-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-581-00-5 | ethyl 2-ethoxy-4-carboxymethylbenzoate | 427-630-2 | 99469-99-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-582-00-0 | reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 427-650-1 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-583-00-6 | 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid | 427-680-5 | 188907-52-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-584-00-1 | trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate | 427-710-7 | 215612-56-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 607-585-00-7 | strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate | 427-930-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-586-00-2 | dodecyl 3-amino-4-chlorobenzoate | 428-020-9 | 6195-20-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-587-00-8 | ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate | 428-030-3 | 67914-69-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H410 | |||
| 607-588-00-3 | reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | 428-050-2 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-589-00-9 | tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate | 428-070-1 | 91788-83-9 | STOT RE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H372** H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H372** H302 H410 | |||
| 607-590-00-4 | hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate | 428-140-1 | 210706-50-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-591-00-X | reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate | 428-400-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-592-00-5 | di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate | 428-870-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-593-00-0 | 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate | 429-000-2 | 159235-16-2 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-594-00-6 | ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 429-020-1 | 204254-96-6 | STOT RE 2 * Skin Sens. 1 | H373** H317 | GHS08 GHS07 Achtg. | H373** H317 | |||
| 607-595-00-1 | N-amidino-N-methylglycine-2-oxopropionate | 429-120-5 | 208535-04-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-596-00-7 | ethyl 2-(4-phenoxyphenyl)lactate | 429-220-9 | 132584-17-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-597-00-2 | tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate | 429-230-3 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-598-00-8 | trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate | 429-240-8 | 212652-59-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-599-00-3 | 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate | 431-610-9 | 68860-54-8 | Org. Perox.
D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H242 H317 H400 H410 | GHS02 GHS07 GHS09 Gef. | H242 H317 H410 | |||
| 607-600-00-7 | (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate | 431-700-8 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-601-00-2 | 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate | 429-370-5 | 220410-74-2 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 607-602-00-8 | ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate | 429-680-0 | 122665-86-5 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-603-00-3 | lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate | 429-730-1 | 193562-37-7 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-604-00-9 | guanidinium benzoate | 429-820-0 | 26739-54-8 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 607-605-00-4 | methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate | 429-890-2 | 144550-06-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-606-00-X | (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid | 430-100-3 | 86978-24-7 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 607-607-00-5 | reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol | 430-180-1 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-608-00-0 | pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate | 430-210-1 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-609-00-6 | ethyl (3R)-4-cyano-3-hydroxybutanoate | 430-220-6 | 141942-85-0 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-610-00-1 | trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate | 430-280-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-611-00-7 | methyl 3-amino-2,2,3-trimethylbutyrate | 431-720-7 | 90886-53-6 | Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 | H314 H302 H412 | GHS05 GHS07 Gef. | H314 H302 H412 | |||
| 607-612-00-2 | reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate | 432-190-1 | 182176-52-9 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 | H302 H373** H318 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 | |||
| 607-613-00-8 | reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water | 432-790-1 | | Acute Tox. 4* | H332 | GHS07 | H332 | | | |
| Acute Tox. 4* | H312 | GHS05 | H312 | |||||||
| Acute Tox. 4* | H302 | GHS08 | H302 | |||||||
| Skin Corr. 1B | H314 | Gef. | H314 | |||||||
| STOT SE 2 | H371 (Augen) | H371 (Augen) | ||||||||
| 607-614-00-3 | 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid | 426-480-5 | 63562-33-4 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 607-615-00-9 | reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance | 431-120-5 | - | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 | H331 H302 H319 H317 | GHS06 Gef. | H331 H302 H319 H317 | |||
| 607-616-00-4 | 2,4-dichloro-5-fluorobenzoylchloride | 428-390-1 | 86393-34-2 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H335 H315 H318 H317 H412 | GHS05 GHS07 Gef. | H335 H315 H318 H317 H412 | |||
| 607-617-00-X | bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate | 430-700-5 | 10138-36-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-618-00-5 | menadione sodium bisulfite; 2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | 204-987-0 | 130-37-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | |||
| 607-619-00-0 | menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | 277-543-7 | 73581-79-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | |||
| 607-620-00-6 | trisodium nitrilotriacetate | 225-768-6 | 5064-31-3 | Carc. 2 Acute Tox. 4 * Eye Irrit. 2 | H351 H302 H319 | GHS08 GHS07 Achtg. | H351 H302 H319 | Carc. 2; H351: C ≥ 5 % | ||
| 607-621-00-1 | milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | - | - | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H410 | M=100 | ||
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | 231-057-1 | 7425-14-1 | Repr. 2 | H361d*** | GHS08 Achtg. | H361d*** | |||
| 607-623-00-2 | Diisobutylphthalat | 201-553-2 | 84-69-5 | Repr. 1B | H360Df | GHS08 Gef. | H360Df | |||
| 607-624-00-8 | perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] | 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] | 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] | Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Lact. Aquatic Chronic 2 | H351 H360D*** H372** H332 H302 H362 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360D*** H372** H332 H302 H362 H411 | |||
| 607-625-00-3 | clodinafop-propargyl (ISO) | - | 105512-06-9 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H317 H410 | Skin Sens. 1; H317: C ≥ 0,001 % M=1 | ||
| 607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | 401-290-5 | 103112-35-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | 416-360-0 | 162221-28-5 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-628-00-X | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | 419-240-6 | 171054-89-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | 419-270-1 | 123599-82-6 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | 419-560-6 | 4369-14-6 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H332 H314 H317 H412 | GHS05 GHS07 Gef. | H332 H314 H317 H412 | |||
| 607-631-00-6 | reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | 442-300-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | 420-210-1 | 111244-14-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | 440-480-2 | 341026-59-3 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-634-00-2 | (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate | 420-610-4 | 36394-75-9 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | H302 H314 H317 | GHS05 GHS07 Gef. | H302 H314 H317 | |||
| 607-635-00-8 | trisodium N-(3-propionato)-l-aspartate | 422-090-4 | 172737-80-3 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-636-00-3 | 1-bromo-2-methylpropyl propionate | 422-900-6 | 158894-67-8 | Flam. Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 | H226 H351 H314 H317 | GHS02 GHS05 GHS08 GHS07 Gef. | H226 H351 H314 H317 | |||
| 607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | 423-730-5 | 250688-43-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | 431-090-3 | 190085-41-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | 431-770-1 | 216698-07-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid | 431-930-9 | 43028-69-9 | Acute Tox. 4 * Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | 432-210-7 | 141631-22-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 607-643-00-1 | dimethyl (2S)-2-hydroxysuccinate | 432-310-0 | 617-55-0 | Flam. Liq. 3 Eye Dam. 1 Skin Sens. 1 | H226 H318 H317 | GHS02 GHS05 GHS07 Gef. | H226 H318 H317 | |||
| 607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | 432-350-9 | 81752-87-6 | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | 432-550-6 | 243858-01-7 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-646-00-8 | d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 432-960-5 | 124655-09-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane | 433-530-1 | 143446-73-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 | H302 H317 H400 | GHS07 GHS09 Achtg. | H302 H317 H400 | |||
| 607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | 433-690-0 | 167678-46-8 | Skin Corr. 1A Skin Sens. 1 | H314 H317 | GHS05 GHS07 Gef. | H314 H317 | |||
| 607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | 433-910-5 | 145153-52-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | 434-360-9 | 91125-43-8 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-652-00-0 | ethyl N 2-dodecanoyl-l-argininate hydrochloride | 434-630-6 | 60372-77-2 | Eye Dam. 1 Aquatic Acute 1 | H318 H400 | GHS05 GHS09 Gef. | H318 H400 | |||
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | 434-840-8 | 225786-91-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-654-00-1 | (S)-3-hydroxy-γ-butyrolactone | 434-990-4 | 7331-52-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-655-00-7 | ethyl 6,8-dichlorooctanoate | 435-080-1 | 1070-64-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | 435-350-7 | 141250-43-3 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 436-920-8 | 172399-10-9 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | 440-770-9 | 371921-63-0 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-659-00-9 | pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | 442-030-0 | 321912-47-4 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | 442-230-8 | 321679-52-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 607-661-00-X | 1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate | 442-850-9 | 114772-40-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | 442-860-3 | 87333-22-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | 442-980-6 | 127474-91-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | 443-120-2 | 393509-79-0 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 607-665-00-1 | trans-methyl-2-ethyl-but-2-enoate | 443-150-6 | 101226-85-1 | Flam. Liq. 3 | H226 | GHS02 Achtg. | H226 | |||
| 607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | 443-560-5 | 88784-33-2 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | 444-950-8 | 99464-83-2 | Muta. 2 Skin Sens. 1 | H341 H317 | GHS08 GHS07 Achtg. | H341 H317 | |||
| 607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxane | 445-770-2 | 42031-28-7 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | 445-990-9 | 376588-17-9 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | 448-700-9 | 500791-70-8 | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373** H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H373** H318 H317 H410 | M=10 | ||
| 607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | 417-310-0 | 72903-27-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-672-00-X | reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | 419-000-0 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | 419-570-0 | - | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 607-675-00-6 | reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid | 422-260-8 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 607-676-00-1 | reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | 423-670-1 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate | 424-660-8 | - | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 | H373** H318 H317 | GHS05 GHS08 GHS07 Gef. | H373** H318 H317 | |||
| 607-678-00-2 | reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | 427-090-8 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-679-00-8 | reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) | 431-440-5 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | 432-810-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-681-00-9 | reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate | 432-910-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-682-00-4 | complex reaction mass of Chinese gum rosin post reacted with acrylic acid | 434-230-1 | 144413-22-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-683-00-X | reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | 435-450-0 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 607-684-00-5 | alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | 435-660-2 | 243662-67-1 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | 441-050-7 | - | Skin Irrit. 2 Eye Dam. 1 | H315 H318 | GHS05 Gef. | H315 H318 | |||
| 607-686-00-6 | 6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | 441-550-5 | - | Self-react.
C **** Carc. 2 | H242 H351 | GHS02 GHS08 Gef. | H242 H351 | |||
| 607-687-00-1 | reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) | 442-800-6 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | 444-320-2 | - | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 607-689-00-2 | reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate ("para-isomer" including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" including cis- and trans-isomers) | 444-920-4 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-690-00-8 | dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate | 432-860-1 | 255387-46-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 607-691-00-3 | magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 448-690-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-692-00-9 | zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 446-470-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | 443-860-6 | 302776-68-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | 443-870-0 | 163520-33-0 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 607-696-00-0 | pentyl formate | 211-340-6 | 638-49-3 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 | H226 H319 H335 | GHS02 GHS07 Gef. | H226 H319 H335 | C | ||
| 607-697-00-6 | tert-butyl propionate | - | 20487-40-5 | Flam. Liq. 2 | H225 | GHS02 Gef. | H225 | C | ||
| 607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | Repr. 1B STOT RE 1 Acute Tox. 4 | H360F H372 H302 | GHS07 GHS08 Gef. | H360F H372 H302 | |||
| 607-699-00-7 | bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate | | 82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | | M = 10000 M = 100000 | |
| Acute Tox. 3 | H331 | GHS08 | H331 | |||||||
| Acute Tox. 2 | H300 | GHS09 | H300 | |||||||
| STOT RE 1 | H372 (Nerven-system) | Gef. | H372 (Nerven-system) | |||||||
| Skin Sens. 1B | H317 | H317 | ||||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 607-700-00-0 | indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] | | 173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | M = 1 M = 1 | | |
| Acute Tox. 4 | H332 | GHS08 | H332 | |||||||
| STOT RE 1 | H372 (Blut, Nervensystem, Herz) | GHS09 | H372 (Blut, Nervensystem, Herz) | |||||||
| Skin Sens. 1B | H317 | Gef. | H317 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] | 144171-61-9 [2] | |||||||||
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | |||
| 607-703-00-7 | ammoniumpentadeca-fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D | |||||||
| Lact. | H362 | GHS05 | H362 | |||||||
| Acute Tox. 4 | H332 | Gef. | H332 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 (Leber) | H372 (Leber) | ||||||||
| Eye Dam.1 | H318 | H318 | ||||||||
| 607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D | |||||||
| Lact. | H362 | GHS05 | H362 | |||||||
| Acute Tox. 4 | H332 | Gef. | H332 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 (Leber) | H372 (Leber) | ||||||||
| Eye Dam. 1 | H318 | H318 | ||||||||
| 607-705-00-8 | benzoic acid | 200-618-2 | 65-85-0 | STOT RE 1 Skin Irrit. 2 Eye Dam. 1 | H372 (Lunge) (Einatmen) H315 H318 | GHS08 GHS05 Gef. | H372 (Lunge) (Einatmen) H315 H318 | |||
| 607-706-00-3 | methyl 2,5-dichlorobenzoate | 220-815-7 | 2905-69-3 | Acute Tox. 4 STOT SE 3 Aquatic Chronic 2 | H302 H336 H411 | GHS07 GHS09 Achtg. | H302 H336 H411 | |||
| 607-707-00-9 | Fenoxaprop-P-ethyl (ISO); Ethyl (2R)-2-{4-[(6-chlor-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoat | - | 71283-80-2 | STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (Nieren) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 (Nieren) H317 H410 | M = 1 M = 1 | ||
| 607-708-00-4 | Octansäure | 204-677-5 | 124-07-2 | Skin Corr. 1C Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 607-709-00-X | Decansäure | 206-376-4 | 334-48-5 | Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 | H315 H319 H412 | GHS07 Achtg. | H315 H319 H412 | |||
| 607-710-00-5 | 1,2-Benzoldicarbonsäure, Dihexylester, verzweigt und linear | 271-093-5 | 68515-50-4 | Repr. 1B | H360FD | GHS08 Gef. | H360FD | |||
| 607-711-00-0 | Spirotetramat (ISO); (5s,8s)-3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-ylethylcarbonat | - | 203313-25-1 | Repr. 2 STOT SE 3 Eye Irrit. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 | H361fd H335 H319 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361fd H335 H319 H317 H410 | M = 1 M = 1 | ||
| 607-712-00-6 | Dodemorphacetat; 4-Cyclododecyl-2,6-dimethylmorpholin-4-ium acetat | 250-778-2 | 31717-87-0 | Repr. 2 STOT RE 2 Skin Corr. 1C Skin Sens. 1A Aquatic Chronic 1 | H361d H373 (Leber) H314 H317 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H361d H373 (Leber) H314 H317 H410 | EUH071 | M = 1 | |
| 607-713-00-1 | Fenpyroximat (ISO); Tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylen]amino}oxy)methyl]benzoat | - | 134098-61-6 | Acute Tox. 3 Acute Tox. 2 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 | H301 H330 H317 H400 H410 | GHS06 GHS09 Gef. | H301 H330 H317 H410 | M = 100 M = 1 000 | ||
| 607-714-00-7 | Triflusulfuron-methyl; Methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoat | - | 126535-15-7 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | M = 100 M = 10 | ||
| 607-715-00-2 | Bifenazat (ISO); Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazincarboxylat | 442-820-5 | 149877-41-8 | STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 H317 H410 | M = 1 M = 1 | ||
| 607-716-00-8 | Bromadiolon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-on | 249-205-9 | 28772-56-7 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,005 % STOT RE 2; H373 (Blut): 0,0005 % ≤ C < 0,005 % M = 1 M = 1 | ||
| 607-717-00-3 | Difethialon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-on | - | 104653-34-1 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H330 H310 H300 H372 (Blut) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H330 H310 H300 H372 (Blut) H410 | EUH070 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 100 M = 100 | |
| 607-718-00-9 | Perfluornonan-1-säure [1] und ihre Natrium- [2] und Ammoniumsalze [3] | 206-801-3 [1] [2] [3] | 375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3] | Carc. 2 Repr. 1B Lakt. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam. 1 | H351 H360Df H362 H332 H302 H372 (Leber, Thymus, Milz) H318 | GSH08 GSH07 GHS05 Gef. | H351 H360Df H362 H332 H302 H372 (Leber, Thymus, Milz) H318 | |||
| 607-719-00-4 | Dicyclohexylphthalat | 201-545-9 | 84-61-7 | Repr. 1B Skin Sens. 1 | H360D H317 | GHS08 GHS07 Gef. | H360D H317 | |||
| 607-720-00-X | Nonadecafluordecansäure; [1] Ammoniumnonadecafluordecanoat; [2] Natriumnonadecafluordecanoat [3] | 206-400-3 [1] 221-470-5 [2] [3] | 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] | Carc. 2 Repr. 1B Lact. | H351 H360Df H362 | GHS08 Gef. | H351 H360Df H362 | |||
| 607-721-00-5 | N,N'-Methylendimorpholin; N,N'-Methylenbismorpholin; [aus N,N2-Methylenbismorpholin freigesetztes Formaldehyd]; [MBM] | 227-062-3 | 5625-90-1 | Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Eye Dam.1 | H350 H341 H332 H312 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 H318 | GHS08 GHS07 GHS05 Gef. | H350 H341 H332 H312 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 | EUH071 | 8 9 | |
| 607-722-00-0 | 2,3,5,6-Tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyanoprop- 1-enyl)-2,2-dimethylcyclopropancarboxylat; Epsilon-momfluorothrin | - | 1065124-65-3 | Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H371 (Nervensystem) H400 H410 | GHS07 GHS08 GHS09 Achtg. | H302 H371 (Nervensystem) H410 | M = 100 M = 100 | ||
| 607-723-00-6 | Tefluthrin (ISO); 2,3,5,6-Tetrafluor-4-methylbenzyl-(1RS,3RS)-3- [(Z)-2-chlor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropancarboxylat | - | 79538-32-2 | Acute Tox. 1 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | M = 10.000 M = 10.000 | ||
| 608-001-00-3 | acetonitrile; cyanomethane | 200-835-2 | 75-05-8 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 | H225 H332 H312 H302 H319 | GHS02 GHS07 Gef. | H225 H332 H312 H302 H319 | |||
| 608-002-00-9 | trichloroacetonitrile | 208-885-7 | 545-06-2 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H331 H311 H301 H411 | GHS06 GHS09 Gef. | H331 H311 H301 H411 | |||
| 608-003-00-4 | acrylonitrile | 203-466-5 | 107-13-1 | Flam. Liq. 2 Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 | (*) | D | |
| 608-004-00-X | 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin | 200-909-4 | 75-86-5 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H310 H300 H410 | |||
| 608-005-00-5 | n-butyronitrile | 203-700-6 | 109-74-0 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H225 H331 H311 H301 | GHS02 GHS06 Gef. | H225 H331 H311 H301 | |||
| 608-006-00-0 | bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol | 216-882-7 | 1689-84-5 | Repr. 2 Acute Tox. 2 (*) Acute Tox. 3 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H330 H301 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H330 H301 H317 H410 | M=10 | ||
| 608-007-00-6 | ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile | 216-881-1 | 1689-83-4 | Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H410 | M=10 | ||
| 608-008-00-1 | chloroacetonitrile | 203-467-0 | 107-14-2 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H331 H311 H301 H411 | GHS06 GHS09 Gef. | H331 H311 H301 H411 | |||
| 608-009-00-7 | malononitrile | 203-703-2 | 109-77-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | |||
| 608-010-00-2 | methacrylonitrile; 2-methyl-2-propene nitrile | 204-817-5 | 126-98-7 | Flam. Liq. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Sens. 1 | H225 H331 H311 H301 H317 | GHS02 GHS06 Gef. | H225 H331 H311 H301 H317 | (*) Skin Sens. 1; H317: C ≥ 0,2 % | D | |
| 608-011-00-8 | oxalonitrile; cyanogen | 207-306-5 | 460-19-5 | Press.
Gas Flam. Gas 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H220 H331 H400 H410 | GHS02 GHS04 GHS06 GHS09 Gef. | H220 H331 H410 | U | ||
| 608-012-00-3 | benzonitrile | 202-855-7 | 100-47-0 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H312 H302 | GHS07 Achtg. | H312 H302 | |||
| 608-013-00-9 | 2-chlorobenzonitrile | 212-836-5 | 873-32-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 | H312 H302 H319 | GHS07 Achtg. | H312 H302 H319 | |||
| 608-014-00-4 | chlorothalonil (ISO); tetrachloroisophthalonitrile | 217-588-1 | 1897-45-6 | Carc. 2 Acute Tox. 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H330 H335 H318 H317 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H351 H330 H335 H318 H317 H410 | M=10 | ||
| 608-015-00-X | dichlobenil (ISO); 2,6-dichlorobenzonitrile | 214-787-5 | 1194-65-6 | Acute Tox. 4 (*) Aquatic Chronic 2 | H312 H411 | GHS07 GHS09 Achtg. | H312 H411 | |||
| 608-016-00-5 | 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene | 401-550-8 | 1897-41-2 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 608-017-00-0 | bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate | 216-885-3 | 1689-99-2 | Repr. 2 Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H331 H302 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H331 H302 H317 H410 | M=10 | ||
| 608-018-00-6 | ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate | 223-375-4 | 3861-47-0 | Repr. 2 Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H301 H319 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H301 H319 H317 H410 | M=10 | ||
| 608-019-00-1 | 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN | 201-132-3 | 78-67-1 | Self-react.
C Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 3 | H242 H332 H302 H412 | GHS02 GHS07 Gef. | H242 H332 H302 H412 | T | ||
| 608-020-00-7 | diphenoxymethylenecyanamide | 427-300-8 | 79463-77-7 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 608-021-00-2 | 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile | 403-710-2 | 76823-93-3 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 608-022-00-8 | 3,7-dimethyloctanenitrile | 403-620-3 | 40188-41-8 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H315 H317 H411 | GHS07 GHS09 Achtg. | H315 H317 H411 | |||
| 608-023-00-3 | fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile | 406-140-2 | 114369-43-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 608-024-00-9 | 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile | 407-650-8 | 97460-76-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-025-00-4 | 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile | 410-970-0 | 117568-27-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-026-00-X | 3-cyano-3,5,5-trimethylcyclohexanone | 411-490-4 | 7027-11-4 | Acute Tox. 4 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 | H302 H373 (*)(*) H317 H412 | GHS08 GHS07 Achtg. | H302 H373 (*)(*) H317 H412 | |||
| 608-027-00-5 | reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile | 412-660-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-028-00-0 | 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate | 413-510-7 | 147374-67-2 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H373 (*)(*) H317 H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H317 H411 | |||
| 608-029-00-6 | 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile | 411-990-2 | 68612-94-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 608-030-00-1 | N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide | 412-340-0 | 147741-93-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 608-031-00-7 | 2-benzyl-2-methyl-3-butenitrile | 407-870-4 | 97384-48-0 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 608-032-00-2 | acetamiprid (ISO); (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine | - | 135410-20-7 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 608-033-00-8 | N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide | 407-970-8 | 75511-91-0 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 608-034-00-3 | chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile | - | 122453-73-0 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H400 H410 | GHS06 GHS09 Gef. | H331 H302 H410 | M=100 | ||
| 608-035-00-9 | (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile | 419-290-9 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 608-036-00-4 | 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile | 419-060-8 | 79026-02-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-037-00-X | reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile | 422-190-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | ||||
| 608-038-00-5 | 2,2,4-trimethyl-4-phenyl-butane-nitrile | 422-580-8 | 75490-39-0 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 608-039-00-0 | 2-phenylhexanenitrile | 423-460-8 | 3508-98-3 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 608-040-00-6 | 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) | 423-490-1 | 130755-46-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 608-041-00-1 | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | 423-500-4 | 138401-24-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | 421-810-4 | 194602-27-2 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 608-043-00-2 | 3-(cis-3-hexenyloxy)propanenitril | 415-220-6 | 142653-61-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H400 H410 | GHS06 GHS09 Gef. | H331 H302 H410 | |||
| 608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | 423-740-1 | 10461-98-0 | Acute Tox. 4 * Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 608-046-00-9 | 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile | 425-310-7 | 77889-90-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-047-00-4 | 2-piperidin-1-yl-benzonitrile | 427-330-1 | 72752-52-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-048-00-X | 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile | 427-450-4 | 152630-47-2 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 | H302 H373** H317 H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H317 H411 | |||
| 608-049-00-5 | 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile | 429-180-2 | 157362-53-3 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 608-050-00-0 | reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile | 429-760-5 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-051-00-6 | (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-760-2 | 219861-18-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 608-052-00-1 | (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-770-7 | 128173-52-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 608-053-00-7 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-780-1 | 103146-25-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 608-054-00-2 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate | 430-790-6 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 608-055-00-8 | Fipronil (ISO); (±)-5-Amino-1-(2,6-dichlor-α,α,α-trifluor-p-tolyl)-4-trifluormethylsulfinylpyrazol-3-carbonitril | 424-610-5 | 120068-37-3 | Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H311 H331 H372* H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H311 H331 H372* H410 | M = 1 000 M = 10 000 | ||
| 608-056-00-3 | N-methyl-N-cyanomethylmorpholiniummethylsulfate | 429-340-1 | - | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 608-057-00-9 | 4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate | 431-200-1 | 208538-34-5 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 | H302 H318 H317 | GHS05 GHS07 Gef. | H302 H318 H317 | |||
| 608-058-00-4 | esfenvalerate (ISO); (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate | - | 66230-04-4 | Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H317 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H317 H410 | M = 10000 | ||
| 608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | 421-240-6 | 120068-79-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | 421-300-1 | 138564-59-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | 422-810-7 | 82380-18-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | 441-070-6 | 61826-76-4 | Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H318 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H301 H318 H317 H410 | |||
| 608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | 433-720-2 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 608-065-00-2 | salts of bromoxynil with the exception of those specified elsewhere in this Annex | - | - | Repr. 2 Acute Tox. 2 (*) Acute Tox. 3 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H330 H301 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H330 H301 H317 H410 | M=10 | A | |
| 608-066-00-8 | salts of ioxynil with the exception of those specified elsewhere in this Annex | - | - | Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H400 H410 | GHS06 GHS08 GHS09 Gef. | H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H410 | M=10 | A | |
| 608-067-00-3 | 3,7-Dimethylocta-2,6-diennitril | 225-918-0 | 5146-66-7 | Muta. 1B | H340 | GHS08 Gef. | H340 | |||
| 609-001-00-6 | 1-nitropropane | 203-544-9 | 108-03-2 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H226 H332 H312 H302 | GHS02 GHS07 Achtg. | H226 H332 H312 H302 | (*) | ||
| 609-002-00-1 | 2-nitropropane | 201-209-1 | 79-46-9 | Flam. Liq. 3 Carc. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) | H226 H350 H332 H302 | GHS02 GHS08 GHS07 Gef. | H226 H350 H332 H302 | |||
| 609-003-00-7 | nitrobenzene | 202-716-0 | 98-95-3 | Carc. 2. | H351 | GHS06 | H351 | | | |
| Repr. 1B | H360F | GHS08 | H360F | |||||||
| Acute Tox. 3 | H301 | Gef. | H301 | |||||||
| Acute Tox. 3 | H331 | H331 | ||||||||
| Acute Tox. 3 | H311 | H311 | ||||||||
| STOT RE 1 | H372 (Blut) | H372 (Blut) | ||||||||
| Aquatic Chronic 3 | H412 | H412 | ||||||||
| 609-004-00-2 | dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] | 246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] | 25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 (*)(*) H410 | |||
| 609-005-00-8 | 1,3,5-trinitrobenzene | 202-752-7 | 99-35-4 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H201 H330 H310 H300 H373** H400 H410 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H330 H310 H300 H373** H410 | |||
| 609-006-00-3 | 4-nitrotoluene | 202-808-0 | 99-99-0 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | |||
| 609-007-00-9 | 2,4-dinitrotoluene; [1] dinitrotoluene [2] | 204-450-0 [1] 246-836-1 [2] | 121-14-2 [1] 25321-14-6 [2] | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H361f*** H331 H311 H301 H373** H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f*** H331 H311 H301 H373** H410 | |||
| 609-008-00-4 | 2,4,6-trinitrotoluene; TNT | 204-289-6 | 118-96-7 | Expl. 1.1 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H201 H331 H311 H301 H373 (*)(*) H411 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H331 H311 H301 H373 (*)(*) H411 | |||
| 609-009-00-X | 2,4,6-trinitrophenol; picric acid | 201-865-9 | 88-89-1 | Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | H201 H331 H311 H301 | GHS01 GHS06 Gef. | H201 H331 H311 H301 | |||
| 609-010-00-5 | salts of picric acid | - | - | Unst. Expl Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) | H201 H331 H311 H301 | GHS01 GHS06 Gef. | H201 H331 H311 H301 | T | ||
| 609-011-00-0 | 2,4,6-trinitroanisole | - | 606-35-9 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 2 | H201 H332 H312 H302 H411 | GHS01 GHS07 GHS09 Achtg. | H201 H332 H312 H302 H411 | |||
| 609-012-00-6 | 2,4,6-trinitro-m-cresol | 210-027-1 | 602-99-3 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H201 H332 H312 H302 | GHS01 GHS07 Achtg. | H201 H332 H312 H302 | |||
| 609-013-00-1 | 2,4,6-trinitro-m-xylene | 211-187-5 | 632-92-8 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) | H201 H332 H312 H302 H373 (*)(*) | GHS01 GHS08 GHS07 Achtg. | H201 H332 H312 H302 H373 (*)(*) | |||
| 609-015-00-2 | 4-nitrophenol; p-nitrophenol | 202-811-7 | 100-02-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) | H332 H312 H302 H373 (*)(*) | GHS08 GHS07 Achtg. | H332 H312 H302 H373 (*)(*) | |||
| 609-016-00-8 | dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] | 247-096-2 [1] 275-732-9 [2] | 25550-58-7 [1] 71629-74-8 [2] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | |||
| 609-018-00-9 | 2,4,6-trinitroresorcinol; styphnic acid | 201-436-6 | 82-71-3 | Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H201 H332 H312 H302 | GHS01 GHS07 Gef. | H201 H332 H312 H302 | |||
| 609-019-00-4 | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate | 239-290-0 | 15245-44-0 | Unst. Expl Repr. 1A Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H200 H360Df H332 H302 H373 (*)(*) H400 H410 | GHS01 GHS08 GHS07 GHS09 Gef. | H200 H360Df H332 H302 H373 (*)(*) H410 | 1 | ||
| 609-019-01-1 | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser) | 239-290-0 | 15245-44-0 | Expl. 1.1 Repr. 1A Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H201 H360Df H332 H302 H373 (*)(*) H400 H410 | GHS01 GHS08 GHS07 GHS09 Gef. | H201 H360Df H332 H302 H373 (*)(*) H410 | 1 | ||
| 609-020-00-X | DNOC (ISO); 4,6-dinitro-o-cresol | 208-601-1 | 534-52-1 | Muta. 2 Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H330 H310 H300 H315 H318 H317 H400 H410 | GHS06 GHS08 GHS05 GHS07 GHS09 Gef. | H341 H330 H310 H300 H315 H318 H317 H410 | EUH044 | ||
| 609-021-00-5 | sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] | 219-007-7 [1] [2] | 2312-76-7 [1] 5787-96-2 [2] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | |||
| 609-022-00-0 | ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide | 221-037-0 | 2980-64-5 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H310 H300 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 (*)(*) H410 | |||
| 609-023-00-6 | dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups | 254-408-0 | 39300-45-3 | Repr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D*** H332 H302 H373** H315 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H360D*** H332 H302 H373** H315 H317 H410 | M=100 | ||
| 609-024-00-1 | binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate | 207-612-9 | 485-31-4 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H360D (*)(*)(*) H312 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H360D (*)(*)(*) H312 H302 H410 | |||
| 609-025-00-7 | dinoseb(ISO); 6-sec-butyl-2,4-dinitrophenol | 201-861-7 | 88-85-7 | Repr. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H360Df H311 H301 H319 H400 H410 | GHS06 GHS08 GHS09 Gef. | H360Df H311 H301 H319 H410 | EUH044 | ||
| 609-026-00-2 | salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | - | - | Repr. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H360Df H311 H301 H319 H400 H410 | GHS06 GHS08 GHS09 Gef. | H360Df H311 H301 H319 H410 | EUH044 | A | |
| 609-027-00-8 | dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate | - | 63919-26-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 609-028-00-3 | dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol | 205-042-5 | 131-89-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | |||
| 609-029-00-9 | salts and esters of dinex | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | A | ||
| 609-030-00-4 | dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol | 215-813-8 | 1420-07-1 | Repr. 1B Acute Tox. 2 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H360D (*)(*)(*) H300 H311 H400 H410 | GHS06 GHS08 GHS09 Gef. | H360D (*)(*)(*) H300 H311 H410 | EUH044 | ||
| 609-031-00-X | salts and esters of dinoterb | - | - | Repr. 1B Acute Tox. 2 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H360D (*)(*)(*) H300 H311 H400 H410 | GHS06 GHS08 GHS09 Gef. | H360D (*)(*)(*) H300 H311 H410 | A | ||
| 609-032-00-5 | bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime | 236-129-6 | 13181-17-4 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 609-033-00-0 | dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol | - | 4097-36-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | |||
| 609-034-00-6 | salts and esters of dinosam | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H410 | A | ||
| 609-035-00-1 | nitroethane | 201-188-9 | 79-24-3 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) | H226 H332 H302 | GHS02 GHS07 Achtg. | H226 H332 H302 | (*) | ||
| 609-036-00-7 | nitromethane | 200-876-6 | 75-52-5 | Flam. Liq. 3 Acute Tox. 4 (*) | H226 H302 | GHS02 GHS07 Achtg. | H226 H302 | (*) | ||
| 609-037-00-2 | 5-nitroacenaphthene | 210-025-0 | 602-87-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 609-038-00-8 | 2-nitronaphthalene | 209-474-5 | 581-89-5 | Carc. 1B Aquatic Chronic 2 | H350 H411 | GHS08 GHS09 Gef. | H350 H411 | |||
| 609-039-00-3 | 4-nitrobiphenyl | 202-204-7 | 92-93-3 | Carc. 1B Aquatic Chronic 2 | H350 H411 | GHS08 GHS09 Gef. | H350 H411 | |||
| 609-040-00-9 | nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether | 217-406-0 | 1836-75-5 | Carc. 1B Repr. 1B Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H360D (*)(*)(*) H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H360D (*)(*)(*) H302 H410 | |||
| 609-041-00-4 | 2,4-dinitrophenol | 200-087-7 | 51-28-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 | H331 H311 H301 H373 (*)(*) H400 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H400 | |||
| 609-042-00-X | pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine | 254-938-2 | 40487-42-1 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 609-043-00-5 | quintozene (ISO); pentachloronitrobenzene | 201-435-0 | 82-68-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 609-044-00-0 | tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene | 204-178-2 | 117-18-0 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 609-045-00-6 | reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 | - | 8069-76-9 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 609-046-00-1 | trifluralin (ISO) (containing < 0,5 ppm NPDA); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA) | 216-428-8 | 1582-09-8 | Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H317 H410 | M=10 | ||
| 609-047-00-7 | 2-nitroanisole | 202-052-1 | 91-23-6 | Carc. 1B Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | |||
| 609-048-00-2 | sodium 3-nitrobenzenesulphonate | 204-857-3 | 127-68-4 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 609-049-00-8 | 2,6-dinitrotoluene | 210-106-0 | 606-20-2 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 | |||
| 609-050-00-3 | 2,3-dinitrotoluene | 210-013-5 | 602-01-7 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H410 | |||
| 609-051-00-9 | 3,4-dinitrotoluene | 210-222-1 | 610-39-9 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 | |||
| 609-052-00-4 | 3,5-dinitrotoluene | 210-566-2 | 618-85-9 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 | |||
| 609-053-00-X | hydrazine-trinitromethane | 414-850-9 | - | Expl. 1.1 (*)(*)(*)(*) Self-react. A Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Sens. 1 | H201 H240 H350 H331 H301 H317 | GHS01 GHS06 GHS08 Gef. | H201 H240 H350 H331 H301 H317 | |||
| 609-054-00-5 | 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] | 200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4] [5] | 66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4] [5] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | |||
| 609-055-00-0 | 2,5-dinitrotoluene | 210-581-4 | 619-15-8 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 | |||
| 609-056-00-6 | 2,2-dibromo-2-nitroethanol | 412-380-9 | 69094-18-4 | Expl. 1.1 Carc. 2 Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H201 H351 H302 H373 (*)(*) H314 H317 H400 H410 | GHS01 GHS08 GHS05 GHS07 GHS09 Gef. | H201 H351 H302 H373 (*)(*) H314 H317 H410 | (*) STOT SE 3; H335: C ≥ 1 % | T | |
| 609-057-00-1 | 3-chloro-2,4-difluoronitrobenzene | 411-980-8 | 3847-58-3 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H317 H410 | |||
| 609-058-00-7 | 2-nitro-2-phenyl-1,3-propanediol | 410-360-4 | 5428-02-4 | STOT RE 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H372 (*)(*) H312 H302 H317 H411 | GHS08 GHS07 GHS09 Gef. | H372 (*)(*) H312 H302 H317 H411 | EUH070 | ||
| 609-059-00-2 | 2-chloro-6-(ethylamino)-4-nitrophenol | 411-440-1 | 131657-78-8 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 609-060-00-8 | 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 406-305-9 | 92952-81-3 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 609-061-00-3 | (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime | 406-100-4 | 94097-88-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 609-062-00-9 | 2-bromo-2-nitropropanol | 407-030-7 | 24403-04-1 | Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H311 H302 H373 (*)(*) H314 H317 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H311 H302 H373 (*)(*) H314 H317 H410 | |||
| 609-063-00-4 | 2-[(4-chloro-2-nitrophenyl)amino]ethanol | 413-280-8 | 59320-13-7 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 609-064-00-X | mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione | - | 104206-82-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 609-065-00-5 | 2-nitrotoluene | 201-853-3 | 88-72-2 | Carc. 1B Muta. 1B Repr. 2 Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H340 H361f (*)(*)(*) H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H340 H361f (*)(*)(*) H302 H411 | |||
| 609-067-00-6 | sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine | 416-280-6 | 156769-97-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 609-068-00-1 | musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene | 201-329-4 | 81-15-2 | Expl. 1.1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H201 H351 H400 H410 | GHS01 GHS08 GHS09 Achtg. | H201 H351 H410 | T | ||
| 609-069-00-7 | musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone | 201-328-9 | 81-14-1 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 609-070-00-2 | 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene | 415-580-4 | 130841-23-5 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 609-071-00-8 | reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol | 423-520-3 | 156137-33-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 609-072-00-3 | 4-mesyl-2-nitrotoluene | 430-550-0 | 1671-49-4 | Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 | H361f*** H302 H317 H412 | GHS08 GHS07 Achtg. | H361f*** H302 H317 H412 | |||
| 609-073-00-9 | lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine | 427-850-9 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 610-001-00-3 | trichloronitromethane; chloropicrin | 200-930-9 | 76-06-2 | Acute Tox. 2 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H330 H302 H319 H335 H315 | GHS06 Gef. | H330 H302 H319 H335 H315 | |||
| 610-002-00-9 | 1,1-dichloro-1-nitroethane | 209-854-0 | 594-72-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | |||
| 610-003-00-4 | chlorodinitrobenzene | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | C | ||
| 610-004-00-X | 2-chloro-1,3,5-trinitrobenzene | 201-864-3 | 88-88-0 | Expl. 1.1 Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H201 H330 H310 H300 H400 H410 | GHS01 GHS06 GHS09 Gef. | H201 H330 H310 H300 H410 | |||
| 610-005-00-5 | 1-chloro-4-nitrobenzene | 202-809-6 | 100-00-5 | Carc. 2 Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H351 H341 H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H351 H341 H331 H311 H301 H373 (*)(*) H411 | |||
| 610-006-00-0 | chloronitroanilines with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Chronic 2 | H330 H310 H300 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 (*)(*) H411 | A C | ||
| 610-007-00-6 | 1-chloro-1-nitropropane | 209-990-0 | 600-25-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H302 | GHS07 Achtg. | H332 H302 | (*) | ||
| 610-008-00-1 | 2,6-dichloro-4-nitroanisole | 403-350-6 | 17742-69-7 | Acute Tox. 3 (*) Aquatic Chronic 2 | H301 H411 | GHS06 GHS09 Gef. | H301 H411 | |||
| 610-009-00-7 | 2-chloro-4-nitroaniline | 204-502-2 | 121-87-9 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 610-010-00-2 | 2-bromo-1-(2-furyl)-2-nitroethylene | 406-110-9 | 35950-52-8 | Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 (*)(*) H314 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H302 H373 (*)(*) H314 H317 H410 | |||
| 611-001-00-6 | azobenzene | 203-102-5 | 103-33-3 | Carc. 1B Muta. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H332 H302 H373 (*)(*) H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H341 H332 H302 H373 (*)(*) H410 | |||
| 611-002-00-1 | azoxybenzene | 207-802-1 | 495-48-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H302 | GHS07 Achtg. | H332 H302 | |||
| 611-003-00-7 | fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate | 205-419-4 | 140-56-7 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Chronic 3 | H301 H312 H412 | GHS06 Gef. | H301 H312 H412 | |||
| 611-004-00-2 | methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate | 209-765-7 | 592-62-1 | Carc. 1B Repr. 1B | H350 H360D (*)(*)(*) | GHS08 Gef. | H350 H360D (*)(*)(*) | |||
| 611-005-00-8 | disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-); CI Direct Brown 95 | 240-221-1 | 16071-86-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 611-006-00-3 | 4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene | 202-591-2 | 97-56-3 | Carc. 1B Skin Sens. 1 | H350 H317 | GHS08 Gef. | H350 H317 | |||
| 611-007-00-9 | tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole; | 255-559-5 | 41814-78-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 611-008-00-4 | 4-aminoazobenzene; 4-phenylazoaniline | 200-453-6 | 60-09-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 611-009-00-X | sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) | 401-220-3 | - | Acute Tox. 4 (*) Aquatic Chronic 3 | H332 H412 | GHS07 Achtg. | H332 H412 | |||
| 611-010-00-5 | 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide | 403-010-7 | 106359-94-8 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 611-011-00-0 | N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate | 403-340-1 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Dg | H318 H411 | |||
| 611-012-00-6 | reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate | 403-410-1 | 114565-65-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-013-00-1 | trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate | 403-650-7 | 117409-78-6 | Expl. 1.3 (*)(*)(*)(*) Aquatic Chronic 2 | H203 H411 | GHS01 GHS09 Gef. | H203 H411 | |||
| 611-014-00-7 | (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide | 404-250-5 | 115099-55-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-015-00-2 | tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | 404-320-5 | 116889-78-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-016-00-8 | reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride | 404-540-1 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-017-00-3 | 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide | 404-910-2 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-018-00-9 | tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate | 405-130-5 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-019-00-4 | tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 405-150-4 | 106028-58-4 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-020-00-X | tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 405-170-3 | 116340-05-7 | Acute Tox. 3 (*) Skin Sens. 1 Aquatic Chronic 3 | H301 H317 H412 | GHS06 Gef. | H301 H317 H412 | |||
| 611-021-00-5 | 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate | 405-480-9 | - | Acute Tox. 4 (*) STOT RE 2 (*) Skin Irrit. 2 Aquatic Chronic 4 | H302 H373 (*)(*) H315 H413 | GHS08 GHS07 Achtg. | H302 H373 (*)(*) H315 H413 | |||
| 611-022-00-0 | 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate | 404-980-4 | - | Self-react.
C Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H242 H331 H301 H312 H373 (*)(*) H318 H317 H400 H410 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H242 H331 H301 H312 H373 (*)(*) H318 H317 H410 | T | ||
| 611-023-00-6 | disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate | 404-600-7 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-024-00-1 | Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex | - | - | Carc. 1B | H350 | GHS08 Gef. | H350 | A | ||
| 611-025-00-7 | disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38 | 217-710-3 | 1937-37-7 | Carc. 1B Repr. 2 | H350 H361d (*)(*)(*) | GHS08 Gef. | H350 H361d (*)(*)(*) | |||
| 611-026-00-2 | tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6 | 220-012-1 | 2602-46-2 | Carc. 1B Repr. 2 | H350 H361d (*)(*)(*) | GHS08 Gef. | H350 H361d (*)(*)(*) | |||
| 611-027-00-8 | disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28 | 209-358-4 | 573-58-0 | Carc. 1B Repr. 2 | H350 H361d (*)(*)(*) | GHS08 Gef. | H350 H361d (*)(*)(*) | |||
| 611-028-00-3 | C,C'-azodi(formamide) | 204-650-8 | 123-77-3 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | G | ||
| 611-029-00-9 | o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex | - | - | Carc. 1B | H350 | GHS08 Gef. | H350 | A | ||
| 611-030-00-4 | o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | - | - | Carc. 1B | H350 | GHS08 Gef. | H350 | A | ||
| 611-031-00-X | 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9 | 209-321-2 | 569-61-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 611-032-00-5 | 1,4,5,8-tetraaminoanthraquinone; C.I. Disperse Blue 1 | 219-603-7 | 2475-45-8 | Carc. 1B Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 | H350 H315 H318 H317 | GHS08 GHS05 GHS07 Gef. | H350 H315 H318 H317 | |||
| 611-033-00-0 | hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) | 400-020-3 | 82027-60-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-034-00-6 | N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide | 402-430-8 | 105076-77-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-035-00-1 | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | 403-660-1 | 107246-80-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-036-00-7 | 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate | 405-440-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-037-00-2 | 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate | 406-055-0 | 124584-00-5 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 611-038-00-8 | trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate | 406-820-9 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 611-039-00-3 | 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid | 407-050-6 | 117715-57-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-040-00-9 | 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid | 407-670-7 | 115099-58-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 611-041-00-4 | 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide | 407-680-1 | 98809-11-1 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 611-042-00-X | trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate | 411-770-6 | 136213-71-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-043-00-5 | reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) | 402-850-1 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-044-00-0 | reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) | 403-720-7 | 117527-94-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-045-00-6 | 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene | 404-830-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-046-00-1 | 4,4'-diamino-2-methylazobenzene | 407-590-2 | 43151-99-1 | Acute Tox. 3 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H373 (*)(*) H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H373 (*)(*) H317 H410 | |||
| 611-047-00-7 | reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 407-890-3 | 111381-11-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-048-00-2 | reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 407-900-6 | 111381-12-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-049-00-8 | reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) | 408-000-6 | 118658-98-3 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 | H373 (*)(*) H317 H412 | GHS08 Achtg. | H373 (*)(*) H317 H412 | |||
| 611-050-00-3 | reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate | 415-350-3 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-051-00-9 | 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride | 411-110-7 | 136213-74-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 611-052-00-4 | monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex | 400-720-9 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-053-00-X | 2,2'-azobis[2-methylpropionamidine] dihydrochloride | 221-070-0 | 2997-92-4 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 611-055-00-0 | C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide | 220-600-8 | 2832-40-8 | Carc. 2 Skin Sens. 1 | H351 H317 | GHS08 GHS07 Achtg. | H351 H317 | |||
| 611-056-00-6 | C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol | 212-668-2 | 842-07-9 | Carc. 2 Muta. 2 Skin Sens. 1 Aquatic Chronic 4 | H351 H341 H317 H413 | GHS08 GHS07 Achtg. | H351 H341 H317 H413 | |||
| 611-057-00-1 | 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile | 400-340-3 | 85136-74-9 | Carc. 1B Aquatic Chronic 4 | H350 H413 | GHS08 Achtg. | H350 H413 | |||
| 611-058-00-7 | (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate | 402-060-7 | 108225-03-2 | Carc. 1B Eye Dam. 1 Aquatic Chronic 2 | H350 H318 H411 | GHS08 GHS05 GHS09 Gef. | H350 H318 H411 | |||
| 611-059-00-2 | octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate | 412-960-1 | 148878-21-1 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 611-060-00-8 | reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid | 413-180-4 | 187285-15-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-061-00-3 | disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate | 412-530-3 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-062-00-9 | octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate | 413-550-5 | - | Skin Irrit. 2 Eye Dam. 1 | H315 H318 | GHS05 Gef. | H315 H318 | |||
| 611-063-00-4 | trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) | 413-590-3 | 164058-22-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 611-064-00-X | 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol | 410-600-8 | 124719-26-2 | STOT RE 2 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 (*)(*) H315 H410 | |||
| 611-065-00-5 | 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol | 410-610-2 | 111850-24-9 | STOT RE 2 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H319 H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 (*)(*) H319 H315 H317 H410 | |||
| 611-066-00-0 | tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | 411-540-5 | 130201-57-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 611-067-00-6 | reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate | 406-910-8 | - | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 611-068-00-1 | tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | 400-690-7 | 85665-98-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-069-00-7 | N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline | 413-380-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-070-00-2 | reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) | 405-665-4 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 611-071-00-8 | tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate | 406-073-9 | 131013-81-5 | Acute Tox. 3 (*) Aquatic Chronic 3 | H301 H412 | GHS06 Gef. | H301 H412 | |||
| 611-072-00-3 | 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride | 407-010-8 | 118208-02-9 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 611-073-00-9 | dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate | 407-310-9 | 122630-55-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-074-00-4 | reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) | 407-100-7 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-075-00-X | reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) | 406-000-0 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 611-076-00-5 | 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole | 406-280-4 | 117584-16-4 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 611-077-00-0 | dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) | 407-230-4 | 126637-70-5 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 611-078-00-6 | (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate | 407-240-9 | 159604-94-1 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-079-00-1 | disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate | 410-390-8 | 147703-64-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-080-00-7 | sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate | 410-150-2 | 147703-65-9 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-081-00-2 | tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) | 411-470-5 | 141048-13-7 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 611-082-00-8 | reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) | 407-570-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-083-00-3 | reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) | 411-560-4 | - | STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 | H372 (*)(*) H317 H411 | GHS08 GHS07 GHS09 Gef. | H372 (*)(*) H317 H411 | |||
| 611-085-00-4 | reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine | 411-880-4 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-086-00-X | monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate | 411-360-7 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-087-00-5 | reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) | 411-710-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-088-00-0 | reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate | 411-890-9 | - | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 611-089-00-6 | 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate | 411-100-2 | 136213-73-5 | STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H373 (*)(*) H317 H410 | |||
| 611-090-00-1 | 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate | 413-290-2 | 93672-52-7 | Self-react.
C Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H242 H302 H318 H317 H412 | GHS02 GHS05 GHS07 Gef. | H242 H302 H318 H317 H412 | T | ||
| 611-091-00-7 | sodium (1,0 -1,95 )/lithium (0,05 -1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate | 413-470-0 | 134595-59-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-092-00-2 | tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate | 413-210-6 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-093-00-8 | sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate | 410-770-3 | 146177-84-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-094-00-3 | reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) | 411-600-0 | 143145-93-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-095-00-9 | hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide | 412-240-7 | 89797-03-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-096-00-4 | methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate | 413-040-2 | 149850-30-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-097-00-X | reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) | 414-150-3 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-098-00-5 | tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate | 405-950-3 | 131013-83-7 | Acute Tox. 3 (*) Aquatic Chronic 3 | H301 H412 | GHS06 Gef. | H301 H412 | |||
| 611-099-00-0 | (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride | 401-500-5 | 118658-99-4 | Carc. 1B Aquatic Chronic 2 | H350 H411 | GHS08 GHS09 Gef. | H350 H411 | |||
| 611-100-00-4 | potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate | 403-810-6 | 140876-13-7 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-101-00-X | 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide | 405-200-5 | 104366-25-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-102-00-5 | reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid | 424-500-7 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-103-00-0 | trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) | 407-110-1 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 611-104-00-6 | reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate | 406-870-1 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-105-00-1 | sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate | 407-800-2 | 136213-75-7 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-106-00-7 | hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate | 410-180-6 | 157627-99-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-107-00-2 | potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate | 412-490-7 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-108-00-8 | disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate | 413-600-6 | 6527-62-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-109-00-3 | reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) | 407-710-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-110-00-9 | tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene | 408-210-8 | 124605-82-9 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-111-00-4 | disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) | 414-230-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-112-00-X | tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate | 413-070-6 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-113-00-5 | lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) | 414-280-0 | 149626-00-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-114-00-0 | lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) | 414-250-7 | 149564-66-9 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 611-115-00-6 | trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) | 414-290-5 | 149564-65-8 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 611-116-00-1 | reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | 414-620-8 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-117-00-7 | 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt | 415-100-3 | 149850-29-3 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 611-118-00-2 | sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt | 413-990-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | ||||
| 611-119-00-8 | tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | 415-400-4 | 148878-22-2 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-120-00-3 | 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt | 418-340-7 | 157707-94-3 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-121-00-9 | main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol | 417-280-9 | 30785-74-1 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 611-122-00-4 | hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel | 417-250-5 | 151436-99-6 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-123-00-X | 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate | 424-310-4 | 178452-66-9 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-124-00-5 | reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate; tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate | 424-320-9 | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | ||||
| 611-125-00-0 | reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex | 423-940-7 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 611-126-00-6 | 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride | 424-120-1 | 174514-06-8 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 611-127-00-1 | pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate | 423-790-2 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | G | ||
| 611-128-00-7 | N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt | 419-500-9 | 171599-85-2 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-129-00-2 | reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid | 418-230-9 | 163879-69-4 | Expl. 1.3 (*)(*)(*)(*) Repr. 2 STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H203 H361f (*)(*)(*) H373 (*)(*) H317 H411 | GHS01 GHS08 GHS07 GHS09 Gef. | H203 H361f (*)(*)(*) H373 (*)(*) H317 H411 | |||
| 611-130-00-8 | tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate | 418-520-5 | 183130-96-3 | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 611-131-00-3 | 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one | 420-580-2 | 151798-26-4 | Repr. 1B Aquatic Chronic 4 | H360D (*)(*)(*) H413 | GHS08 Gef. | H360D (*)(*)(*) H413 | |||
| 611-132-00-9 | pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) | 419-210-2 | 178452-71-6 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-133-00-4 | Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt | 419-260-5 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 611-134-00-X | trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex | 423-770-3 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 611-135-00-5 | reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt | 424-250-9 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-136-00-0 | 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate | 424-260-3 | - | Repr. 2 Eye Dam. 1 Aquatic Chronic 2 | H361f (*)(*)(*) H318 H411 | GHS05 GHS08 GHS09 Gef. | H361f (*)(*)(*) H318 H411 | |||
| 611-137-00-6 | 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole | 419-870-1 | 159038-16-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 611-138-00-1 | 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | 415-910-7 | 152828-25-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 611-139-00-7 | reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride | 424-510-1 | - | Eye Dam. 1 Aquatic Chronic 2 | H318 H411 | GHS05 GHS09 Gef. | H318 H411 | |||
| 611-140-00-2 | azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | - | 68049-83-2 | Repr. 1B STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H360Df H373 (*)(*) H400 H410 | GHS08 GHS09 Gef. | H360Df H373 (*)(*) H410 | M=1000 | ||
| 611-141-00-8 | 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt | 414-410-6 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-142-00-3 | product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride | 425-740-5 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-143-00-9 | reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II) | 428-260-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-144-00-4 | reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt | 429-070-4 | 214362-06-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-145-00-X | reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt | 429-440-5 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-146-00-5 | reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate | 430-070-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-147-00-0 | sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate | 430-090-0 | 205764-96-1 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-148-00-6 | reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol | 429-590-1 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 611-149-00-1 | 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate | 427-570-7 | 193486-83-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 611-150-00-7 | tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate | 440-460-3 | - | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 611-151-00-2 | chrysoidine; 4-(phenylazo)benzene-1,3-diamine | 207-803-7 | 495-54-5 | Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H341 H302 H315 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H341 H302 H315 H410 | |||
| 611-152-00-8 | chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] | 208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] | 532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] | Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H302 H315 H318 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H341 H302 H315 H318 H410 | |||
| 611-153-00-3 | chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] | 286-946-7 [1] 304-236-8 [2] | 85407-90-5 [1] 94247-67-3 [2] | Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 | H341 H302 H315 H318 | GHS05 GHS08 GHS07 Gef. | H341 H302 H315 H318 | |||
| 611-154-00-9 | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate | 403-670-6 | 92408-46-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-155-00-4 | 4,4'-oxybis(benzenesulfonylazide) | 431-850-4 | 7456-68-0 | Expl. 1.1**** STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H201 H373** H400 H410 | GHS01 GHS08 GHS09 Gef. | H201 H373** H410 | |||
| 611-156-00-X | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate | 432-270-4 | 221354-37-6 | Repr. 2 STOT RE 2 * Aquatic Chronic 2 | H361f*** H373** H411 | GHS08 GHS09 Achtg. | H361f*** H373** H411 | |||
| 611-157-00-5 | benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate | 432-590-4 | 243869-48-9 | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 611-158-00-0 | reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | 421-520-8 | - | **** Aquatic Chronic 4 | **** H413 | **** | **** H413 | |||
| 611-159-00-6 | disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate | 421-880-6 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-160-00-1 | reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | 422-760-6 | - | **** Aquatic Chronic 4 | **** H413 | **** | **** H413 | |||
| 611-161-00-7 | trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) | 423-100-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | 429-600-4 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | 429-610-9 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 | H302 H318 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H411 | |||
| 611-164-00-3 | reaction mass of: 2,2-dimethyl-2,2-azobutanenitrile; 2-methylpentanenitrile-2-azo-2-(2-methylpropanenitrile); 2,2-dimethyl-2,2-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2-(2-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2-(2-methylbutanenitrile) | 429-710-2 | - | Self-react.
D Acute Tox. 4 * Aquatic Chronic 2 | H242 H302 H411 | GHS02 GHS07 GHS09 Gef. | H242 H302 H411 | |||
| 611-165-00-9 | reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | 431-830-5 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-166-00-4 | reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | 432-100-9 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-167-00-X | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II) | 435-240-9 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-168-00-5 | reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | 435-440-6 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-169-00-0 | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | 435-800-2 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-170-00-6 | reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2 )-1-phenylmethyl)azo-κ-N1 )-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2 )-1-phenylmethyl)azo-κ-N1 )-4-sulfonatobenzoate-κ-O-(5-))cuprate(II) | 435-880-9 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 611-171-00-1 | reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | 436-890-6 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-172-00-7 | reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate | 438-310-7 | - | Self-react.
C**** Repr. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 | H242 H361f*** H302 H373** H412 | GHS02 GHS08 GHS07 Gef. | H242 H361f*** H302 H373** H412 | |||
| 611-173-00-2 | reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | 440-510-4 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-174-00-8 | reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | 442-290-5 | 457624-86-1 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 611-175-00-3 | reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | 444-050-5 | - | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | 444-250-2 | - | Self-react.
C**** Aquatic Chronic 2 | H242 H411 | GHS02 GHS09 Gef. | H242 H411 | |||
| 611-177-00-4 | reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III) | 444-290-0 | 508202-43-5 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 611-178-00-X | reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | 445-280-9 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 611-179-00-5 | reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | 450-010-8 | - | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 611-180-00-0 | iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | 417-850-7 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-001-00-9 | mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] | 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] | 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] | Flam. Gas 1 Press. Gas Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H220 H332 H335 H315 H318 | GHS02 GHS04 GHS05 GHS07 Gef. | H220 H332 H335 H315 H318 | (*) Skin Irrit. 2; H315: C ≥ 5 % Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: C ≥ 5 % | U5 | |
| 612-001-01-6 | mono-methylamine ...%; [1] di-methylamine ...%; [2] tri-methylamine ...% [3] | 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] | 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] | Flam. Liq. 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H224 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H224 H332 H302 H314 | (*) STOT SE 3; H335: C ≥ 5 % | B | |
| 612-002-00-4 | ethylamine | 200-834-7 | 75-04-7 | Flam. Gas 1 Press. Gas Eye Irrit. 2 STOT SE 3 | H220 H319 H335 | GHS02 GHS04 GHS07 Gef. | H220 H319 H335 | U | ||
| 612-003-00-X | diethylamine | 203-716-3 | 109-89-7 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H225 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 1 % | ||
| 612-004-00-5 | triethylamine | 204-469-4 | 121-44-8 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H225 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 1 % | ||
| 612-005-00-0 | butylamine | 203-699-2 | 109-73-9 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H225 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 1 % | ||
| 612-006-00-6 | ethylenediamine; 1,2-diaminoethane | 203-468-6 | 107-15-3 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 | H226 H312 H302 H314 H334 H317 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H312 H302 H314 H334 H317 | |||
| 612-007-00-1 | 2-aminopropane; isopropylamine | 200-860-9 | 75-31-0 | Flam. Liq. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H224 H319 H335 H315 | GHS02 GHS07 Gef. | H224 H319 H335 H315 | |||
| 612-008-00-7 | aniline | 200-539-3 | 62-53-3 | Carc. 2 Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H351 H341 H331 H311 H301 H372 (*)(*) H318 H317 H400 | GHS06 GHS08 GHS05 GHS09 Gef. | H351 H341 H331 H311 H301 H372 (*)(*) H318 H317 H400 | (*) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % | ||
| 612-009-00-2 | salts of aniline | - | - | Carc. 2 Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H351 H341 H331 H311 H301 H372 (*)(*) H318 H317 H400 | GHS06 GHS08 GHS05 GHS09 Gef. | H351 H341 H331 H311 H301 H372 (*)(*) H318 H317 H400 | (*) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % | A | |
| 612-010-00-8 | chloroanilines (with exception of those specified elsewhere in this Annex) | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | C | ||
| 612-011-00-3 | 4-nitrosoaniline | 211-535-6 | 659-49-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | |||
| 612-012-00-9 | o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] | 201-855-4 [1] 202-729-1 [2] 202-810-1 [3] | 88-74-4 [1] 99-09-2 [2] 100-01-6 [3] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 | H331 H311 H301 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H331 H311 H301 H373 (*)(*) H412 | C | ||
| 612-013-00-4 | 3-aminobenzene sulphonic acid; metanilic acid | 204-473-6 | 121-47-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | |||
| 612-014-00-X | sulphanilic acid; 4-aminobenzenesulphonic acid | 204-482-5 | 121-57-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H319 H315 H317 | GHS07 Achtg. | H319 H315 H317 | |||
| 612-015-00-5 | N-methylaniline | 202-870-9 | 100-61-8 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | |||
| 612-016-00-0 | N,N-dimethylaniline | 204-493-5 | 121-69-7 | Carc. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H351 H331 H311 H301 H411 | GHS06 GHS08 GHS09 Gef. | H351 H331 H311 H301 H411 | |||
| 612-017-00-6 | N-methyl-N-2,4,6-tetranitroaniline; tetryl | 207-531-9 | 479-45-8 | Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 | H201 H331 H311 H301 H373** | GHS01 GHS06 GHS08 Gef. | H201 H331 H311 H301 H373** | |||
| 612-018-00-1 | bis(2,4,6-trinitrophenyl)amine; hexyl | 205-037-8 | 131-73-7 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 | H201 H330 H310 H300 H373** H411 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H330 H310 H300 H373** H411 | |||
| 612-019-00-7 | dipicrylamine, ammonium salt | 220-639-0 | 2844-92-0 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 | H201 H330 H310 H300 H373** H411 | GHS01 GHS06 GHS08 GHS09 Gef. | H201 H330 H310 H300 H373** H411 | |||
| 612-020-00-2 | 1-naphthylamine | 205-138-7 | 134-32-7 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 612-022-00-3 | 2-naphthylamine | 202-080-4 | 91-59-8 | Carc. 1A Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | Carc. 1A; H350: C ≥ 0,01 % | ||
| 612-023-00-9 | phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] phenylhydrazinium sulphate (2:1) [4] | 202-873-5 [1] 200-444-7 [2] 248-259-0 [3] 257-622-2 [4] | 100-63-0 [1] 59-88-1 [2] 27140-08-5 [3] 52033-74-6 [4] | Carc. 1B Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H350 H341 H331 H311 H301 H372 (*)(*) H319 H315 H317 H400 | GHS06 GHS08 GHS09 Gef. | H350 H341 H331 H311 H301 H372 (*)(*) H319 H315 H317 H400 | |||
| 612-024-00-4 | m-toluidine; 3-aminotoluene | 203-583-1 | 108-44-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 | H331 H311 H301 H373 (*)(*) H400 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H400 | |||
| 612-025-00-X | nitrotoluidines, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | C | ||
| 612-026-00-5 | diphenylamine | 204-539-4 | 122-39-4 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H373 (*)(*) H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H410 | |||
| 612-027-00-0 | xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | C | ||
| 612-028-00-6 | p-phenylenediamine | 203-404-7 | 106-50-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H319 H317 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H319 H317 H410 | |||
| 612-029-00-1 | benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride | 210-834-9 | 624-18-0 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H319 H317 H400 H410 | GHS06 GHS09 Gef. | H331 H311 H301 H319 H317 H410 | |||
| 612-030-00-7 | 2-methyl-p-phenylenediamine sulphate [1] | 210-431-8 [1] 228-871-4 [2] | 615-50-9 [1] 6369-59-1 [2] | Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H301 H332 H312 H317 H411 | GHS06 GHS09 Gef. | H301 H332 H312 H317 H411 | |||
| 612-031-00-2 | N,N-dimethylbenzene-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline [2] | 220-623-3 [1] 202-807-5 [2] | 2836-04-6 [1] 99-98-9 [2] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) | H331 H311 H301 | GHS06 Gef. | H331 H311 H301 | C | ||
| 612-032-00-8 | N,N,N',N'-tetramethyl-p-phenylenediamine | 202-831-6 | 100-22-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | |||
| 612-033-00-3 | 2-aminophenol | 202-431-1 | 95-55-6 | Muta. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) | H341 H332 H302 | GHS08 GHS07 Achtg. | H341 H332 H302 | |||
| 612-034-00-9 | 2-amino-4,6-dinitrophenol; picramic acid | 202-544-6 | 96-91-3 | Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H201 H332 H312 H302 H412 | GHS01 GHS07 Gef. | H201 H332 H312 H302 H412 | |||
| 612-034-01-6 | 2-amino-4,6-dinitrophenol; picramic acid; [≥ 20 % water] | 202-544-6 | 96-91-3 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 3 | H332 H312 H302 H412 | GHS07 Achtg. | H332 H312 H302 H412 | G | ||
| 612-035-00-4 | 2-methoxyaniline; o-anisidine | 201-963-1 | 90-04-0 | Carc. 1B Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) | H350 H341 H331 H311 H301 | GHS06 GHS08 Gef. | H350 H341 H331 H311 H301 | |||
| 612-036-00-X | 3,3'-dimethoxybenzidine; o-dianisidine | 204-355-4 | 119-90-4 | Carc. 1B Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | |||
| 612-037-00-5 | salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine | - | - | Carc. 1B Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | A | ||
| 612-038-00-0 | 2-nitro-p-anisidine; 4-methoxy-2-nitroaniline | 202-547-2 | 96-96-8 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Chronic 3 | H330 H310 H300 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H330 H310 H300 H373 (*)(*) H412 | |||
| 612-039-00-6 | 2-ethoxyaniline; o-phenetidine | 202-356-4 | 94-70-2 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) | H331 H311 H301 H373 (*)(*) | GHS06 GHS08 Gef. | H331 H311 H301 H373 (*)(*) | |||
| 612-040-00-1 | 2,4-dinitroaniline | 202-553-5 | 97-02-9 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Chronic 2 | H330 H310 H300 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 (*)(*) H411 | |||
| 612-041-00-7 | 4,4'-bi-o-toluidine | 204-358-0 | 119-93-7 | Carc. 1B Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | |||
| 612-042-00-2 | benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine | 202-199-1 | 92-87-5 | Carc. 1A Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | Carc. 1A; H350: C ≥ 0,01 % | ||
| 612-043-00-8 | N,N'-dimethylbenzidine | - | 2810-74-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H332 H312 H302 | GHS07 Achtg. | H332 H312 H302 | |||
| 612-044-00-3 | N,N'-diacetylbenzidine | 210-338-2 | 613-35-4 | Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H350 H341 H332 H312 H302 | GHS08 GHS07 Gef. | H350 H341 H332 H312 H302 | |||
| 612-046-00-4 | allylamine | 203-463-9 | 107-11-9 | Flam. Liq. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H225 H331 H311 H301 H411 | GHS02 GHS06 GHS09 Gef. | H225 H331 H311 H301 H411 | |||
| 612-047-00-X | benzylamine | 202-854-1 | 100-46-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 612-048-00-5 | dipropylamine | 205-565-9 | 142-84-7 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H225 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H312 H302 H314 | STOT SE 3; H335: C ≥ 1 % | ||
| 612-049-00-0 | di-n-butylamine; [1] di-sec-butylamine [2] | 203-921-8 [1] 210-937-9 [2] | 111-92-2 [1] 626-23-3 [2] | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H226 H332 H312 H302 | GHS02 GHS07 Achtg. | H226 H332 H312 H302 | |||
| 612-050-00-6 | cyclohexylamine | 203-629-0 | 108-91-8 | Flam. Liq. 3 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H226 H361f*** H312 H302 H314 | GHS02 GHS05 GHS08 GHS07 Gef. | H226 H361f*** H312 H302 H314 | |||
| 612-051-00-1 | 4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline | 202-974-4 | 101-77-9 | Carc. 1B Muta. 2 STOT SE 1 STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H350 H341 H370 (*)(*) H373 (*)(*) H317 H411 | GHS08 GHS07 GHS09 Gef. | H350 H341 H370 (*)(*) H373 (*)(*) H317 H411 | |||
| 612-052-00-7 | (S)-sec-butylamine; (S)-2-aminobutane; [1] (R)-sec-butylamine; (R)-2-aminobutane; [2] sec-butylamine; 2-aminobutane [3] | 208-164-7 [1] 236-232-6 [2] 237-732-7 [3] | 513-49-5 [1] 13250-12-9 [2] 13952-84-6 [3] | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A Aquatic Acute 1 | H225 H332 H302 H314 H400 | GHS02 GHS05 GHS07 GHS09 Gef. | H225 H332 H302 H314 H400 | C | ||
| 612-053-00-2 | N-ethylaniline | 203-135-5 | 103-69-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) | H331 H311 H301 H373 (*)(*) | GHS06 GHS08 Gef. | H331 H311 H301 H373 (*)(*) | |||
| 612-054-00-8 | N,N-diethylaniline | 202-088-8 | 91-66-7 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | (*) | ||
| 612-055-00-3 | N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3] | 210-260-9 [1] 211-795-0 [2] 210-769-6 [3] | 611-21-2 [1] 696-44-6 [2] 623-08-5 [3] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 | H331 H311 H301 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H331 H311 H301 H373 (*)(*) H412 | C | ||
| 612-056-00-9 | N,N-dimethyl-p-toluidine; [1] N,N-dimethyl-m-toluidine; [2] N,N-dimethyl-o-toluidine [3] | 202-805-4 [1] 204-495-6 [2] 210-199-8 [3] | 99-97-8 [1] 121-72-2 [2] 609-72-3 [3] | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 | H331 H311 H301 H373 (*)(*) H412 | GHS06 GHS08 Gef. | H331 H311 H301 H373 (*)(*) H412 | (*) | C | |
| 612-057-00-4 | piperazine; [solid] | 203-808-3 | 110-85-0 | Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 | H361fd H314 H334 H317 | GHS05 GHS08 Gef. | H361fd H314 H334 H317 | |||
| 612-057-01-1 | piperazine; [liquid] | 203-808-3 | 110-85-0 | Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 | H361fd H314 H334 H317 | GHS05 GHS08 Gef. | H361fd H314 H334 H317 | |||
| 612-058-00-X | 2,2'-iminodiethylamine; diethylenetriamine | 203-865-4 | 111-40-0 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H312 H302 H314 H317 | GHS05 GHS07 Gef. | H312 H302 H314 H317 | |||
| 612-059-00-5 | 3,6-diazaoctanethylenediamin; triethylenetetramine | 203-950-6 | 112-24-3 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H312 H314 H317 H412 | GHS05 GHS07 Gef. | H312 H314 H317 H412 | |||
| 612-060-00-0 | 3,6,9-triazaundecamethylenediamine; tetraethylenepentamine | 203-986-2 | 112-57-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H312 H302 H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H317 H411 | |||
| 612-061-00-6 | 3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane | 203-680-9 | 109-55-7 | Flam. Liq. 3 Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H226 H302 H314 H317 | GHS02 GHS05 GHS07 Gef. | H226 H302 H314 H317 | |||
| 612-062-00-1 | 3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane | 203-236-4 | 104-78-9 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H226 H312 H302 H314 H317 | GHS02 GHS05 GHS07 Gef. | H226 H312 H302 H314 H317 | |||
| 612-063-00-7 | 3,3'-iminodi(propylamine); dipropylenetriamine | 200-261-2 | 56-18-8 | Acute Tox. 2 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1A Skin Sens. 1 | H330 H311 H302 H314 H317 | GHS06 GHS05 Gef. | H330 H311 H302 H314 H317 | |||
| 612-064-00-2 | 3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine | 223-775-9 | 4067-16-7 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 612-065-00-8 | polyethlyenepolyamines with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H317 H410 | |||
| 612-066-00-3 | dicyclohexylamine | 202-980-7 | 101-83-7 | Acute Tox. 4 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H410 | |||
| 612-067-00-9 | 3-aminomethyl-3,5,5-trimethylcyclohexylamine | 220-666-8 | 2855-13-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H312 H302 H314 H317 H412 | GHS05 GHS07 Gef. | H312 H302 H314 H317 H412 | |||
| 612-068-00-4 | 3,3'-dichlorobenzidine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine | 202-109-0 | 91-94-1 | Carc. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H312 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H312 H317 H410 | |||
| 612-069-00-X | salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine | - | - | Carc. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H312 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H312 H317 H410 | A | ||
| 612-070-00-5 | salts of benzidine | 208-519-6 208-520-1 244-236-4 252-984-8 | 531-85-1 531-86-2 21136-70-9 36341-27-2 | Carc. 1A Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | A | ||
| 612-071-00-0 | salts of 2-naphthylamine | 209-030-0 210-313-6 | 553-00-4 612-52-2 | Carc. 1A Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | A | ||
| 612-072-00-6 | biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl | 202-177-1 | 92-67-1 | Carc. 1A Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | |||
| 612-073-00-1 | salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl | - | - | Carc. 1A Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | A | ||
| 612-074-00-7 | benzyldimethylamine | 203-149-1 | 103-83-3 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Aquatic Chronic 3 | H226 H332 H312 H302 H314 H412 | GHS02 GHS05 GHS07 Gef. | H226 H332 H312 H302 H314 H412 | |||
| 612-075-00-2 | 2-aminoethyldimethylamine; 2-dimethylaminoethylamine | 203-541-2 | 108-00-9 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H225 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H312 H302 H314 | |||
| 612-076-00-8 | ethyldimethylamine | 209-940-8 | 598-56-1 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B | H225 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H302 H314 | |||
| 612-077-00-3 | dimethylnitrosoamine; N-nitrosodimethylamine | 200-549-8 | 62-75-9 | Carc. 1B Acute Tox. 2 (*) Acute Tox. 3 (*) STOT RE 1 Aquatic Chronic 2 | H350 H330 H301 H372 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H350 H330 H301 H372 (*)(*) H411 | Carc. 1B; H350: C ≥ 0,001 % | ||
| 612-078-00-9 | 2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline) | 202-918-9 | 101-14-4 | Carc. 1B Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | |||
| 612-079-00-4 | salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline) | - | - | Carc. 1B Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H410 | A | ||
| 612-080-00-X | 4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine | 202-214-1 | 93-05-0 | Acute Tox. 3 (*) Skin Corr. 1B | H301 H314 | GHS06 GHS05 Gef. | H301 H314 | |||
| 612-081-00-5 | salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine | 210-322-5 265-294-7 277-985-0 | 612-82-8 64969-36-4 74753-18-7 | Carc. 1B Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | A | ||
| 612-082-00-0 | thiourea; thiocarbamide | 200-543-5 | 62-56-6 | Carc. 2 Repr. 2 Acute Tox. 4 (*) Aquatic Chronic 2 | H351 H361d (*)(*)(*) H302 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H361d (*)(*)(*) H302 H411 | |||
| 612-083-00-6 | 1-methyl-3-nitro-1-nitrosoguanidine | 200-730-1 | 70-25-7 | Carc. 1B Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H350 H332 H319 H315 H411 | GHS08 GHS07 GHS09 Gef. | H350 H332 H319 H315 H411 | Carc. 1B; H350: C ≥ 0,01 % | ||
| 612-084-00-1 | dapsone; 4,4'-diamino diphenyl sulfone | 201-248-4 | 80-08-0 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 612-085-00-7 | 4,4'-methylenedi-o-toluidine | 212-658-8 | 838-88-0 | Carc. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H350 H302 H317 H410 | |||
| 612-086-00-2 | amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine | 251-375-4 | 33089-61-1 | Acute Tox. 4 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 (*)(*) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 (*)(*) H317 H410 | M=10 | ||
| 612-087-00-8 | guazatine (ISO) | 108173-90-6 | Acute Tox. 2 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H312 H302 H335 H315 H318 H400 H410 | GHS06 GHS05 GHS09 Gef. | H330 H312 H302 H335 H315 H318 H410 | ||||
| 612-088-00-3 | simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine | 204-535-2 | 122-34-9 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 612-089-00-9 | 1,5-naphthylenediamine | 218-817-8 | 2243-62-1 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 612-090-00-4 | 2,2'-(nitrosoimino)bisethanol | 214-237-4 | 1116-54-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 612-091-00-X | o-toluidine; 2-aminotoluene | 202-429-0 | 95-53-4 | Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Aquatic Acute 1 | H350 H331 H301 H319 H400 | GHS06 GHS08 GHS09 Gef. | H350 H331 H301 H319 H400 | |||
| 612-092-00-5 | N,N'-(2,2-dimethylpropylidene)hexamethylenediamine | 401-660-6 | 1000-78-8 | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 612-093-00-0 | 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline | 401-790-3 | 104147-32-2 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 612-094-00-6 | 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride | 402-190-4 | 113674-95-6 | STOT RE 1 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H372** H302 H373** H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H372** H302 H373** H318 H317 H410 | |||
| 612-095-00-1 | benzyl-2-hydroxydodecyldimethylammonium benzoate | 402-610-6 | 113694-52-3 | Skin Corr. 1B Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H314 H302 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H302 H410 | |||
| 612-096-00-7 | 4,4'-carbonimidoylbis[N,N-dimethylaniline] | 207-762-5 | 492-80-8 | Carc. 2 Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Chronic 2 | H351 H302 H319 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H319 H411 | |||
| 612-097-00-2 | salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] | - | - | Carc. 2 Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Chronic 2 | H351 H302 H319 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H319 H411 | A | ||
| 612-098-00-8 | nitrosodipropylamine | 210-698-0 | 621-64-7 | Carc. 1B Acute Tox. 4 * Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | Carc. 1B; H350: C ≥ 0,001 % | ||
| 612-099-00-3 | 4-methyl-m-phenylenediamine; 2,4-toluenediamine | 202-453-1 | 95-80-7 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 | H350 H341 H361f*** H301 H312 H373** H317 H411 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f*** H301 H312 H373** H317 H411 | |||
| 612-100-00-7 | propylenediamine | 201-155-9 | 78-90-0 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A | H226 H312 H302 H314 | GHS02 GHS05 GHS07 Gef. | H226 H312 H302 H314 | |||
| 612-101-00-2 | methenamine; hexamethylenetetramine | 202-905-8 | 100-97-0 | Flam. Sol. 2 Skin Sens. 1 | H228 H317 | GHS02 GHS07 Achtg. | H228 H317 | |||
| 612-102-00-8 | N,N-bis(3-aminopropyl)methylamine | 203-336-8 | 105-83-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1B | H331 H311 H302 H314 | GHS06 GHS05 Gef. | H331 H311 H302 H314 | |||
| 612-103-00-3 | N,N,N',N'-tetramethylethylenediamine | 203-744-6 | 110-18-9 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H225 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H302 H314 | |||
| 612-104-00-9 | hexamethylenediamine | 204-679-6 | 124-09-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT SE 3 Skin Corr. 1B | H312 H302 H335 H314 | GHS05 GHS07 Gef. | H312 H302 H335 H314 | |||
| 612-105-00-4 | 2-piperazin-1-ylethylamine | 205-411-0 | 140-31-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H312 H302 H314 H317 H412 | GHS05 GHS07 Gef. | H312 H302 H314 H317 H412 | |||
| 612-106-00-X | 2,6-diethylaniline | 209-445-7 | 579-66-8 | Acute Tox. 4 (*) | H302 | - | H302 | |||
| 612-107-00-5 | 1-phenylethylamine; [1] DL-α-methylbenzylamine [2] | 202-706-6 [1] 210-545-8 [2] | 98-84-0 [1] 618-36-0 [2] | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 612-108-00-0 | 3-aminopropyltriethoxysilane | 213-048-4 | 919-30-2 | Acute Tox. 4 (*) Skin Corr. 1B | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | |||
| 612-109-00-6 | bis(2-dimethylaminoethyl)(methyl)amine | 221-201-1 | 3030-47-5 | Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1B | H311 H302 H314 | GHS06 GHS05 Gef. | H311 H302 H314 | |||
| 612-110-00-1 | 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) | 229-962-1 | 6864-37-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1A Aquatic Chronic 2 | H331 H311 H302 H314 H411 | GHS06 GHS05 GHS09 Gef. | H331 H311 H302 H314 H411 | |||
| 612-111-00-7 | 2-methyl-m-phenylenediamine; 2,6-toluenediamine | 212-513-9 | 823-40-5 | Muta. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H341 H312 H302 H317 H411 | GHS08 GHS07 GHS09 Achtg. | H341 H312 H302 H317 H411 | |||
| 612-112-00-2 | p-anisidine; 4-methoxyaniline | 203-254-2 | 104-94-9 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Acute 1 | H330 H310 H300 H373 (*)(*) H400 | GHS06 GHS08 GHS09 Gef. | H330 H310 H300 H373 (*)(*) H400 | |||
| 612-113-00-8 | 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine | 403-240-8 | 106264-79-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 612-114-00-3 | R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate | 404-390-7 | - | Flam. Sol. 1 Skin Sens. 1 Aquatic Chronic 3 | H228 H317 H412 | GHS02 GHS07 Achtg. | H228 H317 H412 | |||
| 612-115-00-9 | dimethyldioctadecylammonium hydrogen sulfate | 404-050-8 | 123312-54-9 | Eye Irrit. 2 Aquatic Chronic 4 | H319 H413 | GHS07 Achtg. | H319 H413 | |||
| 612-116-00-4 | C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate | 404-690-8 | 68132-19-4 | Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H314 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H331 H314 H317 H410 | |||
| 612-117-00-X | C12-14 - tert-alkylamine, methylphosphonic acid salt | 404-750-3 | 119415-07-5 | Acute Tox. 4 (*) Skin Corr. 1B Aquatic Chronic 2 | H302 H314 H411 | GHS05 GHS07 GHS09 Gef. | H302 H314 H411 | |||
| 612-118-00-5 | A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide | 405-080-4 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 612-119-00-0 | benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate | 405-330-2 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H400 H410 | GHS05 GHS09 Gef. | H315 H318 H410 | |||
| 612-120-00-6 | aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline | 277-704-1 | 74070-46-5 | Carc. 2 | H351 | GHS08 | H351 | M = 100 M = 10 | ||
| Skin Sens. 1A | H317 | GHS07 | H317 | |||||||
| Aquatic Acute 1 | H400 | GHS09 | ||||||||
| Aquatic Chronic 1 | H410 | Achtg. | H410 | |||||||
| 612-121-00-1 | amines, polyethylenepoly-; HEPA | 268-626-9 | 68131-73-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H317 H410 | |||
| 612-122-00-7 | hydroxylamine
% [> 55 % in aqueous solution] | 232-259-2 | 7803-49-8 | Unst. Expl. Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H200 H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 | GHS01 GHS05 GHS08 GHS07 GHS09 Gef. | H200 H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 | B | ||
| 612-122-01-4 | hydroxylamine % [≤ 55 % in aqueous solution] | 232-259-2 | 7803-49-8 | Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 | GHS05 GHS08 GHS07 GHS09 Gef. | H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 | B | ||
| 612-123-00-2 | hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] | 226-798-2 [1] 233-118-8 [2] | 5470-11-1 [1] 10039-54-0 [2] | Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H290 H351 H312 H302 H373** H319 H315 H317 H400 | GHS05 GHS08 GHS07 GHS09 Achtg. | H290 H351 H312 H302 H373** H319 H315 H317 H400 | |||
| 612-124-00-8 | N,N,N-trimethylanilinium chloride | 205-319-0 | 138-24-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) | H311 H301 | GHS06 Gef. | H311 H301 | |||
| 612-125-00-3 | 2-methyl-p-phenylenediamine; 2,5-toluenediamine | 202-442-1 | 95-70-5 | Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H301 H332 H312 H317 H411 | GHS06 GHS09 Gef. | H301 H332 H312 H317 H411 | |||
| 612-126-00-9 | toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate | 265-697-8 | 65321-67-7 | Carc. 1B Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H350 H301 H312 H319 H317 H411 | GHS06 GHS08 GHS09 Gef. | H350 H301 H312 H319 H317 H411 | |||
| 612-127-00-4 | 3-aminophenol | 209-711-2 | 591-27-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 2 | H332 H302 H411 | GHS07 GHS09 Achtg. | H332 H302 H411 | |||
| 612-128-00-X | 4-aminophenol | 204-616-2 | 123-30-8 | Muta. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H341 H332 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H341 H332 H302 H410 | |||
| 612-129-00-5 | diisopropylamine | 203-558-5 | 108-18-9 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H225 H332 H302 H314 | GHS02 GHS05 GHS07 Gef. | H225 H332 H302 H314 | STOT SE 3; H335: C ≥ 5 % | ||
| 612-130-00-0 | 2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] 2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] | 218-255-3 [1] 218-256-9 [2] 270-877-4 [3] | 2095-01-4 [1] 2095-02-5 [2] 68479-98-1 [3] | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373 (*)(*) H319 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H312 H302 H373 (*)(*) H319 H410 | C | ||
| 612-131-00-6 | didecyldimethylammonium chloride | 230-525-2 | 7173-51-5 | Acute Tox. 4 (*) Skin Corr. 1B | H302 H314 | GHS05 GHS07 Gef. | H302 H314 | |||
| 612-132-00-1 | N,N'-diphenyl-p-phenylenediamine; N,N'-diphenyl-1,4-benzenediamine | 200-806-4 | 74-31-7 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 612-133-00-7 | (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate | 247-162-0 | 25646-77-9 | Acute Tox. 3 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H373 (*)(*) H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H301 H373 (*)(*) H317 H410 | |||
| 612-134-00-2 | N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate | 247-161-5 | 25646-71-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 612-135-00-8 | N-2-naphthylaniline; N-phenyl-2-naphthylamine | 205-223-9 | 135-88-6 | Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H351 H319 H315 H317 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H319 H315 H317 H411 | |||
| 612-136-00-3 | N-isopropyl-N'-phenyl-p-phenylenediamine | 202-969-7 | 101-72-4 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | Skin Sens. 1; H317: C ≥ 0,1 % | ||
| 612-137-00-9 | 4-chloroaniline | 203-401-0 | 106-47-8 | Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H331 H311 H301 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H331 H311 H301 H317 H410 | |||
| 612-138-00-4 | furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate | 260-875-1 | 57646-30-7 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 612-139-00-X | mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide | 277-328-8 | 73250-68-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-140-00-5 | quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides | 264-151-6 | 63449-41-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Aquatic Acute 1 | H312 H302 H314 H400 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H400 | |||
| 612-141-00-0 | 4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine) | 243-420-1 | 19900-65-3 | Carc. 2 Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H410 | |||
| 612-142-00-6 | biphenyl-2-ylamine | 201-990-9 | 90-41-5 | Carc. 2 Acute Tox. 4 (*) Aquatic Chronic 3 | H351 H302 H412 | GHS08 GHS07 Achtg. | H351 H302 H412 | |||
| 612-143-00-1 | N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride | 218-130-3 | 2051-79-8 | Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H319 H317 H400 H410 | GHS06 GHS09 Gef. | H301 H319 H317 H410 | |||
| 612-144-00-7 | flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine | - | 62924-70-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H317 H410 | |||
| 612-145-00-2 | o-phenylenediamine | 202-430-6 | 95-54-5 | Carc. 2 Muta. 2 Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H341 H301 H332 H312 H319 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H341 H301 H332 H312 H319 H317 H410 | |||
| 612-146-00-8 | o-phenylenediamine dihydrochloride | 210-418-7 | 615-28-1 | Carc. 2 Muta. 2 Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H341 H301 H332 H312 H319 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H351 H341 H301 H332 H312 H319 H317 H410 | |||
| 612-147-00-3 | m-phenylenediamine | 203-584-7 | 108-45-2 | Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H331 H311 H301 H319 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H331 H311 H301 H319 H317 H410 | |||
| 612-148-00-9 | m-phenylenediamine dihydrochloride | 208-790-0 | 541-69-5 | Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H331 H311 H301 H319 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H341 H331 H311 H301 H319 H317 H410 | |||
| 612-149-00-4 | 1,3-diphenylguanidine | 203-002-1 | 102-06-7 | Repr. 2 Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H361f (*)(*)(*) H302 H319 H335 H315 H411 | GHS08 GHS07 GHS09 Achtg. | H361f (*)(*)(*) H302 H319 H335 H315 H411 | |||
| 612-150-00-X | Spiroxamin (ISO); 8-tert-Butyl-1,4-dioxa-spiro[4.5]dec-2-ylmethyl-ethylpropylamin | - | 118134-30-8 | Repr. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H332 H312 H302 H373 (Augen) H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d H332 H312 H302 H373 (Augen) H315 H317 H410 | M = 100 M = 100 | ||
| 612-151-00-5 | methyl-phenylene diamine; diaminotoluene; [technical product - reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | - | - | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H350 H341 H361f*** H301 H312 H373** H319 H317 H411 | GHS06 GHS08 GHS09 Gef. | H350 H341 H361f*** H301 H312 H373** H319 H317 H411 | |||
| 612-152-00-0 | N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine | 406-610-7 | 62478-82-4 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1A Aquatic Chronic 3 | H226 H332 H302 H373 (*)(*) H314 H412 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H332 H302 H373 (*)(*) H314 H412 | |||
| 612-153-00-6 | 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride | 407-020-2 | 132885-85-9 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 612-154-00-1 | 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] | 410-890-6 | 95235-29-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-155-00-7 | 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene | 411-730-8 | 93071-94-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-156-00-2 | reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride | 405-620-9 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 612-157-00-8 | (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride | 410-780-8 | - | Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H373 (*)(*) H318 H317 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H302 H373 (*)(*) H318 H317 H411 | |||
| 612-158-00-3 | reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime | 410-820-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-159-00-9 | Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid | 410-880-1 | - | Acute Tox. 4 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H410 | |||
| 612-160-00-4 | p-toluidine; 4-aminotoluene; [1] toluidinium chloride; [2] toluidine sulphate (1:1) [3] | 203-403-1 [1] 208-740-8 [2] 208-741-3 [3] | 106-49-0 [1] 540-23-8 [2] 540-25-0 [3] | Carc. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H351 H331 H311 H301 H319 H317 H400 | GHS06 GHS08 GHS09 Gef. | H351 H331 H311 H301 H319 H317 H400 | |||
| 612-161-00-X | 2,6-xylidine; 2,6-dimethylaniline | 201-758-7 | 87-62-7 | Carc. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 | H351 H332 H312 H302 H335 H315 H411 | GHS08 GHS07 GHS09 Achtg. | H351 H332 H312 H302 H335 H315 H411 | |||
| 612-162-00-5 | dimethyldioctadecylammonium chloride; DODMAC | 203-508-2 | 107-64-2 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 612-163-00-0 | metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester | - | 70630-17-0 | Acute Tox. 4 (*) Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 612-164-00-6 | 2-butyl-2-ethyl-1,5-diaminopentane | 412-700-7 | 137605-95-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H312 H302 H373 (*)(*) H314 H317 H412 | GHS08 GHS05 GHS07 Gef. | H312 H302 H373 (*)(*) H314 H317 H412 | |||
| 612-165-00-1 | N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine | 413-810-8 | 65181-78-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-166-00-7 | reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) | 411-830-1 | 114765-88-7 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 612-167-00-2 | 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride | 410-490-1 | - | Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H373 (*)(*) H318 H317 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H302 H373 (*)(*) H318 H317 H411 | |||
| 612-168-00-8 | 3,5-dichloro-2,6-difluoropyrdine-4-amine | 220-630-1 | 2840-00-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 2 | H312 H302 H411 | GHS07 GHS09 Achtg. | H312 H302 H411 | |||
| 612-169-00-3 | bis(N-methyl-N-phenylhydrazine)sulfate | 423-170-1 | 618-26-8 | Flam. Liq. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H225 H372** H302 H318 H317 H400 H410 | GHS02 GHS05 GHS08 GHS07 GHS09 Gef. | H225 H372** H302 H318 H317 H410 | |||
| 612-170-00-9 | 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime | 405-260-2 | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 612-171-00-4 | N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane | 410-060-3 | 130728-76-6 | Muta. 2 Skin Sens. 1 Aquatic Chronic 2 | H341 H317 H411 | GHS08 GHS09 Achtg. | H341 H317 H411 | |||
| 612-172-00-X | 4,4'-methylenebis(N,N'-dimethylcyclohexanamine | 412-840-9 | 13474-64-1 | Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1A Aquatic Chronic 3 | H302 H373 (*)(*) H314 H412 | GHS08 GHS05 GHS07 Gef. | H302 H373 (*)(*) H314 H412 | |||
| 612-173-00-5 | lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate | 411-140-0 | 125328-86-1 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 612-174-00-0 | 4,4-dimethoxybutylamine | 407-690-6 | 19060-15-2 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 | H302 H314 H317 H412 | GHS05 GHS07 Gef. | H302 H314 H317 H412 | |||
| 612-175-00-6 | 2-(O-aminooxy)ethylamine dihydrochloride | 412-310-7 | 37866-45-8 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 612-176-00-1 | polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine | 410-570-6 | 143747-73-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 612-177-00-7 | 2-naphthylamino-6-sulfomethylamide | 412-120-4 | 104295-55-8 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H373 (*)(*) H317 H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H317 H411 | |||
| 612-178-00-2 | 1,4,7,10-tetraazacyclododecane disulfate | 412-080-8 | 112193-77-8 | Acute Tox. 4 (*) STOT SE 3 Eye Dam. 1 Aquatic Chronic 3 | H302 H335 H318 H412 | GHS05 GHS07 Gef. | H302 H335 H318 H412 | |||
| 612-179-00-8 | 1-(2-propenyl)pyridinium chloride | 412-740-5 | 25965-81-5 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 612-180-00-3 | 3-aminobenzylamine | 412-230-2 | 4403-70-7 | Acute Tox. 4 (*) Skin Corr. 1B Aquatic Chronic 2 | H302 H314 H411 | GHS05 GHS07 GHS09 Gef. | H302 H314 H411 | |||
| 612-181-00-9 | 2-phenylthioaniline | 413-030-8 | 1134-94-7 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 612-182-00-4 | 1-ethyl-1-methylmorpholinium bromide | 418-210-1 | 65756-41-4 | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 612-183-00-X | 1-ethyl-1-methylpyrrolidinium bromide | 418-200-5 | 69227-51-6 | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 612-184-00-5 | 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one | 403-830-5 | 89331-94-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 612-185-00-0 | 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide | 407-400-8 | 59493-72-0 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 612-186-00-6 | bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate | 406-770-8 | 149057-64-7 | STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H318 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H373 (*)(*) H318 H317 H410 | |||
| 612-187-00-1 | 2,3,4-trifluoroaniline | 407-170-9 | 3862-73-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H312 H302 H373 (*)(*) H315 H318 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H312 H302 H373 (*)(*) H315 H318 H411 | |||
| 612-188-00-7 | 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) | 407-560-9 | 107934-68-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-189-00-2 | 4-amino-2-(aminomethyl)phenol dihydrochloride | 412-510-4 | 135043-64-0 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 612-190-00-8 | 4,4'-methylenebis(2-isopropyl-6-methylaniline) | 415-150-6 | 16298-38-7 | STOT RE 2 (*) Aquatic Chronic 2 | H373 (*)(*) H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H411 | |||
| 612-191-00-3 | polymer of allylamine hydrochloride | 415-050-2 | 71550-12-4 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 612-192-00-9 | 2-isopropyl-4-(N-methyl)aminomethylthiazole | 414-800-6 | 154212-60-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H312 H302 H315 H318 H411 | GHS05 GHS07 GHS09 Gef. | H312 H302 H315 H318 H411 | |||
| 612-193-00-4 | 3-methylaminomethylphenylamine | 414-570-7 | 18759-96-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H312 H302 H314 H317 H410 | |||
| 612-194-00-X | 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride | 414-670-0 | 141890-30-4 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 612-195-00-5 | bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate | 415-210-1 | 160236-81-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H332 H302 H318 H410 | |||
| 612-196-00-0 | 4-chloro-o-toluidine; [1] 4-chloro-o-toluidine hydrochloride [2] | 202-441-6 [1] 221-627-8 [2] | 95-69-2 [1] 3165-93-3 [2] | Carc. 1B Muta. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H350 H341 H331 H311 H301 H400 H410 | GHS06 GHS08 GHS09 Gef. | H350 H341 H331 H311 H301 H410 | |||
| 612-197-00-6 | 2,4,5-trimethylaniline; [1] 2,4,5-trimethylaniline hydrochloride [2] | 205-282-0 [1] [2] | 137-17-7 [1] 21436-97-5 [2] | Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H350 H331 H311 H301 H411 | GHS06 GHS08 GHS09 Gef. | H350 H331 H311 H301 H411 | |||
| 612-198-00-1 | 4,4'-thiodianiline and its salts | 205-370-9 | 139-65-1 | Carc. 1B Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H302 H411 | |||
| 612-199-00-7 | 4,4'-oxydianiline and its salts; p-aminophenyl ether | 202-977-0 | 101-80-4 | Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 | H350 H340 H361f (*)(*)(*) H331 H311 H301 H411 | GHS06 GHS08 GHS09 Gef. | H350 H340 H361f (*)(*)(*) H331 H311 H301 H411 | |||
| 612-200-00-0 | 2,4-diaminoanisole; 4-methoxy-m-phenylenediamine; [1] 2,4-diaminoanisole sulphate [2] | 210-406-1 [1] 254-323-9 [2] | 615-05-4 [1] 39156-41-7 [2] | Carc. 1B Muta. 2 Acute Tox. 4 (*) Aquatic Chronic 2 | H350 H341 H302 H411 | GHS08 GHS07 GHS09 Gef. | H350 H341 H302 H411 | |||
| 612-201-00-6 | N,N,N',N'-tetramethyl-4,4'-methylendianiline | 202-959-2 | 101-61-1 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 | H350 H400 H410 | GHS08 GHS09 Gef. | H350 H410 | |||
| 612-202-00-1 | 3,4-dichloroaniline | 202-448-4 | 95-76-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H318 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H331 H311 H301 H318 H317 H410 | |||
| 612-203-00-7 | C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: < 3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: < 3 %) | 417-360-3 | - | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 | H312 H302 H315 | GHS07 Achtg. | H312 H302 H315 | |||
| 612-204-00-2 | C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | 208-953-6 | 548-62-9 | Carc. 2 Acute Tox. 4 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H318 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H351 H302 H318 H410 | |||
| 612-205-00-8 | C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5) | 208-953-6 | 548-62-9 | Carc. 1B Acute Tox. 4 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H302 H318 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H350 H302 H318 H410 | |||
| 612-206-00-3 | famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione | - | 131807-57-3 | STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H400 H410 | GHS08 GHS09 Achtg. | H373 (*)(*) H410 | |||
| 612-207-00-9 | 4-ethoxyaniline; p-phenetidine | 205-855-5 | 156-43-4 | Muta. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 | H341 H332 H312 H302 H319 H317 | GHS08 GHS07 Achtg. | H341 H332 H312 H302 H319 H317 | |||
| 612-208-00-4 | N-methylbenzene-1,2-diammonium hydrogen phosphate | 424-460-0 | - | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 612-209-00-X | 6-methoxy-m-toluidine; p-cresidine | 204-419-1 | 120-71-8 | Carc. 1B Acute Tox. 4 (*) | H350 H302 | GHS08 GHS07 Gef. | H350 H302 | |||
| 612-210-00-5 | 5-nitro-o-toluidine; [1] 5-nitro-o-toluidine hydrochloride [2] | 202-765-8 [1] 256-960-8 [2] | 99-55-8 [1] 51085-52-0 [2] | Carc. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 3 | H351 H331 H311 H301 H412 | GHS06 GHS08 Gef. | H351 H331 H311 H301 H412 | |||
| 612-211-00-0 | N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide | 416-470-9 | 170292-97-4 | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 612-212-00-6 | 2,6-dichloro-4-trifluoromethylaniline | 416-430-0 | 24279-39-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H315 H317 H410 | |||
| 612-213-00-1 | isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine | 419-850-2 | 148348-13-4 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 612-214-00-7 | 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine | 421-390-2 | 89114-90-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-215-00-2 | 3-chloro-2-(isopropylthio)aniline | 421-700-6 | 179104-32-6 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 612-216-00-8 | 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt | 425-870-2 | 19450-38-5 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 612-217-00-3 | 1-methoxy-2-propylamine | 422-550-4 | 37143-54-7 | Flam. Liq. 2 Skin Corr. 1B Acute Tox. 4 (*) Aquatic Chronic 3 | H225 H314 H302 H412 | GHS02 GHS05 GHS07 Gef. | H225 H314 H302 H412 | |||
| 612-219-00-4 | (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride | 402-200-7 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 612-220-00-X | N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine | 431-060-1 | 153719-38-1 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 612-221-00-5 | 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride | 429-560-8 | 4274-38-8 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 | H314 H332 H312 H302 H373** H317 H400 | GHS05 GHS08 GHS07 GHS09 Gef. | H314 H332 H312 H302 H373** H317 H400 | |||
| 612-222-00-0 | cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine | 425-080-8 | 104860-26-6 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H373** H318 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H312 H302 H373** H318 H410 | |||
| 612-223-00-6 | N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine | 425-300-2 | 186450-73-7 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 612-224-00-1 | N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine | 426-150-0 | 121246-28-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 612-225-00-7 | 1,4,7,10-tetraazacyclododecane | 425-450-9 | 294-90-6 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H314 H312 H302 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H312 H302 H410 | |||
| 612-226-00-2 | 3-(2'-phenoxyethoxy)propylamine | 427-870-8 | 6903-18-0 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H302 H315 H318 H412 | GHS05 GHS07 Gef. | H302 H315 H318 H412 | |||
| 612-227-00-8 | benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride | 428-290-8 | 120606-08-8 | Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 612-228-00-3 | reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine | 414-340-6 | - | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H226 H332 H312 H302 H371 H318 H317 H412 | GHS02 GHS05 GHS08 GHS07 Gef. | H226 H332 H312 H302 H371 H318 H317 H412 | |||
| 612-229-00-9 | mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine | - | 110235-47-7 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 612-230-00-4 | N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide | 431-530-4 | - | Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 612-231-00-X | 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride | 427-370-1 | 164288-56-6 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 612-232-00-5 | reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid | 430-410-9 | 186148-38-9 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 612-237-00-2 | hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] | 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] | 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] | Expl. 1.1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H201 H351 H312 H302 H373** H319 H315 H317 H400 | GHS01 GHS08 GHS07 GHS09 Gef. | H201 H351 H312 H302 H373** H319 H315 H317 H400 | T | ||
| 612-238-00-8 | (3-chloro-2-hydroxypropyl) trimethylammonium chloride % | 222-048-3 | 3327-22-8 | Carc. 2 Aquatic Chronic 3 | H351 H412 | GHS08 Achtg. | H351 H412 | B | ||
| 612-239-00-3 | biphenyl-3,3',4,4'-tetrayltetraamine; diaminobenzidine | 202-110-6 | 91-95-2 | Carc. 1B Muta. 2 | H350 H341 | GHS08 Gef. | H350 H341 | |||
| 612-240-00-9 | pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline | - | 53112-28-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-241-00-4 | piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] | 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] | 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] | Repr. 2 Eye Irrit. 2 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H361fd H319 H315 H334 H317 H412 | GHS08 Gef. | H361fd H319 H315 H334 H317 H412 | |||
| 612-242-00-X | cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | - | 121552-61-2 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M=10 | ||
| 612-243-00-5 | (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | 420-560-3 | 79617-97-3 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | M=10 | ||
| 612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | 421-310-6 | 87691-88-1 | Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f*** H302 H319 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361f*** H302 H319 H317 H410 | |||
| 612-245-00-6 | 2-ethylphenylhydrazine hydrochloride | 421-460-2 | 19398-06-2 | Carc. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H372** H302 H318 H317 H400 H410 | GHS05 GHS08 GHS07 GHS09 Gef. | H351 H372** H302 H318 H317 H410 | M=10 | ||
| 612-246-00-1 | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | 429-740-6 | 40722-80-3 | Carc. 1B Muta. 1B STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 | H350 H340 H373** H317 H412 | GHS08 GHS07 Gef. | H350 H340 H373** H317 H412 | |||
| 612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide | 423-530-8 | 152828-23-4 | STOT RE 1 Acute Tox. 4 * Aquatic Chronic 3 | H372** H302 H412 | GHS08 GHS07 Gef. | H372** H302 H412 | |||
| 612-248-00-2 | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) | 439-540-0 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 | H315 H317 H413 | GHS07 Achtg. | H315 H317 H413 | |||
| 612-249-00-8 | 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | 425-030-5 | 159939-85-2 | Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H361f*** H302 H314 H317 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H361f*** H302 H314 H317 H411 | |||
| 612-250-00-3 | chloro-N,N-dimethylformiminium chloride | 425-970-6 | 3724-43-4 | Repr. 1B Acute Tox. 4 * Skin Corr. 1A | H360D*** H302 H314 | GHS05 GHS08 GHS07 Gef. | H360D*** H302 H314 | EUH014 | ||
| 612-251-00-9 | cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | 426-020-3 | 51229-78-8 | Flam. Sol. 2 Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H228 H361d*** H302 H315 H317 H411 | GHS02 GHS08 GHS07 GHS09 Achtg. | H228 H361d*** H302 H315 H317 H411 | |||
| 612-252-00-4 | imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine | 428-040-8 | 138261-41-3 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] | 429-400-7 | 199327-61-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | 429-400-7 | 199327-61-2 | Repr. 1B Aquatic Chronic 3 | H360D*** H412 | GHS08 Gef. | H360D*** H412 | |||
| 612-254-00-5 | reaction products of diisopropanolamine with formaldehyde (1:4) | 432-440-8 | 220444-73-5 | Carc. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H351 H302 H314 H317 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H351 H302 H314 H317 H411 | |||
| 612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamine | 431-950-8 | 179474-79-4 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 | H312 H302 H314 H412 | GHS05 GHS07 Gef. | H312 H302 H314 H412 | |||
| 612-256-00-6 | benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | 427-470-3 | 137864-22-3 | Acute Tox. 4 * Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 612-257-00-1 | tripropylammonium dihydrogenphosphate | 433-700-3 | 35687-90-2 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | 437-720-3 | 227085-51-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 612-261-00-3 | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | 441-190-9 | 121451-05-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | M=10 | ||
| 612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | 444-360-0 | 191617-13-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 612-266-00-0 | 3-chloro-4-(3-fluorobenzyloxy)aniline | 445-590-4 | 202197-26-0 | Muta. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H341 H302 H373** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H341 H302 H373** H410 | |||
| 612-267-00-6 | bis(hydrogenated tallow C16-18-alkyl)hydroxylamine | 418-370-0 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 612-269-00-7 | reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | 420-720-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-270-00-2 | (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | 433-010-2 | - | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 | H302 H317 H412 | GHS07 Achtg. | H302 H317 H412 | |||
| 612-271-00-8 | reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | 434-970-5 | 160987-57-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 612-272-00-3 | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate | 435-210-5 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 612-273-00-9 | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | 435-650-8 | - | Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H410 | |||
| 612-274-00-4 | (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate | 445-750-3 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H318 H317 H412 | |||
| 612-275-00-X | fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | 447-880-6 | 206565-89-1 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | M=10 | ||
| 612-276-00-5 | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | 451-430-4 | 500717-36-2 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 612-277-00-0 | reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium | 451-440-9 | 586372-44-3 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 612-278-00-6 | ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | 214-984-6 | 1239-45-8 | Muta. 2 Acute Tox. 2 * Acute Tox. 4 * | H341 H330 H302 | GHS06 GHS08 Gef. | H341 H330 H302 | |||
| 612-279-00-1 | (R,S)-2-amino-3,3-dimethylbutane amide | 447-860-7 | 144177-62-8 | Repr. 2 STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H361f*** H373** H319 H315 H317 | GHS08 GHS07 Achtg. | H361f*** H373** H319 H315 H317 | |||
| 612-280-00-7 | 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine | 205-057-7 | 132-32-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 612-281-00-2 | leucomalachite green; N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline | 204-961-9 | 129-73-7 | Carc. 2 Muta. 2 | H351 H341 | GHS08 Achtg. | H351 H341 | |||
| 612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | M = 10 M = 10 | ||
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS08 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | |||||||
| Skin Irrit. 2 | H315 | GHS09 | H315 | |||||||
| Eye Dam. 1 | H318 | Gef. | H318 | |||||||
| Aquatic Acute 1 | H400 | H410 | ||||||||
| Aquatic Chronic 1 | H410 | |||||||||
| 612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | M = 10 M = 10 | ||
| Asp Tox. 1 | H304 | GHS07 | H304 | |||||||
| STOT SE 3 | H335 | GHS08 | H335 | |||||||
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS09 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | |||||||
| Skin Corr. 1B | H314 | Gef. | H314 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | M = 10 M = 10 | ||
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS05 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | |||||||
| Skin Irrit. 2 | H315 | GHS09 | H315 | |||||||
| Eye Dam. 1 | H318 | Gef. | H318 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | M = 10 M = 10 | ||
| Asp. Tox. 1 | H304 | GHS07 | H304 | |||||||
| STOT SE 3 | H335 | GHS08 | H335 | |||||||
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS09 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | |||||||
| Skin Corr. 1B | H314 | Gef. | H314 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | M = 10 M = 10 | ||
| Asp. Tox. 1 | H304 | GHS07 | H304 | |||||||
| STOT RE 2 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | GHS08 | H373 (Magen-Darm-Trakt, Leber, Immunsystem) | |||||||
| Skin Corr. 1B | H314 | GHS09 | H314 | |||||||
| Aquatic Acute 1 | H400 | Gef. | ||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 612-287-00-5 | fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine | - | 79622-59-6 | Repr. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 | H361d H332 H318 H317 H400 H410 | GHS08 GHS07 GHS05 GHS09 Gef. | H361d H332 H318 H317 H410 | M = 10 M = 10 | ||
| 612-288-00-0 | Bupirimat (ISO); 5-Butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulfamat | 255-391-2 | 41483-43-6 | Carc. 2 Skin Sens. 1B Aquatic Chronic 1 | H351 H317 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H317 H410 | M = 1 | ||
| 612-289-00-6 | Triflumizol (ISO); (1E)-N-[4-Chlor-2-(trifluormethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimin | - | 68694-11-1 | Repr. 1B Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H302 H373 (Leber) H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H360D H302 H373 (Leber) H317 H410 | M = 1 M = 1 | ||
| 612-290-00-1 | Reaktionsprodukte von Paraformaldehyd und 2-Hydroxypropylamin (Verhältnis 3:2); [aus 3,3'-Methylenbis[5-methyloxazolidin freigesetztes Formaldehyd] [aus Oxazolidin freigesetztes Formaldehyd]; [MBO] | - | - | Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2 | H350 H341 H332 H311 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H318 H317 H411 | GHS08 GHS06 GHS05 GHS09 Gef. | H350 H341 H332 H311 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 H411 | EUH071 | 8 9 | |
| 612-291-00-7 | Reaktionsprodukte von Paraformaldehyd und 2-Hydroxypropylamin (Verhältnis 1: 1); [aus α,α,α-Trimethyl-1,3,5-triazin-1,3,5 (2H,4H,6H)-triethanol freigesetztes Formaldehyd]; [HPT] | - | - | Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2 | H350 H341 H332 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H318 H317 H411 | GHS08 GHS07 GHS05 GHS09 Gef. | H350 H341 H332 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 H411 | EUH071 | 8 9 | |
| 612-292-00-2 | Methylhydrazin | 200-471-4 | 60-34-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 613-001-00-1 | ethyleneimine; aziridine | 205-793-9 | 151-56-4 | Flam. Liq. 2 Carc. 1B Muta. 1B Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Skin Corr. 1B Aquatic Chronic 2 | H225 H350 H340 H330 H310 H300 H314 H411 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H225 H350 H340 H330 H310 H300 H314 H411 | D | ||
| 613-002-00-7 | pyridine | 203-809-9 | 110-86-1 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) | H225 H332 H312 H302 | GHS02 GHS07 Gef. | H225 H332 H312 H302 | (*) | ||
| 613-003-00-2 | 1,2,3,4-tetranitrocarbazole | - | 6202-15-9 | Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H201 H332 H312 H302 | GHS01 GHS07 Gef. | H201 H332 H312 H302 | |||
| 613-004-00-8 | crimidine (ISO); 2-chloro-6-methylpyrimidin-4-yldimethylamine | 208-622-6 | 535-89-7 | Acute Tox. 2 (*) | H300 | GHS06 Gef. | H300 | |||
| 613-007-00-4 | desmetryne (ISO); 6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine | 213-800-1 | 1014-69-3 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 613-008-00-X | dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione | 208-576-7 | 533-74-4 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H410 | |||
| 613-009-00-5 | 2,4,6-trichloro-1,3,5-triazine; cyanuric chloride | 203-614-9 | 108-77-0 | Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 | H330 H302 H314 H317 | GHS06 GHS05 Gef. | H330 H302 H314 H317 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 613-010-00-0 | ametryn (ISO); N-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine | 212-634-7 | 834-12-8 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M = 100 | ||
| 613-011-00-6 | amitrole (ISO); 1,2,4-triazol-3-ylamine | 200-521-5 | 61-82-5 | Repr. 2 STOT RE 2 (*) Aquatic Chronic 2 | H361d (*)(*)(*) H373 (*)(*) H411 | GHS08 GHS09 Achtg. | H361d (*)(*)(*) H373 (*)(*) H411 | |||
| 613-012-00-1 | bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide | 246-585-8 | 25057-89-0 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H302 H319 H317 H412 | GHS07 Achtg. | H302 H319 H317 H412 | |||
| 613-013-00-7 | cyanazine (ISO); 2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile | 244-544-9 | 21725-46-2 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-014-00-2 | ethoxyquin(ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline | 202-075-7 | 91-53-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-015-00-8 | fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate | 238-134-9 | 14255-88-0 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 613-016-00-3 | fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole | 223-404-0 | 3878-19-1 | Carc. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H373 (Herz) H317 H400 H410 | GHS07 GHS08 GHS09 Achtg. | H351 H302 H373 (Herz) H317 H410 | M=1 | ||
| 613-017-00-9 | bis (8-hydroxyquinolinium) sulphate | 205-137-1 | 134-31-6 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-018-00-4 | morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion | - | 7411-47-4 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 | H302 H319 H335 H315 H412 | GHS07 Achtg. | H302 H319 H335 H315 H412 | |||
| 613-019-00-X | thioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline | 202-272-8 | 93-75-4 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-020-00-5 | tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine | 246-347-3 | 24602-86-6 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H360D (*)(*)(*) H332 H302 H315 H400 H410 | GHS08 GHS07 GHS09 Gef. | H360D (*)(*)(*) H332 H302 H315 H410 | |||
| 613-021-00-0 | dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile | 222-098-6 | 3347-22-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-022-00-6 | pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | A | ||
| 613-023-00-1 | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S(*)(Z)],3β]]-chrysanthemate; pyrethrin I | 204-455-8 | 121-21-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | |||
| 613-024-00-7 | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S(*)(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; pyrethrin II | 204-462-6 | 121-29-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | |||
| 613-025-00-2 | cinerin I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 246-948-0 | 25402-06-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-026-00-8 | cinerin II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate | 204-454-2 | 121-20-0 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-027-00-3 | piperidine | 203-813-0 | 110-89-4 | Flam. Liq. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B | H225 H331 H311 H314 | GHS02 GHS06 GHS05 Gef. | H225 H331 H311 H314 | (*) | ||
| 613-028-00-9 | morpholine | 203-815-1 | 110-91-8 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H226 H332 H312 H302 H314 | GHS02 GHS05 GHS07 Dg | H226 H332 H312 H302 H314 | |||
| 613-029-00-4 | dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid | 220-487-5 | 2782-57-2 | Ox. Sol. 2 Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H272 H302 H319 H335 H400 H410 | GHS03 GHS07 GHS09 Gef. | H272 H302 H319 H335 H410 | EUH031 | T | |
| 613-030-00-X | troclosene potassium; [1] troclosene sodium [2] | 218-828-8 [1] 220-767-7 [2] | 2244-21-5 [1] 2893-78-9 [2] | Ox. Sol. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H272 H302 H319 H335 H400 H410 | GHS03 GHS07 GHS09 Gef. | H272 H302 H319 H335 H410 | EUH031 | * STOT SE 3; H335: C ≥ 10 % EUH031: C ≥ 10 % | G |
| 613-030-01-7 | troclosene sodium, dihydrate | 220-767-7 | 51580-86-0 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H335 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H335 H410 | EUH031 | ||
| 613-031-00-5 | symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion | 201-782-8 | 87-90-1 | Ox. Sol. 2 Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H272 H302 H319 H335 H400 H410 | GHS03 GHS07 GHS09 Gef. | H272 H302 H319 H335 H410 | EUH031 | ||
| 613-032-00-0 | methyl-2,3,5,6-tetrachloro-4-pyridylsulphone; 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine | 236-035-5 | 13108-52-6 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 | H312 H302 H319 H317 | GHS07 Achtg. | H312 H302 H319 H317 | |||
| 613-033-00-6 | 2-methylaziridine; propyleneimine | 200-878-7 | 75-55-8 | Flam. Liq. 2 Carc. 1B Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Eye Dam. 1 Aquatic Chronic 2 | H225 H350 H330 H310 H300 H318 H411 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H225 H350 H330 H310 H300 H318 H411 | Carc. 1B; H350: C ≥ 0,01 % | ||
| 613-034-00-1 | 1,2-dimethylimidazole | 217-101-2 | 1739-84-0 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 | H302 H315 H318 | GHS05 GHS07 Gef. | H302 H315 H318 | |||
| 613-035-00-7 | 1-methylimidazole | 210-484-7 | 616-47-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B | H312 H302 H314 | GHS05 GHS07 Gef. | H312 H302 H314 | |||
| 613-036-00-2 | 2-methylpyridine; 2-picoline | 203-643-7 | 109-06-8 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 | H226 H332 H312 H302 H319 H335 | GHS02 GHS07 Achtg. | H226 H332 H312 H302 H319 H335 | |||
| 613-037-00-8 | 4-methylpyridine; 4-picoline | 203-626-4 | 108-89-4 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H226 H311 H332 H302 H319 H335 H315 | GHS02 GHS06 Gef. | H226 H311 H332 H302 H319 H335 H315 | |||
| 613-038-00-3 | 6-phenyl-1,3,5-triazine-2,4-diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine | 202-095-6 | 91-76-9 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 613-039-00-9 | ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol | 202-506-9 | 96-45-7 | Repr. 1B Acute Tox. 4 (*) | H360D (*)(*)(*) H302 | GHS08 GHS07 Gef. | H360D (*)(*)(*) H302 | |||
| 613-040-00-4 | azaconazole (ISO); 1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole | 262-102-3 | 60207-31-0 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-041-00-X | morpholine-4-carbonyl chloride | 239-213-0 | 15159-40-7 | Carc. 2 Eye Irrit. 2 Skin Irrit. 2 | H351 H319 H315 | GHS08 Achtg. | H351 H319 H315 | EUH014 | ||
| 613-042-00-5 | Imazalil (ISO); 1-[2-(Allyloxy)-2-(2,4-dichlorphenyl)ethyl]-1H-imidazol | 252-615-0 | 35554-44-0 | Carc. 2 Acute Tox. 3 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 1 | H351 H301 H332 H318 H410 | GHS08 GHS06 GHS05 GHS09 Gef. | H351 H301 H332 H318 H410 | M = 10 | ||
| 613-043-00-0 | imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 613-043-01-8 | imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Achtg. | H302 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % | ||
| 613-044-00-6 | captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide | 205-087-0 | 133-06-2 | Carc. 2 Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H351 H331 H318 H317 H400 | GHS06 GHS05 GHS08 GHS09 Gef. | H351 H331 H318 H317 H400 | M=10 | ||
| 613-045-00-1 | folpet (ISO); N-(trichloromethylthio)phthalimide | 205-088-6 | 133-07-3 | Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H351 H332 H319 H317 H400 | GHS08 GHS07 GHS09 Achtg. | H351 H332 H319 H317 H400 | M=10 | ||
| 613-046-00-7 | captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide | 219-363-3 | 2425-06-1 | Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H350 H317 H400 H410 | GHS08 GHS09 Gef. | H350 H317 H410 | |||
| 613-047-00-2 | 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate; dimetilan (ISO) | 211-420-0 | 644-64-4 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | |||
| 613-048-00-8 | carbendazim (ISO); methyl benzimidazol-2-ylcarbamate | 234-232-0 | 10605-21-7 | Muta. 1B Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H340 H360FD H400 H410 | GHS08 GHS09 Gef. | H340 H360FD H410 | |||
| 613-049-00-3 | benomyl (ISO); methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate | 241-775-7 | 17804-35-2 | Muta. 1B Repr. 1B STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H340 H360FD H335 H315 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H340 H360FD H335 H315 H317 H410 | M=10 | ||
| 613-050-00-9 | carbadox (INN); methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide | 229-879-0 | 6804-07-5 | Flam. Sol. 1 Carc. 1B Acute Tox. 4 (*) | H228 H350 H302 | GHS02 GHS08 GHS07 Gef. | H228 H350 H302 | T | ||
| 613-051-00-4 | molinate (ISO); S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate | 218-661-0 | 2212-67-1 | Carc. 2 Repr. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361f (*)(*)(*) H332 H302 H373 (*)(*) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H361f (*)(*)(*) H332 H302 H373 (*)(*) H317 H410 | M=100 | ||
| 613-052-00-X | trifenmorph (ISO); 4-tritylmorpholine | 215-812-2 | 1420-06-0 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-053-00-5 | anilazine (ISO); 2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline | 202-910-5 | 101-05-3 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H315 H400 H410 | GHS07 GHS09 Achtg. | H319 H315 H410 | |||
| 613-054-00-0 | thiabendazol (ISO); 2-(thiazole-4-yl)benzimidazole | 205-725-8 | 148-79-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-056-00-1 | 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate; difenzoquat methyl sulfate | 256-152-5 | 43222-48-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS09 Achtg. | H302 H410 | |||
| 613-057-00-7 | Dodemorph (ISO); 4-Cyclododecyl-2,6-dimethylmorpholin | 216-474-9 | 1593-77-7 | Repr. 2 STOT RE 2 Skin Corr. 1C Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 | H361d H373 (Leber) H314 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H361d H373 (Leber) H314 H317 H410 | EUH071 | M = 1 M = 1 | |
| 613-058-00-2 | permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 258-067-9 | 52645-53-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H332 H302 H317 H410 | M=1000 | ||
| 613-059-00-8 | profluralin (ISO); N-(cyclopropylmethyl)-α, α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine | 247-656-6 | 26399-36-0 | Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H400 H410 | GHS07 GHS09 Achtg. | H319 H410 | |||
| 613-060-00-3 | resmethrin (ISO); 5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate | 233-940-7 | 10453-86-8 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=1000 | ||
| 613-061-00-9 | 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania | 239-732-2 | 15662-33-6 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 613-062-00-4 | sabadilla (ISO); veratrine | - | 8051-02-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H319 H335 H315 | GHS07 Achtg. | H319 H335 H315 | |||
| 613-063-00-X | secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 247-554-1 | 26259-45-0 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H410 | |||
| 613-064-00-5 | 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane; sesamex | - | 51-14-9 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-065-00-0 | simetryn (ISO); 2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine | 213-801-7 | 1014-70-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-066-00-6 | terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 251-637-8 | 33693-04-8 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-067-00-1 | propazine(ISO); 2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine | 205-359-9 | 139-40-2 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 613-068-00-7 | atrazine (ISO); 2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine | 217-617-8 | 1912-24-9 | STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H317 H400 H410 | GHS08 GHS09 Achtg. | H373 (*)(*) H317 H410 | |||
| 613-069-00-2 | ε-caprolactam | 203-313-2 | 105-60-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 | H332 H302 H319 H335 H315 | GHS07 Achtg. | H332 H302 H319 H335 H315 | |||
| 613-070-00-8 | propylenethiourea | - | 2122-19-2 | Repr. 2 Acute Tox. 4 (*) Aquatic Chronic 3 | H361d (*)(*)(*) H302 H412 | GHS08 GHS07 Achtg. | H361d (*)(*)(*) H302 H412 | |||
| 613-071-00-3 | 2-fluoro-5-trifluoromethylpyridine | 400-290-2 | 69045-82-5 | Flam. Liq. 3 Skin Sens. 1 Aquatic Chronic 3 | H226 H317 H412 | GHS02 GHS07 Achtg. | H226 H317 H412 | |||
| 613-072-00-9 | N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine | 401-280-0 | 91273-04-0 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H314 H317 H411 | |||
| 613-073-00-4 | N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine | 401-410-6 | 10357-99-0 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H373 (*)(*) H317 H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H317 H411 | |||
| 613-074-00-X | 3-(3-methylpent-3-yl)isoxazol-5-ylamine | 401-460-9 | 82560-06-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Dam. 1 Aquatic Chronic 3 | H331 H301 H318 H412 | GHS06 GHS05 Gef. | H331 H301 H318 H412 | |||
| 613-075-00-5 | 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 401-570-7 | 89415-87-2 | Ox. Sol. 1 (*)(*)(*)(*) Acute Tox. 3 (*) Skin Corr. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 | H271 H331 H314 H302 H317 H400 | GHS03 GHS06 GHS05 GHS09 Gef. | H271 H331 H314 H302 H317 H400 | |||
| 613-076-00-0 | 3-chloro-5-trifluoromethyl-2-pyridylamine | 401-670-0 | 79456-26-1 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 613-077-00-6 | reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine | 401-940-8 | - | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Chronic 2 | H302 H319 H411 | GHS07 GHS09 Achtg. | H302 H319 H411 | |||
| 613-078-00-1 | N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine | 401-990-0 | 106990-43-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-079-00-7 | 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers | 402-520-7 | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H315 H317 H410 | |||
| 613-080-00-2 | 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione | 402-540-6 | 105254-85-1 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 613-081-00-8 | 1-butyl-2-methylpyridinium bromide | 402-680-8 | 26576-84-1 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 613-082-00-3 | 2-methyl-1-pentylpyridinium bromide | 402-690-2 | - | Acute Tox. 4 ((*)) Acute Tox. 4 ((*)) Aquatic Chronic 3 | H312 H302 H412 | GHS07 Achtg. | H312 H302 H412 | |||
| 613-083-00-9 | 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate | 402-120-2 | - | Skin Corr. 1B STOT RE 2 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H373 (*)(*) H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H314 H373 (*)(*) H317 H410 | |||
| 613-084-00-4 | 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate | 402-490-5 | 106359-93-7 | Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H400 H410 | GHS07 GHS09 Achtg. | H319 H410 | |||
| 613-085-00-X | reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione | 401-970-1 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-086-00-5 | caffeine | 200-362-1 | 58-08-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-087-00-0 | tetrahydrothiophene | 203-728-9 | 110-01-0 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H225 H332 H312 H302 H319 H315 H412 | GHS02 GHS07 Gef. | H225 H332 H312 H302 H319 H315 H412 | |||
| 613-088-00-6 | 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one | 220-120-9 | 2634-33-5 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H302 H315 H318 H317 H400 | GHS05 GHS07 GHS09 Gef. | H302 H315 H318 H317 H400 | Skin Sens. 1; H317: C ≥ 0,05 % | ||
| 613-089-00-1 | diquat dibromide; [1] diquat dichloride; [2] 6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] | 201-579-4 [1] 223-714-6 [2] 301-467-6 [3] | 85-00-7 [1] 4032-26-2 [2] 94021-76-8 [3] | Acute Tox. 2 (*) STOT RE 1 Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H372 (*)(*) H302 H319 H335 H315 H317 H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H372 (*)(*) H302 H319 H335 H315 H317 H410 | |||
| 613-090-00-7 | paraquat dichloride; 1,1-dimethyl-4,4'-bipyridinium dichloride; [1] paraquat dimethylsulfate; 1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] | 217-615-7 [1] 218-196-3 [2] | 1910-42-5 [1] 2074-50-2 [2] | Acute Tox. 2 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H330 H311 H301 H372 (*)(*) H319 H335 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H311 H301 H372 (*)(*) H319 H335 H315 H410 | |||
| 613-091-00-2 | morfamquat dichloride; [1] morfamquat sulfate [2] | 225-062-8 [1] -[2] | 4636-83-3 [1] 29873-36-7 [2] | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 | H302 H319 H335 H315 H412 | GHS07 Achtg. | H302 H319 H335 H315 H412 | |||
| 613-092-00-8 | 1,10-phenanthroline | 200-629-2 | 66-71-7 | Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 613-093-00-3 | hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | 400-050-7 | 85153-92-0 | Resp. Sens. 1 Skin Sens. 1 | H334 H317 | GHS08 Gef. | H334 H317 | |||
| 613-094-00-9 | 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine | 401-360-5 | 5248-39-5 | Acute Tox. 4 (*) STOT RE 2 (*) | H302 H373 (*)(*) | GHS08 GHS07 Achtg. | H302 H373 (*)(*) | |||
| 613-095-00-4 | sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate | 403-080-9 | 92484-48-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-096-00-X | 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine | 403-580-7 | 62096-63-3 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-097-00-5 | 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | 403-690-5 | 111298-82-9 | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H334 H317 H412 | GHS08 Gef. | H334 H317 H412 | |||
| 613-098-00-0 | N-(n-octyl)-2-pyrrolidone | 403-700-8 | 2687-94-7 | Skin Corr. 1B Aquatic Chronic 2 | H314 H411 | GHS05 GHS09 Gef. | H314 H411 | |||
| 613-099-00-6 | 1-dodecyl-2-pyrrolidone | 403-730-1 | 2687-96-9 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H317 H410 | |||
| 613-100-00-X | 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione | 404-230-6 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 613-101-00-5 | N - tert-pentyl-2-benzothiazolesulfenamide | 404-380-2 | 110799-28-5 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-102-00-0 | dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine | 404-200-2 | 110488-70-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-103-00-6 | sodium 5-n-butylbenzotriazole | 404-450-2 | 118685-34-0 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H302 H314 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H314 H317 H411 | |||
| 613-104-00-1 | 5-tert-butyl-3-isoxazolylamine hydrochloride | 404-840-2 | - | Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Aquatic Chronic 3 | H302 H373 (*)(*) H318 H412 | GHS08 GHS05 GHS07 Gef. | H302 H373 (*)(*) H318 H412 | |||
| 613-105-00-7 | hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) | 405-160-9 | 124537-30-0 | Acute Tox. 3 (*) Skin Sens. 1 Aquatic Chronic 3 | H301 H317 H412 | GHS06 Gef. | H301 H317 H412 | |||
| 613-106-00-2 | tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate | 405-240-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 613-107-00-8 | hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate | 405-280-1 | 76508-02-6 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 613-108-00-3 | benzothiazole-2-thiol | 205-736-8 | 149-30-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-109-00-9 | bis(piperidinothiocarbonyl) disulphide | 202-328-1 | 94-37-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 | H319 H335 H315 H317 | GHS07 Achtg. | H319 H335 H315 H317 | |||
| 613-110-00-4 | dimepiperate (ISO); S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate | 262-784-2 | 61432-55-1 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 613-111-00-X | 1,2,4-triazole | 206-022-9 | 288-88-0 | Repr. 2 Acute Tox. 4 (*) Eye Irrit. 2 | H361d (*)(*)(*) H302 H319 | GHS08 GHS07 Achtg. | H361d (*)(*)(*) H302 H319 | |||
| 613-112-00-5 | octhilinone (ISO); 2-octyl-2H-isothiazol-3-one | 247-761-7 | 26530-20-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H302 H314 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H331 H311 H302 H314 H317 H410 | Skin Sens. 1; H317: C ≥ 0,05 % | ||
| 613-113-00-0 | 2-(morpholinothio)benzothiazole | 203-052-4 | 102-77-2 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H315 H317 H411 | GHS07 GHS09 Achtg. | H319 H315 H317 H411 | |||
| 613-114-00-6 | 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine | 225-208-0 | 4719-04-4 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | Skin Sens. 1; H317: C ≥ 0,1 % | ||
| 613-115-00-1 | hymexazol (ISO); 3-hydroxy-5-methylisoxazole | 233-000-6 | 10004-44-1 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 613-116-00-7 | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 211-986-9 | 731-27-1 | Acute Tox. 2* STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H330 H372** H319 H335 H315 H317 H400 | GHS06 GHS08 GHS09 Gef. | H330 H372** H319 H335 H315 H317 H400 | M=10 | ||
| 613-116-01-4 | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 211-986-9 | 731-27-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H319 H335 H315 H317 H400 | GHS07 GHS09 Achtg. | H319 H335 H315 H317 H400 | M=10 | ||
| 613-117-00-2 | diniconazole (ISO); (E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol; (E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol | - | 76714-88-0 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-118-00-8 | flubenzimine (ISO); N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline | 253-703-1 | 37893-02-0 | Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H319 H400 H410 | GHS07 GHS09 Achtg. | H319 H410 | |||
| 613-119-00-3 | (benzothiazol-2-ylthio)methyl thiocyanate; TCMTB | 244-445-0 | 21564-17-0 | Acute Tox. 2 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H302 H319 H315 H317 H400 H410 | GHS06 GHS09 Gef. | H330 H302 H319 H315 H317 H410 | |||
| 613-120-00-9 | bioresmethrin (ISO); (5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate | 249-014-0 | 28434-01-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1000 | ||
| 613-121-00-4 | Chlorsulfuron (ISO); 2-Chlor-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2- yl)amino]carbonyl]benzolsulfonamid | 265-268-5 | 64902-72-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1 000 M = 100 | ||
| 613-122-00-X | diclobutrazol (R (*), R (*))-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol | - | 75736-33-3 | Eye Irrit. 2 Aquatic Chronic 2 | H319 H411 | GHS07 GHS09 Achtg. | H319 H411 | |||
| 613-123-00-5 | 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem | 251-684-4 | 33813-20-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-124-00-0 | fenpropimorph (ISO); cis-4-[3-(p - tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine | 266-719-9 | 67564-91-4 | Repr. 2 Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Chronic 2 | H361d (*)(*)(*) H302 H315 H411 | GHS08 GHS07 GHS09 Achtg. | H361d (*)(*)(*) H302 H315 H411 | |||
| 613-125-00-6 | hexythiazox(ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide | - | 78587-05-0 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-126-00-1 | imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate | - | 81334-34-1 | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 613-127-00-7 | 1,1-dimethylpiperidinium chloride; mepiquat chloride | 246-147-6 | 24307-26-4 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 613-128-00-2 | prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide | 266-994-5 | 67747-09-5 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-129-00-8 | metamitron (ISO); 4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one | 255-349-3 | 41394-05-2 | Acute Tox. 4 (*) Aquatic Acute 1 | H302 H400 | GHS07 GHS09 Achtg. | H302 H400 | |||
| 613-131-00-9 | pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one | - | 57369-32-1 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 613-132-00-4 | hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione | 257-074-4 | 51235-04-2 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H410 | |||
| 613-133-00-X | Etridiazol (ISO); 5-Ethoxy-3-trichlormethyl-1,2,4-thiadiazol | 219-991-8 | 2593-15-9 | Carc. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H317 H410 | M = 1 M = 1 | ||
| 613-134-00-5 | myclobutanil(ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile | - | 88671-89-0 | Repr. 2 Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Chronic 2 | H361d (*)(*)(*) H302 H319 H411 | GHS08 GHS07 GHS09 Achtg. | H361d (*)(*)(*) H302 H319 H411 | |||
| 613-135-00-0 | di(benzothiazol-2-yl) disulphide | 204-424-9 | 120-78-5 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | EUH031 | ||
| 613-136-00-6 | N-cyclohexylbenzothiazole-2-sulphenamide | 202-411-2 | 95-33-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-137-00-1 | methabenzthiazuron (ISO); 1-(1,3-benzothiazol-2-yl)1,3-dimethylurea | 242-505-0 | 18691-97-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-138-00-7 | quinoxyfen (ISO); 5,7-dichloro-4-(4-fluorophenoxy)quinoline | - | 124495-18-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-139-00-2 | metsulfuron-methyl (ISO); methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate | - | 74223-64-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1000 | ||
| 613-140-00-8 | cycloheximide (ISO); 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione | 200-636-0 | 66-81-9 | Muta. 2 Repr. 1B Acute Tox. 2 (*) Aquatic Chronic 2 | H341 H360D (*)(*)(*) H300 H411 | GHS06 GHS08 GHS09 Gef. | H341 H360D (*)(*)(*) H300 H411 | |||
| 613-141-00-3 | 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone | 401-470-3 | 93686-63-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-142-00-9 | trans - N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate | 405-860-4 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-143-00-4 | 1-(3-phenylpropyl)-2-methylpyridinium bromide | 405-930-4 | 10551-42-5 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Chronic 3 | H302 H319 H412 | GHS07 Achtg. | H302 H319 H412 | |||
| 613-144-00-X | reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate | 406-460-2 | 125139-08-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-145-00-5 | (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate | 406-960-0 | 77497-97-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-146-00-0 | N-ethyl-N-methylpiperidinium iodide | 407-780-5 | 4186-71-4 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 613-147-00-6 | 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine | 407-940-4 | 111681-72-2 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-148-00-1 | tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane | 411-240-4 | 143683-23-2 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-149-00-7 | Pyridaben (ISO); 2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-chlorpyridazin-3(2H)-on | 405-700-3 | 96489-71-3 | Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | M = 1 000 M = 1 000 | ||
| 613-150-00-2 | 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione | 406-295-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-151-00-8 | 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine | 406-360-9 | 104218-44-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-152-00-3 | phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate | 406-600-2 | 89392-03-0 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-153-00-9 | 2,3,5-trichloropyridine | 407-270-2 | 16063-70-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-154-00-4 | 2-amino-4-chloro-6-methoxypyrimidine | 410-050-9 | 5734-64-5 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-155-00-X | 5-chloro-2,3-difluoropyridine | 410-090-7 | 89402-43-7 | Flam. Liq. 3 Acute Tox. 4 (*) Aquatic Chronic 3 | H226 H302 H412 | GHS02 GHS07 Achtg. | H226 H302 H412 | |||
| 613-156-00-5 | 2-butyl-4-chloro-5-formylimidazole | 410-260-0 | 83857-96-9 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-157-00-0 | 2,4-diamino-5-methoxymethylpyrimidine | 410-330-0 | 54236-98-5 | Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 | H302 H373 (*)(*) H319 | GHS08 GHS07 Achtg. | H302 H373 (*)(*) H319 | |||
| 613-158-00-6 | 2,3-dichloro-5-trifluoromethyl-pyridine | 410-340-5 | 69045-84-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H332 H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H332 H302 H318 H317 H411 | |||
| 613-159-00-1 | fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline | 410-580-0 | 120928-09-8 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H301 H332 H400 H410 | GHS06 GHS09 Gef. | H301 H332 H410 | |||
| 613-160-00-7 | (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide | 411-000-9 | 125224-62-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 613-161-00-2 | (2,4-diaminopteridin-6-yl)methanol hydrobromide | 430-620-0 | 76145-91-0 | STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 | H373** H317 H412 | GHS08 GHS07 Achtg. | H373** H317 H412 | |||
| 613-162-00-8 | (6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide | 423-260-0 | 100988-63-4 | Muta. 2 Skin Sens. 1 Aquatic Chronic 2 | H341 H317 H411 | GHS08 GHS07 GHS09 Achtg. | H341 H317 H411 | |||
| 613-163-00-3 | azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea | - | 120162-55-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=1000 | ||
| 613-164-00-9 | flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide | - | 142459-58-3 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H317 H410 | M=100 | ||
| 613-165-00-4 | flupyrsulfuron-methyl-sodium (ISO); methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt | - | 144740-54-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=100 | ||
| 613-166-00-X | Flumioxazin (ISO); 2-[7-Fluor-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindol-1,3(2H)-dion | - | 103361-09-7 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360D H400 H410 | GHS08 GHS09 Gef. | H360D H410 | M = 1 000 M = 1 000 | ||
| 613-167-00-5 | reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) | - | 55965-84-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H311 H301 H314 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H331 H311 H301 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1; H317: C ≥ 0,0015 % | ||
| 613-168-00-0 | 1-vinyl-2-pyrrolidone | 201-800-4 | 88-12-0 | Carc. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) STOT SE 3 Eye Dam. 1 | H351 H332 H312 H302 H373 (*)(*) H335 H318 | GHS06 GHS05 GHS09 Gef. | H351 H332 H312 H302 H373 (*)(*) H335 H318 | D | ||
| 613-169-00-6 | 9-vinylcarbazole | 216-055-0 | 1484-13-5 | Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H341 H312 H302 H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H341 H312 H302 H315 H317 H410 | M=100 | ||
| 613-170-00-1 | 2,2-ethylmethylthiazolidine | 404-500-3 | 694-64-4 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 613-171-00-7 | hexaconazole (ISO); (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol | 413-050-7 | 79983-71-4 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 613-172-00-2 | 5-chloro-1,3-dihydro-2H-indol-2-one | 412-200-9 | 17630-75-0 | Repr. 2 Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 | H361f (*)(*)(*) H302 H317 H412 | GHS08 GHS07 Achtg. | H361f (*)(*)(*) H302 H317 H412 | |||
| 613-173-00-8 | fluquinconazole (ISO); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one | 411-960-9 | 136426-54-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H372 (*)(*) H312 H315 H400 H410 | GHS06 GHS08 GHS09 Gef. | H331 H301 H372 (*)(*) H312 H315 H410 | |||
| 613-174-00-3 | tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether | 407-760-6 | 112281-77-3 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 | H332 H302 H411 | GHS07 GHS09 Achtg. | H332 H302 H411 | |||
| 613-175-00-9 | epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane | 406-850-2 | 133855-98-8 | Carc. 2 | H351 | GHS08 | H351 | |||
| Repr. 1B | H360Df | GHS09 | H360Df | |||||||
| Aquatic Chronic 2 | H411 | Gef. | H411 | |||||||
| 613-176-00-4 | 2-methyl-2-azabicyclo[2.2.1]heptane | 404-810-9 | 4524-95-2 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B | H226 H312 H302 H373 (*)(*) H314 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H312 H302 H373 (*)(*) H314 | |||
| 613-177-00-X | 8-amino-7-methylquinoline | 412-760-4 | 5470-82-6 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 | H312 H302 H317 H411 | GHS07 GHS09 Achtg. | H312 H302 H317 H411 | |||
| 613-178-00-5 | 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine | 410-470-2 | 137796-06-6 | Skin Corr. 1B Skin Sens. 1 | H314 H317 | GHS05 GHS07 Gef. | H314 H317 | STOT SE 3; H335: C ≥ 5 % | ||
| 613-179-00-0 | lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide | 411-690-1 | 111337-53-2 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H302 H314 H317 H411 | GHS05 GHS07 Gef. | H302 H314 H317 H411 | |||
| 613-180-00-6 | N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide | 407-430-1 | 3741-80-8 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-181-00-1 | 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone | 405-090-9 | 67485-29-4 | STOT RE 1 Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H372 (*)(*) H302 H319 H400 H410 | GHS08 GHS07 GHS09 Gef. | H372 (*)(*) H302 H319 H410 | |||
| 613-182-00-7 | 1-(1-naphthylmethyl)quinolinium chloride | 406-220-7 | 65322-65-8 | Carc. 2 Muta. 2 Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H351 H341 H302 H315 H318 H412 | GHS08 GHS05 GHS07 Gef. | H351 H341 H302 H315 H318 H412 | |||
| 613-183-00-2 | reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one | 413-640-4 | - | STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H400 H410 | GHS08 GHS09 Achtg. | H373 (*)(*) H410 | |||
| 613-184-00-8 | nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate | 413-670-8 | - | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 613-185-00-3 | 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one | 407-630-9 | 82633-79-2 | Acute Tox. 3 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H301 H318 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H301 H318 H317 H410 | |||
| 613-186-00-9 | (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate | 408-050-9 | 76855-69-1 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H317 H411 | GHS07 GHS09 Achtg. | H319 H317 H411 | |||
| 613-187-00-4 | 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene | 410-530-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 613-188-00-X | 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone | 411-500-7 | 116256-11-2 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 613-189-00-5 | 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane | 414-030-0 | 52667-88-6 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-190-00-0 | disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate | 414-040-5 | 149530-93-8 | Acute Tox. 4 (*) Skin Sens. 1 | H302 H317 | GHS07 Achtg. | H302 H317 | |||
| 613-191-00-6 | 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine | 421-150-7 | 143860-04-2 | Repr. 1B Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360F (*)(*)(*) H314 H400 H410 | GHS08 GHS05 GHS09 Gef. | H360F (*)(*)(*) H314 H410 | |||
| 613-192-00-1 | 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane | 426-750-2 | 151860-15-0 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-193-00-7 | pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate | 414-930-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-194-00-2 | 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt | 418-000-8 | 163062-28-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-195-00-8 | 2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one) | 418-280-1 | 18600-59-4 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 613-196-00-3 | 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt | 418-380-5 | 168113-78-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-197-00-9 | reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine | 420-390-1 | 187547-46-2 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-198-00-4 | 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine | 415-500-8 | 145963-84-4 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 | H302 H373** H412 | GHS08 GHS07 Achtg. | H302 H373** H412 | |||
| 613-199-00-X | reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione | 421-550-1 | - | Carc. 1B Repr. 1B Skin Sens. 1 Aquatic Chronic 3 | H350 H360D (*)(*)(*) H317 H412 | GHS08 Gef. | H350 H360D (*)(*)(*) H317 H412 | |||
| 613-200-00-3 | Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts | 420-980-7 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-201-00-9 | (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole | 422-390-5 | 143322-57-0 | Repr. 2 STOT RE 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f (*)(*)(*) H372 (*)(*) H332 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Gef. | H361f (*)(*)(*) H372 (*)(*) H332 H302 H317 H410 | EUH070 | ||
| 613-202-00-4 | pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one | - | 123312-89-0 | Carc. 2 Aquatic Chronic 3 | H351 H412 | GHS08 Achtg. | H351 H412 | |||
| 613-203-00-X | pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] | - [1] - [2] | 129630-19-9 [1] 129630-17-7 [2] | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=1000 | ||
| 613-204-00-5 | oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | 254-637-6 | 39807-15-3 | Repr. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H361d*** H373** H400 H410 | GHS08 GHS09 Achtg. | H361d*** H373** H410 | M = 1000 | ||
| 613-205-00-0 | propiconazole(ISO); (±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole | 262-104-4 | 60207-90-1 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 613-206-00-6 | fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one | - | 161326-34-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-208-00-7 | imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid | - | 114311-32-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-209-00-2 | cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride | 417-430-3 | 63645-17-0 | Acute Tox. 3 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 | H301 H373 (*)(*) H317 H411 | GHS06 GHS08 GHS09 Gef. | H301 H373 (*)(*) H317 H411 | |||
| 613-210-00-8 | 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane | 417-650-1 | 88128-57-8 | STOT RE 2 (*) Aquatic Chronic 3 | H373 (*)(*) H412 | GHS08 Achtg. | H373 (*)(*) H412 | |||
| 613-211-00-3 | N-methyl-4-(p-formylstyryl)pyridinium methylsulfate | 418-240-3 | 74401-04-0 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-212-00-9 | 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) | 418-320-8 | 133467-41-1 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-213-00-4 | cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline | 416-040-0 | 120807-02-5 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-214-00-X | N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide | 416-260-7 | 147613-95-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-215-00-5 | 2-chloromethyl-3,4-dimethoxypyridinium chloride | 416-440-5 | 72830-09-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H312 H302 H373 (*)(*) H315 H318 H317 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H312 H302 H373 (*)(*) H315 H318 H317 H411 | |||
| 613-216-00-0 | 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole | 416-490-8 | 162208-01-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-217-00-6 | 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine | 416-770-1 | 73754-27-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-218-00-1 | 6-hydroxyindole | 417-020-4 | 2380-86-1 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H302 H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H302 H318 H317 H411 | |||
| 613-219-00-7 | 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole | 417-140-7 | 79185-77-6 | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 613-220-00-2 | trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide | 417-290-3 | 147086-81-5 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 613-221-00-8 | 2-chloro-5-methyl-pyridine | 418-050-0 | 18368-64-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Chronic 3 | H312 H302 H315 H412 | GHS07 Achtg. | H312 H302 H315 H412 | |||
| 613-222-00-3 | 4-(1-oxo-2-propenyl)-morpholine | 418-140-1 | 5117-12-4 | Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 | H302 H373 (*)(*) H318 H317 | GHS08 GHS05 GHS07 Gef. | H302 H373 (*)(*) H318 H317 | |||
| 613-223-00-9 | N-isopropyl-3-(4-fluorophenyl)-1H-indole | 418-790-4 | 93957-49-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-224-00-4 | 2,5-dimercaptomethyl-1,4-dithiane | 419-770-8 | 136122-15-1 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H317 H410 | |||
| 613-225-00-X | reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. | 421-290-9 | - | STOT RE 2 (*) Aquatic Chronic 4 | H373 (*)(*) H413 | GHS08 Achtg. | H373 (*)(*) H413 | |||
| 613-226-00-5 | 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride | 420-950-3 | 163831-67-2 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 613-227-00-0 | (±)-[(R (*),R (*)) and (R (*),S (*))]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-600-2 | 99199-90-3 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 613-228-00-6 | (±)-(R (*),S (*))-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-630-6 | 793669-26-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-229-00-1 | 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine | 411-930-5 | 106917-31-1 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 613-230-00-7 | florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide | - | 145701-23-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-231-00-2 | 2,6-diamino-3-((pyridine-3-yl)azo)pyridine | 421-430-9 | 28365-08-4 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 | H302 H373** H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H411 | |||
| 613-232-00-8 | 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide | 431-030-6 | 163269-30-5 | Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H373** H318 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H331 H373** H318 H410 | |||
| 613-233-00-3 | 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane | 423-230-7 | 56552-15-9 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-234-00-9 | imidazo[1,2-b]pyridazin hydrochloride | 431-510-5 | 18087-70-2 | Acute Tox. 4 * Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 613-235-00-4 | 2,3-dihydro-2,2-dimethyl-1H-perimidine | 424-060-6 | 6364-17-6 | Acute Tox. 4* STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H317 H410 | |||
| 613-236-00-X | 2-chloro-3-trifluoromethylpyridine | 424-520-6 | 65753-47-1 | Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Chronic 3 | H311 H301 H372** H314 H412 | GHS06 GHS05 GHS08 Gef. | H311 H301 H372** H314 H412 | |||
| 613-237-00-5 | 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine | 424-950-4 | 133949-92-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-238-00-0 | sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate | 430-890-1 | 81992-66-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 613-239-00-6 | 2-[3-(methylamino)propyl]-1H-benzimidazole | 425-760-4 | 64137-52-6 | Eye Dam. 1 Aquatic Chronic 3 | H318 H412 | GHS05 Gef. | H318 H412 | |||
| 613-241-00-7 | 3-(2H-tetrazol-5-yl)pyridine | 426-810-8 | 3250-74-6 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-242-00-2 | reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts | 426-860-0 | 191877-09-5 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-243-00-8 | 4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) | 427-350-0 | 182235-14-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-244-00-3 | 5,7-dichloro-4-hydroxyquinoline | 427-420-0 | 21873-52-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-245-00-9 | 2-fluoro-6-trifluoromethylpyridine | 428-100-3 | 94239-04-0 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H226 H332 H302 H412 | GHS02 GHS07 Achtg. | H226 H332 H302 H412 | |||
| 613-246-00-4 | 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | 428-200-7 | 103577-66-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-247-00-X | 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole | 428-910-7 | 107786-36-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-248-00-5 | 3,4-dimethyl-1H-pyrazole | 429-130-1 | 2820-37-3 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 613-249-00-0 | 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate | 429-300-3 | 155601-30-2 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 613-250-00-6 | reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine | 429-990-6 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H318 H317 H412 | GHS05 GHS07 Gef. | H318 H317 H412 | |||
| 613-251-00-1 | (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole | 430-560-5 | 180637-89-2 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 | H302 H373** H318 H317 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 H317 | |||
| 613-253-00-2 | 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5) | 430-580-4 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | EUH019 | ||
| 613-254-00-8 | forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea | - | 68157-60-8 | Carc. 2 Aquatic Chronic 2 | H351 H411 | GHS08 GHS09 Achtg. | H351 H411 | |||
| 613-255-00-3 | reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II) | 424-270-8 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-256-00-9 | 3'5'-anhydro thymidine | 425-810-5 | 38313-48-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-257-00-4 | 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate | 426-400-9 | 170222-39-6 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 613-258-00-X | reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt | 427-730-6 | 202420-04-0 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 613-259-00-5 | reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate | 428-790-6 | 72963-72-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 613-260-00-0 | (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin | 430-730-9 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H400 H410 | GHS05 GHS09 Gef. | H318 H410 | |||
| 613-261-00-6 | pyrazole-1-carboxamidine monohydrochloride | 429-520-1 | 4023-02-3 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H373** H318 H317 H412 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 H317 H412 | |||
| 613-262-00-1 | disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene | 427-310-2 | 180850-95-7 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-263-00-7 | monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate | 429-570-2 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 613-266-00-3 | 2-chloro-5-chloromethylthiazole | 429-830-5 | 105827-91-6 | Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H311 H314 H302 H317 H411 | GHS06 GHS05 GHS09 Gef. | H311 H314 H302 H317 H411 | |||
| 613-267-00-9 | thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine | 428-650-4 | 153719-23-4 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=10 | ||
| 613-268-00-4 | (4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine | 425-930-8 | 151213-39-7 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 | H314 H332 H302 H373** H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H314 H332 H302 H373** H411 | |||
| 613-269-00-X | 2-thiazolidinylidenecyanamide | 427-720-1 | 26364-65-8 | Acute Tox. 4* STOT RE 2 * Aquatic Chronic 3 | H302 H373** H412 | GHS08 GHS07 Achtg. | H302 H373** H412 | |||
| 613-270-00-5 | 5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide | 428-150-6 | 113171-13-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-271-00-0 | tritosulfuron (ISO) (containing ≤ 0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT) | - | 142469-14-5 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M=10 | ||
| 613-272-00-6 | pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate | - | - | Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H331 H315 H400 H410 | GHS06 GHS09 Gef. | H331 H315 H410 | M=100 | ||
| 613-273-00-1 | tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine | 427-600-9 | 192439-46-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-274-00-7 | 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate | 427-400-1 | 140623-89-8 | Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H314 H302 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H314 H302 H317 H410 | |||
| 613-275-00-2 | 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride | 424-530-0 | 93076-03-0 | Acute Tox. 3 * STOT SE 2 STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H301 H371** H373** H318 H317 H411 | GHS06 GHS05 GHS08 GHS09 Gef. | H301 H371** H373** H318 H317 H411 | |||
| 613-276-00-8 | 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one | 426-110-2 | 98377-35-6 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-277-00-3 | (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one | 427-070-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-278-00-9 | (3-aminophenyl)pyridin-3-ylmethanone | 428-230-0 | 79568-06-2 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373** H400 H410 | GHS08 GHS09 Achtg. | H373** H410 | |||
| 613-279-00-4 | 2-ethyl-2,3-dihydro-2-methyl-1H-perimidine | 424-380-6 | 43057-68-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H410 | |||
| 613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea | 230-625-6 | 7226-23-5 | Repr. 2 Acute Tox. 4 * Eye Dam. 1 | H361f*** H302 H318 | GHS05 GHS08 GHS07 Gef. | H361f*** H302 H318 | |||
| 613-281-00-5 | quinoline | 202-051-6 | 91-22-5 | Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H350 H341 H312 H302 H319 H315 H411 | GHS08 GHS07 GHS09 Gef. | H350 H341 H312 H302 H319 H315 H411 | |||
| 613-282-00-0 | triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | - | 131983-72-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 613-283-00-6 | ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | 265-667-4 | 65277-42-1 | Repr. 1B Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H360F*** H301 H373** H400 H410 | GHS06 GHS08 GHS09 Gef. | H360F*** H301 H373** H410 | |||
| 613-284-00-1 | metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | - | 125116-23-6 | Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 | H361d*** H302 H411 | GHS08 GHS07 GHS09 Achtg. | H361d*** H302 H411 | |||
| 613-285-00-7 | 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] | 219-989-7 [1] 219-989-7 [2] | 2592-95-2 [1] 123333-53-9 [2] | Expl. 1.3 | H203 | GHS01 Gef. | H203 | |||
| 613-286-00-2 | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | 418-260-2 | 183196-57-8 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 613-286-01-X | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | 418-260-2 | 183196-57-8 | Repr. 1B Skin Sens. 1 | H360D*** H317 | GHS08 GHS07 Gef. | H360D*** H317 | |||
| 613-287-00-8 | 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | 419-540-7 | 160194-26-3 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | 420-930-4 | 135756-61-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 613-289-00-9 | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | 432-020-4 | 142623-48-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | 432-470-1 | 189012-93-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H318 H317 H410 | |||
| 613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | 434-820-9 | 106461-41-0 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H373** H400 H410 | GHS08 GHS09 Achtg. | H373** H410 | |||
| 613-292-00-5 | N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | 435-010-8 | 26157-73-3 | Muta. 2 Aquatic Chronic 3 | H341 H412 | GHS08 Achtg. | H341 H412 | |||
| 613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | 448-050-6 | 444065-11-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-294-00-6 | 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | 448-260-8 | 379268-96-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-295-00-1 | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride | 448-720-8 | 363138-44-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 613-296-00-7 | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | 418-270-7 | - | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 613-297-00-2 | 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | 420-820-6 | - | Flam. Liq. 3 Acute Tox. 4 * Aquatic Chronic 2 | H226 H302 H411 | GHS02 GHS07 GHS09 Achtg. | H226 H302 H411 | |||
| 613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | 421-560-6 | - | STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 | H373** H318 H411 | GHS05 GHS08 GHS09 Gef. | H373** H318 H411 | |||
| 613-299-00-3 | main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt | 422-610-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | 434-120-3 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate | 443-910-7 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-302-00-8 | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | 432-980-4 | 243858-60-8 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine | 429-800-1 | 95737-68-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | 421-170-6 | 138937-28-7 | Acute Tox. 4 * Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | 448-630-9 | 3147-77-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | 433-520-5 | 82911-69-1 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 | H302 H317 H411 | GHS07 GHS09 Achtg. | H302 H317 H411 | |||
| 613-307-00-5 | clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine | - | 210880-92-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M=10 | ||
| 613-308-00-0 | 2-amino-5-methylthiazole | 423-800-5 | 7305-71-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H373** H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373** H410 | |||
| 613-309-00-6 | 1-methyl-3-phenyl-1-piperazine | 431-180-2 | 5271-27-2 | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 | H312 H302 H315 H318 H412 | GHS05 GHS07 Gef. | H312 H302 H315 H318 H412 | |||
| 613-310-00-1 | (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | 432-360-3 | 105813-13-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 613-311-00-7 | methyl-5-nitrophenyl-guanidine | 435-500-1 | 152460-07-6 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H302 H319 H317 H412 | GHS07 Achtg. | H302 H319 H317 H412 | |||
| 613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | 420-200-5 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H318 H317 H412 | |||
| 613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione | 442-780-9 | 173838-67-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 613-314-00-3 | 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one | 443-770-7 | 7693-82-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 613-315-00-9 | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | 430-390-1 | - | Acute Tox. 4 * Aquatic Chronic 3 | H332 H412 | GHS07 Achtg. | H332 H412 | |||
| 613-316-00-4 | trimethylopropane tri(3-aziridinylpropanoate); (TAZ) | 257-765-0 | 52234-82-9 | Muta. 2 Eye Dam. 1 Skin Sens. 1 | H341 H318 H317 | GHS05 GHS08 GHS07 Gef. | H341 H318 H317 | |||
| 613-317-00-X | penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole | 266-275-6 | 66246-88-6 | Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 | H361d H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361d H302 H410 | M = 1 M = 1 | ||
| 613-318-00-5 | Fenpyrazamin (ISO); S-Allyl-5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazol-1-carbothioat; S-Allyl-5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydropyrazol-1-carbothioat | - | 473798-59-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 10 M = 1 | ||
| 613-319-00-0 | Imidazol | 206-019-2 | 288-32-4 | Repr. 1B Acute Tox. 4 Skin Corr. 1C | H360D H302 H314 | GHS08 GHS07 GHS05 Gef. | H360D H302 H314 | |||
| 613-320-00-6 | Lenacil (ISO); 3-Cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidin-2,4(3H,5H)-dion | 218-499-0 | 2164-08-1 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | M = 10 M = 10 | ||
| 613-321-00-1 | (RS)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazol; Medetomidin | - | 86347-14-0 | Acute Tox. 2 Acute Tox. 2 STOT SE 3 STOT SE 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H336 H370 (Augen) H372 H400 H410 | GHS06 GHS08 GHS09 Gef. | H330 H300 H336 H370 (Augen) H372 H410 | M = 1 M = 100 | ||
| 613-322-00-7 | Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-Chlorphenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-Butyl-β-(4-chlorphenoxy)-1H-1,2,4-triazol-1-ethanol | 259-537-6 | 55219-65-3 | Repr. 1B Lact. Acute Tox. 4 Aquatic Chronic 2 | H360 H362 H302 H411 | GHS08 GHS07 GHS09 Gef. | H360 H362 H302 H411 | |||
| 613-323-00-2 | Terbuthylazin (ISO); N-tert-Butyl-6-chlor-N'-ethyl-1,3,5-triazin-2,4-diamin | 227-637-9 | 5915-41-3 | Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 H400 H410 | GHS07 GHS08 GHS09 Achtg. | H302 H373 H410 | M = 10 M = 10 | ||
| 613-324-00-8 | Chinolin-8-ol 8-Hydroxychinolin | 205-711-1 | 148-24-3 | Repr. 1B Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H360D H301 H318 H317 H400 H410 | GHS08 GHS06 GHS05 GHS09 Gef. | H360D H301 H318 H317 H410 | M = 1 M = 1 | ||
| 613-325-00-3 | Thiacloprid (ISO); (Z)-3-(6-Chlor-3-pyridyl-methyl)-1,3-thiazolidin-2-ylidencyanamid; {(2Z)-3-[(6-Chlorpyridin-3-yl)methyl]-1,3-thiazolidin-2-yliden}cyanamid | - | 111988-49-9 | Carc. 2 Repr. 1B Acute Tox. 4 Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 | H351 H360FD H332 H301 H336 H400 H410 | GHS08 GHS06 GHS09 Gef. | H351 H360FD H332 H301 H336 H410 | M = 100 M = 100 | ||
| 614-001-00-4 | Nicotin (ISO); 3-[(2S)-1-Methylpyrrolidin-2-yl]pyridin | 200-193-3 | 54-11-5 | Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 | H330 H310 H300 H411 | GHS06 GHS09 Gef. | H330 H310 H300 H411 | Einatmung: ATE = 0,19 mg/L (Stäube oder Nebel) Dermal: ATE = 70 mg/kg Oral: ATE = 5 mg/kg | ||
| 614-002-00-X | salts of nicotine | - | - | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Chronic 2 | H330 H310 H300 H411 | GHS06 GHS09 Gef. | H330 H310 H300 H411 | A | ||
| 614-003-00-5 | strychnine | 200-319-7 | 57-24-9 | Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H310 H300 H400 H410 | GHS06 GHS09 Gef. | H310 H300 H410 | |||
| 614-004-00-0 | salts of strychnine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H330 H300 H400 H410 | GHS06 GHS09 Gef. | H330 H300 H410 | A | ||
| 614-005-00-6 | colchicine | 200-598-5 | 64-86-8 | Muta. 1B Acute Tox. 2 * | H340 H300 | GHS06 GHS08 Gef. | H340 H300 | |||
| 614-006-00-1 | brucine; 2,3-dimethoxystrychnine | 206-614-7 | 357-57-3 | Acute Tox. 2 (*) Acute Tox. 2 (*) Aquatic Chronic 3 | H330 H300 H412 | GHS06 Gef. | H330 H300 H412 | |||
| 614-007-00-7 | brucine sulphate; [1] brucine nitrate; [2] strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] | 225-432-9 [1] 227-317-9 [2] 269-439-5 [3] 269-710-8 [4] | 4845-99-2 [1] 5786-97-0 [2] 68239-26-9 [3] 68310-42-9 [4] | Acute Tox. 2 (*) Acute Tox. 2 (*) Aquatic Chronic 3 | H330 H300 H412 | GHS06 Gef. | H330 H300 H412 | A | ||
| 614-008-00-2 | aconitine | 206-121-7 | 302-27-2 | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | |||
| 614-009-00-8 | salts of aconitine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | A | ||
| 614-010-00-3 | atropine | 200-104-8 | 51-55-8 | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | |||
| 614-011-00-9 | salts of atropine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | A | ||
| 614-012-00-4 | hyoscyamine | 202-933-0 | 101-31-5 | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | |||
| 614-013-00-X | salts of hyoscyamine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | A | ||
| 614-014-00-5 | hyoscine | 200-090-3 | 51-34-3 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) | H330 H310 H300 | GHS06 Gef. | H330 H310 H300 | |||
| 614-015-00-0 | salts of hyoscine | - | - | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) | H330 H310 H300 | GHS06 Gef. | H330 H310 H300 | A | ||
| 614-016-00-6 | pilocarpine | 202-128-4 | 92-13-7 | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | |||
| 614-017-00-1 | salts of pilocarpine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | A | ||
| 614-018-00-7 | papaverine | 200-397-2 | 58-74-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 614-019-00-2 | salts of papaverine | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | A | ||
| 614-020-00-8 | physostigmine | 200-332-8 | 57-47-6 | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | |||
| 614-021-00-3 | salts of physostigmine | - | - | Acute Tox. 2 (*) Acute Tox. 2 (*) | H330 H300 | GHS06 Gef. | H330 H300 | A | ||
| 614-022-00-9 | digitoxin | 200-760-5 | 71-63-6 | Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) | H331 H301 H373 (*)(*) | GHS06 GHS08 Gef. | H331 H301 H373 (*)(*) | |||
| 614-023-00-4 | ephedrine | 206-080-5 | 299-42-3 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 614-024-00-X | salts of ephedrine | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | A | ||
| 614-025-00-5 | ouabain | 211-139-3 | 630-60-4 | Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) | H331 H301 H373 (*)(*) | GHS06 GHS08 Gef. | H331 H301 H373 (*)(*) | |||
| 614-026-00-0 | strophantin-K | 234-239-9 | 11005-63-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) | H331 H301 H373 (*)(*) | GHS06 GHS08 Gef. | H331 H301 H373 (*)(*) | |||
| 614-027-00-6 | bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; red squill; scilliroside | 208-077-4 | 507-60-8 | Acute Tox. 2 (*) | H300 | GHS06 Gef. | H300 | |||
| 614-028-00-1 | reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; 2-ethylhexyl di-D-glucopyranoside | 414-420-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 614-029-00-7 | constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside | 419-640-0 | 68784-14-5 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 615-001-00-7 | methyl isocyanate | 210-866-3 | 624-83-9 | Flam. Liq. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Resp. Sens. 1 Skin Sens. 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 | H225 H361d*** H330 H311 H301 H334 H317 H335 H315 H318 | GHS02 GHS06 GHS05 GHS08 Gef. | H225 H361d*** H330 H311 H301 H334 H317 H335 H315 H318 | |||
| 615-002-00-2 | methyl isothiocyanate | 209-132-5 | 556-61-6 | Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H314 H317 H400 H410 | GHS06 GHS05 GHS09 Gef. | H331 H301 H314 H317 H410 | |||
| 615-003-00-8 | thiocyanic acid | 207-337-4 | 463-56-9 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 3 | H332 H312 H302 H412 | GHS07 Achtg. | H332 H312 H302 H412 | EUH032 | ||
| 615-004-00-3 | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H332 H312 H302 H412 | GHS07 Achtg. | H332 H312 H302 H412 | EUH032 | A | |
| 615-005-00-9 | 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate; [1] 2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate; [2] o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate; [3] methylenediphenyl diisocyanate [4] | 202-966-0 [1] 219-799-4 [2] 227-534-9 [3] 247-714-0 [4] | 101-68-8 [1] 2536-05-2 [2] 5873-54-1 [3] 26447-40-5 [4] | Carc. 2 Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 | H351 H332 H373** H319 H335 H315 H334 H317 | GHS08 GHS07 Gef. | H351 H332 H373** H319 H335 H315 H334 H317 | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1 % STOT SE 3; H335: C ≥ 5 % | C2 | |
| 615-006-00-4 | 2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate; [1] 4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate; [2] m-tolylidene diisocyanate; toluene-diisocyanate [3] | 202-039-0 [1] 209-544-5 [2] 247-722-4 [3] | 91-08-7 [1] 584-84-9 [2] 26471-62-5 [3] | Carc. 2 Acute Tox. 2 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H351 H330 H319 H335 H315 H334 H317 H412 | GHS06 GHS08 Gef. | H351 H330 H319 H335 H315 H334 H317 H412 | Resp. Sens. 1; H334: C ≥ 0,1 % | C | |
| 615-007-00-X | 1,5-naphthylene diisocyanate | 221-641-4 | 3173-72-6 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Aquatic Chronic 3 | H332 H319 H335 H315 H334 H412 | GHS08 GHS07 Gef. | H332 H319 H335 H315 H334 H412 | |||
| 615-008-00-5 | 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate | 223-861-6 | 4098-71-9 | Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 | H331 H319 H335 H315 H334 H317 H411 | GHS06 GHS08 GHS09 Gef. | H331 H319 H335 H315 H334 H317 H411 | (*) Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens.1; H317: C ≥ 0,5 % | 2 | |
| 615-009-00-0 | 4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate | 225-863-2 | 5124-30-1 | Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 | H331 H319 H335 H315 H334 H317 | GHS06 GHS08 Gef. | H331 H319 H335 H315 H334 H317 | (*) Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens. 1; H317: C ≥ 0,5 % | 2 | |
| 615-010-00-6 | 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] | 241-001-8 [1] 239-714-4 [2] | 16938-22-0 [1] 15646-96-5 [2] | Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H331 H319 H335 H315 H334 | GHS06 GHS08 Gef. | H331 H319 H335 H315 H334 | (*) Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens. 1; H317: C ≥ 0,5 % | C2 | |
| 615-011-00-1 | hexamethylene-di-isocyanate | 212-485-8 | 822-06-0 | Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 | H331 H319 H335 H315 H334 H317 | GHS06 GHS08 Gef. | H331 H319 H335 H315 H334 H317 | (*) Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens. 1; H317: C ≥ 0,5 % | 2 | |
| 615-012-00-7 | 4-isocyanatosulphonyltoluene; tosyl isocyanate | 223-810-8 | 4083-64-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | EUH014 | Eye Irrit.; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | |
| 615-013-00-2 | Cyanamid; Carbamonitril | 206-992-3 | 420-04-2 | Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1 Skin Sens. 1 Eye Dam. 1 Aquatic Chronic 3 | H351 H361fd H311 H301 H373 (Schilddrüse) H314 H317 H318 H412 | GHS08 GHS06 GHS05 Gef. | H351 H361fd H311 H301 H373 (Schilddrüse) H314 H317 H412 | |||
| 615-014-00-8 | tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate | - | 7276-58-6 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 615-015-00-3 | 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate | 204-081-5 | 115-31-1 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 615-016-00-9 | potassium cyanate | 209-676-3 | 590-28-3 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 615-017-00-4 | calcium cyanamide | 205-861-8 | 156-62-7 | Acute Tox. 4 (*) STOT SE 3 Eye Dam. 1 | H302 H335 H318 | GHS05 GHS07 Gef. | H302 H335 H318 | |||
| 615-018-00-X | 2-(2-butoxyethoxy)ethyl thiocyanate | 203-985-7 | 112-56-1 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 3 (*) | H226 H311 H301 | GHS02 GHS06 Gef. | H226 H311 H301 | |||
| 615-019-00-5 | dicyclohexylcarbodiimide | 208-704-1 | 538-75-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 | H311 H302 H318 H317 | GHS06 GHS05 Gef. | H311 H302 H318 H317 | |||
| 615-020-00-0 | methylene dithiocyanate | 228-652-3 | 6317-18-6 | Acute Tox. 2 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 | H330 H301 H314 H317 H400 | GHS06 GHS05 GHS09 Gef. | H330 H301 H314 H317 H400 | |||
| 615-021-00-6 | 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC | 219-514-3 | 2451-62-9 | Muta. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H340 H331 H301 H373 (*)(*) H318 H317 H412 | GHS06 GHS08 GHS05 Gef. | H340 H331 H301 H373 (*)(*) H318 H317 H412 | |||
| 615-022-00-1 | methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate | 410-550-7 | 79277-18-2 | STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 | H373** H334 H317 | GHS08 Gef. | H373** H334 H317 | EUH014 | ||
| 615-023-00-7 | 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate | 410-900-9 | 83056-32-0 | Flam. Liq. 3 Muta. 2 Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Resp. Sens. 1 | H226 H341 H332 H373 (*)(*) H318 H334 | GHS02 GHS08 GHS05 GHS07 Gef. | H226 H341 H332 H373 (*)(*) H318 H334 | EUH014 | ||
| 615-024-00-2 | 2-phenylethylisocyanate | 413-080-0 | 1943-82-4 | Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 | H331 H302 H314 H334 H317 H411 | GHS06 GHS08 GHS05 GHS09 Gef. | H331 H302 H314 H334 H317 H411 | |||
| 615-025-00-8 | 4,4'-ethylidenediphenyl dicyanate | 405-740-1 | 47073-92-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H332 H302 H373 (*)(*) H318 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H332 H302 H373 (*)(*) H318 H410 | |||
| 615-026-00-3 | 4,4'-methylenebis(2,6-dimethylphenyl cyanate) | 405-790-4 | 101657-77-6 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 615-028-00-4 | ethyl 2-(isocyanatosulfonyl)benzoate | 410-220-2 | 77375-79-2 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 | H302 H373** H318 H334 H317 | GHS05 GHS08 GHS07 Gef. | H302 H373** H318 H334 H317 | EUH014 | ||
| 615-029-00-X | 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane | 411-280-2 | - | Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 | H330 H302 H314 H334 H317 H412 | GHS06 GHS08 GHS05 Gef. | H330 H302 H314 H334 H317 H412 | |||
| 615-030-00-5 | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 | H332 H312 H302 H412 | GHS07 Achtg. | H332 H312 H302 H412 | A | ||
| 615-031-00-0 | thallium thiocyanate | 222-571-7 | 3535-84-0 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 Aquatic Chronic 2 | H330 H300 H312 H373** H411 | GHS06 GHS08 GHS09 Gef. | H330 H300 H312 H373** H411 | |||
| 615-032-00-6 | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H332 H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H332 H312 H302 H410 | A | ||
| 615-033-00-1 | reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097) | 430-980-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-034-00-7 | reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) | 430-750-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-035-00-2 | reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) | 430-930-6 | 122886-55-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-036-00-8 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) | 430-940-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-037-00-3 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) | 430-950-5 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-038-00-9 | reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) | 430-960-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-039-00-4 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) | 430-970-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 615-044-00-1 | 4-chlorophenylisocyanate | 203-176-9 | 104-12-1 | Acute Tox. 2 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H330 H302 H335 H315 H318 H334 H400 H410 | GHS06 GHS05 GHS08 GHS09 Gef. | H330 H302 H335 H315 H318 H334 H410 | |||
| 615-045-00-7 | 4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | 420-530-1 | - | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 | H334 H317 H413 | GHS08 Gef. | H334 H317 H413 | |||
| 616-001-00-X | N,N-dimethylformamide; dimethyl formamide | 200-679-5 | 68-12-2 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 | H360D (*)(*)(*) H332 H312 H319 | GHS08 GHS07 Gef. | H360D (*)(*)(*) H332 H312 H319 | |||
| 616-002-00-5 | 2-fluoroacetamide | 211-363-1 | 640-19-7 | Acute Tox. 2 (*) Acute Tox. 3 (*) | H300 H311 | GHS06 Gef. | H300 H311 | |||
| 616-003-00-0 | acrylamide; prop-2-enamide | 201-173-7 | 79-06-1 | Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 (*) STOT RE 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 | H350 H340 H361f (*)(*)(*) H301 H372 (*)(*) H332 H312 H319 H315 H317 | GHS06 GHS08 Gef. | H350 H340 H361f (*)(*)(*) H301 H372 (*)(*) H332 H312 H319 H315 H317 | D | ||
| 616-004-00-6 | allidochlor (ISO); N,N-diallylchloroacetamide | 202-270-7 | 93-71-0 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H312 H302 H319 H315 H411 | GHS07 GHS09 Achtg. | H312 H302 H319 H315 H411 | |||
| 616-005-00-1 | chlorthiamid (ISO); 2,6-dichloro (thiobenzamide) | 217-637-7 | 1918-13-4 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. | H302 | |||
| 616-006-00-7 | Dichlofluanid (ISO); N-[(Dichlorfluormethyl)thio]-N',N'-dimethyl-N-phenylsulfamid | 214-118-7 | 1085-98-9 | Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 | H332 H319 H317 H400 | GHS07 GHS09 Achtg. | H332 H319 H317 H400 | M = 10 | ||
| 616-007-00-2 | diphenamid (ISO); N,N-dimethyl-2,2-diphenylacetamide | 213-482-4 | 957-51-7 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-008-00-8 | propachlor (ISO); 2-chloro-N-isopropylacetanilide; α-chloro-N-isopropylacetanilide | 217-638-2 | 1918-16-7 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H319 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H319 H317 H410 | |||
| 616-009-00-3 | propanil (ISO); 3',4'-dichloropropionanilide | 211-914-6 | 709-98-8 | Acute Tox. 4 * Aquatic Acute 1 | H302 H400 | GHS07 GHS09 Achtg. | H302 H400 | M=10 | ||
| 616-010-00-9 | tosylchloramide sodium | 204-854-7 | 127-65-1 | Acute Tox. 4 (*) Skin Corr. 1B Resp. Sens. 1 | H302 H314 H334 | GHS08 GHS05 GHS07 Dg | H302 H314 H334 | EUH031 | ||
| 616-011-00-4 | N,N-Dimethylacetamid | 204-826-4 | 127-19-5 | Repr. 1B Acute Tox. 4* Acute Tox. 4* | H360D*** H332 H312 | GHS08 GHS07 Gef. | H360D*** H332 H312 | |||
| 616-012-00-X | N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide | 211-952-3 | 719-96-0 | Skin Irrit. 2 | H315 | GHS07 Achtg. | H315 | |||
| 616-013-00-5 | butyraldehyde oxime | 203-792-8 | 110-69-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 | H311 H302 H319 | GHS06 Gef. | H311 H302 H319 | |||
| 616-014-00-0 | 2-butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime | 202-496-6 | 96-29-7 | Carc. 2 Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 | H351 H312 H318 H317 | GHS08 GHS05 GHS07 Gef. | H351 H312 H318 H317 | |||
| 616-015-00-6 | alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide | 240-110-8 | 15972-60-8 | Carc. 2 Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H317 H410 | M=10 | ||
| 616-016-00-1 | 1-(3,4-dichlorophenylimino) thiosemicarbazide | - | 5836-73-7 | Acute Tox. 2 (*) | H300 | GHS06 Gef. | H300 | |||
| 616-017-00-7 | cartap hydrochloride | 239-309-2 | 15263-52-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H312 H302 H400 H410 | GHS07 GHS09 Achtg. | H312 H302 H410 | |||
| 616-018-00-2 | N,N-diethyl-m-toluamide; deet | 205-149-7 | 134-62-3 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H302 H319 H315 H412 | GHS07 Achtg. | H302 H319 H315 H412 | |||
| 616-019-00-8 | perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; | 253-718-3 | 37924-13-3 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 616-020-00-3 | tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | 251-793-7 | 34014-18-1 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 616-021-00-9 | thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea | 246-901-4 | 25366-23-8 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 616-022-00-4 | acetamide | 200-473-5 | 60-35-5 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 616-023-00-X | N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide | 401-980-6 | - | Skin Irrit. 2 Skin Sens. 1 | H315 H317 | GHS07 Achtg. | H315 H317 | |||
| 616-024-00-5 | 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide | 402-260-4 | 54942-74-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-025-00-0 | valinamide | 402-840-7 | 20108-78-5 | Repr. 2 Eye Irrit. 2 Skin Sens. 1 | H361f (*)(*)(*) H319 H317 | GHS08 Achtg. | H361f (*)(*)(*) H319 H317 | |||
| 616-026-00-6 | thioacetamide | 200-541-4 | 62-55-5 | Carc. 1B Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 | H350 H302 H319 H315 H412 | GHS08 GHS07 Gef. | H350 H302 H319 H315 H412 | |||
| 616-027-00-1 | tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate | 403-760-5 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-028-00-7 | N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | 403-790-9 | 108673-51-4 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-029-00-2 | N,N'-ethylenebis(vinylsulfonylacetamide) | 404-790-1 | 66710-66-5 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 616-030-00-8 | ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | 250-010-6 | 30043-49-3 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 616-031-00-3 | dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; | 256-625-6 | 50563-36-5 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 616-032-00-9 | diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide | - | 83164-33-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-033-00-4 | cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide | 274-050-9 | 69581-33-5 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 | H301 H312 H400 H410 | GHS06 GHS09 Gef. | H301 H312 H410 | |||
| 616-034-00-X | pyracarbolid; (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide | 246-419-4 | 24691-76-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-035-00-5 | cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361fd H302 H373 (Blut, Thymusdrüse) H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H361fd H302 H373 (Blut, Thymusdrüse) H317 H410 | M = 1 M = 1 | ||
| 616-036-00-0 | 2-chloracetamide | 201-174-2 | 79-07-2 | Repr. 2 Acute Tox. 3 (*) Skin Sens. 1 | H361f (*)(*)(*) H301 H317 | GHS06 GHS08 Gef. | H361f (*)(*)(*) H301 H317 | Skin Sens. 1; H317: C ≥ 0,1 % | ||
| 616-037-00-6 | Acetochlor (ISO); 2-Chlor-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamid | 251-899-3 | 34256-82-1 | Carc. 2 Repr. 2 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361f H332 H335 H373 (Nieren) H315 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H361f H332 H335 H373 (Nieren) H315 H317 H410 | M = 1 000 M = 100 | ||
| 616-038-00-1 | (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride | 406-010-5 | 88918-84-7 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H318 H317 H411 | GHS05 GHS07 GHS09 Gef. | H318 H317 H411 | |||
| 616-039-00-7 | 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide | 406-200-8 | 117827-06-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-040-00-2 | potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide | 406-650-5 | 97888-41-0 | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 616-041-00-8 | 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide | 406-840-8 | 101664-25-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-042-00-3 | N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide | 407-070-5 | 142859-67-4 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-043-00-9 | isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide | 407-190-8 | 82558-50-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-044-00-4 | N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide | 402-510-2 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-045-00-X | 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide | 405-190-2 | 122371-93-1 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-046-00-5 | N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | 406-390-2 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-047-00-0 | reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide | 406-640-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-048-00-6 | 3'-trifluoromethylisobutyranilide | 406-740-4 | 1939-27-1 | STOT RE 2 (*) Aquatic Chronic 2 | H373 (*)(*) H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H411 | |||
| 616-049-00-1 | 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide | 408-150-2 | 99141-89-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-050-00-7 | lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide | 410-690-9 | 103055-07-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 616-051-00-2 | reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene | 411-070-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-052-00-8 | formamide | 200-842-0 | 75-12-7 | Repr. 1B | H360D (*)(*)(*) | GHS08 Gef. | H360D (*)(*)(*) | |||
| 616-053-00-3 | N-methylacetamide | 201-182-6 | 79-16-3 | Repr. 1B | H360D (*)(*)(*) | GHS08 Gef. | H360D (*)(*)(*) | |||
| 616-054-00-9 | iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide | 253-178-9 | 36734-19-7 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 616-055-00-4 | propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide | 245-951-4 | 23950-58-5 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H400 H410 | GHS08 GHS09 Achtg. | H351 H410 | |||
| 616-056-00-X | N-methylformamide | 204-624-6 | 123-39-7 | Repr. 1B Acute Tox. 4 (*) | H360D (*)(*)(*) H312 | GHS08 GHS07 Dg | H360D (*)(*)(*) H312 | |||
| 616-057-00-5 | reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide | 412-790-8 | - | Carc. 1B Muta. 2 STOT RE 2 (*) | H350 H341 H373 (*)(*) | GHS08 Gef. | H350 H341 H373 (*)(*) | |||
| 616-058-00-0 | 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene | 412-570-1 | 119462-56-5 | STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H318 H317 H400 H410 | GHS08 GHS05 GHS07 GHS09 Gef. | H373 (*)(*) H318 H317 H410 | |||
| 616-059-00-6 | 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide | 412-650-6 | 121487-83-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-060-00-1 | Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) | 413-770-1 | - | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H314 H317 H410 | |||
| 616-061-00-7 | N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide | 413-610-0 | 124172-53-8 | Eye Irrit. 2 Aquatic Chronic 3 | H319 H412 | GHS07 Achtg. | H319 H412 | |||
| 616-062-00-2 | N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide | 411-590-8 | 70693-57-1 | Skin Corr. 1B Aquatic Chronic 3 | H314 H412 | GHS05 Gef. | H314 H412 | |||
| 616-063-00-8 | 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione | 411-920-0 | 106917-30-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H373 (*)(*) H314 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H331 H302 H373 (*)(*) H314 H410 | |||
| 616-064-00-3 | N - tert-butyl-3-methylpicolinamide | 406-720-5 | 32998-95-1 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-065-00-9 | 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea | 411-970-3 | 79881-89-3 | Acute Tox. 4 (*) STOT RE 2 (*) | H302 H373 (*)(*) | GHS08 GHS07 Achtg. | H302 H373 (*)(*) | |||
| 616-066-00-4 | 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone | 405-100-1 | 115662-06-1 | Repr. 2 | H361f (*)(*)(*) | GHS08 Achtg. | H361f (*)(*)(*) | |||
| 616-067-00-X | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate | 407-300-4 | 92683-20-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-068-00-5 | potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate | 406-500-9 | 174393-75-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-069-00-0 | 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide | 406-210-2 | 110560-22-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-070-00-6 | reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | 406-530-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-071-00-1 | reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) | 406-550-1 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-072-00-7 | 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine | 407-120-6 | 55612-11-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-073-00-2 | 4'-ethoxy-2-benzimidazoleanilide | 407-600-5 | 120187-29-3 | Muta. 2 Aquatic Chronic 4 | H341 H413 | GHS08 Achtg. | H341 H413 | |||
| 616-074-00-8 | N-butyl-2-(4-morpholinylcarbonyl)benzamide | 407-730-2 | 104958-67-0 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H317 H412 | GHS07 Achtg. | H319 H317 H412 | |||
| 616-075-00-3 | D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) | 408-120-9 | 65197-96-8 | Acute Tox. 4 (*) Eye Dam. 1 | H302 H318 | GHS05 GHS07 Gef. | H302 H318 | |||
| 616-076-00-9 | tebufenozide (ISO); N - tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide | 412-850-3 | 112410-23-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-077-00-4 | reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate | 411-310-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. | H318 | |||
| 616-078-00-X | 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide | 411-330-3 | 104541-33-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-079-00-5 | 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate | 411-700-4 | 140921-24-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-080-00-0 | 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) | 411-850-0 | 119018-29-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-081-00-6 | 5-bromo-8-naphtholactam | 413-480-5 | 24856-00-6 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | |||
| 616-082-00-1 | N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide | 413-200-1 | 129604-78-0 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-083-00-7 | [2-[(4-nitrophenyl)amino]ethyl]urea | 410-700-1 | 27080-42-8 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 616-084-00-2 | 2,4-bis[N'-(4-methylphenyl)ureido]toluene | 411-790-5 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-085-00-8 | 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione | 412-190-6 | 168900-02-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-086-00-3 | 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene | 412-250-1 | 102387-48-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-087-00-9 | reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate; 7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate | 412-260-6 | 52658-19-2 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H319 H317 H411 | GHS07 GHS09 Achtg. | H319 H317 H411 | |||
| 616-088-00-4 | 2-aminosulfonyl-N,N-dimethylnicotinamide | 413-440-7 | 112006-75-4 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 616-089-00-X | 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran | 415-360-8 | 41107-56-6 | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 616-090-00-5 | 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride | 415-660-9 | 70918-74-0 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 | H331 H311 H301 H373 (*)(*) H411 | GHS06 GHS08 GHS09 Gef. | H331 H311 H301 H373 (*)(*) H411 | |||
| 616-091-00-0 | 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione | 423-400-0 | 59653-74-6 | Muta. 1B Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 | H340 H331 H302 H373 (*)(*) H318 H317 | GHS06 GHS08 GHS05 Gef. | H340 H331 H302 H373 (*)(*) H318 H317 | |||
| 616-092-00-6 | Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide | 404-035-6 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-093-00-1 | Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride | 406-620-1 | 129217-90-9 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-094-00-7 | 3,3-Dicyclohexyl-1'1'-methylenbis-(4,1-phenylen)diharnstoff | 406-370-3 | 58890-25-8 | Aquatic Chronic 4 | H413 | H413 | ||||
| 616-095-00-2 | 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | 406-690-3 | 43136-14-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-096-00-8 | N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide | 408-110-4 | 110483-07-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-097-00-3 | N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide | 411-840-6 | 83372-55-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-098-00-9 | 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide | 411-750-7 | 119126-15-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-099-00-4 | 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide | 414-170-2 | 135937-20-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-100-00-8 | 1,3-dimethyl-1,3-bis(trimethylsilyl)urea | 414-180-7 | 10218-17-4 | Acute Tox. 4 (*) Skin Irrit. 2 | H302 H315 | GHS07 Achtg. | H302 H315 | |||
| 616-101-00-3 | (S)-N - tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide | 414-600-9 | 149182-72-9 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-102-00-9 | reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene); 1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol; 1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] | 415-870-0 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-103-00-4 | (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide | 415-030-3 | 120298-38-6 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | |||
| 616-104-00-X | benalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate | 275-728-7 | 71626-11-4 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-105-00-5 | chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea | 239-592-2 | 15545-48-9 | Carc. 2 Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H361d (*)(*)(*) H400 H410 | GHS08 GHS09 Achtg. | H351 H361d (*)(*)(*) H410 | |||
| 616-106-00-0 | phenmedipham (ISO); methyl 3-(3-methylcarbaniloyloxy)carbanilate | 237-199-0 | 13684-63-4 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-107-00-6 | cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate | - | 142891-20-1 | Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H351 H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H317 H410 | |||
| 616-108-00-1 | iodosulfuron-methyl-sodium; sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide | - | 144550-36-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-109-00-7 | sulfosulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea | - | 141776-32-1 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-110-00-2 | cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid | 419-150-7 | 113136-77-9 | Acute Tox. 4 (*) Aquatic Chronic 2 | H302 H411 | GHS07 GHS09 Achtg. | H302 H411 | |||
| 616-111-00-8 | fenhexamid (ISO); N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid | 422-530-5 | 126833-17-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-112-00-3 | oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate | - | 144651-06-9 | STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 | H373 (*)(*) H400 H410 | GHS08 GHS09 Achtg. | H373 (*)(*) H410 | |||
| 616-113-00-9 | desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate | 237-198-5 | 13684-56-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=10 | ||
| 616-114-00-4 | dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- | 418-010-2 | 136897-58-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-115-00-X | N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | 416-150-9 | 136450-06-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-116-00-5 | N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate | 416-790-9 | 143052-96-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-117-00-0 | N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide | 416-860-9 | 777891-21-1 | Repr. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H361f (*)(*)(*) H317 H400 H410 | GHS08 GHS09 Achtg. | H361f (*)(*)(*) H317 H410 | |||
| 616-118-00-6 | N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride | 417-950-0 | 65797-42-4 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-119-00-1 | 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide | 418-060-5 | 118020-93-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-120-00-7 | reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; N-(3-dimethylamino-2-methyl-phenyl)-benzamide; N-(3-dimethylamino-3-methyl-phenyl)-benzamide | 420-600-1 | - | STOT RE 2 (*) Aquatic Chronic 2 | H373 (*)(*) H411 | GHS08 GHS09 Achtg. | H373 (*)(*) H411 | |||
| 616-121-00-2 | 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide | 419-090-1 | 129205-19-2 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-122-00-8 | methyl-neodecanamide | 414-460-9 | 105726-67-8 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 616-123-00-3 | N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide | 414-740-0 | 96141-86-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-124-00-9 | lithium bis(trifluoromethylsulfonyl)imide | 415-300-0 | 90076-65-6 | Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B Aquatic Chronic 3 | H311 H301 H373** H314 H412 | GHS06 GHS05 GHS08 Gef. | H311 H301 H373** H314 H412 | |||
| 616-125-00-4 | 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide | 415-730-9 | 151338-11-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | 410 | |||
| 616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide | 423-960-6 | 139756-01-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 | H302 H373** H412 | GHS08 GHS07 Achtg. | H302 H373** H412 | |||
| 616-127-00-5 | reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide); 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide) | 430-050-2 | - | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-128-00-0 | N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide | 417-530-7 | 123590-00-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-129-00-6 | N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide | 419-710-0 | 42774-15-2 | Acute Tox. 4 (*) Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 616-130-00-1 | N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide | 421-780-2 | 150919-56-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-131-00-7 | 1-aminocyclopentanecarboxamide | 422-950-9 | 17193-28-1 | STOT RE 1 Acute Tox. 4 * Eye Dam. 1 | H372** H302 H318 | GHS05 GHS08 GHS07 Gef. | H372** H302 H318 | |||
| 616-132-00-2 | N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide | 423-250-6 | 130016-98-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-133-00-8 | N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide | 423-990-1 | 149118-66-1 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 616-134-00-3 | 3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide | 401-820-5 | 793710-14-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-135-00-9 | (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide | 430-230-0 | 136522-17-3 | Acute Tox. 4 (*) Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-136-00-4 | reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1) | 430-380-7 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-137-00-X | 4-dichloroacetyl-1-oxa-4-azaspiro[4,5]decane | 401-130-4 | 71526-07-3 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-138-00-5 | benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide | 431-600-4 | 112226-61-6 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-139-00-0 | (3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide | 420-380-5 | 136465-81-1 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 | H302 H318 H412 | GHS05 GHS07 Gef. | H302 H318 H412 | |||
| 616-140-00-6 | N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea] | 429-380-1 | 133336-92-2 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-141-00-1 | zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide | - | 156052-68-5 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H317 H400 H410 | GHS07 GHS09 Achtg. | H317 H410 | M=10 | ||
| 616-142-00-7 | 1,3-Bis(vinylsulfonylacetamido)propane | 428-350-3 | 93629-90-4 | Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H341 H318 H317 H412 | GHS08 GHS05 GHS07 Gef. | H341 H318 H317 H412 | |||
| 616-143-00-2 | N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide | 422-560-9 | 149591-38-8 | Repr. 2 Eye Irrit. 2 Aquatic Chronic 4 | H361f (*)(*)(*) H319 H413 | GHS08 Achtg. | H361f (*)(*)(*) H319 H413 | |||
| 616-144-00-8 | 3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl] benzamide | 431-130-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-145-00-3 | pethoxamide (ISO); 2-chloro-N-(2- ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide | - | 106700-29-2 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | M=100 | ||
| 616-146-00-9 | N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4- dimethyl-3-oxopentanoic acidamide | 431-330-7 | 142776-95-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-147-00-4 | 1- methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide | 424-160-1 | 139481-22-4 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-148-00-X | N-[6,9-dihydro-9-[[2- hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide | 424-550-1 | 84245-12-5 | Carc. 1B Muta. 1B Repr. 1B | H350 H340 H360FD | GHS08 Gef. | H350 H340 H360FD | |||
| 616-150-00-0 | (2R,3S )-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride | 425-260-6 | - | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H373** H318 H317 H411 | GHS05 GHS08 GHS07 GHS09 Gef. | H373** H318 H317 H411 | |||
| 616-151-00-6 | N-(2-amino-4,6- dichloropyrimidin-5-yl)formamide | 425-650-6 | 171887-03-9 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 | H302 H318 H317 H412 | GHS05 GHS07 Gef. | H302 H318 H317 H412 | |||
| 616-152-00-1 | 4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide | 425-850-3 | 125971-96-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-153-00-7 | 4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide | 425-860-8 | 125971-57-5 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-154-00-2 | 3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide | 431-110-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-155-00-8 | N,N,N',N'- tetracyclohexyl-1,3-benzenedicarboxamide | 431-040-0 | 104560-40-9 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-156-00-3 | 6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino] acetanilide | 430-500-8 | 204277-61-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-157-00-9 | 3-amino-4-hydroxy-N-(3- isopropoxypropyl)benzenesulfonamide hydrochloride | 427-780-9 | 114565-70-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H318 H400 H410 | GHS05 GHS07 GHS09 Gef. | H302 H318 H410 | |||
| 616-158-00-4 | N-[4-cyano-3-trifluoromethylphenyl]methacrylamide | 427-880-2 | 90357-53-2 | STOT RE 2 * Aquatic Chronic 2 | H373** H411 | GHS08 GHS09 Achtg. | H373** H411 | |||
| 616-160-00-5 | 2,2'- azobis[N-(2-hydroxyethyl)-2-methylpropionamide] | 429-090-3 | 61551-69-7 | Skin Sens. 1 Aquatic Chronic 3 | H317 H412 | GHS07 Achtg. | H317 H412 | |||
| 616-161-00-0 | 2,4-dichloro-5-hydroxyacetanilide | 429-110-0 | 67669-19-6 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-162-00-6 | isostearic acid monoisopropanolamide | 431-540-9 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 616-163-00-1 | 4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide] | 430-350-3 | 192463-88-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-164-00-7 | dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl] acetamide | - | 149961-52-4 | Carc. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H361d*** H332 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H361d*** H332 H410 | M=10 | ||
| 616-165-00-2 | beflubutamid (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide | - | 113614-08-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=100 | ||
| 616-166-00-8 | cyazofamid (ISO); 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide | - | 120116-88-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M=10 | ||
| 616-167-00-3 | N,N-dibutyl-(2,5-dihydro-5-thioxo-1 H-tetrazol-1-yl)acetamide | 418-290-6 | 168612-06-4 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | 418-440-0 | 136997-71-2 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3- pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one | 420-220-4 | 92771-56-7 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-170-00-X | (2R)-2-amino-2- phenylacetamide | 420-370-0 | 6485-67-2 | Eye Irrit. 2 Skin Sens. 1 | H319 H317 | GHS07 Achtg. | H319 H317 | |||
| 616-171-00-5 | 2-(para-chlorophenyl)glycineamide | 420-830-0 | 102333-75-5 | Eye Dam. 1 Skin Sens. 1 | H318 H317 | GHS05 GHS07 Gef. | H318 H317 | |||
| 616-172-00-0 | N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl) acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl | 423-840-3 | 14691-89-5 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | 424-560-4 | 151257-01-1 | Acute Tox. 4 * Eye Irrit. 2 | H302 H319 | GHS07 Achtg. | H302 H319 | |||
| 616-175-00-7 | 2-(2-hexyldecyloxy) benzamide | 431-230-3 | 202483-62-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-176-00-2 | 3-N,N-bis(methoxyethyl) aminoacetanilide | 432-530-7 | 24294-01-7 | Acute Tox. 4 * Aquatic Chronic 3 | H302 H412 | GHS07 Achtg. | H302 H412 | |||
| 616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5- dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{butyl[(4-methylphenyl) sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl] tetradecanamide | 432-970-1 | 217324-98-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-178-00-3 | N-(5-(bis(2- methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide | 434-500-9 | 52583-35-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-179-00-9 | 2-chloro-N-(4-methylphenyl)acetamide | 435-170-9 | 16634-82-5 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H318 H317 H410 | |||
| 616-180-00-4 | N,N-(dimethylamino)thioacetamide hydrochloride | 435-470-1 | 27366-72-9 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H360D*** H400 H410 | GHS08 GHS09 Gef. | H360D*** H410 | |||
| 616-181-00-X | 4'-methyldodecane-1-sulfonanilide | 435-490-9 | 17417-32-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-182-00-5 | N'-(1,3-dimethylbutylidene)-3-hydroxy-2- naphthohydrazide | 435-860-1 | 214417-91-1 | Skin Sens. 1 Aquatic Chronic 2 | H317 H411 | GHS07 GHS09 Achtg. | H317 H411 | |||
| 616-183-00-0 | N-dodecyl-4-methoxybenzamide | 442-340-6 | 1854-15-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide | 442-560-2 | 105043-55-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-186-00-7 | N,N'-(2-chloro-1,4-phenylene)bis(3- oxobutaneamide) | 443-010-4 | 53641-10-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 616-188-00-8 | 2-(5,5-dimethyl-2,4- dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide | 443-980-9 | 221215-20-9 | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl] acetamide | 444-780-4 | 452962-97-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-190-00-9 | N-decyl-4- nitrobenzamide | 445-880-0 | 64026-19-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-191-00-4 | 2-ethyl-N-methyl-N -(3-methylphenyl)butanamide | 446-190-2 | 406488-30-0 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H302 H319 H315 H317 H411 | GHS07 GHS09 Achtg. | H302 H319 H315 H317 H411 | |||
| 616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide | 448-060-0 | 727678-39-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-193-00-5 | N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H- isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide | 449-940-7 | 368450-39-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-194-00-0 | 2,2-diethoxy-N,N-dimethylacetamide | 449-950-1 | 34640-92-1 | Eye Irrit. 2 | H319 | GHS07 Achtg. | H319 | |||
| 616-196-00-1 | disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy) ethoxy)-N-dodecyl-2-naphthamide | 419-990-4 | - | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 616-197-00-7 | reaction mass of: potassium N-[3-(dimethyloxidoamino) propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino) propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide | 422-500-1 | - | STOT RE 2 * | H373** | GHS08 Achtg. | H373** | |||
| 616-198-00-2 | 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene | 423-300-7 | - | Skin Sens. 1 Aquatic Chronic 4 | H317 H413 | GHS07 Achtg. | H317 H413 | |||
| 616-200-00-1 | reaction mass of N,N′- ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N′-ethane-1,2- diylbis(12-hydroxyoctadecan amide) | 432-430-3 | Aquatic Chronic 4 | H413 | H413 | |||||
| 616-201-00-7 | 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine | 432-840-2 | 220926-97-6 | Acute Tox. 4 * Aquatic Chronic 4 | H332 H413 | GHS07 Achtg. | H332 H413 | |||
| 616-202-00-2 | reaction mass of: 2,2'-[(3,3'- dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'- dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3- oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl] azo]-N-(2-carboxylphenyl)-3-oxo-butanamide | 434-330-5 | - | Carc. 2 Skin Sens. 1 Aquatic Chronic 4 | H351 H317 H413 | GHS08 GHS07 Achtg. | H351 H317 H413 | |||
| 616-203-00-8 | reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl] acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl] acetamide | 442-280-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-204-00-3 | N,N''-(methylenedi-4,1-phenylene) bis[N'-octylurea] | 451-060-3 | 122886-55-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 616-205-00-9 | Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide | 266-583-0 | 67129-08-2 | Skin Sens. 1B Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 | H317 H351 H400 H410 | GHS07 GHS08 GHS09 Achtg. | H317 H351 H410 | M = 100 M = 100 | ||
| 616-206-00-4 | flufenoxuron (ISO); 1-(4-(2- cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea | 417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | M = 10000 M = 10000 | ||
| Aquatic Acute 1 | H400 | Achtg. | ||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 616-207-00-X | Polyhexamethylen-biguanid-hydrochlorid; PHMB | - | 32289-58-0 27083-27-8 | Carc. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 | H351 H330 H302 H372 (Atemwege) (Einatmen) H318 H317 H400 H410 | GHS08 GHS06 GHS05 GHS09 Gef. | H351 H330 H302 H372 (Atemwege) (Einatmen) H318 H317 H410 | M = 10 M = 10 | ||
| 616-208-00-5 | N-ethyl-2-pyrrolidone; 1- ethylpyrrolidin-2-one | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08 Gef. | H360D | |||
| 616-209-00-0 | amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea | 407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | H410 | | M = 100 M = 100 | |
| Aquatic Chronic 1 | H410 | Achtg. | ||||||||
| 616-210-00-6 | tebufenpyrad (ISO); N-(4-tertbutylbenzyl)- 4-chloro-3-ethyl-1- methyl-1Hpyrazole-5- carboxamide | | 119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | | M = 10 M = 10 | |
| Acute Tox. 4 | H332 | GHS08 | H332 | |||||||
| STOT RE 2 | H373 (Magen-Darm-Trakt) (oral) | GHS09 | H373 (Magen-Darm-Trakt) (oral) | |||||||
| Skin Sens. 1B | H317 | Gef. | H317 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 616-211-00-1 | proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one | | 189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | M = 1 | | |
| Aquatic Acute 1 | H400 | GHS09 | M = 10 | |||||||
| Aquatic Chronic 1 | H410 | Achtg. | H410 | |||||||
| 616-212-00-7 | 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H331 H302 H372 (Kehlkopf) H318 H317 H400 H410 | GHS06 GHS08 GHS05 GHS09 Gef. | H331 H302 H372 (Kehlkopf) H318 H317 H410 | M = 10 M = 1 | ||
| 616-213-00-2 | Mandipropamid (ISO); 2-(4-Chlorphenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1- yloxy)acetamid | - | 374726-62-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1 M = 1 | ||
| 616-214-00-8 | Metosulam (ISO); N-(2,6-Dichlor-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2- sulfonamid | - | 139528-85-1 | Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H351 H373 (Augen, Nieren) H400 H410 | GHS08 GHS09 Achtg. | H351 H373 (Augen, Nieren) H410 | M = 1 000 M = 100 | ||
| 616-215-00-3 | Dimethenamid-P (ISO); 2-Chlor-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamid | - | 163515-14-8 | Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Achtg. | H302 H317 H410 | M = 10 M = 10 | ||
| 616-216-00-9 | Flonicamid (ISO); N-(Cyanomethyl)-4-(trifluormethyl)pyridin-3-carboxamid | - | 158062-67-0 | Acute Tox. 4 | H302 | GHS07 Achtg. | H302 | |||
| 616-217-00-4 | Sulfoxaflor (ISO); [Methyl(oxo){1-[6-(trifluormethyl)-3-pyridyl]ethyl}-λ6-sulfanyliden]cyanamid | - | 946578-00-3 | Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | M = 1 M = 1 | ||
| 616-218-00-X | Benzovindiflupyr (ISO); N-[9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaphthalin-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carbonsäureamid | - | 1072957-71-1 | Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 | H331 H301 H400 H410 | GHS06 GHS09 Gef. | H331 H301 H410 | M = 100 M = 100 | ||
| 616-219-00-5 | Fluopyram (ISO); N-{2-[3-Chlor-5-(trifluormethyl)pyridin-2-yl]ethyl}-2-(trifluormethyl)benzamid | - | 658066-35-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 616-220-00-0 | Pencycuron (ISO); 1-[(4-Chlorphenyl)methyl]-1-cyclopentyl-3-phenylharnstoff | 266-096-3 | 66063-05-6 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1 M = 1 | ||
| 616-221-00-6 | Hexaflumuron (ISO); 1-(3,5-Dichlor-4-(1,1,2,2-tetrafluorethoxy)phenyl)-3-(2,6-difluorbenzoyl) harnstoff | 401-400-1 | 86479-06-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1 000 M = 10 000 | ||
| 616-222-00-1 | Penthiopyrad (ISO); (RS)-N-[2-(1,3-Dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)pyrazol-4-carboxamid | - | 183675-82-3 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | M = 1 M = 1 | ||
| 616-223-00-7 | Carbetamid (ISO); (R)-1-(Ethylcarbamoyl) ethylcarbanilat; (2R)-1-(ethylamino)-1-oxopropan-2-ylphenylcarbamat | 240-286-6 | 16118-49-3 | Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 | H351 H360D H302 H411 | GHS08 GHS07 GHS09 Gef. | H351 H360D H302 H411 | |||
| 617-001-00-2 | di-tert-butyl peroxide | 203-733-6 | 110-05-4 | Org. Perox.
E Flam. Liq. 2 Muta. 2 | H242 H225 H341 | GHS02 GHS08 Gef. | H242 H225 H341 | |||
| 617-002-00-8 | α,α-dimethylbenzyl hydroperoxide; cumene hydroperoxide | 201-254-7 | 80-15-9 | Org. Perox.
E Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Aquatic Chronic 2 | H242 H331 H312 H302 H373 (*)(*) H314 H411 | GHS02 GHS06 GHS08 GHS05 GHS09 Gef. | H242 H331 H312 H302 H373 (*)(*) H314 H411 | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Dam. 1; H318: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 3 % STOT SE 3; H335: C < 10 % | ||
| 617-003-00-3 | dilauroyl peroxide | 203-326-3 | 105-74-8 | Org. Perox. D | H242 | GHS02 Gef. | H242 | |||
| 617-004-00-9 | 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide | 212-230-0 | 771-29-9 | Org. Perox.
D Acute Tox. 4 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 | H242 H302 H314 H400 H410 | GHS02 GHS05 GHS07 GHS09 Gef. | H242 H302 H314 H410 | STOT SE 3; H335: C ≥ 5 % | ||
| 617-006-00-X | bis(α,α-dimethylbenzyl) peroxide | 201-279-3 | 80-43-3 | Org. Perox.
F Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 | H242 H319 H315 H411 | GHS02 GHS07 GHS09 Achtg. | H242 H319 H315 H411 | |||
| 617-007-00-5 | tert-butyl α,α-dimethylbenzyl peroxide | 222-389-8 | 3457-61-2 | Org. Perox.
E Skin Irrit. 2 Aquatic Chronic 2 | H242 H315 H411 | GHS02 GHS07 GHS09 Achtg. | H242 H315 H411 | |||
| 617-008-00-0 | dibenzoyl peroxide; benzoyl peroxide | 202-327-6 | 94-36-0 | Org. Perox.
B Eye Irrit. 2 Skin Sens. 1 | H241 H319 H317 | GHS01 GHS02 GHS07 Gef. | H241 H319 H317 | |||
| 617-010-00-1 | 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] 1,1-dioxybiscyclohexan-1-ol; [2] cyclohexylidene hydroperoxide; [3] cyclohexanone, peroxide [4] | 201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] | 78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] | Org. Perox.
A Skin Corr. 1B Acute Tox. 4 * | H240 H314 H302 | GHS01 GHS05 GHS07 Gef. | H240 H314 H302 | STOT SE 3; H335: C ≥ 5 % | C | |
| 617-010-01-9 | 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] 1,1'-dioxybiscyclohexan-1-ol; [2] cyclohexylidene hydroperoxide; [3] cyclohexanone, peroxide [4] [≤ 91 % solution] | 201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] | 78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] | Org. Perox.
C Acute Tox. 4 (*) Skin Corr. 1B | H242 H302 H314 | GHS02 GHS05 GHS07 Gef. | H242 H302 H314 | STOT SE 3; H335: C ≥ 5 % | C T | |
| 617-012-00-2 | 8-p-menthyl hydroperoxide; p-menthane hydroperoxide | 201-281-4 | 80-47-7 | Org. Perox.
D Skin Corr. 1B Acute Tox. 4 (*) | H242 H314 H332 | GHS02 GHS05 GHS07 Gef. | H242 H314 H332 | STOT SE 3; H335: C ≥ 5 % | ||
| 617-013-00-8 | O,O - tert-butyl O-docosyl monoperoxyoxalate | 404-300-6 | 116753-76-5 | Org. Perox.
C (*)(*)(*)(*) Aquatic Acute 1 Aquatic Chronic 1 | H242 H400 H410 | GHS02 GHS09 Gef. | H242 H410 | |||
| 617-014-00-3 | 6-(nonylamino)-6-oxo-peroxyhexanoic acid | 406-680-9 | 104788-63-8 | Org. Perox.
C (*)(*)(*)(*) Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 | H242 H318 H317 H400 | GHS02 GHS05 GHS07 GHS09 Gef. | H242 H318 H317 H400 | |||
| 617-015-00-9 | bis(4-methylbenzoyl)peroxide | 407-950-9 | 895-85-2 | Org. Perox.
B (*)(*)(*)(*) Aquatic Acute 1 Aquatic Chronic 1 | H241 H400 H410 | GHS01 GHS02 GHS09 Gef. | H241 H410 | |||
| 617-016-00-4 | 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate | 413-910-1 | - | Org. Perox.
C (*)(*)(*)(*) Flam. Liq. 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H242 H226 H315 H400 H410 | GHS02 GHS07 GHS09 Gef. | H242 H226 H315 H410 | |||
| 617-017-00-X | reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene | 412-140-3 | 32144-25-5 | Org. Perox.
D Aquatic Chronic 4 | H242 H413 | GHS02 Gef. | H242 H413 | T | ||
| 617-018-00-5 | reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight; 1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight | 410-840-3 | 71566-50-2 | Org. Perox.
C (*)(*)(*)(*) Aquatic Chronic 2 | H242 H411 | GHS02 GHS09 Gef. | H242 H411 | T | ||
| 617-019-00-0 | 6-(phthalimido)peroxyhexanoic acid | 410-850-8 | 128275-31-0 | Org. Perox.
D Eye Dam. 1 Aquatic Acute 1 | H242 H318 H400 | GHS02 GHS05 GHS09 DgGef. | H242 H318 H400 | T | ||
| 617-020-00-6 | 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) | 420-060-5 | 117663-11-3 | Flam. Liq. 3 Org. Perox. D (*)(*)(*)(*) Aquatic Chronic 2 | H226 H242 H411 | GHS02 GHS09 Gef. | H226 H242 H411 | |||
| 617-021-00-1 | methylethylketone peroxide trimer | 429-320-2 | - | Org. Perox.
B**** Asp. Tox. 1 Skin Irrit. 2 Skin Sens. 1 | H241 H304 H315 H317 | GHS01 GHS02 GHS08 GHS07 Gef. | H241 H304 H315 H317 | |||
| 617-022-00-7 | reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate | 442-480-8 | - | Org. Perox.
C Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 | H242 H302 H314 H317 H411 | GHS02 GHS05 GHS07 GHS09 Gef. | H242 H302 H314 H317 H411 | |||
| 617-023-00-2 | tert-Butylhydroperoxid | 200-915-7 | 75-91-2 | Muta. 2 | H341 | GHS08 Achtg. | H341 | |||
| 647-001-00-8 | glucosidase, β- | 232-589-7 | 9001-22-3 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 647-002-00-3 | cellulase | 232-734-4 | 9012-54-8 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 647-003-00-9 | cellobiohydrolase, exo- | 253-465-9 | 37329-65-0 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 647-004-00-4 | cellulases with the exception of those specified elsewhere in this Annex | - | - | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | A | ||
| 647-005-00-X | bromelain, juice | 232-572-4 | 9001-00-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-006-00-5 | ficin | 232-599-1 | 9001-33-6 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-007-00-0 | papain | 232-627-2 | 9001-73-4 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-008-00-6 | pepsin A | 232-629-3 | 9001-75-6 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-009-00-1 | rennin | 232-645-0 | 9001-98-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-010-00-7 | trypsin | 232-650-8 | 9002-07-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-011-00-2 | chymotrypsin | 232-671-2 | 9004-07-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-012-00-8 | subtilisin | 232-752-2 | 9014-01-1 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 | H335 H315 H318 H334 | GHS08 GHS05 GHS07 Gef. | H335 H315 H318 H334 | |||
| 647-013-00-3 | proteinase, microbial neutral | 232-966-6 | 9068-59-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-014-00-9 | proteases with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 | H319 H335 H315 H334 | GHS08 GHS07 Gef. | H319 H335 H315 H334 | |||
| 647-015-00-4 | amylase, α- | 232-565-6 | 9000-90-2 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 647-016-00-X | amylases with the exception of those specified elsewhere in this Annex | - | - | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 647-017-00-5 | laccase | 420-150-4 | 80498-15-3 | Resp. Sens. 1 | H334 | GHS08 Gef. | H334 | |||
| 648-001-00-0 | Distillates (coal tar), benzole fraction; Light Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4to C10 and distilling in the approximate range of 80 oC to 160 oC (175oF to 320oF).] | 283-482-7 | 84650-02-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 648-002-00-6 | Tar oils, brown-coal; Light Oil; [The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] | 302-674-4 | 94114-40-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-003-00-1 | Benzol forerunnings (coal); Light Oil Redistillate, low boiling; [The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.] | 266-023-5 | 65996-88-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-004-00-7 | Distillates (coal tar), benzole fraction, BTX-rich; Light Oil Redistillate, low boiling; [A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).] | 309-984-9 | 101896-26-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-005-00-2 | Aromatic hydrocarbons, C6-10, C8-rich; Light Oil Redistillate, low boiling | 292-697-5 | 90989-41-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-006-00-8 | Solvent naphtha (coal), light; Light Oil Redistillate, low boiling | 287-498-5 | 85536-17-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-007-00-3 | Solvent naphtha (coal), xylene-styrene cut; Light Oil Redistillate, intermediate boiling | 287-502-5 | 85536-20-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-008-00-9 | Solvent naphtha (coal), coumarone-styrene contg.; Light Oil Redistillate, intermediate boiling | 287-500-4 | 85536-19-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-009-00-4 | Naphtha (coal), distn. residues; Light Oil Redistillate, high boiling; [The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] | 292-636-2 | 90641-12-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-010-00-X | Aromatic hydrocarbons, C8; Light Oil Redistillate, high boiling | 292-694-9 | 90989-38-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-012-00-0 | Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product; Light Oil Redistillate, high boiling; [A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).] | 295-281-1 | 91995-20-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-013-00-6 | Aromatic hydrocarbons, C9-12, benzene distn.; Light Oil Redistillate, high boiling | 295-551-9 | 92062-36-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-014-00-1 | Extract residues (coal), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.] | 295-323-9 | 91995-61-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-015-00-7 | Extract residues (coal tar), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).] | 309-868-8 | 101316-63-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-016-00-2 | Extract residues (coal), benzole fraction acid; Light Oil Extract Residues, low boiling; [An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] | 298-725-2 | 93821-38-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-017-00-8 | Extract residues (coal), light oil alk., distn. overheads; Light Oil Extract Residues, low boiling; [The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8aliphatic and aromatic hydrocarbons.] | 292-625-2 | 90641-02-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-018-00-3 | Extract residues (coal), light oil alk., acid ext., indene fraction; Light Oil Extract Residues, intermediate boiling | 309-867-2 | 101316-62-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-019-00-9 | Extract residues (coal), light oil alk., indene naphtha fraction; Light Oil Extract Residues, high boiling; [The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.] | 292-626-8 | 90641-03-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-020-00-4 | Solvent naphtha (coal); Light Oil Extract Residues, high boiling; [The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] | 266-013-0 | 65996-79-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-021-00-X | Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.] | 309-971-8 | 101794-90-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-022-00-5 | Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling; [This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).] | 292-609-5 | 90640-87-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-023-00-0 | Distillates (coal tar), light oils; Carbolic Oil; [A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).] | 283-483-2 | 84650-03-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-024-00-6 | Tar oils, coal; Carbolic Oil; [The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] | 266-016-7 | 65996-82-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-026-00-7 | Extract residues (coal), light oil alk., acid ext.; Carbolic Oil Extract Residue; [The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] | 292-624-7 | 90641-01-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-027-00-2 | Extract residues (coal), tar oil alk.; Carbolic Oil Extract Residue; [The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] | 266-021-4 | 65996-87-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-028-00-8 | Extract oils (coal), light oil; Acid Extract; [The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] | 292-622-6 | 90640-99-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-029-00-3 | Pyridine, alkyl derivs.; Crude Tar Bases; [The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] | 269-929-9 | 68391-11-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-030-00-9 | Tar bases, coal, picoline fraction; Distillate Bases; [Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] | 295-548-2 | 92062-33-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-031-00-4 | Tar bases, coal, lutidine fraction; Distillate Bases | 293-766-2 | 91082-52-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-032-00-X | Extract oils (coal), tar base, collidine fraction; Distillate Bases; [The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] | 273-077-3 | 68937-63-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-033-00-5 | Tar bases, coal, collidine fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] | 295-543-5 | 92062-28-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-034-00-0 | Tar bases, coal, aniline fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] | 295-541-4 | 92062-27-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-035-00-6 | Tar bases, coal, toluidine fraction; Distillate Bases | 293-767-8 | 91082-53-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-036-00-1 | Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction; Redistillates; [A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).] | 295-292-1 | 91995-31-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-037-00-7 | Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.] | 295-295-8 | 91995-35-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-038-00-2 | Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate; Redistillates; [The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] | 295-329-1 | 91995-66-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-039-00-8 | Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.] | 310-170-0 | 122070-79-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-040-00-3 | Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues; Redistillates; [Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] | 310-171-6 | 122070-80-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-041-00-9 | Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500oF to 554oF).] | 309-851-5 | 101316-45-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-042-00-4 | Distillates (coal tar), upper, fluorene-rich; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] | 284-900-0 | 84989-11-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-043-00-X | Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate; [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] | 292-606-9 | 90640-85-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-044-00-5 | Distillates (coal tar), heavy oils; Heavy Anthracene Oil; [Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464oF to 752oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.] | 292-607-4 | 90640-86-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 648-045-00-0 | Distillates (coal tar), upper; Heavy Anthracene Oil; [The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428oF to 842oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] | 266-026-1 | 65996-91-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-046-00-6 | Anthracene oil, acid ext.; Anthracene Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617oF to 689oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] | 295-274-3 | 91995-14-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-047-00-1 | Distillates (coal tar); Heavy Anthracene Oil; [The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212oF to 842oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] | 266-027-7 | 65996-92-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-048-00-7 | Distillates (coal tar), pitch, heavy oils; Heavy Anthracene Oil; [The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572oF to 878oF). The product may also contain heteroatoms.] | 295-312-9 | 91995-51-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-049-00-2 | Distillates (coal tar), pitch; Heavy Anthracene Oil; [The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392oF to greater than 752oF).] | 309-855-7 | 101316-49-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-050-00-8 | Distillates (coal tar), heavy oils, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662oF to 752oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.] | 295-304-5 | 91995-42-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-051-00-3 | Distillates (coal tar), pitch, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.] | 295-313-4 | 91995-52-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-052-00-9 | Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated; Coal Tar Extract; [A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-296-6 | 97926-76-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-053-00-4 | Paraffin waxes (coal), brown-coal high-temp tar, clay-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-297-1 | 97926-77-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-054-00-X | Pitch; Pitch | 263-072-4 | 61789-60-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-055-00-5 | pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 266-028-2 | 65996-93-2 | Carc. 1A | H350 | GHS08 | H350 | | M = 1000 M = 1000 | |
| Muta. 1B | H340 | GHS09 | H340 | |||||||
| Repr. 1B | H360FD | Gef. | H360FD | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 648-056-00-0 | Pitch, coal tar, high-temp., heat-treated; Pitch; [The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176oF to 356oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 310-162-7 | 121575-60-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-057-00-6 | Pitch, coal tar, high-temp., secondary; Pitch Redistillate; [The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284oF to 392oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.] | 302-650-3 | 94114-13-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-058-00-1 | Residues (coal tar), pitch distn.; Pitch Redistillate; [Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752oF to 846oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] | 295-507-9 | 92061-94-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-059-00-7 | Tar, coal, high-temp., distn. and storage residues; Coal Tar Solids Residue; [Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] | 295-535-1 | 92062-20-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-060-00-2 | Tar, coal, storage residues; Coal Tar Solids Residue; [The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] | 293-764-1 | 91082-50-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-061-00-8 | Tar, coal, high-temp., residues; Coal Tar Solids Residue; [Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] | 309-726-5 | 100684-51-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-062-00-3 | Tar, coal, high-temp., high-solids; Coal Tar Solids Residue; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] | 273-615-7 | 68990-61-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-063-00-9 | Waste solids, coal-tar pitch coking; Coal Tar Solids Residue; [The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] | 295-549-8 | 92062-34-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-064-00-4 | Extract residues (coal), brown; Coal Tar Extract; [The residue from extraction of dried coal.] | 294-285-0 | 91697-23-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-065-00-X | Paraffin waxes (coal), brown-coal-high-temp. tar; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] | 295-454-1 | 92045-71-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-066-00-5 | Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] | 295-455-7 | 92045-72-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-067-00-0 | Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-298-7 | 97926-78-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-068-00-6 | Tar, coal, low-temp., distn. residues; Tar Oil, intermediate boiling; [Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572oF). Composed primarily of aromatic compounds.] | 309-887-1 | 101316-85-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-069-00-1 | Pitch, coal tar, low-temp; Pitch Residue; [A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104oF to 356oF). Composed primarily of a complex mixture of hydrocarbons.] | 292-651-4 | 90669-57-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-070-00-7 | Pitch, coal tar, low-temp., oxidized; Pitch Residue, oxidised; [The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158oF to 356oF). Composed primarily of a complex mixture of hydrocarbons.] | 292-654-0 | 90669-59-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-071-00-2 | Pitch, coal tar, low-temp., heat-treated; Pitch Residue, oxidised; Pitch Residue, heat-treated; [A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122oF to 284oF). Composed primarily of a complex mixture of aromatic compounds.] | 292-653-5 | 90669-58-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-072-00-8 | Distillates (coal-petroleum), condensed-ring arom; Distillates; [The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428oF to 842oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.] | 269-159-3 | 68188-48-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-073-00-3 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived; Pyrolysis Products; [A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.] | 309-956-6 | 101794-74-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-074-00-9 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.] | 309-957-1 | 101794-75-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-075-00-4 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.] | 309-958-7 | 101794-76-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-076-00-X | Pitch, coal tar-petroleum; Pitch Residues; [The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140oF to 356oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] | 269-109-0 | 68187-57-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-077-00-5 | Phenanthrene, distn. residues; Heavy Anthracene Oil Redistillate; [Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644oF to 788oF). It consists predominantly of phenanthrene, anthracene and carbazole.] | 310-169-5 | 122070-78-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-078-00-0 | Distillates (coal tar), upper, fluorene-free; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] | 284-899-7 | 84989-10-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-079-00-6 | Anthracene oil; Anthracene oil; [A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572oF to 752oF). Composed primarily of phenanthrene, anthracene and carbazole.] | 292-602-7 | 90640-80-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-080-00-1 | Residues (coal tar), creosote oil distn.; Wash Oil Redistillate; [The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.] | 295-506-3 | 92061-93-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-081-00-7 | Tar, coal; Coal tar; [The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.] | 232-361-7 | 8007-45-2 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 648-082-00-2 | Tar, coal, high-temp.; Coal tar; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] | 266-024-0 | 65996-89-6 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 648-083-00-8 | Tar, coal, low-temp.; Coal oil; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] | 266-025-6 | 65996-90-9 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 648-084-00-3 | Distillates (coal), coke-oven light oil, naphthalene cut; Naphthalene Oil; [The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).] | 285-076-5 | 85029-51-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-085-00-9 | Distillates (coal tar), naphthalene oils; Naphthalene Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).] | 283-484-8 | 84650-04-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-086-00-4 | Distillates (coal tar), naphthalene oils, naphthalene-low; Naphthalene Oil Redistillate; [A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] | 284-898-1 | 84989-09-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-087-00-X | Distillates (coal tar), naphthalene oil crystn. mother liquor; Naphthalene Oil Redistillate; [A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] | 295-310-8 | 91995-49-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-088-00-5 | Extract residues (coal), naphthalene oil, alk.; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] | 310-166-9 | 121620-47-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-089-00-0 | Extract residues (coal), naphthalene oil, alk., naphthalene-low; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] | 310-167-4 | 121620-48-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-090-00-6 | Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.; Naphthalene Oil Extract Residue; [The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] | 292-612-1 | 90640-90-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-091-00-1 | Extract residues (coal), naphthalene oil alk., distn. overheads; Naphthalene Oil Extract Residue; [The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] | 292-627-3 | 90641-04-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-092-00-7 | Distillates (coal tar), naphthalene oils, methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).] | 309-985-4 | 101896-27-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-093-00-2 | Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).] | 309-972-3 | 101794-91-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-094-00-8 | Distillates (coal tar), naphthalene oils, acid exts.; Methylnaphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] | 295-309-2 | 91995-48-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-095-00-3 | Extract residues (coal), naphthalene oil alk., distn. residues; Methylnaphthalene Oil Extract Residue; [The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] | 292-628-9 | 90641-05-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-096-00-9 | Extract oils (coal), acidic, tar-base free; Methylnaphthalene Oil Extract Residue; [The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] | 284-901-6 | 84989-12-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-097-00-4 | Distillates (coal tar), benzole fraction, distn. residues; Wash Oil; [A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.] | 310-165-3 | 121620-46-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-098-00-X | Creosote oil, acenaphthene fraction; Wash Oil; [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] | 292-605-3 | 90640-84-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-099-00-5 | Creosote oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).] | 263-047-8 | 61789-28-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-100-00-9 | Creosote oil, high-boiling distillate; Wash Oil; [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).] | 274-565-9 | 70321-79-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-101-00-4 | Creosote; [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] | 232-287-5 | 8001-58-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 648-102-00-X | Extract residues (coal), creosote oil acid; Wash Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] | 310-189-4 | 122384-77-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-103-00-5 | Anthracene oil, anthracene paste; Anthracene Oil Fraction; [The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] | 292-603-2 | 90640-81-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-104-00-0 | Anthracene oil, anthracene-low; Anthracene Oil Fraction; [The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] | 292-604-8 | 90640-82-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-105-00-6 | Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction; [The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.] | 295-505-8 | 92061-92-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-106-00-1 | Anthracene oil, anthracene paste, anthracene fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.] | 295-275-9 | 91995-15-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-107-00-7 | Anthracene oil, anthracene paste, carbazole fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.] | 295-276-4 | 91995-16-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-108-00-2 | Anthracene oil, anthracene paste, distn. lights; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.] | 295-278-5 | 91995-17-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-109-00-8 | Tar oils, coal, low-temp.; Tar Oil, high boiling; [A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).] | 309-889-2 | 101316-87-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-110-00-3 | Extract residues (coal), low temp. coal atar alk.; [The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] | 310-191-5 | 122384-78-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-111-00-9 | Phenols, ammonia liquor ext.; Alkaline Extract; [The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1 292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.] | 284-881-9 | 84988-93-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-112-00-4 | Distillates (coal tar), light oils, alk. exts.; Alkaline Extract; [The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 292-610-0 | 90640-88-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-113-00-X | Extracts, coal tar oil alk.; Alkaline Extract; [The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 266-017-2 | 65996-83-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-114-00-5 | Distillates (coal tar), naphthalene oils, alk. exts.; Alkaline Extract; [The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 292-611-6 | 90640-89-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-115-00-0 | Extract residues (coal), tar oil alk., carbonated, limed; Crude Phenols; [The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] | 292-629-4 | 90641-06-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-116-00-6 | Tar acids, coal, crude; Crude Phenols; [The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] | 266-019-3 | 65996-85-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-117-00-1 | Tar acids, brown-coal, crude; Crude Phenols; [An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] | 309-888-7 | 101316-86-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-118-00-7 | Tar acids, brown-coal gasification; Crude Phenols; [A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] | 295-536-7 | 92062-22-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-119-00-2 | Tar acids, distn. residues; Distillate Phenols; [A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).] | 306-251-5 | 96690-55-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-120-00-8 | Tar acids, methylphenol fraction; Distillate Phenols; [The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] | 284-892-9 | 84989-04-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-121-00-3 | Tar acids, polyalkylphenol fraction; Distillate Phenols; [The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.] | 284-893-4 | 84989-05-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-122-00-9 | Tar acids, xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] | 284-895-5 | 84989-06-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-123-00-4 | Tar acids, ethylphenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] | 284-891-3 | 84989-03-7 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-124-00-X | Tar acids, 3,5-xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] | 284-896-0 | 84989-07-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-125-00-5 | Tar acids, residues, distillates, first-cut; Distillate Phenols; [The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.] | 270-713-1 | 68477-23-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-126-00-0 | Tar acids, cresylic, residues; Distillate Phenols; [The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.] | 271-418-0 | 68555-24-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-127-00-6 | Phenols, C9-11; Distillate Phenols | 293-435-2 | 91079-47-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-128-00-1 | Tar acids, cresylic; Distillate Phenols; [A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.] | 295-540-9 | 92062-26-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-129-00-7 | Tar acids, brown-coal, C2-alkylphenol fraction; Distillate Phenols; [The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.] | 302-662-9 | 94114-29-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-130-00-2 | Extract oils (coal), naphthalene oils; Acid Extract; [The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] | 292-623-1 | 90641-00-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-131-00-8 | Tar bases, quinoline derivs.; Distillate Bases | 271-020-7 | 68513-87-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-132-00-3 | Tar bases, coal, quinoline derivs. fraction; Distillate Bases | 274-560-1 | 70321-67-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-133-00-9 | Tar bases, coal, distn. residues; Distillate Bases; [The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] | 295-544-0 | 92062-29-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-134-00-4 | Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).] | 309-745-9 | 100801-63-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-135-00-X | Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).] | 309-748-5 | 100801-65-8 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-136-00-5 | Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).] | 309-749-0 | 100801-66-9 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-137-00-0 | Extract residues (coal), tar oil alk., naphthalene distn. residues; Naphthalene Oil Extract Residue; [The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] | 277-567-8 | 73665-18-6 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-138-00-6 | Creosote oil, low-boiling distillate; Wash Oil; [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).] | 274-566-4 | 70321-80-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-139-00-1 | Tar acids, cresylic, sodium salts, caustic solns.; Alkaline Extract | 272-361-4 | 68815-21-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-140-00-7 | Extract oils (coal), tar base; Acid Extract; [The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] | 266-020-9 | 65996-86-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-141-00-2 | Tar bases, coal, crude; Crude Tar Bases; [The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] | 266-018-8 | 65996-84-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | JM | ||
| 648-142-00-8 | Residues (coal), liq. solvent extn.; [A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] | 302-681-2 | 94114-46-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-143-00-3 | Coal liquids, liq. solvent extn. soln.; [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] | 302-682-8 | 94114-47-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-144-00-9 | Coal liquids, liq. solvent extn.; [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] | 302-683-3 | 94114-48-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | M | ||
| 648-145-00-4 | Tar brown-coal; [An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302oF to 680oF).] | 309-885-0 | 101316-83-0 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 648-146-00-X | Tar, brown-coal, low-temp.; [A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] | 309-886-6 | 101316-84-1 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 648-147-00-5 | Light oil (coal), coke-oven; Crude benzole; [The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1 292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] | 266-012-5 | 65996-78-3 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-148-00-0 | Distillates (coal), liq. solvent extn., primary; [The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] | 302-688-0 | 94114-52-0 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-149-00-6 | Distillates (coal), solvent extn., hydrocracked; [Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] | 302-689-6 | 94114-53-1 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-150-00-1 | Naphtha (coal), solvent extn., hydrocracked; [Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] | 302-690-1 | 94114-54-2 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-151-00-7 | Gasoline, coal solvent extn., hydrocracked naphtha; [Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86oF to 356oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] | 302-691-7 | 94114-55-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 648-152-00-2 | Distillates (coal), solvent extn., hydrocracked middle; [Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] | 302-692-2 | 94114-56-4 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-153-00-8 | Distillates (coal), solvent extn., hydrocracked hydrogenated middle; [Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] | 302-693-8 | 94114-57-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 648-154-00-3 | Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated; [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356oF to 473oF). Composed primarily of hydrogenated two-ringhydrocarbons and theiralkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] | 302-694-3 | 94114-58-6 | Carc. 2 | H351 | GHS08 Achtg. | H350 | |||
| 648-155-00-9 | Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392oF to 536oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] | 302-695-9 | 94114-59-7 | Carc. 2 | H351 | GHS08 Achtg. | H350 | |||
| 648-156-00-4 | Light oil (coal), semi-coking process; Fresh oil; [The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1 292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] | 292-635-7 | 90641-11-5 | Carc. 1B Muta. 1B | H350 H340 | GHS08 Gef. | H350 H340 | J | ||
| 649-001-00-3 | Extracts (petroleum), light naphthenic distillate solvent | 265-102-1 | 64742-03-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-002-00-9 | Extracts (petroleum), heavy paraffinic distillate solvent | 265-103-7 | 64742-04-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-003-00-4 | Extracts (petroleum), light paraffinic distillate solvent | 265-104-2 | 64742-05-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-004-00-X | Extracts (petroleum), heavy naphthenic distillate solvent | 265-111-0 | 64742-11-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-005-00-5 | Extracts (petroleum), light vacuum gas oil solvent | 295-341-7 | 91995-78-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-006-00-0 | hydrocarbons C26-55, arom-rich | 307-753-7 | 97722-04-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-007-00-6 | fatty acids, tall-oil, reaction products with iminodiethanol and boric acid | 400-160-5 | - | Skin Irrit. 2 Aquatic Chronic 2 | H315 H411 | GHS07 GHS09 Achtg. | H315 H411 | |||
| 649-008-00-1 | Residues (petroleum), atm. tower; Heavy Fuel oil; [A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-045-2 | 64741-45-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-009-00-7 | Gas oils (petroleum), heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and boiling in the range of approximately 350 oC to 600 oC (662oF to 1112oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-058-3 | 64741-57-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-010-00-2 | Distillates (petroleum), heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-063-0 | 64741-61-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-011-00-8 | Clarified oils (petroleum), catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-064-6 | 64741-62-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-012-00-3 | Residues (petroleum), hydrocracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF).] | 265-076-1 | 64741-75-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-013-00-9 | Residues (petroleum), thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-081-9 | 64741-80-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-014-00-4 | Distillates (petroleum), heavy thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15through C36 and boiling in the range of approximately 260 oC to 480 oC (500oF to 896oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-082-4 | 64741-81-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-015-00-X | Gas oils (petroleum), hydrotreated vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13through C50 and boiling in the range of approximately 230 oC to 600 oC (446oF to 1112oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-162-9 | 64742-59-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-016-00-5 | Residues (petroleum), hydrodesulfurized atmospheric tower; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-181-2 | 64742-78-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-017-00-0 | Gas oils (petroleum), hydrodesulfurized heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-189-6 | 64742-86-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-018-00-6 | Residues (petroleum), steam-cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 265-193-8 | 64742-90-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-019-00-1 | Residues (petroleum), atmospheric; Heavy Fuel oil; [A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 269-777-3 | 68333-22-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-020-00-7 | Clarified oils (petroleum), hydrodesulfurized catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 269-782-0 | 68333-26-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-021-00-2 | Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401oF to 842oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] | 269-783-6 | 68333-27-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-022-00-8 | Distillates (petroleum), hydrodesulfurized heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 269-784-1 | 68333-28-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-023-00-3 | Fuel oil, residues-straight-run gas oils, high-sulfur; Heavy Fuel oil | 270-674-0 | 68476-32-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-024-00-9 | Fuel oil, residual; Heavy Fuel oil; [The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] | 270-675-6 | 68476-33-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-025-00-4 | Residues (petroleum), catalytic reformer fractionator residue distn.; Heavy Fuel oil; [A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750oF).] | 270-792-2 | 68478-13-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-026-00-X | Residues (petroleum), heavy coker gas oil and vacuum gas oil; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446oF).] | 270-796-4 | 68478-17-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-027-00-5 | Residues (petroleum), heavy coker and light vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446oF).] | 270-983-0 | 68512-61-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-028-00-0 | Residues (petroleum), light vacuum; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446oF).] | 270-984-6 | 68512-62-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-029-00-6 | Residues (petroleum), steam-cracked light; Heavy Fuel oil; [A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214oF to 1030oF).] | 271-013-9 | 68513-69-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-030-00-1 | Fuel oil, No 6; Heavy Fuel oil; [A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100oF) to a maximum of 9000 SUS at 37.7 oC (100oF).] | 271-384-7 | 68553-00-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-031-00-7 | Residues (petroleum), topping plant, low-sulfur; Heavy Fuel oil; [A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] | 271-763-7 | 68607-30-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-032-00-2 | Gas oils (petroleum), heavy atmospheric; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250oF to 950oF).] | 272-184-2 | 68783-08-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-033-00-8 | Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.; Heavy Fuel oil; [A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.] | 272-187-9 | 68783-13-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-034-00-3 | Distillates (petroleum), petroleum residues vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] | 273-263-4 | 68955-27-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-035-00-9 | Residues (petroleum), steam-cracked, resinous; Heavy Fuel oil; [A complex residuum from the distillation of steam-cracked petroleum residues.] | 273-272-3 | 68955-36-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-036-00-4 | Distillates (petroleum), intermediate vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14through C42 and boiling in the range of approximately 250 oC to 545 oC (482oF to 1013oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 274-683-0 | 70592-76-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-037-00-X | Distillates (petroleum), light vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11through C35 and boiling in the range of approximately 250 oC to 545 oC (482oF to 1013oF).] | 274-684-6 | 70592-77-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-038-00-5 | Distillates (petroleum), vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50and boiling in the range of approximately 270 oC to 600 oC (518oF to 1112oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 274-685-1 | 70592-78-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-039-00-0 | Gas oils (petroleum), hydrodesulfurized coker heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579oF to 1018oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 285-555-9 | 85117-03-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-040-00-6 | Residues (petroleum), steam-cracked, distillates; Heavy Fuel oil; [A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] | 292-657-7 | 90669-75-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-041-00-1 | Residues (petroleum), vacuum, light; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734oF).] | 292-658-2 | 90669-76-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-042-00-7 | Fuel oil, heavy, high-sulfur; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752oF).] | 295-396-7 | 92045-14-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-043-00-2 | Residues (petroleum), catalytic cracking; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392oF).] | 295-511-0 | 92061-97-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-044-00-8 | Distillates (petroleum), intermediate catalytic cracked, thermally degraded; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428oF to 842oF). This stream is likely to contain organic sulfur compounds.] | 295-990-6 | 92201-59-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-045-00-3 | Residual oils (petroleum); Heavy Fuel oil; [A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] | 298-754-0 | 93821-66-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-046-00-9 | Residues, steam cracked, thermally treated; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356oF).] | 308-733-0 | 98219-64-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-047-00-4 | Distillates (petroleum), hydrodesulfurized full-range middle; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302oF to 752oF).] | 309-863-0 | 101316-57-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-048-00-X | Residues (petroleum), catalytic reformer fractionator; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320oF to 725oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.] | 265-069-3 | 64741-67-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-049-00-5 | Petroleum; Crude oil; [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] | 232-298-5 | 8002-05-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-050-00-0 | Distillates (petroleum), light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] | 265-051-5 | 64741-50-0 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-051-00-6 | Distillates (petroleum), heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] | 265-052-0 | 64741-51-1 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-052-00-1 | Distillates (petroleum), light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-053-6 | 64741-52-2 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-053-00-7 | Distillates (petroleum), heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-054-1 | 64741-53-3 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-054-00-2 | Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-117-3 | 64742-18-3 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-055-00-8 | Distillates (petroleum), acid-treated light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-118-9 | 64742-19-4 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-056-00-3 | Distillates (petroleum), acid-treated heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100oF (19cSt at 40 oC).] | 265-119-4 | 64742-20-7 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-057-00-9 | Distillates (petroleum), acid-treated light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-121-5 | 64742-21-8 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-058-00-4 | Distillates (petroleum), chemically neutralized heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] | 265-127-8 | 64742-27-4 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-059-00-X | Distillates (petroleum), chemically neutralized light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-128-3 | 64742-28-5 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-060-00-5 | Distillates (petroleum), chemically neutralized heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-135-1 | 64742-34-3 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-061-00-0 | Distillates (petroleum), chemically neutralized light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-136-7 | 64742-35-4 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 649-062-00-6 | Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] | 270-755-0 | 68477-73-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-063-00-1 | Gases (petroleum), catalytic cracker; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-756-6 | 68477-74-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-064-00-7 | Gases (petroleum), catalytic cracker, C1-5-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] | 270-757-1 | 68477-75-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-065-00-2 | Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] | 270-758-7 | 68477-76-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-066-00-8 | Gases (petroleum), catalytic reformer, C1-4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] | 270-760-8 | 68477-79-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-067-00-3 | Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed; Petroleum gas; [A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] | 270-765-5 | 68477-83-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-068-00-9 | Gases (petroleum), C4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] | 270-767-6 | 68477-85-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-069-00-4 | Gases (petroleum), deethanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] | 270-768-1 | 68477-86-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-070-00-X | Gases (petroleum), deisobutanizer tower overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] | 270-769-7 | 68477-87-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-071-00-5 | Gases (petroleum), depropanizer dry, propene-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.] | 270-772-3 | 68477-90-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-072-00-0 | Gases (petroleum), depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 270-773-9 | 68477-91-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-073-00-6 | Gases (petroleum), gas recovery plant depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] | 270-777-0 | 68477-94-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-074-00-1 | Gases (petroleum), Girbotol unit feed; Petroleum gas; [A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 270-778-6 | 68477-95-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-075-00-7 | Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free; Petroleum gas | 270-782-8 | 68477-99-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-076-00-2 | Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-802-5 | 68478-21-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-077-00-8 | Tail gas (petroleum), catalytic cracked naphtha stabilization absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-803-0 | 68478-22-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-078-00-3 | Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1through C5.] | 270-804-6 | 68478-24-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-079-00-9 | Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 270-806-7 | 68478-26-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-080-00-4 | Tail gas (petroleum), saturate gas plant mixed stream, C4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] | 270-813-5 | 68478-32-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-081-00-X | Tail gas (petroleum), saturate gas recovery plant, C1-2-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.] | 270-814-0 | 68478-33-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-082-00-5 | Tail gas (petroleum), vacuum residues thermal cracker; Petroleum gas; [A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-815-6 | 68478-34-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-083-00-0 | Hydrocarbons, C3-4-rich, petroleum distillate; Petroleum gas; [A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] | 270-990-9 | 68512-91-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-084-00-6 | Gases (petroleum), full-range straight-run naphtha dehexanizer off; petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-000-8 | 68513-15-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-085-00-1 | Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich; Petroleum gas; [A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] | 271-001-3 | 68513-16-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-086-00-7 | Gases (petroleum), light straight-run naphtha stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-002-9 | 68513-17-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-087-00-2 | Residues (petroleum), alkylation splitter, C4-rich; Petroleum gas; [A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 °C to 27.8 °C (11 °F to 82 °F).] | 271-010-2 | 68513-66-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-088-00-8 | Hydrocarbons, C1-4; Petroleum gas; [A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0.5 °C (- 263 °F to 31 °F).] | 271-032-2 | 68514-31-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-089-00-3 | Hydrocarbons, C1-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 °C to - 0.5 °C (- 263 °F to 31 °F).] | 271-038-5 | 68514-36-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-090-00-9 | Hydrocarbons, C1-3; Petroleum gas; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (- 263 °F to - 44 °F).] | 271-259-7 | 68527-16-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-091-00-4 | Hydrocarbons, C1-4, debutanizer fraction; Petroleum gas | 271-261-8 | 68527-19-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-092-00-X | Gases (petroleum), C1-5, wet; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 271-624-0 | 68602-83-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-093-00-5 | Hydrocarbons, C2-4; Petroleum gas | 271-734-9 | 68606-25-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-094-00-0 | Hydrocarbons, C3; Petroleum gas | 271-735-4 | 68606-26-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-095-00-6 | Gases (petroleum), alkylation feed; Petroleum gas; [A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] | 271-737-5 | 68606-27-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-096-00-1 | Gases (petroleum), depropanizer bottoms fractionation off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] | 271-742-2 | 68606-34-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-097-00-7 | Gases (petroleum), refinery blend; Petroleum gas; [A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-183-7 | 68783-07-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-098-00-2 | Gases (petroleum), catalytic cracking; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3through C5.] | 272-203-4 | 68783-64-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-099-00-8 | Gases (petroleum), C2-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2through C4 and boiling in the range of approximately - 51 °C to - 34 °C (- 60 °F to - 30 °F).] | 272-205-5 | 68783-65-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-100-00-1 | Gases (petroleum), crude oil fractionation off; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-871-7 | 68918-99-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-101-00-7 | Gases (petroleum), dehexanizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-872-2 | 68919-00-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-102-00-2 | Gases (petroleum), light straight run gasoline fractionation stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-878-5 | 68919-05-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-103-00-8 | Gases (petroleum), naphtha unifiner desulfurization stripper off; Petroleum gas; [A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-879-0 | 68919-06-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-104-00-3 | Gases (petroleum), straight-run naphtha catalytic reforming off; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] | 272-882-7 | 68919-09-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-105-00-9 | Gases (petroleum), fluidized catalytic cracker splitter overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.] | 272-893-7 | 68919-20-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-106-00-4 | Gases (petroleum), straight-run stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-883-2 | 68919-10-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-107-00-X | Gases (petroleum), catalytic cracked naphtha debutanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 273-169-3 | 68952-76-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-108-00-5 | Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 273-170-9 | 68952-77-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-109-00-0 | Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber; petroleum gas; [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C6.] | 273-175-6 | 68952-81-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-110-00-6 | Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 273-176-1 | 68952-82-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-111-00-1 | Gases (petroleum, light steam-cracked, butadiene conc.; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.] | 273-265-5 | 68955-28-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-112-00-7 | Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 273-270-2 | 68955-34-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-113-00-2 | Hydrocarbons, C4; Petroleum gas | 289-339-5 | 87741-01-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-114-00-8 | Alkanes, C1-4, C3-rich; Petroleum gas | 292-456-4 | 90622-55-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-115-00-3 | Gases (petroleum), steam-cracker C3-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 °C to 0 °C (- 94 °F to 32 °F).] | 295-404-9 | 92045-22-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-116-00-9 | Hydrocarbons, C4, steam-cracker distillate; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).] | 295-405-4 | 92045-23-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-117-00-4 | Petroleum gases, liquefied, sweetened, C4 fraction; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] | 295-463-0 | 92045-80-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K S U | ||
| 649-118-00-X | Hydrocarbons, C4, 1,3-butadiene- and isobutene-free; Petroleum gas | 306-004-1 | 95465-89-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-119-00-5 | Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas | 307-769-4 | 97722-19-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-120-00-0 | Gases (petroleum), amine system feed; Refinery gas; [The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1through C5 may also be present.] | 270-746-1 | 68477-65-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-121-00-6 | Gases (petroleum), benzene unit hydrodesulfurizer off; Refinery gas; [Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] | 270-747-7 | 68477-66-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-122-00-1 | Gases (petroleum), benzene unit recycle, hydrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.] | 270-748-2 | 68477-67-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-123-00-7 | Gases (petroleum), blend oil, hydrogen-nitrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-749-8 | 68477-68-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-124-00-2 | Gases (petroleum), catalytic reformed naphtha stripper overheads; Refinery gas; [A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 270-759-2 | 68477-77-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-125-00-8 | Gases (petroleum), C6-8 catalytic reformer recycle; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-761-3 | 68477-80-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-126-00-3 | Gases (petroleum), C6-8 catalytic reformer; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] | 270-762-9 | 68477-81-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-127-00-9 | Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich; Refinery gas | 270-763-4 | 68477-82-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-128-00-4 | Gases (petroleum), C2-return stream; Refinery gas; [A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] | 270-766-0 | 68477-84-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-129-00-X | Gases (petroleum), dry sour, gas-concn.-unit-off; Refinery gas; [The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 270-774-4 | 68477-92-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-130-00-5 | Gases (petroleum), gas concn. reabsorber distn.; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1through C3.] | 270-776-5 | 68477-93-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-131-00-0 | Gases (petroleum), hydrogen absorber off; Refinery gas; [A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] | 270-779-1 | 68477-96-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-132-00-6 | Gases (petroleum), hydrogen-rich; Refinery gas; [A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] | 270-780-7 | 68477-97-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-133-00-1 | Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich; Refinery gas; [A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-781-2 | 68477-98-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-134-00-7 | Gases (petroleum), recycle, hydrogen-rich; Refinery gas; [A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] | 270-783-3 | 68478-00-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-135-00-2 | Gases (petroleum), reformer make-up, hydrogen-rich; Refinery gas; [A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1through C5.] | 270-784-9 | 68478-01-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-136-00-8 | Gases (petroleum), reforming hydrotreater; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] | 270-785-4 | 68478-02-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-137-00-3 | Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2through C5.] | 270-787-5 | 68478-03-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-138-00-9 | Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-788-0 | 68478-04-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-139-00-4 | Gases (petroleum), thermal cracking distn.; Refinery gas; [A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-789-6 | 68478-05-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-140-00-X | Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas; [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1through C3.] | 270-805-1 | 68478-25-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-141-00-5 | Tail gas (petroleum), catalytic reformed naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-807-2 | 68478-27-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-142-00-0 | Tail gas (petroleum), catalytic reformed naphtha stabilizer; Refinery gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-808-8 | 68478-28-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-143-00-6 | Tail gas (petroleum), cracked distillate hydrotreater separator; Refinery gas; [A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-809-3 | 68478-29-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-144-00-1 | Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1through C6.] | 270-810-9 | 68478-30-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-145-00-7 | Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] | 270-999-8 | 68513-14-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-146-00-2 | Gases (petroleum), reformer effluent high-pressure flash drum off; Refinery gas; [A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-003-4 | 68513-18-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-147-00-8 | Gases (petroleum), reformer effluent low-pressure flash drum off; Refinery gas; [A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-005-5 | 68513-19-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-148-00-3 | Gases (petroleum), oil refinery gas distn. off; Refinery gas; [A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] | 271-258-1 | 68527-15-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-149-00-9 | Gases (petroleum), benzene unit hydrotreater depentanizer overheads; Refinery gas; [A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] | 271-623-5 | 68602-82-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-150-00-4 | Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator; Refinery gas; [A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 271-625-6 | 68602-84-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-151-00-X | Petroleum products, refinery gases; Refinery gas; [A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-750-6 | 68607-11-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-152-00-5 | Gases (petroleum), hydrocracking low-pressure separator; Refinery gas; [A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 272-182-1 | 68783-06-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-153-00-0 | Gases (petroleum), refinery; Refinery gas; [A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 272-338-9 | 68814-67-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-154-00-6 | Gases (petroleum), platformer products separator off; Refinery gas; [A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 272-343-6 | 68814-90-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-155-00-1 | Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off; Refinery gas; [The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] | 272-775-5 | 68911-58-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-156-00-7 | Gases (petroleum), hydrotreated sour kerosine flash drum; Refinery gas; [A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] | 272-776-0 | 68911-59-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-157-00-2 | Gases (petroleum), distillate unifiner desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] | 272-873-8 | 68919-01-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-158-00-8 | Gases (petroleum), fluidized catalytic cracker fractionation off; Refinery gas; [A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-874-3 | 68919-02-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-159-00-3 | Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off; Refinery gas; [A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] | 272-875-9 | 68919-03-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-160-00-9 | Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-876-4 | 68919-04-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-161-00-4 | Gases (petroleum), platformer stabilizer off, light ends fractionation; Refinery gas; [A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.] | 272-880-6 | 68919-07-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-162-00-X | Gases (petroleum), preflash tower off, crude distn.; Refinery gas; [A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-881-1 | 68919-08-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-163-00-5 | Gases (petroleum), tar stripper off; Refinery gas; [A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-884-8 | 68919-11-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-164-00-0 | Gases (petroleum), unifiner stripper off; Refinery gas; [A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] | 272-885-3 | 68919-12-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-165-00-6 | Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] | 273-173-5 | 68952-79-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-166-00-1 | Tail gas (petroleum), straight-run naphtha hydrodesulfurizer; Refinery gas; [A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 273-174-0 | 68952-80-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-167-00-7 | Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation; Refinery gas; [A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 273-269-7 | 68955-33-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-168-00-2 | Gases (petroleum), crude distn. and catalytic cracking; Refinery gas; [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 273-563-5 | 68989-88-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-169-00-8 | Gases (petroleum), gas oil diethanolamine scrubber off; Refinery gas; [A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] | 295-397-2 | 92045-15-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-170-00-3 | Gases (petroleum), gas oil hydrodesulfurization effluent; Refinery gas; [A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 295-398-8 | 92045-16-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-171-00-9 | Gases (petroleum), gas oil hydrodesulfurization purge; Refinery gas; [A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 295-399-3 | 92045-17-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-172-00-4 | Gases (petroleum), hydrogenator effluent flash drum off; Refinery gas; [A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1through C6.] | 295-400-7 | 92045-18-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-173-00-X | Gases (petroleum), naphtha steam cracking high-pressure residual; Refinery gas; [A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] | 295-401-2 | 92045-19-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-174-00-5 | Gases (petroleum), residue visbaking off; Refinery gas; [A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 295-402-8 | 92045-20-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-175-00-0 | Foots oil (petroleum), acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] | 300-225-7 | 93924-31-3 | Flam. Gas 1 Press. Gas Carc. 1B | H220 H350 H340 | GHS02 GHS04 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-176-00-6 | Foots oil (petroleum), clay-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] | 300-226-2 | 93924-32-4 | Flam. Gas 1 Press. Gas Carc. 1B | H220 H350 H340 | GHS02 GHS04 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-177-00-1 | Gases (petroleum), C3-4; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 °C to - 1 °C (- 60 °F to 30 °F.)] | 268-629-5 | 68131-75-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-178-00-7 | Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber; Petroleum gas; [The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C4.] | 269-617-2 | 68307-98-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-179-00-2 | Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] | 269-618-8 | 68307-99-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-180-00-8 | Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 269-619-3 | 68308-00-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-181-00-3 | Tail gas (petroleum), cracked distillate hydrotreater stripper; Petroleum gas; [A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 269-620-9 | 68308-01-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-182-00-9 | Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 269-630-3 | 68308-10-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-183-00-4 | Tail gas (petroleum), gas oil catalytic cracking absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C5.] | 269-623-5 | 68308-03-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-184-00-X | Tail gas (petroleum), gas recovery plant; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C5.] | 269-624-0 | 68308-04-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-185-00-5 | Tail gas (petroleum), gas recovery plant deethanizer; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-625-6 | 68308-05-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-186-00-0 | Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-626-1 | 68308-06-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-187-00-6 | Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C6.] | 269-627-7 | 68308-07-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-188-00-1 | Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-629-8 | 68308-09-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-189-00-7 | Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-631-9 | 68308-11-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-190-00-2 | Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 269-632-4 | 68308-12-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-191-00-8 | Gases (petroleum), catalytic cracked overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 °C to 32 °C (- 54 °F to 90 °F).] | 270-071-2 | 68409-99-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-193-00-9 | Alkanes, C1-2; Petroleum gas | 270-651-5 | 68475-57-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-194-00-4 | Alkanes, C2-3; Petroleum gas | 270-652-0 | 68475-58-1 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-195-00-X | Alkanes, C3-4; petroleum gas | 270-653-6 | 68475-59-2 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-196-00-5 | Alkanes, C4-5; Petroleum gas | 270-654-1 | 68475-60-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-197-00-0 | Fuel gases; Petroleum gas; [A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] | 270-667-2 | 68476-26-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-198-00-6 | Fuel gases, crude oil of distillates; Petroleum gas; [A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 °C to - 12 °C (- 423 °F to 10 °F).] | 270-670-9 | 68476-29-9 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-199-00-1 | Hydrocarbons, C3-4; Petroleum gas | 270-681-9 | 68476-40-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-200-00-5 | Hydrocarbons, C4-5; Petroleum gas | 270-682-4 | 68476-42-6 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-201-00-0 | Hydrocarbons, C2-4, C3-rich; Petroleum gas | 270-689-2 | 68476-49-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-202-00-6 | Petroleum gases, liquefied; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 °C to 80 °C (- 40 °F to 176 °F).] | 270-704-2 | 68476-85-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K S U | ||
| 649-203-00-1 | Petroleum gases, liquefied, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 °C to 80 °C (- 40 °F to 176 °F).] | 270-705-8 | 68476-86-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K S U | ||
| 649-204-00-7 | gases (petroleum), C3-4, isobutane-rich; Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] | 270-724-1 | 68477-33-8 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-205-00-2 | Distillates (petroleum), C3-6, piperylene-rich; Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] | 270-726-2 | 68477-35-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-206-00-8 | Gases (petroleum), butane splitter overheads; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] | 270-750-3 | 68477-69-0 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-207-00-3 | Gases (petroleum), C2-3-; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] | 270-751-9 | 68477-70-3 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-208-00-9 | Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] | 270-752-4 | 68477-71-4 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-209-00-4 | Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] | 270-754-5 | 68477-72-5 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-210-00-X | Tail gas (petroleum), isomerized naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1through C4.] | 269-628-2 | 68308-08-7 | Press.
Gas Flam. Gas 1 Carc. 1A Muta. 1B | H220 H350 H340 | GHS04 GHS02 GHS08 Gef. | H220 H350 H340 | K U | ||
| 649-211-00-5 | Foots oil (petroleum), carbon-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-126-0 | 97862-76-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-212-00-0 | Distillates (petroleum), sweetened middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302oF to 653oF).] | 265-088-7 | 64741-86-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-213-00-6 | Gas oils (petroleum), solvent-refined; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401oF to 752oF).] | 265-092-9 | 64741-90-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-214-00-1 | Distillates (petroleum), solvent-refined middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302oF to 653oF).] | 265-093-4 | 64741-91-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-215-00-7 | Gas oils (petroleum), acid-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752oF).] | 265-112-6 | 64742-12-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-216-00-2 | Distillates (petroleum), acid-treated middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401oF to 653oF).] | 265-113-1 | 64742-13-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-217-00-8 | Distillates (petroleum), acid-treated light; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302oF to 554oF).] | 265-114-7 | 64742-14-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-218-00-3 | Gas oils (petroleum), chemically neutralized; Gasoil - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752oF).] | 265-129-9 | 64742-29-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-219-00-9 | Distillates (petroleum), chemically neutralized middle; Gasoil - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401oF to 653oF).] | 265-130-4 | 64742-30-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-220-00-4 | Distillates (petroleum), clay-treated middle; Gasoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302oF to 653oF).] | 265-139-3 | 64742-38-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-221-00-X | Distillates (petroleum), hydrotreated middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11through C25 and boiling in the range of approximately 205 oC to 400 oC (401oF to 752oF).] | 265-148-2 | 64742-46-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-222-00-5 | Gas oils (petroleum), hydrodesulfurized; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752oF).] | 265-182-8 | 64742-79-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-223-00-0 | Distillates (petroleum), hydrodesulfurized middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401oF to 752oF).] | 265-183-3 | 64742-80-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-224-00-6 | Fuels, diesel; Gasoil - unspecified; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325oF to 675oF).] | 269-822-7 | 68334-30-5 | Carc. 2 | H351 | GHS08 Achtg. | H351 | N | ||
| 649-225-00-1 | Fuel oil, No 2; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100oF) to a maximum of 37,9 SUS at 37,7 oC (100oF).] | 270-671-4 | 68476-30-2 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 649-226-00-7 | Fuel oil, No 4; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100oF) to a maximum of 125 SUS at 37,7 oC (100oF).] | 270-673-5 | 68476-31-3 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 649-227-00-2 | Fuels, diesel, No 2; Gasoil - unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100oF).] | 270-676-1 | 68476-34-6 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 649-228-00-8 | Distillates (petroleum), catalytic reformer fractionator residue, high-boiling; Gasoil - unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650oF to 750oF).] | 270-719-4 | 68477-29-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-229-00-3 | Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling; Gasoil - unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550oF to 700oF).] | 270-721-5 | 68477-30-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-230-00-9 | Distillates (petroleum), catalytic reformer fractionator residue, low-boiling; Gasoil - unspecified; [The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550oF).] | 270-722-0 | 68477-31-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-231-00-4 | Distillates (petroleum), highly refined middle; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] | 292-615-8 | 90640-93-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-232-00-X | Distillates (petroleum) catalytic reformer, heavy arom. conc.; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10through C16 and boiling in the range of approximately 200 oC to 300 oC (392oF to 572oF).] | 295-294-2 | 91995-34-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-233-00-5 | Gas oils, paraffinic; Gasoil - unspecified; [A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374oF to 594oF).] | 300-227-8 | 93924-33-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-234-00-0 | Naphtha (petroleum), solvent-refined hydrodesulfurized heavy; Gasoil - unspecified | 307-035-3 | 97488-96-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-235-00-6 | Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554oF to 662oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212oF).] | 307-659-6 | 97675-85-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-236-00-1 | Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights; Gasoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12through C20 and boiling in the range of approximately 230 oC to 350 oC (446oF to 662oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212oF).] | 307-660-1 | 97675-86-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-237-00-7 | Hydrocarbons, C11-17, solvent-extd. light naphthenic; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392oF to 572oF).] | 307-757-9 | 97722-08-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-238-00-2 | Gas oils, hydrotreated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626oF to 644oF).] | 308-128-1 | 97862-78-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-239-00-8 | Distillates (petroleum), carbon-treated light paraffinic; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] | 309-667-5 | 100683-97-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-240-00-3 | Distillates (petroleum), intermediate paraffinic, carbon-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] | 309-668-0 | 100683-98-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-241-00-9 | Distillates (petroleum), intermediate paraffinic, clay-treated; Gasoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] | 309-669-6 | 100683-99-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-242-00-4 | Alkanes, C12-26-branched and linear | 292-454-3 | 90622-53-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-243-00-X | Lubricating greases; Grease; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] | 278-011-7 | 74869-21-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-244-00-5 | Slack wax (petroleum); Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 265-165-5 | 64742-61-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-245-00-0 | Slack wax (petroleum), acid-treated; Slack wax; [A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 292-659-8 | 90669-77-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-246-00-6 | Slack wax (petroleum), clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] | 292-660-3 | 90669-78-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-247-00-1 | Slack wax (petroleum), hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 295-523-6 | 92062-09-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-248-00-7 | Slack wax (petroleum), low-melting; Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 295-524-1 | 92062-10-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-249-00-2 | Slack wax (petroleum), low-melting, hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 295-525-7 | 92062-11-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-250-00-8 | Slack wax (petroleum), low-melting, carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-155-9 | 97863-04-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-251-00-3 | Slack wax (petroleum), low-melting, clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-156-4 | 97863-05-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-252-00-9 | Slack wax (petroleum), low-melting, silicic acid-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-158-5 | 97863-06-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-253-00-4 | Slack wax (petroleum), carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] | 309-723-9 | 100684-49-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-254-00-X | Petrolatum; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] | 232-373-2 | 8009-03-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-255-00-5 | Petrolatum (petroleum), oxidized; Petrolatum; [A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] | 265-206-7 | 64743-01-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-256-00-0 | Petrolatum (petroleum), alumina-treated; Petrolatum; [A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] | 285-098-5 | 85029-74-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-257-00-6 | Petrolatum (petroleum), hydrotreated; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] | 295-459-9 | 92045-77-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-258-00-1 | Petrolatum (petroleum), carbon-treated; Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] | 308-149-6 | 97862-97-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-259-00-7 | Petrolatum (petroleum), silicic acid-treated; Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] | 308-150-1 | 97862-98-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-260-00-2 | Petrolatum (petroleum), clay-treated; Petrolatum; [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] | 309-706-6 | 100684-33-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | N | ||
| 649-261-00-8 | Gasoline, natural; Low boiling point naphtha; [A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (- 4 °F to 248 °F).] | 232-349-1 | 8006-61-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-262-00-3 | Naphtha; Low boiling point naphtha; [Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).] | 232-443-2 | 8030-30-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-263-00-9 | Ligroine; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).] | 232-453-7 | 8032-32-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-264-00-4 | Naphtha (petroleum), heavy straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).] | 265-041-0 | 64741-41-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-265-00-X | Naphtha (petroleum), full-range straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 220 °C (- 4 °F to 428 °F).] | 265-042-6 | 64741-42-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-266-00-5 | Naphtha (petroleum), light straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately - 20 °C to 180 °C (- 4 °F to 356 °F).] | 265-046-8 | 64741-46-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-267-00-0 | Solvent naphtha (petroleum), light aliph.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).] | 265-192-2 | 64742-89-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-268-00-6 | Distillates (petroleum), straight-run light; Low boiling point naphtha; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 °C to 99 °C (- 127 °F to 210 °F).] | 270-077-5 | 68410-05-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-269-00-1 | Gasoline, vapor-recovery; Low boiling point naphtha; [A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 196 °C (- 4 °F to 384 °F).] | 271-025-4 | 68514-15-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-270-00-7 | Gasoline, straight-run, topping-plant; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).] | 271-727-0 | 68606-11-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-271-00-2 | Naphtha (petroleum), unsweetened; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).] | 272-186-3 | 68783-12-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-272-00-8 | Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.] | 272-931-2 | 68921-08-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-273-00-3 | Naphtha (petroleum), heavy straight run, arom.-contg.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).] | 309-945-6 | 101631-20-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-274-00-9 | Naphtha (petroleum), full-range alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).] | 265-066-7 | 64741-64-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-275-00-4 | Naphtha (petroleum), heavy alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).] | 265-067-2 | 64741-65-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-276-00-X | Naphtha (petroleum), light alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).] | 265-068-8 | 64741-66-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-277-00-5 | Naphtha (petroleum), isomerization; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] | 265-073-5 | 64741-70-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-278-00-0 | Naphtha (petroleum), solvent-refined light; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).] | 265-086-6 | 64741-84-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-279-00-6 | Naphtha (petroleum), solvent-refined heavy; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-095-5 | 64741-92-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-280-00-1 | Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] | 270-088-5 | 68410-71-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-281-00-7 | Raffinates (petroleum), reformer, Lurgi unit-sepd.; Low boiling point modified naphtha; [The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] | 270-349-3 | 68425-35-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-282-00-2 | Naphtha (petroleum), full-range alkylate, butane-contg.; Low boiling point modified naphta; [A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).] | 271-267-0 | 68527-27-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-283-00-8 | Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] | 295-315-5 | 91995-53-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-284-00-3 | Naphtha (petroleum), C4-12, butane-alkylate, isooctane-rich; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).] | 295-430-0 | 92045-49-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-285-00-9 | Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).] | 295-436-3 | 92045-55-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-286-00-4 | Naphtha (petroleum), isomerization, C6-fraction; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).] | 295-440-5 | 92045-58-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-287-00-X | Hydrocarbons, C6-7, naphtha-cracking, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).] | 295-446-8 | 92045-64-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-288-00-5 | Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).] | 309-871-4 | 101316-67-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-289-00-0 | Naphtha (petroleum), heavy catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.] | 265-055-7 | 64741-54-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-290-00-6 | Naphtha (petroleum), light catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.] | 265-056-2 | 64741-55-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-291-00-1 | Hydrocarbons, C3-11, catalytic cracker distillates; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).] | 270-686-6 | 68476-46-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-292-00-7 | Naphtha (petroleum), catalytic cracked light distd.; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-185-8 | 68783-09-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-293-00-2 | Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.; Low boiling point cat-cracked naphtha.; [A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.] | 295-311-3 | 91995-50-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-294-00-8 | Naphtha (petroleum), heavy catalytic cracked, sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).] | 295-431-6 | 92045-50-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-295-00-3 | Naphtha (petroleum), light catalytic cracked sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).] | 295-441-0 | 92045-59-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-296-00-9 | Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).] | 295-794-0 | 92128-94-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-297-00-4 | Hydrocarbons, C8-12, catalytic cracker distillates; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).] | 309-974-4 | 101794-97-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-298-00-X | Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened; Low boiling point cat-cracked naphtha | 309-987-5 | 101896-28-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-299-00-5 | Naphtha (petroleum), light catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] | 265-065-1 | 64741-63-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-300-00-9 | Naphtha (petroleum), heavy catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-070-9 | 64741-68-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-301-00-4 | Distillates (petroleum), catalytic reformed depentanizer; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3through C6 and boiling in the range of approximately - 49 °C to 63 °C (- 57 °F to 145 °F).] | 270-660-4 | 68475-79-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-302-00-X | Hydrocarbons, C2-6, C6-8 catalytic reformer; Low boiling point cat-reformed naphtha | 270-687-1 | 68476-47-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-303-00-5 | Residues (petroleum), C6-8 catalytic reformer; Low boiling point cat-reformed naphtha; [A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2through C6.] | 270-794-3 | 68478-15-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-304-00-0 | Naphtha (petroleum), light catalytic reformed, arom.-free; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] | 270-993-5 | 68513-03-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-305-00-6 | Distillates (petroleum), catalytic reformed straight-run naphtha overheads; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-008-1 | 68513-63-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-306-00-1 | Petroleum products, hydrofiner-powerformer reformates; Low boiling point cat-reformed naphtha; [The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).] | 271-058-4 | 68514-79-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-307-00-7 | Naphtha (petroleum), full-range reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).] | 272-895-8 | 68919-37-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-308-00-2 | Naphtha (petroleum), catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] | 273-271-8 | 68955-35-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-309-00-8 | Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction; Low boiling point cat-reformed naphtha; [A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).] | 285-509-8 | 85116-58-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-310-00-3 | Aromatic hydrocarbons, C8, catalytic reforming-derived; Low boiling point cat-reformed naphtha | 295-279-0 | 91995-18-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-311-00-9 | Aromatic hydrocarbons, C7-12, C8-rich; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).] | 297-401-8 | 93571-75-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-312-00-4 | Gasoline, C5-11, high-octane stabilised reformed; Low boiling point cat-reformed naphtha; [A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).] | 297-458-9 | 93572-29-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-313-00-X | Hydrocarbons, C7-12, C>9-arom.-rich, reforming heavy fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.] | 297-465-7 | 93572-35-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-314-00-5 | Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.] | 297-466-2 | 93572-36-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-315-00-0 | Foots oil (petroleum), silicic acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-127-6 | 97862-77-6 | Carc. 1B | H350 H304 | GHS08 Gef. | H350 H304 | L | ||
| 649-316-00-6 | Naphtha (petroleum), light thermal cracked; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4through C8 and boiling in the range of approximately - 10 °C to 130 °C (14 °F to 266 °F).] | 265-075-6 | 64741-74-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-317-00-1 | Naphtha (petroleum), heavy thermal cracked; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).] | 265-085-0 | 64741-83-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-318-00-7 | Distillates (petroleum), heavy arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] | 267-563-4 | 67891-79-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-319-00-2 | Distillates (petroleum), light arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] | 267-565-5 | 67891-80-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-320-00-8 | Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1 500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).] | 270-344-6 | 68425-29-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-321-00-3 | Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1 500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] | 270-658-3 | 68475-70-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-322-00-9 | Distillates (petroleum), thermal cracked naphtha and gas oil; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).] | 271-631-9 | 68603-00-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-323-00-4 | Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).] | 271-632-4 | 68603-01-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-324-00-X | Distillates (petroleum), thermal cracked naphtha and gas oil, extractive; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).] | 271-634-5 | 68603-03-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-325-00-5 | Distillates (petroleum), light thermal cracked, debutanized arom.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] | 273-266-0 | 68955-29-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-326-00-0 | Naphtha (petroleum), light thermal cracked, sweetened; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).] | 295-447-3 | 92045-65-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-327-00-6 | Naphtha (petroleum), hydrotreated heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).] | 265-150-3 | 64742-48-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-328-00-1 | Naphtha (petroleum), hydrotreated light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4through C11 and boiling in the range of approximately minus 20 °C to 190 °C (- 4 °F to 374 °F).] | 265-151-9 | 64742-49-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-329-00-7 | Naphtha (petroleum), hydrodesulfurized light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).] | 265-178-6 | 64742-73-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-330-00-2 | naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-185-4 | 64742-82-1 | Carc. 1B | H350 | GHS08 | H350 | | | P |
| Muta. 1B | H340 | Gef. | H340 | |||||||
| STOT RE 1 | H372 (zentrales Nervensystem) | H372 (zentrales Nervensystem) | ||||||||
| Asp. Tox. 1 | H304 | H304 | ||||||||
| 649-331-00-8 | Distillates (petroleum), hydrotreated middle, intermediate boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).] | 270-092-7 | 68410-96-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-332-00-3 | Distillates (petroleum), light distillate hydrotreating process, low-boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).] | 270-093-2 | 68410-97-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-333-00-9 | Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3through C6 and boiling in the range of approximately - 49 °C to 68 °C (- 57 °F to 155 °F).] | 270-094-8 | 68410-98-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-334-00-4 | Solvent naphtha (petroleum), light arom., hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).] | 270-988-8 | 68512-78-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-335-00-X | Naphtha (petroleum), hydrodesulfurized thermal cracked light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).] | 285-511-9 | 85116-60-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-336-00-5 | Naphtha (petroleum), hydrotreated light, cycloalkane-contg.; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).] | 285-512-4 | 85116-61-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-337-00-0 | Naphtha (petroleum), heavy steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha | 295-432-1 | 92045-51-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-338-00-6 | Naphtha (petroleum), hydrodesulfurized full-range; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).] | 295-433-7 | 92045-52-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-339-00-1 | Naphtha (petroleum), hydrotreated light steam-cracked; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).] | 295-438-4 | 92045-57-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-340-00-7 | Hydrocarbons, C4-12, naphtha-cracking, hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).] | 295-443-1 | 92045-61-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-341-00-2 | Solvent naphtha (petroleum), hydrotreated light naphthenic; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).] | 295-529-9 | 92062-15-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-342-00-8 | Naphtha (petroleum), light steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.] | 296-942-7 | 93165-55-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-343-00-3 | Hydrocarbons, C6-11, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-852-0 | 93763-33-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-344-00-9 | Hydrocarbons, C9-12, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-853-6 | 93763-34-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-345-00-4 | stoddard solvent; Low boiling point naphtha - unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] | 232-489-3 | 8052-41-3 | Carc. 1B | H350 | GHS08 | H350 | | | P |
| Muta. 1B | H340 | Gef. | H340 | |||||||
| STOT RE 1 | H372 (zentrales Nervensystem) | H372 (zentrales Nervensystem) | ||||||||
| Asp. Tox. 1 | H304 | H304 | ||||||||
| 649-346-00-X | Natural gas condensates (petroleum); Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] | 265-047-3 | 64741-47-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-347-00-5 | Natural gas (petroleum), raw liq. mix; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] | 265-048-9 | 64741-48-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-348-00-0 | Naphtha (petroleum), light hydrocracked; Low boiling naphtha - unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately - 20 °C to 180 °C (- 4 °F to 356 °F).] | 265-071-4 | 64741-69-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-349-00-6 | Naphtha (petroleum), heavy hydrocracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).] | 265-079-8 | 64741-78-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-350-00-1 | Naphtha (petroleum), sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately - 10 °C to 230 °C (14 °F to 446 °F).] | 265-089-2 | 64741-87-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-351-00-7 | Naphtha (petroleum), acid-treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-115-2 | 64742-15-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-352-00-2 | Naphtha (petroleum), chemically neutralized heavy; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).] | 265-122-0 | 64742-22-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-353-00-8 | Naphtha (petroleum), chemically neutralized light; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).] | 265-123-6 | 64742-23-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-354-00-3 | Naphtha (petroleum), catalytic dewaxed; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).] | 265-170-2 | 64742-66-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-355-00-9 | Naphtha (petroleum), light steam-cracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (- 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.] | 265-187-5 | 64742-83-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-356-00-4 | Solvent naphtha (petroleum), light arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).] | 265-199-0 | 64742-95-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-357-00-X | Aromatic hydrocarbons, C6-10, acid-treated, neutralized; Low boiling point naphtha - unspecified | 268-618-5 | 68131-49-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-358-00-5 | Distillates (petroleum), C3-5, 2-methyl-2-butene-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] | 270-725-7 | 68477-34-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-359-00-0 | Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12fraction; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5through C12.] | 270-735-1 | 68477-50-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-360-00-6 | Distillates (petroleum), steam-cracked, C5-12 fraction; Low boiling point naphtha - unspecified; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5through C12.] | 270-736-7 | 68477-53-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-361-00-1 | Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction; Low boiling point naphtha - unspecified | 270-738-8 | 68477-55-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-362-00-7 | Extracts (petroleum), cold-acid, C4-6; Low boiling point naphtha - unspecified; [A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] | 270-741-4 | 68477-61-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-363-00-2 | Distillates (petroleum), depentanizer overheads; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] | 270-771-8 | 68477-89-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-364-00-8 | Residues (petroleum), butane splitter bottoms; Low boiling point naphtha - unspecified; [A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] | 270-791-7 | 68478-12-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-365-00-3 | Residual oils (petroleum), deisobutanizer tower; Low boiling point naphtha - unspecified; [A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] | 270-795-9 | 68478-16-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-366-00-9 | Naphtha (petroleum), full-range coker; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).] | 270-991-4 | 68513-02-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-367-00-4 | Naphtha (petroleum), steam-cracked middle arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).] | 271-138-9 | 68516-20-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-368-00-X | Naphtha (petroleum), clay-treated full-range straight-run; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 °C to 220 °C (- 4 °F to 429 °F).] | 271-262-3 | 68527-21-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-369-00-5 | Naphtha (petroleum), clay-treated light straight-run; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).] | 271-263-9 | 68527-22-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-370-00-0 | Naphtha (petroleum), light steam-cracked arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).] | 271-264-4 | 68527-23-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-371-00-6 | Naphtha (petroleum), light steam-cracked, debenzenized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).] | 271-266-5 | 68527-26-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-372-00-1 | Naphtha (petroleum), arom.-contg.; Low boiling point naphtha - unspecified | 271-635-0 | 68603-08-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-373-00-7 | Gasoline, pyrolysis, debutanizer bottoms; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] | 271-726-5 | 68606-10-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-374-00-2 | Naphtha (petroleum), light, sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3through C6 and boiling in the range of approximately - 20 °C to 100 °C (- 4 °F to 212 °F).] | 272-206-0 | 68783-66-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-375-00-8 | Natural gas condensates; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] | 272-896-3 | 68919-39-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-376-00-3 | Distillates (petroleum), naphtha unifiner stripper; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 272-932-8 | 68921-09-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-377-00-9 | Naphtha (petroleum), catalytic reformed light, arom.-free fraction; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).] | 285-510-3 | 85116-59-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-378-00-4 | Gasoline; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).] | 289-220-8 | 86290-81-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-379-00-X | Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues; Low boiling point naphtha - unspecified | 292-698-0 | 90989-42-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-380-00-5 | Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).] | 295-298-4 | 91995-38-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-381-00-0 | Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] | 295-302-4 | 91995-41-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-382-00-6 | Extracts (petroleum), catalytic reformed light naphtha solvent; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).] | 295-331-2 | 91995-68-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-383-00-1 | Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).] | 295-434-2 | 92045-53-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-384-00-7 | Naphtha (petroleum), light, C5-rich, sweetened; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).] | 295-442-6 | 92045-60-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-385-00-2 | Hydrocarbons, C8-11, naphtha-cracking, toluene cut; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).] | 295-444-7 | 92045-62-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-386-00-8 | Hydrocarbons, C4-11, naphtha-cracking, arom.-free; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).] | 295-445-2 | 92045-63-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-387-00-3 | Naphtha (petroleum), light heat-soaked, steam-cracked; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).] | 296-028-8 | 92201-97-3 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-388-00-9 | Distillates (petroleum), C6-rich; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).] | 296-903-4 | 93165-19-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-389-00-4 | Gasoline, pyrolysis, hydrogenated; Low boiling point naphtha-unspecified; [A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).] | 302-639-3 | 94114-03-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-390-00-X | Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] | 305-750-5 | 95009-23-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-391-00-5 | Extracts (petroleum) heavy naphtha solvent, clay-treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).] | 308-261-5 | 97926-43-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-392-00-0 | Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).] | 308-713-1 | 98219-46-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-393-00-6 | Naphtha (petroleum), light steam-cracked, thermally treated; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).] | 308-714-7 | 98219-47-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-394-00-1 | Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).] | 309-862-5 | 101316-56-7 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-395-00-7 | Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).] | 309-870-9 | 101316-66-9 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-396-00-2 | Naphtha (petroleum), hydrodesulfurised full-range coker; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).] | 309-879-8 | 101316-76-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-397-00-8 | Naphtha (petroleum), sweetened light; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).] | 309-976-5 | 101795-01-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-398-00-3 | Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] | 310-012-0 | 102110-14-5 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-399-00-9 | Hydrocarbons, C5-rich, dicyclopentadiene-contg.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).] | 310-013-6 | 102110-15-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-400-00-2 | Residues (petroleum), steam-cracked light, arom.; Low boiling point naphtha - unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).] | 310-057-6 | 102110-55-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-401-00-8 | Hydrocarbons, C>5, C5-6-rich; Low boiling point naphtha - unspecified | 270-690-8 | 68476-50-6 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-402-00-3 | Hydrocarbons, C5-rich; Low boiling point naphtha - unspecified | 270-695-5 | 68476-55-1 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-403-00-9 | Aromatic hydrocarbons, C8-10; Low boiling point naphtha - unspecified | 292-695-4 | 90989-39-2 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 H340 H304 | GHS08 Gef. | H350 H340 H304 | P | ||
| 649-404-00-4 | Kerosine (petroleum); Straight run kerosine; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320oF to 554oF).] | 232-366-4 | 8008-20-6 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-405-00-X | solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] | 265-191-7 | 64742-88-7 | STOT RE 1 | H372 (zentrales Nervensystem) | GHS08 | H372 (zentrales Nervens ystem) | | | |
| Asp. Tox. 1 | H304 | Gef. | H304 | |||||||
| 649-406-00-5 | Solvent naphtha (petroleum) heavy aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374oF to 554oF).] | 265-200-4 | 64742-96-7 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-407-00-0 | Kerosine (petroleum), straight-run wide-cut; Straight run kerosine; [A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158oF to 428oF).] | 295-418-5 | 92045-37-9 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-408-00-6 | Distillates (petroleum), steam-cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190oF to 554oF).] | 265-194-3 | 64742-91-2 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-409-00-1 | Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264oF to 382oF).] | 270-728-3 | 68477-39-4 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-410-00-7 | Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] | 270-729-9 | 68477-40-7 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-411-00-2 | Distillates (petroleum), steam-cracked, C8-12 fraction; Cracked kerosine; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] | 270-737-2 | 68477-54-3 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-412-00-8 | Kerosine (petroleum), hydrodesulfurized thermal cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284oF to 541oF).] | 285-507-7 | 85116-55-8 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-413-00-3 | Aromtic hydrocarbons, C>10, steam-cracking, hydrotreated; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302oF to 608oF).] | 292-621-0 | 90640-98-5 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-414-00-9 | Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284oF to 392oF).] | 292-637-8 | 90641-13-7 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-415-00-4 | Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212oF to 482oF.] | 309-866-7 | 101316-61-4 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-416-00-X | Distillates (petroleum), catalytic cracked heavy tar light; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212oF to 482oF).] | 309-938-8 | 101631-13-4 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-417-00-5 | Solvent naphtha (petroleum), hydrocracked heavy arom.; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455oF to 554oF).] | 309-881-9 | 101316-80-7 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-418-00-0 | Distillates (petroleum), steam-cracked heavy tar light; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212oF to 482oF).] | 309-940-9 | 101631-15-6 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-419-00-6 | Distillates (petroleum), alkylate; Kerosine - unspecified; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401oF to 608oF).] | 265-074-0 | 64741-73-7 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-420-00-1 | Extracts (petroleum), heavy naphtha solvent; Kerosine - unspecified; [A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194oF to 428oF).] | 265-099-7 | 64741-98-6 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-421-00-7 | Distillates (petroleum), chemically neutralized light; Kerosine - unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302oF to 554oF).] | 265-132-5 | 64742-31-0 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-422-00-2 | Distillates (petroleum), hydrotreated light; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9through C16 and boiling in the range of approximately 150 oC to 290 oC (302oF to 554oF).] | 265-149-8 | 64742-47-8 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-423-00-8 | Kerosine (petroleum), hydrodesulfurized; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302oF to 554oF).] | 265-184-9 | 64742-81-0 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-424-00-3 | Solvent naphtha (petroleum), heavy arom.; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330oF to 554oF).] | 265-198-5 | 64742-94-5 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-425-00-9 | Naphtha (petroleum), heavy coker; Kerosine - unspecified; [A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315oF to 550oF).] | 269-778-9 | 68333-23-3 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-426-00-4 | Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction; Kerosine - unspecified; [A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208oF to 424oF).] | 285-508-2 | 85116-57-0 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-427-00-X | Kerosine (petroleum), sweetened; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266oF to 554oF).] | 294-799-5 | 91770-15-9 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-428-00-5 | Kerosine (petroleum), solvent-refined sweetened; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302oF to 500oF).] | 295-416-4 | 92045-36-8 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-429-00-0 | Hydrocarbons, C9-16, hydrotreated, dearomatized; Kerosine - unspecified; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-854-1 | 93763-35-0 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-430-00-6 | Kerosine (petroleum), solvent-refined hydrodesulfurized; Kerosine - unspecified | 307-033-2 | 97488-94-3 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-431-00-1 | Distillates (petroleum), hydrodesulfurized full-range middle coker; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248oF to 541oF).] | 309-864-6 | 101316-58-9 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-432-00-7 | Solvent naphtha (petroleum), hydrodesulfurized heavy arom.; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10through C13 and boiling in the range of approximately 180 oC to 240 oC (356oF to 464oF).] | 309-882-4 | 101316-81-8 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-433-00-2 | Solvent naphtha (petroleum), hydrodesulfurized medium; Kerosine - unspecified; [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10through C13 and boiling in the range of approximately 175 oC to 220 oC (347oF to 428oF).] | 309-884-5 | 101316-82-9 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-434-00-8 | Kerosine (petroleum), hydrotreated; Kerosine - unspecified; [A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446oF to 518oF).] | 309-944-0 | 101631-19-0 | Asp. Tox. 1 | H304 | GHS08 Gef. | H304 | |||
| 649-435-00-3 | Distillates (petroleum), light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302oF to 752oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] | 265-060-4 | 64741-59-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-436-00-9 | Distillates (petroleum), intermediate catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401oF to 842oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] | 265-062-5 | 64741-60-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-437-00-4 | Distillates (petroleum), light hydrocracked; Cracked gasoil; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320oF to 608oF).] | 265-078-2 | 64741-77-1 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 649-438-00-X | Distillates (petroleum), light thermal cracked; Cracked gasoil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10through C22 and boiling in the range of approximately 160 oC to 370 oC (320oF to 698oF).] | 265-084-5 | 64741-82-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-439-00-5 | Distillates (petroleum), hydrodesulfurized light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302oF to 752oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] | 269-781-5 | 68333-25-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-440-00-0 | Distillates (petroleum), light steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] | 270-662-5 | 68475-80-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-441-00-6 | Distillates (petroleum), cracked steam-cracked petroleum distillates; Cracked gasoil; [A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] | 270-727-8 | 68477-38-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-442-00-1 | Gas oils (petroleum), steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400oF to 752oF).] | 271-260-2 | 68527-18-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-443-00-7 | Distillates (petroleum), hydrodesulfurized thermal cracked middle; Cracked gasoil; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401oF to 752oF).] | 285-505-6 | 85116-53-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-444-00-2 | Gas oils (petroleum), thermal-cracked, hydrodesulfurized; Cracked gasoil | 295-411-7 | 92045-29-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-445-00-8 | Residues (petroleum), hydrogenated steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32oF to 662oF).] | 295-514-7 | 92062-00-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-446-00-3 | Residues (petroleum), steam-cracked naphtha distn.; Cracked gasoil; [A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297oF to 572oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] | 295-517-3 | 92062-04-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-447-00-9 | Distillates (petroleum), light catalytic cracked, thermally degraded; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374oF to 644oF). This stream is likely to contain organic sulfur compounds.] | 295-991-1 | 92201-60-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-448-00-4 | Residues (petroleum), steam-cracked heat-soaked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302oF to 662oF).] | 297-905-8 | 93763-85-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-449-00-X | Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue; Cracked gasoil; [A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] | 307-662-2 | 97675-88-2 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 649-450-00-5 | Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized; Cracked gasoil; [A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518oF to 698oF).] | 308-278-8 | 97926-59-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-451-00-0 | Distillates (petroleum), hydrodesulfurized middle coker; Cracked gasoil; [A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392oF to 680oF).] | 309-865-1 | 101316-59-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-452-00-6 | Distillates (petroleum), heavy steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482oF to 752oF).] | 309-939-3 | 101631-14-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | |||
| 649-453-00-1 | Distillates (petroleum), heavy hydrocracked; Baseoil - unspecified; [A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500oF to 1112oF).] | 265-077-7 | 64741-76-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-454-00-7 | Distillates (petroleum), solvent-refined heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC).] | 265-090-8 | 64741-88-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-455-00-2 | Distillates (petroleum), solvent-refined light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-091-3 | 64741-89-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-456-00-8 | Residual oils (petroleum), solvent deasphalted; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752oF).] | 265-096-0 | 64741-95-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-457-00-3 | Distillates (petroleum), solvent-refined heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt a 40 oC). It contains relatively few normal paraffins.] | 265-097-6 | 64741-96-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-458-00-9 | Distillates (petroleum), solvent-refined light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-098-1 | 64741-97-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-459-00-4 | Residual oils (petroleum,) solvent-refined; Baseoil - unspecified; [A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752oF).] | 265-101-6 | 64742-01-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-460-00-X | Distillates (petroleum), clay-treated paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-137-2 | 64742-36-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-461-00-5 | Distillates (petroleum), clay-treated light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-138-8 | 64742-37-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-462-00-0 | Residual oils (petroleum), clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752oF).] | 265-143-5 | 64742-41-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-463-00-6 | Distillates (petroleum), clay-treated heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-146-1 | 64742-44-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-464-00-1 | Distillates (petroleum), clay-treated light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-147-7 | 64742-45-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-465-00-7 | Distillates (petroleum), hydrotreated heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-155-0 | 64742-52-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-466-00-2 | Distillates (petroleum), hydrotreated light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-156-6 | 64742-53-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-467-00-8 | Distillates (petroleum), hydrotreated heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-157-1 | 64742-54-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-468-00-3 | Distillates (petroleum), hydrotreated light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-158-7 | 64742-55-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-469-00-9 | Distillates (petroleum), solvent-dewaxed light paraffinic; Baseoil - unspecified; [A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-159-2 | 64742-56-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-470-00-4 | Residual oils (petroleum), hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752oF).] | 265-160-8 | 64742-57-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-471-00-X | Residual oils (petroleum), solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752oF).] | 265-166-0 | 64742-62-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-472-00-5 | Distillates (petroleum), solvent-dewaxed heavy naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 .through C50 and produces a finished oil of not less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-167-6 | 64742-63-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-473-00-0 | Distillates (petroleum), solvent-dewaxed light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-168-1 | 64742-64-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-474-00-6 | Distillates (petroleum), solvent-dewaxed heavy paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-169-7 | 64742-65-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-475-00-1 | Naphthenic oils (petroleum), catalytic dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-172-3 | 64742-68-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-476-00-7 | Naphthenic oils (petroleum), catalytic dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-173-9 | 64742-69-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-477-00-2 | Paraffin oils (petroleum), catalytic dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC).] | 265-174-4 | 64742-70-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-478-00-8 | Paraffin oils (petroleum), catalytic dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC).] | 265-176-5 | 64742-71-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-479-00-3 | Naphthenic oils (petroleum), complex dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-179-1 | 64742-75-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-480-00-9 | Naphthenic oils (petroleum), complex dewaxed light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-180-7 | 64742-76-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-481-00-4 | Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] | 276-736-3 | 72623-85-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-482-00-X | Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] | 276-737-9 | 72623-86-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-483-00-5 | Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] | 276-738-4 | 72623-87-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-484-00-0 | Lubricating oils; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] | 278-012-2 | 74869-22-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-485-00-6 | Distillates (petroleum), complex dewaxed heavy paraffinci; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 292-613-7 | 90640-91-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-486-00-1 | Distillates (petroleum), complex dewaxed light paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 292-614-2 | 90640-92-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-487-00-7 | Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 292-616-3 | 90640-94-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-488-00-2 | Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 292-617-9 | 90640-95-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-489-00-8 | Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated; Baseoil - unspecified; [A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] | 292-618-4 | 90640-96-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-490-00-3 | Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] | 292-620-5 | 90640-97-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-491-00-9 | Residual oils (petroleum), hydrotreated solvent dewaxed; Baseoil - unspecified | 292-656-1 | 90669-74-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-492-00-4 | Residual oils (petroleum), catalytic dewaxed; Baseoil - unspecified | 294-843-3 | 91770-57-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-493-00-X | Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] | 295-300-3 | 91995-39-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-494-00-5 | Distillates (petroleum), dewaxed light paraffinic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] | 295-301-9 | 91995-40-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-495-00-0 | Distillates (petroleum), hydrocracked solvent-refined, dewaxed; Baseoil - unspecified; [A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] | 295-306-6 | 91995-45-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-496-00-6 | Distillates (petroleum), solvent-refined light naphthenic, hydrotreated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] | 295-316-0 | 91995-54-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-497-00-1 | Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated; Baseoil - unspecified | 295-423-2 | 92045-42-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-498-00-7 | Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined; Baseoil - unspecified | 295-424-8 | 92045-43-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-499-00-2 | Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716oF).] | 295-499-7 | 92061-86-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-500-00-6 | Paraffin oils (petroleum), solvent-refined dewaxed heavy; Baseoil - unspecified; [A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] | 295-810-6 | 92129-09-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-501-00-1 | Lubricating oils (petroleum), base oils, paraffinic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100oF (23cSt at 40 oC).] | 297-474-6 | 93572-43-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-502-00-7 | Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed; Baseoil - unspecified | 297-857-8 | 93763-38-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-503-00-2 | Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate; Baseoil - unspecified | 300-257-1 | 93924-61-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-504-00-8 | Distillates (petroleum), solvent-refined hydrotreated heavy; hydrogenated; Baseoil - unspecified | 305-588-5 | 94733-08-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-505-00-3 | Distillates (petroleum), solvent-refined hydrocracked light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18through C27 and boiling in the range of approximately 370 oC to 450 oC (698oF to 842oF).] | 305-589-0 | 94733-09-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-506-00-9 | Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698oF to 1022oF).] | 305-594-8 | 94733-15-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-507-00-4 | Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698oF to 1022oF).] | 305-595-3 | 94733-16-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-508-00-X | Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate; Baseoil - unspecified | 305-971-7 | 95371-04-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-509-00-5 | Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate; Baseoil - unspecified | 305-972-2 | 95371-05-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-510-00-0 | Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues; Baseoil - unspecified | 305-974-3 | 95371-07-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-511-00-6 | Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues; Baseoil - unspecified | 305-975-9 | 95371-08-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-512-00-1 | Distillates (petroleum), hydrocracked solvent-refined light; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18through C27 and boiling in the range of approximately 370 oC to 450 oC (698oF to 842oF.] | 307-010-7 | 97488-73-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-513-00-7 | Distillates (petroleum), solvent-refined hydrogenated heavy; Baseoil - unspecified; [A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19through C40 and boiling in the range of approximately 390 oC to 550 oC (734oF to 1022oF).] | 307-011-2 | 97488-74-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-514-00-2 | Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed; Baseoil - unspecified | 307-034-8 | 97488-95-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-515-00-8 | Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572oF to 752oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212oF).] | 307-661-7 | 97675-87-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-516-00-3 | Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights; Baseoil - unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592oF to 932oF).] | 307-755-8 | 97722-06-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-517-00-9 | Hydrocarbons, C13-27, solvent-extd. light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464oF to 752oF.] | 307-758-4 | 97722-09-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-518-00-4 | Hydrocarbons, C14-29, solvent-extd. light naphthenic; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482oF to 797oF).] | 307-760-5 | 97722-10-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-519-00-X | Hydrocarbons, C27-42, dearomatized; Baseoil - unspecified | 308-131-8 | 97862-81-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-520-00-5 | Hydrocarbons, C17-30, hydrotreated distillates, distn. lights; Baseoil - unspecified | 308-132-3 | 97862-82-3 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-521-00-0 | Hydrocarbons, C27-45, naphthenic vacuum distn.; Baseoil - unspecified | 308-133-9 | 97862-83-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-522-00-6 | Hydrocarbons, C27-45, dearomatized; Baseoil - unspecified | 308-287-7 | 97926-68-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-523-00-1 | Hydrocarbons, C20-58, hydrotreated; Baseoil - unspecified | 308-289-8 | 97926-70-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-524-00-7 | Hydrocarbons, C27-42, naphthenic; Baseoil - unspecified | 308-290-3 | 97926-71-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-525-00-2 | Residual oils (petroleum), carbon-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] | 309-710-8 | 100684-37-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-526-00-8 | Residual oils (petroleum), clay-treated solvent-dewaxed; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] | 309-711-3 | 100684-38-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-527-00-3 | Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212oF).] | 309-874-0 | 101316-69-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-528-00-9 | Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104oF.] | 309-875-6 | 101316-70-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-529-00-4 | Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104oF).] | 309-876-1 | 101316-71-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-530-00-X | Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated; Baseoil - unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104oF).] | 309-877-7 | 101316-72-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-531-00-5 | Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.; Distillate aromatic extract (treated); [An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] | 272-175-3 | 68783-00-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-532-00-0 | Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 272-180-0 | 68783-04-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-533-00-6 | Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] | 272-342-0 | 68814-89-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-534-00-1 | Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100oF).] | 292-631-5 | 90641-07-9 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-535-00-7 | Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662oF to 896oF). | 292-632-0 | 90641-08-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-536-00-2 | Extracts (petroleum), light paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536oF to 752oF).] | 292-633-6 | 90641-09-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-537-00-8 | Extracts (petroleum), hydrotreated light paraffinic distillate solvent; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16through C36.] | 295-335-4 | 91995-73-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-538-00-3 | Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] | 295-338-0 | 91995-75-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-539-00-9 | Extracts (petroleum), light paraffinic distillate solvent, acid-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 295-339-6 | 91995-76-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-540-00-4 | Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] | 295-340-1 | 91995-77-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-541-00-X | Extracts (petroleum), light vacuum gas oil solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] | 295-342-2 | 91995-79-8 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-542-00-5 | Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] | 296-437-1 | 92704-08-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-543-00-0 | Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] | 297-827-4 | 93763-10-1 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-544-00-6 | Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] | 297-829-5 | 93763-11-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-545-00-1 | Extracts (petroleum), light paraffinic distillate solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 309-672-2 | 100684-02-4 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-546-00-7 | Extracts (petroleum), light paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 309-673-8 | 100684-03-5 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-547-00-2 | Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13through C30.] | 309-674-3 | 100684-04-6 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-548-00-8 | Extracts (petroleum), light vacuum gas oil solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13through C30.] | 309-675-9 | 100684-05-7 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-549-00-3 | Foots oil (petroleum); Foots oil; [A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 265-171-8 | 64742-67-2 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 649-550-00-9 | Foots oil (petroleum), hydrotreated; Foots oil | 295-394-6 | 92045-12-0 | Carc. 1B | H350 | GHS08 Gef. | H350 | L | ||
| 650-002-00-6 | turpentine, oil | 232-350-7 | 8006-64-2 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 | H226 H332 H312 H302 H304 H319 H315 H317 H411 | GHS02 GHS08 GHS07 GHS09 Gef. | H226 H332 H312 H302 H304 H319 H315 H317 H411 | |||
| 650-003-00-1 | fenson (ISO); 4-chlorophenyl benzenesulphonate; | 201-274-6 | 80-38-6 | Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 | H302 H319 H411 | GHS07 GHS09 Achtg. | H302 H319 H411 | |||
| 650-004-00-7 | norbormide (ISO); 5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide | 213-589-6 | 991-42-4 | Acute Tox. 4 * | H302 | GHS07 Achtg. | H302 | |||
| 650-005-00-2 | (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone | 201-501-9 | 83-79-4 | Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 | H301 H319 H335 H315 H400 H410 | GHS06 GHS09 Gef. | H301 H319 H335 H315 H410 | |||
| 650-006-00-8 | benquinox (ISO); p-benzoquinone 1-benzoylhydrazone 4-oxime | 207-807-9 | 495-73-8 | Acute Tox. 3 * Acute Tox. 4 * | H301 H312 | GHS06 Gef. | H301 H312 | |||
| 650-007-00-3 | chlordimeform (ISO); N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine | 228-200-5 | 6164-98-3 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H312 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H312 H302 H410 | |||
| 650-008-00-9 | drazoxolon (ISO); 4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone | 227-197-8 | 5707-69-7 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 | H301 H400 H410 | GHS06 GHS09 Gef. | H301 H410 | |||
| 650-009-00-4 | chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine hydorchloride | 243-269-1 | 19750-95-9 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H351 H302 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H351 H302 H410 | |||
| 650-010-00-X | benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate | 216-901-9 | 1694-09-3 | Carc. 2 | H351 | GHS08 Achtg. | H351 | |||
| 650-012-00-0 | erionite | - | 12510-42-8 | Carc. 1A | H350 | GHS08 Gef. | H350 | |||
| 650-013-00-6 | asbestos | - - - - - - - | 12001-28-4 132207-32-0 12172-73-5 77536-66-4 77536-68-6 77536-67-5 12001-29-5 | Carc. 1A STOT RE 1 | H350 H372 ** | GHS08 Gef. | H350 H372 ** | |||
| 650-014-00-1 | diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate | 401-770-4 | - | Skin Corr. 1B Acute Tox. 4 * | H314 H302 | GHS05 GHS07 Gef. | H314 H302 | |||
| 650-015-00-7 | rosin; colophony | 232-475-7 232-484-6 277-299-1 | 8050-09-7 8052-10-6 73138-82-6 | Skin Sens. 1 | H317 | GHS07 Achtg. | H317 | |||
| 650-016-00-2 | Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] | - | - | Carc. 2 | H351 | GHS08 Achtg. | H351 | AQR | ||
| 650-017-00-8 | Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18 % by weight] | - | - | Carc. 1B | H350i | GHS08 Achtg. | H350i | AR | ||
| 650-018-00-3 | Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid | 406-230-1 | - | Flam. Liq. 3 Carc. 2 Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H226 H351 H314 H332 H317 H400 H410 | GHS02 GHS08 GHS05 GHS07 GHS09 Gef. | H226 H351 H314 H332 H317 H410 | |||
| 650-031-00-4 | bis(4-hydroxy-N-methylanilinium) sulphate | 200-237-1 | 55-55-0 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H373 ** H317 H400 H410 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H317 H410 | |||
| 650-032-00-X | Cyproconazol (ISO); (2RS,3RS;2RS,3SR)-2-(4-Chlorphenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 94361-06-5 | Repr. 1B Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 | H360D H301 H373 (Leber) H400 H410 | GHS08 GHS06 GHS09 Gef. | H360D H301 H373 (Leber) H410 | M = 10 M = 1 | |||
| 650-041-00-9 | triasulfuron (ISO); 1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea | - | 82097-50-5 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| 650-042-00-4 | reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates | 417-450-2 | - | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 | H319 H315 H317 H412 | GHS07 Achtg. | H319 H315 H317 H412 | |||
| 650-043-00-X | reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate | 420-310-3 | - | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 | H302 H400 H410 | GHS07 GHS09 Achtg. | H302 H410 | |||
| 650-044-00-5 | mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin | 420-480-9 | 158570-99-1 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H317 H400 H410 | GHS07 GHS09 Achtg. | H315 H317 H410 | |||
| 650-045-00-0 | reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate | 417-110-3 | - | Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 | H225 H315 H318 H411 | GHS02 GHS05 GHS09 Gef. | H225 H315 H318 H411 | |||
| 650-046-00-6 | di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates | 416-180-2 | 12222-04-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 | H302 H373 ** H411 | GHS08 GHS07 GHS09 Achtg. | H302 H373 ** H411 | |||
| 650-047-00-1 | dibenzylphenylsulfonium hexafluoroantimonate | 417-760-8 | 134164-24-2 | STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 | H372 ** H302 H318 H317 H411 | GHS08 GHS05 GHS07 GHS09 Gef. | H372 ** H302 H318 H317 H411 | |||
| 650-048-00-7 | reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid | 420-070-1 | - | Org. Perox.
D **** Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 | H242 H332 H312 H302 H314 H400 | GHS02 GHS05 GHS07 GHS09 Gef. | H242 H332 H312 H302 H314 H400 | |||
| 650-049-00-2 | 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl | 417-960-5 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H315 H318 H317 H400 H410 | GHS05 GHS07 GHS09 Gef. | H315 H318 H317 H410 | |||
| 650-050-00-8 | reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate; 1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers; 1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers | 423-600-8 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 650-055-00-5 | silver sodium zirconium hydrogenphosphate | 422-570-3 | 155925-27-2 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 | GHS09 Achtg. | H410 | |||
| *) Umgerechnete Punktschätzung der akuten Toxizität gemäß der Tabelle 3.1.2 in Anhang I. | ||||||||||
 | weiter | |